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Background: Dementia with challenging behaviour (CB) causes significant distress for caregivers and the
person with dementia. It is associated with breakdown of care at home and disruption in care homes.
Challenge Demcare aimed to assist care home staff and mental health practitioners who support families
at home to respond effectively to CB.
Objectives: To study the management of CB in care homes (ResCare) and in family care (FamCare).
Following a conceptual overview, two systematic reviews and scrutiny of clinical guidelines, we (1) developed
and tested a computerised intervention; (2) conducted a cluster randomised trial (CRT) of the intervention for
dementia with CB in care homes; (3) conducted a process evaluation of implementation of the intervention;
and (4) conducted a longitudinal observational cohort study of the management of people with dementia
with CB living at home, and their carers.
Review methods: Cochrane review of randomised controlled trials; systematic meta-ethnographic review
of quantitative and qualitative studies.
Design: ResCare – survey, CRT, process evaluation and stakeholder consultations. FamCare – survey,
longitudinal cohort study, participatory development design process and stakeholder consultations.
Comparative examination of baseline levels of CB in the ResCare trial and the FamCare study participants.
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Settings: ResCare – 63 care homes in Yorkshire. FamCare – 33 community mental health teams for older
people (CMHTsOP) in seven NHS organisations across England.
Participants: ResCare – 2386 residents and 861 staff screened for eligibility; 555 residents with dementia
and CB; 277 ‘other’ residents; 632 care staff; and 92 staff champions. FamCare – every new referral
(n = 5360) reviewed for eligibility; 157 patients with dementia and CB, with their carer; and 26 mental
health practitioners. Stakeholder consultations – initial workshops with 83 practitioners and managers
from participating organisations; and 70 additional stakeholders using eight group discussions and nine
individual interviews.
Intervention: An online application for case-specific action plans to reduce CB in dementia, consisting of
e-learning and bespoke decision support care home and family care e-tools.
Main outcome measures: ResCare – survey with the Challenging Behaviour Scale; measurement of CB
with the Neuropsychiatric Inventory (NPI) and medications taken from prescriptions; implementation with
thematic views from participants and stakeholders. FamCare – case identification from all referrals to
CMHTsOP; measurement of CB with the Revised Memory and Behaviour Problems Checklist and NPI;
medications taken from prescriptions; and thematic views from stakeholders. Costs of care calculated for
both settings. Comparison of the ResCare trial and FamCare study participants used the NPI, Clinical
Dementia Rating and prescribed medications.
Results: ResCare – training with group discussion and decision support for individualised interventions did
not change practice enough to have an impact on CB in dementia. Worksite e-learning opportunities were
not readily taken up by care home staff. Smaller homes with a less hierarchical management appear more
ready than others to engage in innovation. FamCare – home-dwelling people with dementia and CB are
referred to specialist NHS services, but treatment over 6 months, averaging nine contacts per family, had
no overall impact on CB. Over 60% of people with CB had mild dementia. Families bear the majority
of the care costs of dementia with CB. A care gap in the delivery of post-diagnostic help for families
supporting relatives with dementia and significant CB at home has emerged. Higher levels of CB were
recorded in family settings; and prescribing practices were suboptimal in both care home and family settings.
Limitations: Functionality of the software was unreliable, resulting in delays. This compromised the
feasibility studies and undermined delivery of the intervention in care homes. A planned FamCare CRT
could not proceed because of insufficient referrals.
Conclusions: A Cochrane review of individualised functional analysis-based interventions suggests that
these show promise, although delivery requires a trained dementia care workforce. Like many staff training
interventions, our interactive e-learning course was well received by staff when delivered in groups with
facilitated discussion. Our e-learning and decision support e-tool intervention in care homes, in its current
form, without ongoing review of implementation of recommended action plans, is not effective at
reducing CB when compared with usual care. This may also be true for staff training in general. A shift in
priorities from early diagnosis to early recognition of dementia with clinically significant CB could bridge
the emerging gap and inequities of care to families. Formalised service improvements in the NHS, to
co-ordinate such interventions, may stimulate better opportunities for practice models and pathways.
Separate services for care homes and family care may enhance the efficiency of delivery and the quality
of research on implementation into routine care.
Future work: There is scope for extending functional analysis-based interventions with communication
and interaction training for carers. Our clinical workbooks, video material of real-life episodes of CB
and process evaluation tool resources require further testing. There is an urgent need for evaluation of
interventions for home-dwelling people with dementia with clinically significant CB, delivered by trained
dementia practitioners. Realist evaluation designs may illuminate how the intervention might work, and for
whom, within varying service contexts.
Trial registration: Current Controlled Trials ISRCTN02553381 (the ResCare trial) and ISRCTN58876649
(the FamCare study).
ABSTRACT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
viii
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants
for Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 5, No. 15. See the NIHR Journals Library website for further project information.
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
ix

Contents
List of tables xvii
List of figures xxiii
List of boxes xxv
List of abbreviations xxvii
Plain English summary xxix
Scientific summary xxxi
Chapter 1 Introduction and background 1
Chapter overview 1
Definition of challenging behaviour in dementia 1
Management of challenging behaviour in dementia 2
Elusiveness of the syndrome: aetiology and other contextual factors 3
Implications for methodology 4
Rationale for current study 5
Functional analysis-based interventions 6
Challenge Demcare 7
Literature reviews on the management of challenging behaviour in dementia 7
Outline of studies within Challenge Demcare: Chapters 2–6 8
Chapter 2 Development and testing of an online application of functional
analysis approaches to intervention for challenging behaviour in dementia 11
Abstract 11
Aim 11
Method 11
Results 11
Conclusions 11
Introduction 11
Development of the intervention 12
Summary of the Challenge Demcare intervention 14
Methods 15
The e-learning course in care homes 15
The decision support e-tool in care homes 16
The decision support e-tool in the community 16
Results 16
The e-learning course in care homes 16
Uptake of the e-learning course after completion of the ResCare trial 22
The decision support e-tool in care homes 23
The decision support e-tool in the community 27
Discussion 28
Limitations 30
Conclusions 30
Implications for the design of the care home (ResCare) and family care (FamCare)
studies: major design changes 31
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xi
Chapter 3 Challenge ResCare: a cluster randomised trial of the clinical
effectiveness and cost-effectiveness of online training and decision support for
care home staff to deliver functional analysis-based interventions for challenging
behaviour in dementia 33
Abstract 33
Aim 33
Design and methods 33
Results 33
Conclusions 34
Trial registration 34
Introduction 34
Research questions 34
Methods 34
Design 34
Governance and study approvals 34
Changes to the protocol 35
The intervention 35
Study population 35
Eligibility criteria for residents 35
Sample size 36
Recruitment procedures 36
Informed consent 36
Ethical arrangements 37
Randomisation 37
Blinding 37
Data collection 38
Measures 38
Data management 39
Data analyses 40
Economic analyses 42
Results 43
Randomised allocation 43
Dropouts 43
Maintenance of ‘blind’ follow-up assessments 46
Descriptive analyses 47
Analysis of serious adverse events, reactions and unexpected reactions 56
Analyses of primary outcome measures 56
Analyses of secondary outcome measures 57
Effect sizes 59
Intraclass correlation coefficients 59
Dose effect of the intervention 59
Further analysis of residents with inpatient stays 63
Economic analyses 63
Discussion 73
Summary of findings 73
Limitations and implications for research 74
Fidelity and adherence to the intervention 75
Health economics findings 77
Conclusions 78
Chapter 4 Challenge ResCare: a process evaluation of the implementation of e-tools
for the management of dementia with challenging behaviour in care homes 79
Abstract 79
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xii
Aim 79
Methods 79
Results 79
Conclusions 79
Introduction 79
Studying implementation processes from findings of the ResCare trial 80
Methods 81
Participants: intervention case study homes 82
Participants: stakeholders 83
Interview topic guides 83
Ethical considerations 85
Data analyses 85
Results 86
Implementation of the intervention in homes 87
Collective action: enacting the work required for implementing research and
the intervention 93
Reflexive monitoring: appraising the effects of implementing the research process
and intervention 96
Thematic findings from wider stakeholder interviews and groups 102
Training and functional analysis: ‘ringing true’? 103
Enablers and facilitators 105
Problems and barriers 107
Resources and implementation 109
Making decisions 109
Discussion 110
Limitations to this evaluation 113
Conclusions 114
Chapter 5 Challenge FamCare: a naturalistic study of people with dementia and
challenging behaviour living at home and their carers 115
Abstract 115
Aim 115
Design and methods 115
Results 115
Conclusions 115
Trial registration 115
Introduction 115
Rationale for and background to the present study 116
Changes to protocol 117
Research questions 117
Methods 118
Design 118
Governance and study approvals 118
Study population 118
Eligibility criteria 118
Sample size 119
Recruitment procedures 119
Informed consent 119
Ethical arrangements 120
Data collection procedures 120
Measures 120
Data management 122
Data analyses 122
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xiii
Missing data 122
Outliers 122
Research question 1 122
Research question 2 122
Research question 3 123
Results 125
Recruitment to the study 125
Follow-up dropout rates 126
Descriptive data 126
Reported problems at baseline 128
Main outcomes over time 128
Prescribed medication 3 months prior to baseline 131
Contacts with practitioners from the community mental health teams for older people
for treatment 131
Dropout analysis 133
Research question 1 135
Research question 2 137
Research question 3 140
Economic analyses 141
Service use at baseline 141
Research question 4 141
Research question 5 144
Research question 6 147
Research question 7 148
Consultation with stakeholders 151
Discussion 155
Recognition of dementia and challenging behaviour in family settings 156
Management of dementia and challenging behaviour in family settings 156
Health economics 158
Health economics: consideration of financial benefits for family carers 159
Limitations 159
Conclusions 160
Implications for services 160
Implications for practice 160
Implications for research 161
Chapter 6 Discussion: overview of key findings from Challenge Demcare and
implications for future research and practice 163
Overview of Challenge Demcare 163
Background to the programme 163
Background to the intervention 163
Rationale for the intervention 164
Chapter outline 164
Key findings 165
Key findings: the ResCare trial 165
Key findings: the FamCare observational study 165
Key findings: prescribing practices, antipsychotics and costs across the Challenge
Demcare programme 166
Summary of key findings 167
Limitations 168
Implications for research methodology 170
Challenging behaviour in dementia care home and family care settings: a comparison of
clinical presentations 172
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xiv
Discussion: the management of challenging behaviour in dementia 173
Staff training interventions for dementia with challenging behaviour in care homes 175
Implications for service improvements and practice 175
Recommendations for future research 178
Staff training and support for dementia with challenging behaviour 178
Future research on interventions for dementia with challenging behaviour 179
Conclusions 180
Acknowledgements 183
References 187
Appendix 1 Description of the e-learning and decision support tool 211
Appendix 2 The FamCare study: changes to protocol 217
Appendix 3 The FamCare study: summary of the recruitment context 219
Appendix 4 The ResCare trial: ethical permissions 223
Appendix 5 Management of the research 225
Appendix 6 Measures 227
Appendix 7 Unit costs and sources 233
Appendix 8 ResCare: factors affecting resident and staff dropout 237
Appendix 9 The ResCare trial: tables relating to the analysis of the dose effect
of the intervention 239
Appendix 10 The ResCare trial: analysis of residents with inpatient stays 243
Appendix 11 The ResCare trial: breakdown of resource use and costs in the
4 months up to follow-up 247
Appendix 12 The FamCare study: ethical permissions 249
Appendix 13 The FamCare study: reasons for declining participation 251
Appendix 14 The FamCare study: results of the backward regression analysis
(using the data set after the 25% missing rule for predictors of change) 255
Appendix 15 The FamCare study service use frequencies and costs for
participants with data recorded at all time points 257
Appendix 16 The FamCare study service use frequencies and costs for all
participants available at each of the individual time points 269
Appendix 17 The FamCare study: mean monthly frequencies of health- and
social-care contacts for participants with data recorded at all time points 281
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xv
Appendix 18 The FamCare study: alternative accommodation 285
Appendix 19 The FamCare study: medication prescribing for people with
dementia in the 3 months before baseline (whole sample) 287
Appendix 20 Comparisons of the ResCare trial and the FamCare study 289
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xvi
List of tables
TABLE 1 Dementia and computer training: champions compared with other care
home staff 18
TABLE 2 Highest qualification: champions compared with other care home staff 18
TABLE 3 Learning styles of champions compared with other care home staff 21
TABLE 4 Behaviours selected for resident action plans (n= 199) 25
TABLE 5 Residents with action plans and CBS incidence at three time points (n= 180) 26
TABLE 6 The ResCare trial: outcome measures for participants 39
TABLE 7 The ResCare trial: resident group distribution per home 45
TABLE 8 The ResCare trial: resident dropout rates by allocated group 45
TABLE 9 The ResCare trial: baseline measures for CB sample dropout group
compared with CB sample retained 46
TABLE 10 The ResCare trial: staff dropout rates by allocated group 46
TABLE 11 The ResCare trial: breakdown of researcher perception of care home
randomisation at follow-up 47
TABLE 12 The ResCare trial: demographic details of the care homes 48
TABLE 13 The ResCare trial: demographic details of the care home staff at baseline 48
TABLE 14 The ResCare trial: age of care home staff broken down into groups 49
TABLE 15 The ResCare trial: previous training of care home staff 49
TABLE 16 The ResCare trial: summary of outcomes measured on care home staff
at baseline 50
TABLE 17 The ResCare trial: demographic details of the residents 51
TABLE 18 The ResCare trial: summary of baseline outcomes by sample and
treatment allocated 52
TABLE 19 The ResCare trial: CBS behaviours by sample and treatment allocated 53
TABLE 20 The ResCare trial: frequencies by medication for the 3 months
before baseline 55
TABLE 21 The ResCare trial: mean NPI frequency scores and differences at
follow-up 56
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xvii
TABLE 22 The ResCare trial: mean NPI severity scores and differences at follow-up 57
TABLE 23 The ResCare trial: secondary outcomes means and differences at
follow-up 58
TABLE 24 The ResCare trial: cross-tabulation between baseline and follow-up
frequencies for medication categories 60
TABLE 25 The ResCare trial: effect sizes and intraclass correlation coefficients 62
TABLE 26 The ResCare trial: baseline characteristics of the economic sample 64
TABLE 27 The ResCare trial: cost of the intervention 65
TABLE 28 The ResCare trial: community-based service use for the 3 months
before baseline (per resident) 66
TABLE 29 The ResCare trial: hospital use for the 3 months before baseline
(per resident) 67
TABLE 30 The ResCare trial: costs of resident medication for the 3 months
before baseline 68
TABLE 31 The ResCare trial: resource use and costs in the 4 months up to follow-up 70
TABLE 32 The ResCare trial: cost-effectiveness analysis 70
TABLE 33 The ResCare trial: typology of intervention group care homes
according to implementation mechanisms 88
TABLE 34 The ResCare trial: overview of the context for case study homes 89
TABLE 35 The ResCare trial: case study care home staff interviewed 89
TABLE 36 The ResCare trial: coherence; real and ideal conditions for making
sense of the research and intervention 91
TABLE 37 The ResCare trial: cognitive participation – real and ideal conditions
for investing in the research and computer-assisted intervention 94
TABLE 38 The ResCare trial: collective action – real and ideal conditions to
promote the enactment of the research and intervention 97
TABLE 39 The ResCare trial: collective action processes of implementation in case
study homes 97
TABLE 40 The ResCare trial: reflexive monitoring – real and ideal conditions for
appraising the intervention 102
TABLE 41 The ResCare trial: overview of the outcomes of implementation in case
study homes 102
TABLE 42 The FamCare study: outcome measures 121
LIST OF TABLES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xviii
TABLE 43 The FamCare study: demographic characteristics 127
TABLE 44 The FamCare study: relationship to the person with dementia and
whether or not they live together 127
TABLE 45 The FamCare study: summary of CDR score over time (all participants) 128
TABLE 46 The FamCare study: change in CDR score over 6 months (n= 109) 128
TABLE 47 The FamCare study: summary of the RMBPC baseline scores of the
24 items 129
TABLE 48 The FamCare study: values for main outcome measures at each
time point 130
TABLE 49 The FamCare study: frequencies for the use of medication
(by category) in the 3 months before baseline 132
TABLE 50 The FamCare study: summary of number and total length of specialist
mental health service contacts with dyads by contact type 133
TABLE 51 The FamCare study: summary of number and total length of specialist
mental health service contacts per dyad by profession 134
TABLE 52 The FamCare study: summary of the number and total length of
specialist mental health service contacts per dyad by profession across 6 months 135
TABLE 53 Estimates and test results of time as a fixed effect on five imputed
data sets 136
TABLE 54 Selected model for RMBPC Box–Cox-transformed frequency applied on
available cases, data after 25% missing rule and five imputations 136
TABLE 55 Selected model for Box–Cox-transformed RMBPC reaction applied on
available cases, data after 25% missing rule and five imputations 137
TABLE 56 Relationship between mental health service contacts and outcome
measures: analysis for the model using time as a random effect within
participant and fixed effects as shown 138
TABLE 57 The FamCare study: summary of reported behaviour changes across time 140
TABLE 58 The FamCare study: baseline characteristics of people with dementia
and their family carers 142
TABLE 59 The FamCare study: mean monthly frequencies of health- and
social-care services at each time point 143
TABLE 60 The FamCare study: mean monthly costs of health- and social-care
contacts at each time point (excluding informal care and prescribing costs) 144
TABLE 61 The FamCare study: hours spent each week caring for the person
with dementia 146
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xix
TABLE 62 The FamCare study: replacement costs per week for ‘unpaid’ informal
carers (n= 114) 146
TABLE 63 The FamCare study: frequencies for medication changes between
baseline and second follow-up 148
TABLE 64 The FamCare study: average monthly medication costs for
participant dyads 149
TABLE 65 The FamCare study: mean annual costs of care for people with
dementia with CB 150
TABLE 66 The FamCare study audit: new referrals to CMHTsOP 220
TABLE 67 The FamCare study audit: referred straight to other services 220
TABLE 68 Health- and social-care unit costs 233
TABLE 69 Hospital unit costs 235
TABLE 70 Day care unit costs 235
TABLE 71 The ResCare trial: logistic regression results of resident dropouts by the
forward (Wald) selection method using data after 25% missing rule 237
TABLE 72 The ResCare trial: chi-squared/Fisher’s results of demographic factors
on the staff dropouts 237
TABLE 73 The ResCare trial: NPI frequency model 1 results 239
TABLE 74 The ResCare trial: NPI frequency model 2 results 239
TABLE 75 The ResCare trial: NPI severity model 1 results 240
TABLE 76 The ResCare trial: NPI severity model 2 results 240
TABLE 77 The ResCare trial: hospital inpatient days model 1 results 240
TABLE 78 The ResCare trial: hospital inpatient days model 2 results 241
TABLE 79 The ResCare trial: resource use and costs in the 4 months up to follow-up 247
TABLE 80 The FamCare study: selected model using general linear regression
with backward regression analysis on RMBPC frequency 255
TABLE 81 The FamCare study: selected model using general linear regression
with backward regression analysis on RMBPC reaction 255
TABLE 82 The FamCare study: selected model using general linear regression
with backward regression analysis on NPI total score (frequency × severity) 255
TABLE 83 The FamCare study: selected model using general linear regression
with backward regression analysis on NPI distress 256
LIST OF TABLES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xx
TABLE 84 The FamCare study: community-based service use for the 3 months
before baseline – person with dementia (n= 114) 258
TABLE 85 The FamCare study: community-based service use for the 3 months
before baseline – carer (n= 114) 259
TABLE 86 The FamCare study: community-based service use for the 2 months
between baseline and first follow-up – person with dementia (n= 114) 260
TABLE 87 The FamCare study: community-based service use for the 2 months
between baseline and first follow-up – carer (n= 114) 261
TABLE 88 The FamCare study: community-based service use for the 4 months
between first and second follow-up – person with dementia (n= 114) 262
TABLE 89 The FamCare study: community-based service use for the 4 months
between first and second follow-up – carer (n= 114) 263
TABLE 90 The FamCare study: day care use for the 3 months before baseline –
person with dementia only (n= 114) 264
TABLE 91 The FamCare study: day care use for the 2 months between baseline
and first follow-up – person with dementia only (n= 114) 264
TABLE 92 The FamCare study: day care use for the 4 months between first and
second follow-up – person with dementia only (n= 114) 264
TABLE 93 The FamCare study: hospital use for the 3 months before baseline –
person with dementia and carer (n= 114) 265
TABLE 94 The FamCare study: hospital use for the 2 months between baseline
and first follow-up – person with dementia and carer (n= 114) 266
TABLE 95 The FamCare study: hospital use for the 4 months between first and
second follow-up – person with dementia and carer (n= 114) 267
TABLE 96 The FamCare study: community-based service use for the 3 months
before baseline – person with dementia (n= 157) 270
TABLE 97 The FamCare study: community-based service use for the 3 months
before baseline – carer (n= 157) 271
TABLE 98 The FamCare study: community-based service use for the 2 months
between baseline and first follow-up – person with dementia (n= 126) 272
TABLE 99 The FamCare study: community-based service use for the 2 months
between baseline and first follow-up – carer (n= 126) 273
TABLE 100 The FamCare study: community-based service use for the 4 months
between first and second follow-up – person with dementia (n= 117) 274
TABLE 101 The FamCare study: community-based service use for the 4 months
between first and second follow-up – carer (n= 117) 275
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxi
TABLE 102 The FamCare study: day care use for the 3 months before baseline –
person with dementia only (n= 157) 276
TABLE 103 The FamCare study: day care use for the 2 months between baseline
and first follow-up – person with dementia only (n= 126) 276
TABLE 104 The FamCare study: day care use for the 4 months between first and
second follow-up – person with dementia only (n= 117) 276
TABLE 105 The FamCare study: hospital use for the 3 months before baseline –
person with dementia and carer (n= 157) 277
TABLE 106 The FamCare study: hospital use for the 2 months between baseline
and first follow-up – person with dementia and carer (n= 126) 278
TABLE 107 The FamCare study: hospital use for the 4 months between first and
second follow-up – person with dementia and carer (n= 117) 279
TABLE 108 The FamCare study: health- and social-care contacts – person with
dementia (n= 114) 281
TABLE 109 The FamCare study: health- and social-care contacts – carer (n= 114) 282
TABLE 110 The FamCare study: nights spent in alternative accommodation –
person with dementia 286
TABLE 111 The FamCare study: medication prescribing in the 3 months before
baseline – person with dementia (n= 157) 287
TABLE 112 The ResCare trial and FamCare study: dementia rating (CDR score) 289
TABLE 113 The ResCare trial and FamCare study: NPI scores 289
LIST OF TABLES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxii
List of figures
FIGURE 1 Age distribution of care home staff selected as champions (n= 92)
compared with other staff working in the homes 17
FIGURE 2 Average CBS incidence scores over three time points in care homes 22
FIGURE 3 Challenging behaviour in residents within the intervention group 23
FIGURE 4 The ResCare trial: participant flow through the trial by treatment allocated 44
FIGURE 5 The ResCare trial: cost-effectiveness plane for the NPI with 1000
bootstrapped ICER estimates 71
FIGURE 6 The ResCare trial: cost-effectiveness plane for the proxy-rated EQ-5D
with 1000 bootstrapped ICER estimates 71
FIGURE 7 The ResCare trial: cost-effectiveness plane for self-report EQ-5D with
1000 bootstrapped ICER estimates 71
FIGURE 8 The ResCare trial: cost-effectiveness acceptability curve for NPI 72
FIGURE 9 The ResCare trial: cost-effectiveness acceptability curve for
proxy-scored EQ-5D 72
FIGURE 10 The ResCare trial: cost-effectiveness acceptability curve for self-rated
EQ-5D 72
FIGURE 11 The ResCare trial: mechanisms of implementation taken from the
analysis of process and outcome data from the ResCare trial 86
FIGURE 12 The ResCare trial: what needs to be in place to support
implementation, as identified by NPT analysis 87
FIGURE 13 The FamCare study: participant flow through the study 126
FIGURE 14 The FamCare study: proportion of people with dementia accessing
selected services at each time point (n= 114) 143
FIGURE 15 The FamCare study: proportion of carers accessing selected services at
each time point (n= 114) 143
FIGURE 16 The FamCare study: mean number of participants with dementia
prescribed each medication category and mean cost per participant per month
(n= 114) 150
FIGURE 17 The ResCare trial: box dot plot of NPI frequency by categories of
inpatient stays 243
FIGURE 18 The ResCare trial: box dot plot of NPI severity by categories of
inpatient stays 243
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxiii
FIGURE 19 The ResCare trial: box dot plot of CBS frequency × difficulty by
categories of inpatient stays 244
FIGURE 20 The ResCare trial: box dot plot of total inpatient cost by categories of
inpatient stays 244
FIGURE 21 The ResCare trial: box dot plot of follow-up medication cost by
categories of inpatient stays 245
FIGURE 22 The ResCare trial and FamCare study: incidence of NPI behaviours
at baseline 290
LIST OF FIGURES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxiv
List of boxes
BOX 1 Care home champions’ comments on what they had learned 19
BOX 2 The ResCare trial: contextual data sources for care homes where the
ResCare trial intervention occurred 82
BOX 3 The ResCare trial: process and outcome data sources relating to
implementing the intervention 82
BOX 4 The ResCare trial: interview guide for case study interviews with care
home managers 84
BOX 5 The ResCare trial: interview guide for case study interviews with care staff 85
BOX 6 The ResCare trial: key changes made to the implementation process by
the research team 90
BOX 7 Generic list of functions of CB used in the decision support tool 213
BOX 8 Domains included in the decision support tool assessment summary 214
BOX 9 Assessment domains for community version of the decision support tool 215
BOX 10 Reasons declined to take part in the FamCare study (n= 99) 251
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxv

List of abbreviations
A&E accident and emergency
ADQ Approaches to Dementia
Questionnaire
B/Z/A benzodiazepines/z-hypnotics
BPSD behavioural and psychological
symptoms of dementia
CAIT communication and interaction
training
CB challenging behaviour
CBS Challenging Behaviour Scale
CDR Clinical Dementia Rating
CDR-SB Clinical Dementia Rating-sum of
the boxes
CI confidence interval
CMAI Cohen–Mansfield Agitation
Inventory
CMHN community mental health nurse
CMHT community mental health team
CMHTOP community mental health team for
older people
CONSORT Consolidated Standards of
Reporting Trials
CQC Care Quality Commission
CRM cluster representation mechanism
CRT cluster randomised trial
CSRI Client Service Receipt Inventory
DMEC Data Monitoring and Ethics
Committee
DSM-IV Diagnostic and Statistical Manual
of Mental Disorders-Fourth Edition
EQ-5D EuroQol-5 Dimensions
FITS Focused Intervention Training
and Support
GHQ-12 General Health Questionnaire-12
items
GP general practitioner
GS Guilt Scale
HADS Hospital Anxiety and Depression
Scale
ICC intracluster correlation coefficient
ICECAP-O ICEpop CAPability measure for
Older people
ICER incremental cost-effectiveness ratio
ICT information and communication
technology
IMS information management system
ISRCTN International Standard Randomised
Controlled Trial Number
IT information technology
LMM linear mixed model
MAS Memory Assessment Service
MBI Maslach Burnout Inventory
MBI-DP Maslach Burnout Inventory-
Depersonalisation
MBI-EE Maslach Burnout Inventory-
Emotional Exhaustion
MBI-PA Maslach Burnout Inventory-
Personal Accomplishment
MICE multivariate imputation by
chained equations
MRC Medical Research Council
NICE National Institute for Health and
Care Excellence
NIHR National Institute for Health
Research
NMDS-SC National Minimum Data Set for
Social Care
NPI Neuropsychiatric Inventory
NPI-NH Neuropsychiatric Inventory-Nursing
Home
NPS neuropsychiatric symptom
NPT normalisation process theory
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxvii
NVQ National Vocational Qualification
NWORTH North Wales Organisation for
Randomised Trials in Health
PbR Payment by Results
POMH-UK Prescribing Observatory for Mental
Health
PSC Programme Steering Committee
QALY quality-adjusted life-year
QCPR Quality of Caregiver/Patient
Relationship scale
QoL-AD Quality of Life in Alzheimer’s
Disease
R&D research and development
RCT randomised controlled trial
REC Research Ethics Committee
REMCARE REMiniscence groups for people
with dementia and their
family CAREgivers
RMBPC Revised Memory and Behaviour
Problems Checklist
RSS Relative Stress Scale
SAE serious adverse event
SAR serious adverse reaction
SCIE Social Care Institute for Excellence
SD standard deviation
SE standard error
SES Self-Efficacy Scale
SF-12 Short Form questionnaire-12 items
SSCQ Short Sense of Competence
Questionnaire
SSRI selective serotonin reuptake
inhibitor
VAK visual–auditory–kinaesthetic
VAS visual analogue scale
LIST OF ABBREVIATIONS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxviii
Plain English summary
Dementia brings behavioural changes in a person that families and staff in care homes can findchallenging. Causes of these ‘challenging behaviours’ (CBs) are complex and not always attributable to
the dementia condition itself. Simple responses, such as ‘reasoning’ with the person or giving ‘calming’
drugs, have limited use. Instead, a skilled ‘detective-like’ approach to understand the sometimes hidden
need(s) of each person with dementia is required.
We developed an online system with comprehensive training and individually tailored care plans to assist
care home staff and community practitioners to use this detective-like approach to find solutions for
common CBs.
This was tested for people with dementia and significant CBs in care homes. The intervention was not
effective in reducing CBs, compared with those who did not receive it. Care staff did not readily access
worksite-based online training, despite significant provision for back-fill time and information technology
resources. Off-worksite training facilitated by an experienced dementia practitioner, with opportunity for
discussion and practice in tailoring care plans, received positive feedback.
The intervention with home-dwelling people with dementia and CBs was not tested because of insufficient
referrals. An observational study was conducted in home-dwelling people with dementia and CB. Over
60% of these had mild dementia. An average of nine clinical contacts over 6 months did not have an
overall impact on CB. The changing landscape of NHS practices may have undermined timely responses to
dementia with CB. Furthermore, families found it hard to know when they were deserving of specialist
support from the NHS. Families bear the majority of the care costs for dementia with CB. A care gap in the
delivery of post-diagnostic help for families supporting relatives with dementia and significant CB at home
has emerged.
Our evidence suggests that priorities for a skilled NHS-led dementia workforce should shift from early
diagnosis to early recognition and clinical support of family and staff carers who are challenged by
dementia-related behaviours. Our programme has produced clinical protocols and resources for the
recognition of significant CBs and manualised guidance for practitioners to deliver interventions. These
require dissemination and further evaluation.
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Scientific summary
Background
The aim of this programme was to study the management of challenging behaviour (CB) in people with
dementia living at home and in care homes. CB associated with dementia includes a wide range of
symptoms and behaviours. Often it is a manifestation of distress experienced by that person, whose
cognitive impairment increasingly limits their ability to carry out desired actions, to express their needs or
to inhibit their own behaviour.
The phenomena are also referred to as neuropsychiatric symptoms (NPSs) or behavioural and psychological
symptoms of dementia (BPSD). These concepts acknowledge the psychological suffering in people with
dementia, but are limited in their reach of the multiple interacting contextual factors around BPSD, some
of which have little to do with dementia itself. Other health, psychosocial and environmental factors
can contribute to an episode of CB. For example, undetected discomfort because of pain can result in
resistance to care or misunderstanding of need and the way care is carried out can precipitate an episode
of aggression.
Therefore, we defined CB as ‘a manifestation of distress or suffering for the person with dementia or of
distress in a carer or others, thus threatening the quality of life of one or both parties’.
Overall, two related but distinct programmes of work were planned, with development work leading to
two cluster randomised trials (CRTs). These were set within the real world of 63 care homes with 861 care
staff, and in seven large specialist NHS mental health organisations across England, with 33 mental health
teams who provided care to people with dementia and CB living at home.
The first CRT (ResCare) and its embedded process evaluations examined an intervention of e-learning and
e-tool decision support for ‘action plans’ to assist staff in care homes in the effective management of
people with dementia and clinically significant CB. The second study (FamCare) aimed to assist specialist
community mental health practitioners working with families to deliver such interventions for people with
dementia and clinically significant CB living in their own homes, and to evaluate this within a CRT.
The FamCare CRT could not proceed because of a lack of referrals from the community mental health
teams for older people (CMHTsOP) that were commissioned to support home-dwelling people with
dementia and CB. At the start of recruitment, continuing for an average of 31 weeks, 33 CMHTsOP across
seven NHS organisations received 5360 new referrals; only 452 (8.4%) patients referred had dementia and
were potentially eligible for this study. The remaining profiles of those referred to CMHTsOP for specialist
mental health care were no dementia diagnosis, but other mental health conditions present (n = 198,
37%); resided in care homes (n = 1190, 22%); dementia, but no informal carer (n = 307, 5.7%); or had
died or had been admitted to hospital before evaluation (n = 41, 0.8%). A further 25.8% of new cases
(n = 1385) were signposted elsewhere before being assessed by the CMHTsOP.
Therefore, the FamCare CRT, to study the management of dementia with clinically significant CB in
families, continued as an observational cohort study in six NHS organisations. Recruitment was slow,
continuing for 15 months, with ongoing stakeholder consultations across each NHS organisation. Later
recruitment strategies resulted in 16.6% of participants being located in newly emerging Memory
Assessment Services and memory clinics.
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Rationale for the intervention
The intervention was refined from the behaviour management literature that was outlined in the 2007
National Institute for Health and Care Excellence (NICE)–Social Care Institute for Excellence (SCIE) National
Clinical Practice Guideline Number 42 as ‘behavioural and functional analysis conducted by professionals
with specific skills, in conjunction with carers and care workers’ (National Collaborating Centre for Mental
Health. Dementia: A NICE–SCIE Guideline on Supporting People with Dementia and their Carers in Health
and Social Care. Leicester: The British Psychological Society and the Royal College of Psychiatrists; 2007.
p. 260). We updated this with a Cochrane review (Moniz Cook ED, Swift K, James I, Malouf R, De Vugt M,
Verhey F. Functional analysis-based interventions for challenging behaviour in dementia. Cochrane
Database Syst Rev 2012;2:CD006929), which concluded that functional analysis-based interventions
continue to show promise. These interventions essentially involve a biopsychosocial approach to
assessment, analysis and systematic testing, with adjustment, where necessary, of the most relevant
interventions for a particular case of CB. The approach is also known as individualised formulation-led
intervention (Holle D, Halek M, Holle B, Pinkert C. Individualized formulation-led interventions for analysing
and managing challenging behavior of people with dementia – an integrative review. Aging Ment Health
2016;10:1–19) and is usually algorithmic to enhance case specificity.
To widen the scope for delivery of interventions for the management of CB in dementia, we considered an
online application of intervention algorithms based on functional analysis. This was because a review,
unrelated to the dementia literature, of computerised clinical decision support systems by Garg et al.
(Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of
computerized clinical decision support systems on practitioner performance and patient outcomes: a
systematic review. JAMA 2005;293:1223–38) suggested that these may improve practitioner performance,
but the effects on patient outcomes were understudied. In addition, a survey by Flint and Cream in 2014
(Flint V, Cream J. E-learning: does it work in dementia care? J Dement Care 2014;22:22–5) suggested that
care staff were enthusiastic about e-learning opportunities about dementia care.
We were interested in determining whether or not the training provided by the bespoke e-learning would
permit staff to utilise clinical protocols effectively with minimal supervision and support. In essence, we
were building on preliminary work in the dementia literature that had separately demonstrated the value
of clinical algorithms, and current interest in and the use of e-tool technology. If successful, we would
have produced a cost-effective programme that enabled staff to assess problematic presentations; identify
causes and underlying needs; develop appropriate care plans; and, based on the learning from the earlier
training modules, execute the plans effectively, with minimal external supervision.
The intervention
The interactive online intervention comprised an e-learning course and two suites of decision support
systems for the targeting of individualised interventions for CB in dementia: one for staff in care homes
and the other for staff supporting family carers in the community.
Three e-learning modules introduced staff to observational skills and the algorithmic approach to
intervention choice. The decision support system comprised relevant assessment tools to collect information
of key contributory factors associated with CB, such as the person’s current health and functional status,
their life story, interpersonal and communication style and how others respond to the person during an
episode of CB. Algorithms provided two sets of biopsychosocial groups of action plans, extracted from
the literature as ways of meeting the person’s health and/or psychosocial need. Actions for the third
component arose from a new concept derived from our overview of the needs of the caregiving system.
These were bespoke to the needs of family carers (Feast A, Orrell M, Charlesworth G, Melunsky N, Poland F,
Moniz-Cook E. Behavioural and psychological symptoms in dementia and the challenges for family carers:
systematic review. Br J Psychiatry 2016;208:429–34) and care home staff.
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The ResCare trial and the FamCare study
We screened 2386 residents living in 63 care homes for people with dementia and CB. In all, we trained
92 care staff, from 27 care homes in Yorkshire, and 26 senior mental health practitioners, from six specialist
mental health NHS organisations across England, in functional analysis to manage CB in dementia.
We then (1) developed and tested a computerised intervention; (2) conducted a CRT of this in care homes;
(3) conducted a process evaluation of its implementation; and (4) conducted a longitudinal observational
cohort study of ‘usual care’ (from CMHTsOP) for the management of people with dementia with CB living
at home.
Study 1: development and testing of an online application of functional
analysis approaches to intervention for challenging behaviour in
dementia
Method
An e-learning course and two decision support e-tools were developed to help staff to use functional
analysis-based interventions for up to 25 commonly reported CBs in dementia. The intervention was tested
with 92 nominated ‘staff champions’, from 27 care homes, and 26 community mental health practitioners,
from six NHS organisations across England.
Results
The course was well received and strongly recommended by care home staff champions (n = 92), but only
when this occurred at an external venue, with opportunity for facilitated discussion and practice. Although
freely available within homes, e-learning take-up by other staff was limited. Staff selected as champions by
their managers were on average younger [t(606) = 2.12; p = 0.032], had higher educational attainment
(Fisher’s exact test; p = 0.0448) and were more likely to have had dementia training (χ2 = 4.38; p = 0.036)
than others at the care homes. E-tool-assisted action plans were developed for 199 residents with CB.
Immediately after training, staff appeared to have expanded the way they viewed some behaviour. They
were less likely to perceive behaviour as ‘challenging’, with a significant reduction in ratings of CB following
training [t(178) = 7.4; p < 0.001]. Community mental health practitioners, who tested the community
decision support system for their home-dwelling patients with CB, valued its logical assessment framework
and the ‘if–then’ algorithmic method for choosing potentially helpful case-specific interventions.
Conclusions
Worksite-based e-learning opportunities are not readily taken up by staff in care homes. Computerised
decision support for interventions for CB appear premature in care homes, but show promise for training
community dementia practitioners. However, usability will depend on successful collaboration between
clinical experts, information technology advisors within NHS organisations and software engineers.
Study 2: Challenge ResCare – a cluster randomised trial of the effectiveness
and cost-effectiveness of online training and decision support for care
home staff to deliver functional analysis-based interventions for
challenging behaviour in dementia
Design and methods
A CRT allocating 63 care homes in Yorkshire between intervention and usual care. The primary outcome
was measured by the Neuropsychiatric Inventory (NPI) using frequency and severity scores taken at 4 months
to examine whether or not the intervention reduces CB in dementia. Secondary outcome measures (n = 21)
monitored both residents and staff and included resident quality of life, measured using the EuroQol-5
Dimensions. The statistical model for effectiveness analysed follow-up scores by treatment group,
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corresponding baseline scores and other covariates for both residents and care home. Resources used by
residents with CB were costed by adapting the Client Service Receipt Inventory (CSRI) to focus on health and
social care over 4 months and assuming no marginal change in care home resources, as these are less likely
to change and more difficult to cost.
Results
Eight hundred and thirty-two residents (555 with CB) and 609 care staff at baseline were reduced to
658 (79%) residents [428 (77%) with CB] and 436 staff (72%) at follow-up. The NPI showed that the
intervention reduced the frequency of NPSs by 0.60 relative to treatment as usual, but this finding was
not statistically significant. Though the intervention also reduced the severity of those symptoms by 0.45
[95% confidence interval (CI) –1.03 to 1.93], this also lacked statistical significance. Although 14 of
the 21 secondary outcome measures showed positive effects of the intervention, none reached statistical
significance. Furthermore, the intervention generated little change in the prescription of drugs relevant to
dementia – notably antipsychotics (χ2 > 0.999), antidepressants (χ2 = 0.635), hypnotics and anxiolytics
(χ2 = 0.215), anticonvulsants (χ2 > 0.999) and the anti-dementia drugs (such as the cholinesterase inhibitors)
(χ2 > 0.999), or those for pain relief, both the opioids (χ2 = 0.399) and the non-opioids (χ2 = 0.996). Hence,
there is no evidence that the intervention changed the care of CB in dementia. Health- and social-care costs
over 4 months did not differ significantly between groups (mean cost was £331 lower in the intervention
group, with bootstrapped 95% CI from –£927 to £272), and staff reports of quality-adjusted life-years
over 4 months differed little between groups. Hence, there is no evidence that the online intervention was
cost-effective.
Conclusions
This computer-assisted intervention was neither effective nor cost-effective. Comprehensive e-learning and
assisted decision support to provide case-specific interventions for residents with dementia and clinically
significant CB were not enough to reduce clinically significant CB in dementia in care homes.
Study 3: Challenge ResCare – a process evaluation of the implementation
of e-tools for the management of dementia with challenging behaviour
in care homes
Methods
Normalisation process theory and framework analysis were used in a re-analysis of ResCare study data to
examine how innovations may become embedded in everyday work. Barriers to, and facilitators of, change
in care homes were studied by considering ‘process problems’ in social care settings, and ‘structural
problems’ affecting the integration of new systems into those settings. Following analysis of contextual
data collected during the trial for the intervention homes, a typology of ‘organisational cultures’ for the
computer-assisted intervention was developed. From this, four ‘case study’ homes were extracted and
seven participants from a sample of 14 were individually interviewed. These participants included home
managers, senior care staff and care assistants. A specialist dementia care intervention therapist and a
research nurse, who collected data during the study, were interviewed together. Nine additional qualitative
interviews with care home staff included those from the control condition, and three focus groups using
nominal group techniques with a maximum variation sample (n = 22) of wider stakeholders, provided
opportunities to consider how far the findings of the ResCare trial resonated with their experiences and
how they interpreted the trial and its findings.
Results
Three explanatory themes for the findings of the ResCare trial emerged: variation in care home managers’
trust of their staff; variation in the extent to which managers commissioned training; and variation in
cultures of training and practices within care homes. The findings also suggest that care homes are not
ideal environments for implementing new approaches, but implementation can be feasible in smaller care
homes and in those with less hierarchical structures.
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Conclusions
The implementation of interventions for the management of CB and dementia depends on the readiness
of care homes to invest in innovation. Capable leadership and collective willingness are also important.
The toolkit developed for implementing online interventions in care homes has scope for informing future
practice innovations and research.
Study 4: Challenge FamCare – an observational study of people with
dementia and challenging behaviour living at home and their carers
Aim
To describe the characteristics and resource use and changes over time over 6 months of a cohort of
people with dementia and CB living at home, and their carers, referred to specialist community mental
health NHS services for older people across England; and to elicit stakeholder views on CB service provision
and about the findings from the cohort study.
Design and methods
Cohort study of people with dementia referred for CB to six NHS mental health organisations. Participants
were people who met the diagnostic criteria for dementia and CB and their carers (dyads). The primary
outcome measure was the Revised Memory and Behaviour Problems Checklist at baseline and at 2 and
6 months; and the extent and cost of formal and informal care – using an adapted CSRI and NHS records of
contacts with specialist mental health practitioners. Secondary measures included quality of life for the
person with dementia and the family carer; and distress, guilt, mood and coping (sense of competence) in
the family carer. Stakeholders debated emerging findings.
Results
Over 15 months we recruited 157 dyads (154 included family carers), among which 61% of those with
dementia had mild dementia with clinically significant CB; we followed up 126 dyads at 2 months and
117 dyads at 6 months. Dyads had an average of nine contacts with mental health practitioners over
6 months, but there was little overall change in levels of CB. Increased contact with practitioners significantly
reduced levels of guilt (p = 0.016) among carers. There was significant variation in trends for CB among
dyads, but no stable clusters of those who improved, remained the same or deteriorated over time were
identified. Family carers estimated that they devoted an average of 112 hours a week to providing care at
baseline, rising, though not significantly, to 129 hours at 6 months. They contributed over 80% of the total
estimated cost of care. Stakeholder consultations revealed concerns about the equity of access to CB
services for these carers.
Conclusions
People living at home with mild dementia can present with clinically significant CB. CB fluctuates for some,
even over a short 6-month period. Families require trained practitioners, irrespective of where dementia
service pathways are located, to systematically assess their varied needs and provide timely patient-specific
interventions. Commissioning practice should reconsider the priority given to specialist assistance for
families experiencing CB.
Discussion: key findings, limitations and conclusions
The research was about the management of dementia and clinically significant CB. Therefore, we used
setting-specific measures and cut-off points for clinically significant CB, for both care home and family
care studies.
Our attempt to produce a cost-effective online program that enabled staff to manage dementia with
clinically significant CB in care homes with minimal external supervision was not successful. Aside from the
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significant difficulties we encountered with technology, a key limitation was lack of data comparing
algorithm-led clinical protocols for functional analysis-based interventions used by therapists with the
online intervention.
However, a related important limitation, and an implication for practice and future research, surrounds the
combination of support required for the delivery of functional analysis-based interventions in care homes.
An Australian study by McCabe et al. (McCabe MP, Bird M, Davison TE, Mellor D, MacPherson S, Hallford D,
et al. An RCT to evaluate the utility of a clinical protocol for staff in the management of behavioral and
psychological symptoms of dementia in residential aged-care settings. Aging Ment Health 2015;19:799–807)
using a clinical protocol for functional analysis delivered by trained dementia practitioners found that,
compared with other conditions (i.e. training, clinical support and clinical protocol alone), the clinical
protocol plus clinical support showed the most sustained effectiveness. The staff training literature for CB
also concludes that the most beneficial training interventions are those combined with additional on-site
visits, so care staff can have clinical supervision to work with individuals (Fossey J, Masson S, Stafford J,
Lawrence V, Corbett A, Ballard C. The disconnect between evidence and practice: a systematic review
of person-centred interventions and training manuals for care home staff working with people with
dementia. Int J Geriatr Psychiatry 2014;29:797–807). A trained practitioner is usually required, as a key skill
in working in this area is the ability to be flexible and have the capability to alter care plans as new needs
arise. Therefore, the process remains iterative, but the functional analytical skills remain at the core of the
plan. Many of the UK’s specialist CB teams, which were conceived using the Newcastle clinical protocols
(James IA. Understanding Behaviour in Dementia that Challenges: A Guide to Assessment and Treatment.
London: Jessica Kingsley; 2011), now use a 12-week protocol when treating BPSD, with the final 6 weeks
being a monitoring/support phase for the implementation of the care plan. The interventions included in
our Cochrane review also used external clinical support, with access to multidisciplinary medical and
psychologist expert professionals where the intervention phase was 4, 6 or 10 months. Specialist support
following training to support staff in implementing care plans was described in some studies as occurring
weekly or twice weekly.
Thus, we conclude that, as with staff training, e-learning does not, on its own, hold traction for the
sustained reduction of CB in dementia in care homes. No one intervention can meet the case-specific
needs of people with dementia and CB or the varying cultures and needs of staff in care homes. In
addition to staff training, which may consist of online programs, clinical support from a practitioner trained
in formulaic interventions remains a necessary ingredient for the management of dementia with clinically
significant CB.
The Cochrane review found good evidence for functional analysis-based interventions conducted in family
care settings. Relatively fewer studies conducted in care homes contributed to the evidence described.
Our inability to deliver the intervention in wide-ranging NHS services was therefore disappointing, as was our
observation of usual care from specialist services, where an average of nine clinical contacts over a 6-month
period did not have an overall impact in reducing levels of CB. Families bear the majority of the care costs for
dementia with CB, and stakeholder families reported difficulties in knowing when they were deserving of
specialist support from the NHS. Furthermore, the changing landscape of NHS commissioning and practices
may have undermined timely responses to dementia with CB. A care gap in the delivery of post-diagnostic
help for families supporting relatives with dementia and significant CB at home has emerged.
Also disappointing, given the current policies to drive down the use of antipsychotics in dementia care
(Banerjee S. The Use of Antipsychotic Medication for People with Dementia: Time for Action. London:
Department of Health; 2009), was the overall suboptimal prescribing practices noted for both care home
and family settings.
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Future work
Priorities for a skilled NHS-led dementia workforce should shift from early diagnosis to early recognition
and clinical support of family and staff carers supporting people with dementia and clinically significant CB.
Caregiver contexts for delivery of interventions in care homes and family care are not equivalent. NHS
service improvements, with separate resource bundles for care homes and family care support, may
enhance the efficiency of delivery, and the quality of research on implementation into routine care.
High levels of CB were noted in family settings. There is an urgent need for evaluation of interventions for
home-dwelling people with dementia with clinically significant CB.
Challenge Demcare has produced clinical protocols and resources for the recognition of clinically significant
CBs and manualised guidance for practitioners to deliver such interventions. These require dissemination
and further evaluative research across relevant pathways for both care home and home care settings.
There is scope for extending this intervention with additional communication and interaction training –
CAIT [James IA. The use of CBT in dementia care: a rationale for Communication and Interaction Therapy
(CAIT) and therapeutic lies. Cogn Behav Ther 2015;8:10] for carers.
Pilot work, extending the Newcastle clinical protocol, is currently ongoing. In this, specific CAIT has been
added to the functional analysis approach to treatment within care homes. This will require future
evaluation in care homes and family care settings. Realist evaluation (Wong G, Greenhalgh T, Pawson R.
Internet-based medical education: a realist review of what works, for whom and in what circumstances.
BMC Med Educ 2010;10:12) designs may illuminate how the intervention might work, and for whom,
within the varying service contexts.
Trial registration
These trials are registered as Current Controlled Trials ISRCTN02553381 (the ResCare trial) and
ISRCTN58876649 (the FamCare observational study).
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 Introduction and background
Understanding does not only help find solutions, but it can generate tolerance as the behaviour loses
its mystery. With tolerance comes the potential to cope, even with situations that are basically
unchanged.
Stokes G. Behavioural, Ecobehavioural and Functional Analysis. In Stokes G, editor.
Challenging Behaviour in Dementia: A Person-Centred Approach. pp. 142–541
Chapter overview
In this chapter we describe the background to our programme of assisting mental health practitioners and
care home staff to respond effectively to challenging behaviour (CB) from people with dementia living at
home and in care homes. First, we provide a conceptual overview and definitional rationale for CB in
dementia care. This includes the layers of complexity that need to be considered in the management
of CB in dementia within the ‘real world’ of family life and care home settings. Next, we summarise the
development of functional analysis, as an approach to systematic assessment and associated management;
the findings of our literature review of interventions based on this method; and a second review of the
range of psychological and emotional needs of family carers that are associated with caring for people
with dementia with CB. The conceptual overview and review findings provide a theoretical and empirically
informed grounding for this approach to systematic assessment and the tailoring interventions to individual
needs, in the management of CB in dementia care. Finally, we outline and discuss the studies we
conducted in the chapters that follow.
Definition of challenging behaviour in dementia
Challenging behaviour associated with dementia includes a wide range of behaviours such as violent
resistance to help with personal care and other aggressive responses, repetitive questioning, yelling or
screaming, sexual disinhibition and apathy. It causes significant distress to caregivers. Often it is itself
a manifestation of distress experienced by the person with dementia, whose cognitive impairment
increasingly limits their ability to carry out desired actions, or to express their needs or to inhibit their own
behaviour – as would be ‘normal’ for them within their interpersonal and social context. Two influential
theories that partially, but far from comprehensively, account for these phenomena are the ‘unmet needs’
hypothesis2 and the ‘progressively lowered stress threshold’ hypothesis.3
Together with incontinence, CB is the most common reason why family members pass over care
responsibilities to residential facilities such as care homes.4 This may be because the person’s behaviour has
passed a threshold of intolerability or is deemed unmanageable at home. In care homes these behaviours
then have to be managed by care staff,5–7 many of whom are poorly paid, are accorded low status and are
insufficiently resourced and supported.8,9 Behaviours can become more ‘florid’ (e.g. screaming or violent
aggression) and frequent after a move to a care home. Increased frequency of these behaviours in care
homes may be attributable to heightened distress, as the person is away from ‘home’ and familiar faces or
routines, and does not have the cognitive capacity to adjust to the care home, or possibly because of
deficiencies in care.
Phenomena or symptoms associated with CB in dementia are sometimes referred to as neuropsychiatric
symptoms (NPSs) or behavioural and psychological symptoms of dementia (BPSD), which are defined as
‘signs and symptoms of disturbed perception, thought content, mood or behaviour that frequently occur in
patients with dementia’.10 This definition has the advantage of acknowledging the strong component of
psychological suffering by the person and that there can be comorbid or accompanying mental illness,
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such as mood disorders, hallucinations and delusions. The definition is less satisfactory, in that it roots the
phenomena solidly in the dementia, when this may not necessarily be the case,11 and it mixes up a diverse
range of behaviours and mood states. However, its most serious disadvantage is that it takes no account
of the context in which the behaviour occurs.
The importance of context in the management of CB in dementia was recognised within the National
Institute for Health and Care Excellence (NICE) and Social Care Institute for Excellence (SCIE)’s Dementia
Practice Guideline Number 42, in the term ‘behaviour that challenges’ (p. 210).12 This includes the
wide-ranging ways in which people with dementia and others in their environment respond to the
phenomena of BPSD. Some of these responses can exacerbate distress for the person and/or their family
or staff carers, or others in their environment. In line with these understandings, CB in dementia has been
defined as a manifestation of distress or suffering for the person with dementia and/or distress in a carer’
(p. 573),13 and in this programme we extend this definition to describe a person’s behaviour as challenging
when it causes distress to the person or the carer or others, thus threatening the quality of life of one or
both parties.
There are no good data comparing the level of distress between family members and care home staff, but
there is reason to believe that some family members may be more distressed by the unfamiliar and often
embarrassing or threatening behaviour of a family member they thought they knew well. In contrast,
disturbed behaviour may be seen as part of the job for care home staff, as they can at least look forward
to relief at the end of their shift. However, the difficulties14 or ‘occupational disruption’ experienced by
care workers faced with CB, regardless of whether or not they actually go on to become distressed later,
remains a key factor in them seeking help from specialist services, admissions to hospital, accident and
emergency (A&E) use, or transfer to another care home for the person with dementia. This in turn
potentially results in increased levels of ‘excess disability’, meaning that functional abilities of people with
dementia decline more quickly than can be accounted for by reducing cognition alone over the same
period. We use the term CB here because its key component is that, for behaviour to become a clinical
problem in need of treatment, it has to challenge the capacity of those exposed to it (usually family or
staff carers) to cope.
There are no precise prevalence data because of widely differing perceptions of what is ‘challenging’
among those exposed to it; differences in how symptoms are ascertained and variable thresholds of
severity and setting where behaviour problems are said to be ubiquitous.15,16 Nonetheless, the cost of
CB in dementia should not be underestimated, as 35.6 million people and families worldwide live with
dementia,17 with an estimated cost of care of US$604B in 2010.18 Breakdown of care at home becomes an
inevitable extra cost if the public purse has to meet the costs of a proportion of the one-third of people
with dementia who live in care homes. Although prevalence is hard to estimate, over 80% of people
who move to nursing homes can have at least two or more of these behaviours.19 The Neuropsychiatric
Inventory (NPI) is a commonly used measure20 of NPSs and the incremental cost of just a one-point increase
in score in a family care setting has been estimated, in the context of the USA, at US$30 per month on
average, resulting in urgent calls for targeted intervention to reduce this significant cost.21
Management of challenging behaviour in dementia
Treatment is problematic. There is extensive evidence of over-reliance on psychotropic medication, in
particular antipsychotics,22 despite meta-analyses from 1990 to date showing modest efficacy at best, as
well as frequent problematic side effects.23–25 A rough measure of ineffectiveness is that half to two-thirds
of participants referred to intervention studies because of unresolved problem behaviour will already be
taking antipsychotic medication.26,27 Because of the mounting evidence of harm from antipsychotic use in
older people with dementia, there are occasional surges of interest in other compounds, in particular
anticonvulsants (mood stabilisers), but the evidence is that they are equally ineffective and have equally
harmful side effects.28,29 The dangers of benzodiazepines for older people have long been known30,31
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and their use for CB has declined, though a substantial number of medical practitioners are reported as
remaining unaware of the literature.32 The inadequacies of psychotropic drugs mean that there are
frequent recommendations to make non-pharmacological interventions the routine first-line treatment.29
Such calls are honoured more in the breach than the observance but, in any case, the evidence for
standard psychosocial approaches is at least as weak as that for psychopharmacology. Systematic reviews
of various discrete approaches, such as aromatherapy, light therapy or activity programmes, describe them
as showing promise, but most studies lack the methodological rigour required to determine whether or
not they are truly effective.33 In 2005, in one of the most comprehensive meta-analyses of drug trials,
Sink et al.29 concluded that there was ‘no magic pill for neuropsychiatric symptoms of dementia’.
This applies equally to standardised psychosocial interventions.
It should be no surprise that where the main clinical target is the suppression of behaviour, standardised
pharmacological or psychosocial interventions are only intermittently effective. Interventions often appear
to be based on a ‘one syndrome standard treatment’ paradigm.13 The syndrome is the behaviour or,
mostly, a cluster of behaviours and other phenomena usually labelled BPSD or agitation, and treatments
applied include interventions for multisensory stimulation such as snoezelen,34 antipsychotics such as
risperidone,29 and analgesics.35 The primary problem is that the behaviour alone is the wrong target for
intervention, as the syndrome-standard treatment model takes little or no account of the multifaceted
context of the behaviour and its effects. This includes causal or exacerbating factors for the behaviour,
why it becomes a clinical or care problem in any one case, and the characteristics and capabilities of those
involved. The syndrome is actually very elusive because each of these contextual matters varies widely from
case to case and over time. This has profound implications for the nature of clinical interventions, how
they are delivered and their utility, as well as for measurement and methodology in intervention research.
Elusiveness of the syndrome: aetiology and other contextual factors
Many current guidelines, including the International Psychogeriatric Association’s Complete Guide to
Behavioral and Psychological Symptoms of Dementia36 and Dementia: A NICE–SCIE Guideline on
Supporting People with Dementia and their Carers in Health and Social Care (p. 210),12 acknowledge
multiple aetiologies for CB, including genetic, neurobiological, psychosocial, medical and physical
factors. Given such a complex causal mix, it follows that there will be wide variability between individuals,
even if the behaviour is the same, and that a case-specific approach will often be required. Genetic and
neurobiological variables are not currently adjustable, but many psychosocial and physical/medical factors
are actually or potentially treatable. For example, many treatable or modifiable factors, often in interaction,
can contribute to screaming or yelling in dementia, including pain or depression,37 the way care is carried out,38
sensory loss,39 overstimulation40 or loneliness.41 Similarly, the cause of sleep disturbance or night-wandering
can be staff noise or active waking of residents;42 too much sleep/dozing or inactivity during the day;43
inability to find the toilet or the way back to a room at night;44 previous night-time regimes;13 or any
combination of these.45 Addressing potentially treatable case-specific aetiological factors such as these is
an obvious first step, and some studies do acknowledge and treat common conditions underlying CB, such
as delirium or, in particular, pain, which is grossly undertreated in dementia.35 However, in the main, trials
of standard psychosocial or pharmacological treatments aimed at the behaviour do not typically address
causal factors. At best, this is poor practice, but it is also pernicious, leading to non-treatment or wrong
treatment of causes of suffering. For example, several studies have shown that, by contrast with cognitively
intact older people, people with dementia who are in pain are more likely to be given antipsychotics
than analgesics.46
The elusiveness of the syndrome is not just because of idiosyncratic causes of behaviour. It applies equally
to distress among family carers or care staff, and in care homes there may also be distress caused to other
residents. Hence, distress in others or the potential for injury to the person and others is what defines the
behaviour as ‘challenging’. For example, in family care settings, frequent behaviours are not necessarily the
most challenging for carers;47 the carer’s own characteristics (independent of dementia severity) and their
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sense of a declining relationship with their relative can contribute to the development or maintenance of
CB.48,49 Emotional responses to, and perception of, the behaviour vary widely,26,50 from extreme distress to
regarding the behaviour as ‘no problem’. Most people are distressed by behaviours such as screaming,
repetitive questions, violence or behaviour of great intensity. Nevertheless, in many cases, individual
characteristics of family carers51,52 or care staff are often as important as severity of behaviour in
determining whether or not, or to what degree, the behaviour is perceived as challenging. These factors
include limited understanding of the changes associated with dementia; lack of support; limited skills;
pejorative attitudes to people with dementia or older people; and mood disorders in caregivers.53,54 In an
early example, Hinchliffe et al.55 found that treating depressed family carers changed their perception of
the behaviour, from ‘intolerable’ to ‘no problem’. Thus, in a significant number of cases, though far from
all, CB can be described as being in ‘the eye of the beholder’, and a successful intervention can be one
that does not change the behaviour but leads to carers no longer perceiving that behaviour as a problem,
or at least as not so great a problem.
In residential care, the characteristics of the home contribute to the elusiveness of the syndrome in much
the same way. It tends not to depend on the formal classification of the home and nature of funding
(subsidised or non-subsidised), but more on individual differences between homes.56 Even if residents have
much the same profiles, in relatively stable facilities where the culture fosters a high level of dementia
literacy, empathy and skills, and strong support, disturbed behaviour is less likely to occur, or, where it
does occur, it is less likely to be perceived as challenging.53,57 This means that it is not only the syndrome
that is elusive, but also any sense of a standard treatment, because the nature of the intervention and how
it is delivered will depend on the existing skill set and culture. However, not even here can stability be
assumed. The residential care sector is often in flux; organisational changes, including takeovers and loss
of staff, are common, even during intervention studies.9 Accordingly, attention must be paid to how to
engage sufficient staff to make a sustained difference.58
In summary, because of the multiple interacting contextual factors surrounding BPSD, many of which
may have nothing to do with dementia per se, and some of which have little to do with the person
with dementia or the objective severity of the behaviour, standardised pharmacological or psychosocial
treatments are always going to have strictly limited effectiveness. This is exactly what the literature shows.
Treatment should vary in each individual case depending on the aetiology and/or the context in which it
occurs, including characteristics of carers, practitioners and the person with dementia – which will
determine what is possible in any given case. Thus, the identified focus may be the person with dementia
and/or family and/or staff members and/or a whole facility, and treatment may include pharmacological
and/or psychosocial methods. Injunctions to use psychosocial methods first are incorrect. If the cause of
someone being violent in personal care is painful joints, pharmacological pain relief is likely to be the
front-line treatment adjunct with empathic support during personal care. If the cause is poor staff skills,
treatment is likely to be psychosocial. If the cause is a combination of both, for example where a care
worker with low skills is also insensitive to the fact that the resident is in pain, then the treatment is likely
to be both analgesics and training with supportive supervision of the staff member. Where the behaviour
is simply dangerous (to self or others), the first line of treatment will often involve psychotropic medication,
including antipsychotics, if there is no other alternative (p. 261),12 but usually there are alternatives.59
Implications for methodology
As there is no standard syndrome based on the behaviour and, therefore, no standard treatment,
a range of measures must cover multiple domains in intervention studies. By definition, CB involves both
an individual’s behaviour and another’s response to this; therefore, measures of both are needed, and
the response must be linked to the referred behaviour. Measures of behaviour must include the actual
behaviours that are distressing carers or practitioners, but also generic behaviour measures so that change
over time can be aggregated across a diverse range of behaviours of widely varying frequency. Given that
severity of behaviour often predicts carer distress, measures of severity as well as frequency are required;
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for example, the effects of a very low-frequency behaviour, such as physical aggression, can be much more
serious than, for example, high-frequency pacing or walking up and down. This often leads to problems in
determining what constitutes ‘caseness’, that is, the threshold for offering a clinical intervention, and,
equally, what constitutes a successful intervention. In residential care, because of variability between staff
and the influence of care culture in determining the quality of care, as well as receptivity to interventions,
there must be more general measures (e.g. staff morale, knowledge, skill levels, whether or not
organisational change occurs), to enable an analysis of staff and care home factors likely to predict benefit
from an intervention. Because of large differences between care homes’ organisation and facilities, there
must be a representative sample of them rather than just one or two and, because of the effect of culture,
the facility or specific unit rather than individual residents must be the unit of randomisation.
Rationale for current study
A number of trials have delivered education to family carers or care staff as the sole or an important
component of interventions, variously covering generic and client-specific skills and knowledge, and/or
providing emotional support. That is, they recognise the case- and context-specific nature of CB by
attempting to enhance the emotional, attitudinal and practical skills of care providers such that they can
flexibly adapt to each new case or change care practices to prevent or minimise CB occurring. Few of
these trials have had adequate methodology (for reviews see McCabe et al.58 and Spector et al.60),
but there have been encouraging, though not conclusive, results in trials of adequate rigour. Changes
in behaviour or family carer or staff distress are more likely to occur in programmes that are more case
or client specific, that is, education that is person centred or more explicitly links interventions to the
specific environment.60
Examples of outcomes for people with dementia living in residential care have been reductions in
frequency and perceived severity of the target behaviour and general practitioner (GP) call-outs,50
reductions in antipsychotic use,27 reductions in agitated behaviour and increases in observed participant
pleasure,61 reductions in behaviour frequency and perceived severity, hospitalisations, antipsychotic use,
and drug side effects;26,62 and for staff, reductions in stress and short-term improvements in the perception
of how challenging staff found the behaviour.63 Systematic interventions of this type, targeting a variety
of outcomes within family care settings, are less common, but they can be found, including within NHS
settings in England, where they have demonstrated reductions in CB and improvements in carer
mental health.55,64,65
Many of these studies, especially those involving supervision, required expert clinicians to work with family
carers or with residential care facilities. However, Bird et al.26 showed that the individualised formulaic
‘case-specific’ approach was no more time consuming when compared with ‘usual care’ practice in residential
care settings, but it still required a mean of 5.5 clinical visits per case. Applying a similar approach to
‘treatment-resistant cases’, in care homes, Davison et al.50 required a median of 3 months per case, spread
over three visits, to achieve improvements in some, but not necessarily in more complex or treatment-resistant
cases. This necessitates significant time/resource investment, namely addressing the shortage of clinicians with
the requisite skills to provide the necessary assessment and subsequent intervention to the large and growing
number of older people with dementia and CB, and those who care for them. Such ‘expert’ interventions are
expensive, so alternative models of service provision are required. In residential care, where the most florid
behaviour occurs, there seems to be the potential for staff, if given enough sustained support, to gain and
retain these skills for themselves. Furthermore, most of the information required to assess CB, from the
resident’s health status to the way intimate personal care is carried out, is already available in the care
home, and care staff members are often the primary source of the information that is required by visiting
professionals. Support for CB in family care settings in the UK has traditionally been provided by community
mental health nurses (CMHNs) working within community mental health teams for older people (CMHTsOP).
By providing these practitioners with specialist supervision to target their interventions, reductions in CB and
improvements in carer mental health have been demonstrated.65
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Given the elusiveness of the syndrome, our first challenge was to devise a method to assist care home staff
and community practitioners themselves to gather and analyse information required for CB interventions in a
sufficiently standardised manner to be taught in a generic way, but which also takes as much account as
possible of the idiosyncratic biomedical, social, environmental and other contextual factors of each case
where behaviour is perceived as challenging. The closest approximation is a well-established range of
techniques known as ‘functional analysis’ (see Functional analysis-based interventions), which has been used
in a number of single case studies or case series.66–69 Our second challenge was to devise a means to engage
staff in a way that they perceive as relevant to their working experience and with sufficient power to change
or expand the way they perceive and respond to behaviour they find challenging. There are preliminary
studies of successful interactive online programs using actors to simulate common behaviours in context
followed by demonstration of how effective responses can be achieved.70–73 There is also increasing interest
in online education.72–75 Furthermore, emerging approaches towards personalised electronic decision support
systems for targeting dementia care in community settings are being developed.76 However, these are at an
early stage and are yet to be considered for CB.
Functional analysis-based interventions
Functional analysis is a systematic framework for assessment that takes into account potential factors that
may cause or contribute to a given behaviour (i.e. the function of the behaviour) for an individual at a given
time and within a given social interaction or environmental setting. Following a functional analysis that has
fully considered the potential cause(s) or contributory factors underlying the person’s behaviour in their
interpersonal situation, the practitioner can then generate ideas of ways of intervening and then test these
out in the individual case. If the challenge has not been resolved in an acceptable way, the practitioner
can return to other creative ways of addressing the cause and associated challenge. If the challenge has
not been resolved in a satisfactory way or if the practitioner wants to consider the function of the same
behaviour in a different context or another behaviour, s/he can continue to use the information from the
comprehensive assessment, together with observations in the relevant interpersonal setting, to consider
other potential ways of intervening. The approach is essentially one of systematic ‘hypothesis generation’,
akin to an iterative ‘detective’-like approach to CB in dementia, and overcomes the aforementioned pitfalls
of the search for a magic psychosocial or medical ‘pill’ to overcome the challenges that face individual and
groups of carers in dementia care. The interventions that arise from a functional analysis are referred to
here as functional analysis-based interventions and can include factors, such as pain or infection, that cause
discomfort, as well as psychological or social need. Next we outline the development of functional analysis
as a means of managing CB in dementia in the UK.
Firmly nested in the tradition of applied behaviour analysis, the functional analytic perspective came
to prominence initially in the field of intellectual (learning) disability where, from the early 1980s,
conceptualisation and research gradually moved away from the reductionist ‘behaviour modification’
approach to a perspective that encompasses a more person-centred functional analytic perspective.
Thus, the term ‘challenging behaviour’ – used in the USA in 1988 by The Association for Persons with
Severe Handicaps, replaced that of ‘problem’ or ‘disruptive’ behaviour.77 This change of terminology
signalled an important relocation of responsibility from the individuals displaying the behaviour to the
systems around them. A significant body of research emerged over the subsequent two decades attesting
to the importance of functional analysis in the field of CB.78 Although the emerging literature on functional
analysis from the USA emphasised the importance of tightly controlled hypotheses-driven behavioural
experiments, the literature from the UK also included analysis of the wider context of the person’s life and
variables that were closer to the concept of function, where the ‘meaning’ or ‘purpose’ of behaviour
was also considered. Thus, the British conceptualisation of functional analysis combined the rigours of
experimental analysis with a more anthropological and contextual emphasis on function,79 and some
professional societies in the UK provided associated guidance for practitioners.80,81
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In 2000, Stokes1 (see chapter 8) provided an overview of the translation of applied behaviour analysis and
the growth of functional analytical approaches to dementia care from around the mid-1980s in the UK.
By the mid-1990s a parallel movement associated with the person-centred model of dementia strengthened
the potential for application of applied behavioural analysis by allowing researchers to identify the functional
significance of many ‘bizarre’ CBs. The challenge was now for services, professionals and carers to find more
effective methods of understanding the origins and meaning of a person’s behaviour. This person-centred
approach also saw the growth of attempts to find creative ways of responding to the challenges to services.1
However, although modelling and testing of functional analysis through single case studies exist,1,65–69 these
tend to be located in the care home setting. Systematic attempts by professionals and researchers alike to
reduce the need of a person with dementia to engage in ‘behaviour that challenges’, where the guideline
outlines the same considerations that we have also described previously within a functional analytical
assessment framework (see Dementia: A NICE–SCIE Guideline on Supporting People with Dementia and
their Carers in Health and Social Care, p. 210),12 have been, on the whole, anecdotal and intuitive. This may
be because making systematic choices about the most appropriate and often multicomponent interventions
in a given case can be difficult for the practitioner. This is also the case when the practitioner requires to
assist a professional or family carer to respond, through understanding of the sometimes ‘idiosyncratic’
meaning of the ‘behaviour that challenges’ in an individual who may be communicating an unmet need
and/or distress through their behaviour.
Challenge Demcare
The programme of work reported here sought to use the wider conceptualisation of functional analysis as the
basis of its methodology and associated technology, using the internet to expand availability of the method
as widely as possible. In order to apply our theoretical stance to a functional analysis-based framework for CB
interventions in dementia, we conducted two literature reviews, which will be outlined next.
Literature reviews on the management of challenging behaviour
in dementia
First, we conducted a systematic Cochrane review of functional analysis-based interventions for the
management of CB in dementia in 2009–10 (updated and published in 2012).82 This integrated a number
of features taken from the conceptual overview described above, including the growth of functional
analysis in dementia care and the importance of including the context of CB in the analysis. Thus, although
a central tenet of the approach was to teach staff and practitioners to carefully observe the person and
their immediate environment before making assumptions about the function of the behaviour, the analysis
of function moved beyond the mere completion of antecedent–behaviour–consequence charts and the
reductionist assumption that behaviour is a function of its consequences. The review therefore also focused
on interventions that included identifying the function of behaviour for an individual, based on knowledge
of the person’s life story, to understanding the ‘unmet need’ that was being communicated by the
distressed person. Finally, the review included interventions that incorporated training and specialist support
of staff in care homes, and trained community practitioners who provided care to families, to apply,
monitor, evaluate and adjust individually tailored interventions to reduce CB in dementia. Our primary
outcome measure was CB, including the behaviour and responses or reactions to this.
All randomised controlled studies that included functional analysis-based interventions for dementia
compared with a control condition were included if they had a valid outcome measure of reported
occurrence, in terms of frequency or incidence of CB. Participants included those living at home or in care
homes or those cared for in hospital or other dementia facilities, such as assisted living units. The primary
outcome was change in reported behaviour or mood on standardised measures, and secondary measures
included changes in the caregiver, that is, their reaction, distress, perceived management difficulty and
well-being (mood, morale efficacy and burden). The searches located 3335 references, from which
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144 abstracts were retrieved. One hundred and twenty-six papers were excluded following our quality
ratings and checks for duplication, and 18 were selected for review (see Moniz Cook et al.,82 table 2), with a
baseline total of 2558 care recipients. The majority of these (n = 13) were within family care settings and just
three were conducted in care homes. Of these, only two family care studies were conducted in England, in
Kent64 and Hull,65 and only one care home study, in Manchester.83 The review concluded that functional
analysis within multicomponent interventions that are geared to the context of either the family or the care
home shows promise. A striking finding from the studies reviewed in family settings was the importance
of providing support to meet the psychological needs of the family carer. This was consistent with our
conceptual understanding of CB that was described earlier, that is, attending to context within the family
system is an important target for interventions to reduce CB in dementia. The relatively few randomised
controlled trials (RCTs) in care home settings made it hard to properly evaluate the importance of
intervening in the system or context of the care home. However, one of these three studies from England,27
in which person-centred care was offered to reduce the use of antipsychotic medication (but did not show
change on behaviour outcomes), has been recently upscaled in an implementation study. The authors
achieved reductions in antipsychotics equivalent to the original study in some cases, but conclude by
outlining contextual barriers to implementation; they recommend revisions to the intervention to address
these barriers.84
Second, given the findings from the Cochrane review on the functional analysis-based interventions,82
that effective interventions usually involve a component of psychotherapy or counselling directed at
the family carer, we conducted a second review to gain an in-depth understanding of the potentially
‘hidden’ needs of families living with dementia and CB. This was thought to be important as a focus for
the content of a multicomponent intervention for the management of CB in dementia in family settings,
as two-thirds of families that receive professional support report an unmet need associated with behaviour
management in dementia.85 A meta-ethnographic approach was chosen to review studies that employed
qualitative and quantitative methods of family carer experiences of dementia and CB. Our wide-ranging
search strategy identified 10,375 references, of which 70 studies met our initial inclusion criteria and
25 high-quality studies were finally included in the review. Reasons for CB were associated with changes
in communication and misunderstandings about the meaning of the relative’s behavior, which was seen by
some carers as ‘antisocial’.86
Our conceptual overview and review findings together provide a theoretical and empirically informed
grounding for a functional analysis-based framework for choosing interventions for the management of
CB. Thus, we conceived case-specific functional analysis-based interventions for CB to include the health
and psychological needs of the person with dementia at a given time, as well as attention to the physical
and social environment and the caregiving context. This then included the support needs of staff within
a given care home or, for example, the psychological needs of families. In the design of an interactive
online intervention for CB in dementia, we created algorithms for intervention within each of these three
domains, ensuring that the third domain differed for people living at home or in a care home.
Outline of studies within Challenge Demcare: Chapters 2–6
Our interactive online intervention aimed to provide easy access for care home staff and community
practitioners to training and support to meet the needs of people with dementia and CB (see Chapter 2).
The ‘e-intervention’ consisted of an e-learning course for staff that was graded across three modules and a
decision support system consisting of two e-tools that followed the e-learning course. These e-tools were
context specific and tailored for use by staff supporting people with dementia either at home or in a care
home. Our aim, in keeping with the applied behaviour analysis roots of functional analysis, was to help
care home staff to alter their interactions with the person through an understanding of the basic principles
of functional analysis. But we hoped to go beyond behaviour change alone, by changing attitudes as well
as behaviour. We anticipated that by paying more attention to the functions of a person’s behaviour, staff
would go beyond a ‘rule-governed’ approach that assumed function (‘He’s just doing it to get attention’)
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and develop a shared sense of humanity and affinity with the person. In this way, we hoped to build a
higher tolerance to those CBs that were unlikely to change. For community practitioners, such as CMHNs
working in CMHTsOP across England, who provide support to family carers, we expected the training to
provide the background and tools for functional analysis-based interventions. Thus, the e-learning course
and decision support e-tool were structured in the same way to facilitate the production of a targeted
action plan, referred to as functional analysis-based interventions for the management of CB in dementia.
Application of the interactive e-learning course for staff from the intervention arm of our care home study,
ResCare, and experiences with the decision support e-tool in our family care study, FamCare, are outlined
in Chapter 2.
Following adjustments to the procedure of delivery of functional analysis-based interventions in care
homes, the clinical effectiveness and cost-effectiveness of the web-assisted intervention were evaluated
within a cluster randomised trial (CRT) (see Chapter 3).
We then conducted a comprehensive process evaluation to throw light on the mechanisms responsible for
our findings in the ResCare trial (see Chapter 4).
Chapter 5 describes the FamCare observational study, our study of specialist community mental health
services for people with dementia and CB living in family care settings in England.
Finally, we conclude by reflecting on our programme across care home and family care settings. We
summarise key findings, and, on the basis of observed limitations to our care home intervention, important
implications for the design of future research of this type are outlined. We also consider the implications
for future research and practice in the delivery of support for CB in dementia care, in the light of changing
policies and services for people with dementia and CB (see Chapter 6).
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Chapter 2 Development and testing of an online
application of functional analysis approaches to
intervention for challenging behaviour in dementia
Abstract
Aim
To describe the development and field testing of an interactive online training and decision support
intervention, using functional analysis approaches for the management of CB in dementia.
Method
An e-learning course and two decision support e-tools were developed to help staff to use functional
analysis-based interventions for up to 25 commonly reported CBs in dementia. The intervention was tested
(2011–12) with 92 nominated ‘staff champions’ from 27 care homes and 26 community mental health
practitioners from six NHS organisations across England.
Results
The course was well received and strongly recommended by care home staff champions who completed an
evaluation sheet (n = 92), but only when this occurred at an external venue, with opportunity for facilitated
discussion and practice. Although freely available within homes, e-learning take-up by other staff was limited.
Staff selected as champions by their managers were, on average, younger [t(606) = 2.12; p = 0.032], had
higher educational attainment (Fisher’s exact test p = 0.0448) and were more likely to have had dementia
training (χ2 = 4.38; p = 0.036) than others working in the care homes. E-tool-assisted action plans were
developed for 199 residents with CB. Aggression was mostly selected by staff where 58 action plans (29%)
were delivered. Immediately after training, staff appeared to have expanded the way in which they viewed
some behaviour. They were less likely to perceive behaviour as challenging, with a significant reduction in
ratings of CB following training [t(178) = 7.4; p < 0.001]. Community mental health practitioners, who tested
the community decision support system for their patients with CB, valued its logical assessment framework
and the ‘if–then’ algorithmic method for choosing potentially helpful case-specific interventions.
Conclusions
Worksite-based e-learning opportunities are not at present readily taken up by staff working in care homes
in England. Computerised decision support for interventions for CB appears premature in care homes, but
shows promise for training community dementia practitioners. However, usability will depend on successful
collaboration between clinical experts, information technology (IT) advisors within NHS organisations and
software engineers.
Introduction
The concept for the design of the intervention is outlined in Chapter 1. Our aim was to devise a means to
engage staff in a way that they perceived as relevant to their working experiences and that had sufficient
power to change or expand the way in which they responded to behaviours they found challenging. The
intention was to provide an easily available and sustained resource in care homes for staff to learn about
behaviours seen as challenging, common contextual reasons why they occur and effective ways to respond,
that is, to make them aware that the syndrome is elusive and that, as a consequence, standard responses based
only on the nature of the behaviour will be ineffective. By providing a structured framework for capturing the
syndrome, with some examples from family and care home settings, we considered this resource to also be
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relevant for community mental health practitioners working with family carers, in the management of CB in the
home setting. Second, when CB does occur, our intervention was designed to enable care home staff and
community mental health practitioners to use functional analysis to assess all the parameters of the case
sufficiently comprehensively and thus apply systematic support to reduce the impact of CB in dementia care.
Development of the intervention
We conceived a multimedia interactive functional analysis-based intervention for CB in dementia. This
comprised a training programme, together with two suites of decision support systems (one for staff in care
homes and the other for staff supporting family carers in the community) for the targeting of individualised
or person-centred interventions for CB in dementia. A range of options for the platform was considered,
including our original plan to develop DVD and CD materials. We explored the potential strengths of an
online solution, which were as follows: increased accessibility to information, where content could be
standardised, easily updated and revised (see Ruiz et al.87 for an overview of e-learning in education); options
for self-pacing to overcome time pressures;88 immediate feedback with options for improvement, which is an
important approach for adult learners;89 and fidelity of presentation with automated documentation, such as
tracking and reporting of the learner’s activity,73 to allow monitoring of usage and problems with the program
itself and thus facilitate improvements to meet the needs of the learner. In addition, feasibility studies in
the USA have noted that direct care workers in nursing homes respond positively to internet-based
multimedia training, including the management of aggression.70,71,73 In family care settings, information and
communication technology (ICT)-based solutions have been piloted74 and are also described as important
uncharted territory in supporting families to cope with CB at home.90 Given the huge growth of internet use
in recent years, we considered that the online option would offer greater flexibility for those, including care
home workers and community practitioners, who may wish to access the e-learning aspect of the resource
from other venues, including potentially their own home.
The e-learning course was a multimedia, interactive, skills-based method, to encourage comprehensive
assessment, such that knowledge about the person with dementia’s behaviour in their environment
could be understood in order to provide solutions. These could include signposting or referral to other
professionals when needed. Its aim was to encourage staff to systematically consider variables such as the
person’s medical status, life story, communication and a host of other ‘unobservables’ that may give clues
about the function of the behaviour. The information management systems (IMSs) for the two decision
support e-tools were designed to follow on from a ‘functional analysis’ of the behaviour, in selecting
approaches that were likely to ameliorate the behaviour, the emotional response to it or both. Three
e-learning modules (outlined below) were developed, using actors to simulate common behaviours seen in
people with dementia in context.70,73,91 The learner is required to observe the potential function of the
behaviour from observations and knowledge provided about the person’s past and present circumstances
and then consider supportive actions within three domains (i.e. health, psychological and caregiving
context) to meet their needs. The e-learning course was underpinned by a learning management system
that allowed users to manage their learning and user input to be recorded and potentially assessed and
used for targeted feedback. The e-tools that followed led to an assessment summary and algorithms for
developing an action plan, in each of the three domains, with the third domain being relevant to the
context of either a care home or family care setting. These were structured in line with the third e-learning
module, to provide functional analysis-based interventions for up to 25 CBs in dementia. The three
e-learning modules are as follows:
1. Module 1: an introductory module, introducing person-centred approaches in which CB is seen as a
response to a frightening environment or unmet need. This introduced the notion of a shared sense of
humanity and affinity with the person, in line with the philosophy underlying person-centred care.92
2. Module 2: a skill development module, using interactive video-clips to practise observation and
interviewing. This allowed staff to move away from the traditional ‘antecedent–behaviour–consequence’
observational approach to that of observing the relationship between emotion and communication
through the behaviour,93 in order to enhance emotion-orientated care94 where relevant. The intention
was to enable staff to appreciate the ‘language of behaviour’,95 that is, the feelings and intentions of the
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person with dementia that were being communicated by the behaviour, using observation of real-life
practice in the care setting and thus recognise triggers and early warning signs that can then be acted on
to prevent escalation of the behaviour into full-blown CB.96
3. Module 3: this comprised nine case examples of graded complexity, incorporating video-clips, and an
interactive procedure for accessing information about the person, relevant to a functional analysis of
the behaviour. This was followed by a case-specific intervention summarised in an ‘action plan’ to
address unmet need97 and thus reduce CB. Cases were derived from the clinical situation in which some
cases have been documented in the literature.1,13,68,69,98 Learners were guided through interactive
video-clips, resources that are relevant to the person with dementia, such as life story information or case
notes, audio-clips on views of others within the care context, and then provided with structured feedback
to set their observations of the person’s CB in the context of ‘causation’.49 The learning focused on
guiding staff to use ‘why’ questions63 to consider the potentially multiple causes for what they had
observed about the person and the behaviour in the vignette.13 Through using information about the
person’s current health and functional status, their life story and how others respond to the person with
dementia during an episode of CB, key concepts for managing CB13,99 were systematically covered to
address causation and possible methods of remediation. Three groups of ‘actions’ or interventions were
designed and tested in the clinical situation, including those to address unmet somatic and psychological
need97,100 in the person with dementia, as well as the caregiving environment, in which consideration of
the particular needs of the staff group or family carer were considered.86,101 These we refer to as
functional analysis-based interventions for the management of CB in dementia. These groups were
(1) ‘actions to support health needs’, for example signposting for help by the GP, to alleviate pain or
discomfort due to constipation, or review of medications, such as antipsychotics or sedatives that may
have been overlooked;100 (2) ‘actions to meet the psychological need of the person, such as how to
support the person who may be surrounded by a sense of ‘disorder’, perhaps trying to escape from this,
or feeling ‘trapped’ or ‘set aside’;102 and (3) ‘actions to support the caregiving context, environment or
system’,101 such as accessing support for care home staff or psychological therapy for the family carer.
Thus, in addition to the commonly advocated biopsychosocial approach for the management of CB in
dementia care,103 our system included interventions to address contextual needs such as those of people
providing care, which can be associated with CB,49,86 and are often overlooked (see Chapter 1).
The decision support e-tools were based on clinical practice guidelines76,104 with our assessment questions
firmly set within Dementia: A NICE–SCIE Guideline on Supporting People with Dementia and their Carers in
Health and Social Care for ‘behaviours that challenge’ in dementia.12,105 The questions that were used to
provide the ‘assessment summary’ are found in Appendix 1. We used case-based reasoning,106 in which
information collected about the person with dementia and their setting is stored and can be used as a
knowledge source to develop personalised interventions for particular problems. The case-based reasoning
method then flows into the action-planning part, in which the individual’s assessment is collated and ‘if–then’
logic is applied to generate choices for the practitioner to consider. The stored information can be used to
work on different problems, as a setting-specific (care homes and family care settings) CB checklist is supplied
at the beginning. The information source can also be updated; for example, if the person has a change in
their health or if they have recently experienced a bereavement or if new knowledge of a person’s life story or
personal ways of managing life is discovered. Our e-tool started with the 25-item Challenging Behaviour
Scale (CBS) of commonly reported behaviours in care homes107 for staff to select a behaviour to work on.
This scale has been recommended as a helpful measure for use in care homes across the UK (see Appendix 2
in Brechin et al.108). For community settings, we used the Problem Checklist,109 as this was based on the
concerns of UK family carers and had been used effectively in our previous study.65,109 This was seen as
important, as many guidelines for the management of aggression, for example, have poor representation of
some of the important individualised and contextual characteristics necessary for management.110 Having
chosen the person’s behaviour to work on, the staff member or practitioner is then asked to input selective
information about the person with dementia and CB, as they had discovered was necessary in module 3 of
the e-learning course. They are guided through the assessment process (see Appendix 1 for a detailed
description), concluding with a printable summary of the individual’s assessment. This summary includes
documentation of the potential cause(s) or function(s) of the behaviour that was based on the staff member’s
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or practitioner’s responses (see Appendix 1, Box 7).65,109 The practitioner is thus provided with a systematic
assessment framework where questions they considered covered important aspects of the person’s life story,
health status and other factors13 (see also Appendix 1). The next part of the decision support system is
the ‘algorithmic’ flow of the information into considering what interventions can be tried. The IMS was
conceived to use algorithms (which we tested in the clinical situation using a paper workbook), using the
aforementioned ‘if–then’ logic to provide options for treatment – in this case functional analysis-based
interventions for given behaviour that is seen as challenging. The interventions in our system are structured
within the three action groups that had been used in module 3. These are (1) support for health need, such
as considering the effects of commonly encountered medical conditions or the effects and side effects of
psychotropic and other medication; (2) support for psychological need, such as needs for reassurance, privacy,
comfort and occupation or activity; and (3) support for contextual needs, such as advice on how to optimise
the environment or system around the person. For each suggested action, tailored information is provided
on what staff can do themselves and when and whom to access for further help. Many of the options for
intervention for the first two groups of interventions are outlined in Dementia: A NICE–SCIE Guideline
on Supporting People with Dementia and their Carers in Health and Social Care.12 However, a structured
approach to making decisions about treatment based on the particular cause(s) underlying CB (functional
analysis) has been absent to date. The algorithms used for the decision support enable the care home staff or
community mental health practitioner to apply a structured methodology to choose a set of actions that are
possible for them to try within the resources available to them in their routine practice settings. The logic for
the case-based reasoning, using tailored assessments, and the algorithms for action plans was developed by
the co-chief investigator (BW). It was tested by the chief investigator (EM-C) using a paper workbook with
19 residents who had a score of 4 or more (eight residents) or 10 or more (11 residents) on the CBS.107 These
residents were drawn from eight care homes that were not involved in the CRT (see Chapter 3) and one
inpatient dementia unit. All of the 25 items of CB were covered when testing the logic, and actions were
refined at this stage. A separate paper workbook for family settings was tested with 15 cases of clinically
significant CB determined by a score of 5 and above on a widely used research tool – the Revised Memory
and Behaviour Problems Checklist (RMBPC).111 The practitioner was provided with the Problem Checklist,109
as this was based on the concerns of UK family carers. Action suggestions were further refined to add
opportunities that were available in NHS contexts, during our feasibility test with 26 community practitioners
from six NHS organisations. The software engineers who were employed to develop the IMS were required to
design the system to allow clinical experts (such as physicians, psychiatrists, psychologists and pharmacists) to
add content for the functional analysis-based interventions, described within three action plan groupings.
Thus, the utility of the action-planning component was that of flexibility for new actions that could be added
on an ongoing basis to the system, as experience with the system grew.
Summary of the Challenge Demcare intervention
We used three modules of e-learning to introduce care staff to observational skills and the algorithmic
approach to interventions comprising the first two components of the decision support e-tool. This
required the practitioner, working with the care staff and the family, to collect important information on
key contributory factors associated with CB (see Dementia: A NICE–SCIE Guideline on Supporting People
with Dementia and their Carers in Health and Social Care, section 8.6.1.1 on p. 260 and section 8.6.3.1
on pp. 262–312), such as the person’s current health and functional status, their life story, interpersonal
and communication style and how others respond to the person during an episode of CB. The decision
support system comprised relevant assessment tools and systems to collect this information with algorithms
to provide two sets of biopsychosocial groups of ‘action plans’ where practitioners could choose the
most relevant way to meet the person’s health or psychosocial need. These are referred to as functional
analysis-based interventions, as the approach was to assist practitioners to assess, analyse and then choose
the most appropriate set of interventions (‘actions’) for a given episode of CB. Actions for these two
components were extracted from the literature, including our overview in Chapter 1, the Cochrane
review,82 guidance from the International Psychogeriatric Association (see Complete Guide to Behavioral
and Psychological Symptoms of Dementia),36 the range of interventions for CB from Dementia: A
NICE–SCIE Guideline on Supporting People with Dementia and their Carers in Health and Social Care12 and
policy initiatives to reduce the use of antipsychotics in dementia.112
DEVELOPMENT AND TESTING OF AN ONLINE APPLICATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
14
Interventions included in the third component of the decision support tool were not related to the person’s
unmet need, but arose from a new concept derived from our overview (see Chapter 1), relating to the
needs of the caregiving system. These reflected, for example, the needs of the family carer for those living
at home (such as counselling or skills training) and those of staff or the environment (such as training, skills
enhancement or altering lighting or sound in a room). Algorithms for this component of the interventions
were therefore bespoke to the care home or family care setting, where the focus was the need of the
caregiving environment or system.
Methods
The e-learning course in care homes
The training, consisting of the three e-learning modules, was planned to occur within the care home, to
facilitate ease of access by all staff who wished to engage with this. As noted by researchers in Canada113
and the Netherlands,104 we too found very early on in the process that the majority of the care homes did
not have adequate computer equipment to offer online training. For example, most had just one or two
computers in the home for sole use by the manager and/or administrator. Therefore, a lengthy process of
installing the necessary additional equipment to enable access to the internet ensued. We supplied and
installed computers in 19 of the 27 experimental homes (14 laptops and five desktop computers), and
provided 16 printers. As noted by researchers in the USA when implementing internet-based training for
nursing assistants, buildings were also not always designed to accommodate computers and the internet, in
terms of either wiring or space.73 We arranged for broadband installation in three homes and new telephone
lines for broadband in two homes. On one occasion, a wireless internet booster had to be installed in a
resident’s bedroom and, to activate the wireless access, the router (located underneath the manager’s desk)
had to be switched on each time the staff required to access training. In some homes we provided memory
upgrades to the existing computer, wireless access points, power extension cables and headphones to allow
staff to access the interactive program without disturbing others. Apart from access to equipment and the
internet, organisational obstacles had to be overcome to facilitate staff access to the e-learning. These
included support from the research team when home managers were unable to ascertain whether
or not they had internet access, obtaining permissions from organisation head offices where their policies
would not allow for internet use in the home and negotiating with IT departments where technical support
for care homes was outsourced.
Once access to the technology required was in place, as with the US and Canadian research teams,73,113
a specialist dementia care therapist needed to work with individual staff in the first three care homes to
assist them with logging in and troubleshooting user errors or computer problems. We additionally offered
homes money to backfill staff in order that others could complete the training. Thus, we overcame some
of the impeding factors to e-learning in the care home setting, that is, a lack of ready access to computer
equipment or internet services and low-speed connections that could detract from the utility of the
programs, and staff confidence and motivation to use the training in their work environment. However,
despite everyone’s best efforts, our strategy for in-home access to training was not successful because
of interruptions, when staff felt that they were needed to help with care tasks or when they felt guilty
because they thought that their colleagues might be busy or struggling. An alternative strategy was then
used following discussion with care home managers, who nominated staff champions to undertake
training, with the intention that they would then support other staff in delivery of support to residents
with CB. As noted by others in this field,70,73 we needed to arrange training at an external venue where
computer suites were available, to allow staff protected time to complete training within small facilitated
group sessions. Funding for travel and time for backfill at the care home was made available. However,
training facilities within small groups were still not used to capacity, as it was difficult at times for some
homes to release staff to participate. Nonetheless, this worked much better than our attempts at offering
in-home access to e-learning, as staff champions had their own uninterrupted learning time, with access to
the specialist dementia care therapist and the opportunity to share and discuss with staff from other homes.
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The decision support e-tool in care homes
The technological underpinning for, and functionality of, the decision support software proved unreliable,
because of what may have been computer coding and software design problems with the IMS. The
case-based aspect of the system was mostly, but not always, successful in producing case-specific assessment
summaries, although these required some editing for presentation. The rule-based aspect was less successful
and the range of actions built into the system remained smaller than desirable. Moreover, the IMS did not
allow clinical experts to add management content on an ongoing basis. It had always been envisaged that
input from a specialist dementia care therapist, such as a CMHN or a psychologist, would be required to
assist with the care home intervention and support the action plans. With the limited range of actions
available from the decision support e-tool, this was indeed the case. Therefore, a specialist dementia care
therapist checked and, when necessary, edited the assessment summaries produced by the system using the
rule-based logic we developed, and worked with staff champions to provide an action plan that the
champions considered feasible to deliver in their home.
The decision support e-tool in the community
A second software company was employed to work on the community decision support e-tool. Community
practitioners from six NHS organisations were selected by their managers to deliver the intervention. They
had access to the e-learning course and were additionally trained in a small group setting by clinical experts
from the research team, using relevant cases from module 3 of the e-learning course. This was supplemented
by education about the rationale for case-specific functional analysis-based intervention, use of a training
manual comprising tools and resources necessary for functional analysis in people with dementia and CB
living at home (see Appendix 1, Box 9), and ‘hands-on’ practice with the community e-tool. For this case
practice they used the e-tool, with anonymised cases from their own experiences, and engaged in facilitated
group discussion with the clinical expert team and each other. These discussions focused on how to use the
functional analysis for the anonymised case to develop action plans that were feasible to deliver in their own
NHS context and its local resources.
Unlike the care home staff, all community mental health practitioners had access to computers and IT
facilities within their NHS organisations. For them, the use of computers was a routine part of their job.
Overall, the case-specific aspect leading to the assessment summary was superior to that of the care home
e-tool, in terms of functionality, presentation and navigation; that is, the assessment summary was of the
quality that was envisaged by the clinical expert research team. However, the software engineers did not
deliver a system that was fully populated with actions or one that allowed flexibility for new actions to be
added by the clinical experts. Therefore, the community mental health practitioners were provided with
our manualised resources, including validated tools to assess common CBs in family settings, and other
relevant contributory factors such as pain or discomfort in people with dementia or other family concerns
(see Appendix 1, Box 9). This provided them with a workbook, to assist them in adopting a systematic
functional analysis-based approach to individualised interventions for clinically significant CB in dementia
within family care settings.
Results
The e-learning course in care homes
Ninety-two staff champions across 27 care homes that constituted the experimental arm of the ResCare
trial (see Chapter 3) were trained on the e-learning course: 10 managers/deputy managers, 36 senior care
assistants, 45 care assistants and one administrator. Of these, seven staff completed the online training within
their care home setting and 85 attended sessions over 1.5 days. These occurred at a training centre with a
large computer suite. As with e-learning at the care home, this was facilitated by the specialist dementia
care therapist, but it additionally offered staff the opportunity for group discussion and demonstration of
the e-tool using anonymous cases of residents with dementia and CB from their own care home. In total,
11 training sessions were held outside the home over a 12-month time period (June 2011–June 2012).
Attendance ranged from 5 to 10 staff for each cohort (average of eight staff per group).
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In all homes the manager agreed to select at least two staff champions for training. Two of the homes
were unable to meet this requirement. The number of staff who attended training from the homes varied,
ranging from one to nine. Managers were asked to select ‘appropriate’ staff for the training, that is, staff
who were involved in care planning for residents with CB and dementia and, to the best of the manager’s
knowledge, were likely to be working in that home regularly for the foreseeable future. However, those
who ultimately attended the training were not always the most appropriate, as was the case of an
administrator who had no involvement in resident care and was not sure why they had been selected by
the care home manager.
Characteristics of staff champions
The majority of participating care home staff across both arms of the ResCare trial were female (89.7%),
and those designated as champions showed a similar gender balance to the overall pattern, with
89.1% being female. However, staff champions were slightly younger in age [mean 36.3 years, standard
deviation (SD) 11.8 years] than other staff (mean 39.6 years, SD 13.3 years), that is, those not trained
in experimental homes and all the staff in control homes. The difference in age was statistically significant
[t(606) = 2.12; p = 0.032].
Figure 1 shows the age groups of the champions compared with the ‘other’ non-champion staff members
in the ResCare trial, with differences particularly evident in the proportion of people aged ≥ 55 years and
between 25 years and 34 years.
All staff reported whether or not they had received previous training in dementia care or in the use of
computers and provided details of their highest qualification. Tables 1 and 2 summarise these data,
comparing staff selected as champions with the rest in the ResCare trial. The majority (n = 585) provided
most of the details requested.
Champions were significantly more likely to have had previous dementia training (χ2 = 4.38; p = 0.036),
but were no more likely to have had computer training. As seen in Table 2, champions were more likely
to have reached a higher educational level than other staff. Over half the champions (55.3%) had the
equivalent of two Advanced (A) Levels or a National Vocational Qualification (NVQ) of level 3 or above,
compared with 41.8% of the non-champions. This difference (higher vs. lower educational attainment) is
statistically significant (Fisher’s exact test, p = 0.0448).
It may be that some managers’ decisions in selecting staff to receive training and to oversee the
management of residents with CB may have been influenced by their perceptions of strengthening
capability for future leaders within the home, by selecting younger staff, with higher educational
qualifications and previous dementia care training.
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Staff champion feedback
Following the e-learning course, staff champions were asked to complete an anonymous questionnaire
using a set of study-specific open and closed questions, to access their views on the training, including
how it might be improved in the future. Eighty-five of the 92 care staff who received training completed
the evaluation questionnaire.
Only four participants identified aspects for improvement. The majority found the modules interesting,
understandable and easy to navigate. Ease of use was reported as follows: module 1, 95%; module 2,
82%; and module 3, 69%. Apart from one participant, the staff rated the modules as manageable to
TABLE 2 Highest qualification: champions compared with other care home staff
Qualification level
Staff
All staff
(N= 557)
Champions
(N= 76)
Other
(N= 481)
n % n % n %
No qualifications 3 3.9 25 5.2 28 5.0
One to four O Levels/CSEs/GCSEs (any grades), entry level, Foundation
Diploma, NVQ level 1, Foundation GNVQ, basic skills
6 7.9 68 14.1 74 13.3
Five or more O Levels (passes)/CSEs (grade 1)/GCSEs (grades A*–C), School
Certificate, one A Level/two or three AS Levels/VCEs, Higher Diploma, NVQ
level 2, Intermediate GNVQ, City & Guilds Craft, BTEC First/General Diploma,
RSA Diploma
24 31.6 175 36.4 199 35.7
Apprenticeship, two or more A Levels/VCEs, four or more AS Levels, Higher
School Certificate, Progression/Advanced Diploma, NVQ level 3, Advanced
GNVQ, City & Guilds Advanced Craft, ONC, OND, BTEC National, RSA
Advanced Diploma
29 38.2 139 28.9 168 30.2
Degree (e.g. BA, BSc), higher degree (e.g. MA, PhD, PGCE), NVQ level 4 or 5,
HNC, HND, RSA Higher Diploma, BTEC Higher Level
10 13.2 36 7.5 46 8.3
Professional qualifications (e.g. teaching, nursing, accountancy) 3 3.9 26 5.4 29 5.2
Other 1 1.3 12 2.5 13 2.3
A Level, Advanced Level; AS, Advanced Subsidiary; BA, Bachelor of Arts; BSc, Bachelor of Science; BTEC, Business and
Technology Education Council; CSE, Certificate of Secondary Education; GCSE, General Certificate of Secondary Education;
GNVQ, General National Vocational Qualification; HNC, Higher National Certificate; HND, Higher National Diploma;
MA, Masters; NVQ, National Vocational Qualification; O Level, Ordinary Level; ONC, Ordinary National Certificate;
OND, Ordinary National Diploma; PGDE, Postgraduate Diploma in Education; PhD, Doctor of Philosophy; RSA, The Royal
Society of Arts; VCE, Vocational Certificate of Education.
TABLE 1 Dementia and computer training: champions compared with other care home staff
Previous training
Staff
Chi-squared test p-value
All staff (N= 564)Champions (N= 77) Other (N= 487)
n % n % n %
Previous dementia training
Yes 62 80.5 331 68.0 4.38 0.036 393 69.7
No 15 19.5 156 32.0 171 30.3
Previous computer training
Yes 32 41.6 171 35.1 0.94 0.333 203 36.0
No 45 58.4 316 64.9 361 64.0
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navigate. In a few cases learners had difficulties with the system crashing but, generally, they reported that
this was overcome with help from the specialist dementia care therapist, who assisted with restoring
connectivity. The majority of participants reported that the additional information provided by the system
(such as a glossary and specific help/information boxes, particularly those relating to medication) had been
very useful.
Most responses on aspects of the three individual modules were positive (Box 1). Only five people stated
that they found parts of the individual modules difficult. The few negative comments were mainly
regarding some aspects of the commentary, which was described as repetitive, and when suggestions for
improvement ‘to vary the narrators’ were made.
All those completing the evaluation form stated they would recommend the e-learning to other colleagues
working in similar care roles. Examples of comments taken from the questionnaires from those completing
the e-learning course were as follows:
I enjoyed the training because I could listen and watch at the same time – this was important because
I have dyslexia.
I liked everything about it. I really enjoyed the course and found it very helpful and have learned a lot
. . . would recommend all my work colleagues to take the course.
I would like the lecturer to bring the computer to my residential home so everybody could do the training.
BOX 1 Care home champions’ comments on what they had learned
Module 1
l People with dementia act the same as other people (36%).
l I learnt something about myself (25%).
l Greater awareness about behaviour in general (16%).
l We are all individuals (13%).
l A mixture of the first two responses (5%).
l Strategies for coping with CB (4%).
Module 2
l Videos and strategies to manage CB (30%).
l Similar behaviour may be for different reasons (28%).
l A basic grasp of functional analysis (i.e. look for reasons behind the behaviour) (17%).
l Generalised comments about what they had observed and the use of videos of real situations that helped
them become more aware of resident ‘communication’ (14%).
l Greater awareness of self-stimulation for pleasure (8%).
l Comments about self-development (3%).
Module 3
l Each person is unique and this impacts on their behaviour (38%).
l Comments about usefulness of videos of their situations and strategies to manage CB (29%).
l Stressed the need for effective care planning (18%).
l Greater understanding about behaviour in general (10%).
l Ill health as a causal factor (3%).
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Liked it all – I wish I had this teacher when I was at school.
It’s so lifelike.
The video clips showed just how it can really can be.
I learnt that the same type of behaviour can mean lots of different things.
Some answers were a bit tricky and really made me think.
It was very realistic and well planned out.
Learnt how to manage situations better – and also how to interact with the residents.
To look at the whole person, not just one problem . . . that’s what I learned.
The computer training and the teacher information was helpful and helped me to ask questions and
share my ideas. I would like the tutor to come to the home.
That I could do it at my own pace but could ask the teacher questions.
I found this tool very insightful and look forward to putting it into practice.
Staff learning styles
Applying knowledge to practice can depend on how closely training can accommodate the learning
preferences of the learner. In the previous section we outlined how preferences associated with self-pacing,
training away from the work environment and for facilitated small group learning in the cohort of staff
champions were addressed. Some theorists have suggested that the effectiveness of training can also be
influenced by how well its methods are matched to an individual’s own learning style.114 This is thought to
be particularly important for online learning, compared with traditional instructor-based classes.115 Some
studies have concluded that learning style makes no difference to learning outcomes,116 but most of these
studies were with student or professional populations and employed a variety of instruments, depending on
the theoretical underpinnings of the researchers, to measure learning style.114 One of many approaches
used by educators to understand individual preferences for learning among unqualified staff, such as care
assistants, is the visual–auditory–kinaesthetic (VAK) learning style model. The VAK questionnaire117 is
thought to identify preferences for learning that may influence the effectiveness of practice-based training.
As far as we can ascertain there are no normative data, but one study118 indicated that care staff
predominantly prefer visual learning (i.e. learning that seeing pictures or visual displays and demonstrations
of ‘how to do’). Kinaesthetic learning (i.e. learning through actively doing a task) is less popular, with
auditory learning (i.e. listening to a lecture) being the least preferred method among care staff.118
The Challenge Demcare e-learning course was strongly biased towards visual real-life situations. The course
contains an insignificant element of auditory learning (i.e. listening alone), as it does not provide didactic
instruction-based training and narration is usually combined with visual and interactive technology to
prompt the learner to think creatively.
To examine the hypothesis that the design of the e-learning modules was compatible with the learning
needs of staff, the VAK learning styles questionnaire117 was completed by most staff in the ResCare trial.
Thus, data were also available for 78 of the 92 staff champions, as well as ‘other staff’ from both intervention
(experimental) and control homes across the study. Table 3 shows the learning styles of the 78 staff
champions compared with the rest of the care home staff (n = 407).
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Nearly two-thirds of the responding staff champions (61.5%, n = 48) had a predominantly visual learning
style or a style that included visual preference in combination with others, that is, essentially a preference
for seeing or observing things such as films, pictures and demonstrations of how to perform a new task,
before trying it out themselves. An even greater proportion (74.0%, n = 301) of the ‘other staff’ had a
predominantly visual learning style or a combination that included a visual style preference. Combining the
champions who completed the e-learning and the ‘other care home staff’, this strong preference for visual
learning represented 71.9% (n = 349) of the total staff group. Only 12.6% (n = 61) of care home staff
were classified as having a purely kinaesthetic learning style, meaning that in order to learn they would
need someone to show them what to do.
If the widely used VAK learning style model and its questionnaire117 is an appropriate measure of learning
preferences in unqualified care workers, our findings suggest that an interactive system using real-life
situations through video and related materials is a potentially effective type of training for most care staff,
whose training needs/preferences appear to be weighted towards visual demonstrations of ‘how to do’.
Effects of staff training on reports of challenging behaviour in care home residents
Of the 92 staff trained on the e-learning course, 83 provided baseline CBS data for 78 residents with
dementia and CB in the ResCare trial. Of these, 55 staff champions subsequently provided follow-up data
for 112 residents with dementia and CB. Those staff champions who did not provide follow-up data
had not left the care home: in three cases, the care home itself had withdrawn from the study and 25
champions were simply not available at the time of data collection (e.g. were on holiday, off sick or had
switched to night shift).
Most CBs were reported to have declined between baseline and after staff training; for example,
perseveration was recorded as a problem for 61.1% of residents at baseline, but for only 24.4% of
residents following staff training, and levels of this behaviour remained lower at follow-up (reported in
46.1% of residents). Restlessness and lack of self-care also reduced following staff training, but this
reduction was not maintained at follow-up. In contrast, small increases in certain behaviours, namely
physical and verbal aggression, self-harm and inappropriate sexual behaviour, were reported (see Table 5).
All residents with action plans and for whom questionnaires were completed at all three time points
were included in an analysis of change over time. Residents’ CB incidence scores, as measured on the CBS,
decreased directly after staff training but returned to the baseline level by follow-up (Figure 2). The difference
between baseline and post-staff training was significant [t(178)= 7.4; p < 0.001] and the difference between
post-staff training and follow-up was also significant [t(178) = 7.6; p < 0.001].
TABLE 3 Learning styles of champions compared with other care home staff
Learning style
Staff, n (%)
Total (N= 485), n (%)Champions (N= 78) Other (N= 407)
V 34 (43.6) 200 (49.1) 234 (48.2)
A 13 (16.7) 53 (13.0) 66 (13.6)
K 14 (17.9) 47 (11.5) 61 (12.6)
VAK 5 (6.4) 34 (8.4) 39 (8.0)
VA 6 (7.7) 35 (8.6) 41 (8.5)
VK 3 (3.8) 32 (7.9) 35 (7.2)
AK 3 (3.8) 6 (1.5) 9 (1.9)
A, auditory; K, kinaesthetic; V, visual.
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Uptake of the e-learning course after completion of the ResCare trial
Following completion of the ResCare trial, managers at 54 of the study care homes were sent a letter
thanking them and their staff for their help. Homes were not sent a letter if they had dropped out of the
study or had closed down. In this letter managers were offered free licences for the e-learning course;
those in the control homes were offered up to a maximum of five free licences and the experimental
homes were offered up to three. Only 30% (n = 16) of homes requested any free licences. In control
homes, between three and five licences were requested, and in experimental homes this number ranged
from one to three.
In total, we provided 60 free licences (April 2013) to care homes in the study. Sixteen weeks later, data
extracted from the learning management system showed that only 12 staff from six homes had activated
their licence and started training. Of these, only six accessed training for > 1 hour in total, and a further six
accessed training for < 5 minutes. The majority of staff trained during the ResCare trial took around 5 hours
in total to complete the three modules of the e-learning course. Therefore, staff who used the e-learning
for < 1 hour are unlikely to have completed more than the first module. Once a licence is activated,
training can be accessed online for 3 months. Users who successfully complete all three modules are issued
with a certificate, which can be downloaded and printed off. Only two staff members completed the full
e-learning course in the 16 weeks from the time the licences were provided. They were both from the same
care home; one user took 3 hours 35 minutes and the other just under 5 hours to complete the course.
The low take-up rate of free e-learning for functional analysis-based training in dementia and CB is
disappointing, particularly as the learning styles analysis showed that the type of training being offered
through our e-learning course is compatible with the dominant preferred (i.e. visual) learning style in care
home staff. Given that all those who completed an evaluation form following the e-learning said that they
would recommend the training package, it was surprising that only 30% of the homes requested the free
licences on offer. This perhaps confirms our initial experience that e-learning is hard to implement in care
home environments, where staff have other duties to consider and practice development may not be
the norm.
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The decision support e-tool in care homes
Action plans
Following the training of staff champions using the e-learning course, three research therapists, including
the specialist dementia care therapist, then worked with the care home staff on the development of
functional analysis-based interventions for 199 residents with dementia and CB (defined as having a score
of ≥ 4 on the 25-item CBS107 at baseline data collection). Residents were living in 26 intervention homes, in
which an action plan was developed for an average of 7.65 residents (range 2–18 residents). Initially, there
were 28 intervention homes; however, one home declined the intervention but remained in the study and
another withdrew prior to the intervention. As seen in Figure 3, the main reasons for not providing action
plans were that the resident had died or that the care home had either declined the intervention or
withdrawn from the study.
Research therapists gathered the information required about residents using the decision support e-tool.
The specialist dementia care therapist was responsible for developing and checking the feasibility of the
action plans to address CB for each resident with the relevant staff champion. The other two research
therapists assisted with the gathering and inputting of information for populating the action plans in 64%
of the 199 residents for whom care plans were developed, but they were not involved in communicating
with staff champions in the final development of these. Twenty per cent of the resident action plans were
checked and refined, if necessary, by one of the clinical experts from the research team.
Excluding travel time, the research therapists spent 158 hours with care home staff champions (n = 49)
gathering information required for the development of action plans. Therapists spent a further 273 hours
inputting the information into the e-tool, most of which was done away from the care home. The
specialist dementia care therapist then spent an additional 464 hours enhancing the action plans that were
Baseline 
(n = 286)a,b
No action plan developed (n = 87)
• Participant died, n = 33
• Moved care home, n = 9
• Care home withdrew prior to the
   intervention, n = 11a
• Care home declined the intervention, n = 12b
• Staff did not perceive resident as 
   having CB requiring intervention, n = 10
• Now required end-of-life care, n = 7
• Currently ill, n = 2
• Premorbid functional illness requiring 
   alternative care, n = 2
• Current care plan was working well, n = 1
Follow-up (n = 22)
Action plan developed (n = 199)
Follow-up (n = 180)
Withdrawn from trial (n = 65)
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• Care home withdrew, n = 16
• Moved care home, n = 11
• In hospital, n = 1
• In palliative care, n = 1
Withdrawn from trial (n = 19)
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• Care home withdrew, n = 4
• Moved care home, n = 1
FIGURE 3 Challenging behaviour in residents within the intervention group. a, Two homes withdrew from the
study (one before action-planning and one after); b, one intervention home declined the intervention, but
contributed to follow-up assessment.
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produced via the system for 199 residents, and an additional 69 hours with care staff (n = 36) going
through them. Additionally, a further 33 hours of resource was provided to homes (n = 17), in the form of
‘booster’ visits or telephone calls, whereby the specialist dementia care therapist provided extra support or
information to staff in relation to action plans, for approximately 65% of residents (n = 139). Across all
tasks involved in the development of the action plans, 101 hours of research therapist travel time was also
incurred, with an additional 8 hours spent on visits to seven of the care homes at various points being
unproductive because care home staff were not available for pre-arranged meetings. Excluding travel time
and unproductive visits, research therapists spent a total of 997 hours on the generation and delivery of
the action plans. This equates to an average of 5 hours per action plan produced. The action-planning
aspect of the intervention may be described as ‘low intensity’,119 in terms of specialist input to the care
home, particularly as significant time was spent interacting with the technology. Higher-intensity
interventions were described in our functional analysis-based interventions review,82 in which just three
studies in the care home setting were found.
Selection of the behaviour
The action plans were seen as the potential mechanism for changes in incidence, frequency and severity
of CB in the intervention homes, either directly, by making a difference to the targeted behaviour, or
indirectly through modelling a problem-solving approach. In practice, staff did not use the option of
adding a behaviour that was not included on the 25-item CBS,107 apart from for one resident in whom
‘fear of walking’ was seen as important and for whom a second action plan was developed. This suggests
that the CBS107 remains a relevant and comprehensive assessment tool in the care home context. The
behaviour most frequently selected by staff champions for an action plan was physical aggression; from
199 action plans, 18.1% focused on this (Table 4). Verbal aggression and shouting were each the focus of
more than 10% of action plans, with the remaining 60% spread across 20 other behaviours.
For residents who were the subject of an action plan, incidence scores [i.e. does the behaviour occur?
(yes/no)] for each of the 25 CBS items were available from the baseline assessment (time point 1),
immediately after the staff training (time point 2) and at the 4-month follow-up assessment (time point 3).
Table 5 shows the CBS107 items for 180 residents for whom action plans were developed and follow-up
data were also available, at all three time points. The behaviour selected for the action plan is also noted
(see Table 5).
The most frequently chosen behaviour for action-planning was physical aggression, selected for one-third
of residents who showed this behaviour. On the other hand, over 50% of residents were recorded as
having ‘lack of self-care’ at all observational time points, but only 5.5% of residents with self-care
problems had an action plan focused on this behaviour. Other behaviours such as wandering (21.6%),
non-compliance (21.3%), inappropriate urination (19.0%), shouting (18.4%) and verbal aggression
(17.0%) were more likely to be selected if they occurred. Some rarely occurring behaviours, such as
inappropriate sexual behaviour, were more likely to be selected (33.3%), but others, such as dangerous
behaviour, were not selected for management by any of the staff champions. Perseveration (repeated
physical or verbal actions) reduced from 61.1% to 24.4% following training, with just 9.1% selected for
a management plan. Restless behaviour was selected in only 11.1% of action plans, though 61.7% of
residents were recorded with this CB at baseline (time point 1). These choices may reflect the perceived
severity of managing the particular resident’s behaviour or the intention by some staff to consider action
plans for other behaviours later. The incidence of some behaviours increased over time; for example, the
prevalence of physical aggression increased at each of the three time points.
Booster visits: feedback from the specialist dementia care therapist
The specialist dementia care therapist had access to clinical experts from the research team for
development and delivery of the action plans. This specialist therapist also provided ‘booster’ calls to
support staff in delivery of the action plans in 17 homes. Key extracts from the clinical expert team’s
process notes reflecting themes associated with particular aspects of delivery were those relating to action
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plans; those relating to residents; and those relating to the therapist’s experience of the e-tool during its
delivery. These are summarised as follows:
1. Action plans:
Some action plans had in part, signposted staff to contact the person’s GP to elicit help with
interventions such as pain management or review of antipsychotic medication if relevant. In one home
the GP had not been forthcoming for a resident and the staff champion appeared to have lost
confidence in considering such actions for other residents. The specialist dementia care therapist acting
as part of the research team did not feel it appropriate to talk with the GP.
In contrast, within developing multidisciplinary supported ‘in-reach’ for CB to care homes97 a CMHN
or other practitioner, acting in the role of a dementia specialist therapist, would have access to expertise
of other professionals such as a psychiatrist and may be in a better position to communicate with the
GP about the medical care of a particular resident.
TABLE 4 Behaviours selected for resident action plans (n= 199)
Behaviour selected for action plan Number selected for action plans (% of total)
Physical aggression 36 (18.1)
Verbal aggression 22 (11.1)
Shouting 22 (11.1)
Wandering 16 (8.0)
Non-compliance 16 (8.0)
Lack of motivation 10 (5.0)
Screaming 9 (4.5)
Restlessness 8 (4.0)
Interfering with other people 7 (3.5)
Lack of self-care 6 (3.0)
Demands attention 6 (3.0)
Lack of occupation 6 (3.0)
Suspiciousness 5 (2.5)
Perseveration 4 (2.0)
Clinging 4 (2.0)
Pilfering/hoarding 4 (2.0)
Inappropriate urination 4 (2.0)
Sleep problems 4 (2.0)
Faecal smearing 3 (1.5)
Inappropriate sexual behaviour 3 (1.5)
Self-harm 2 (1.0)
Spitting 1 (0.5)
Manipulative 1 (0.5)
Dangerous behaviour 0
Stripping 0
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2. Residents:
The specialist dementia care therapist and staff have had difficulty in finding a behaviour that requires
an action plan. The CBS has just three items identified and none of these are of concern to staff.
Although an action plan was developed, the therapist did not feel it a worthwhile task for the
particular resident.
3. Specialist dementia care therapist experience:
I have to word process these Assessment Summaries to improve presentation and typos . . .; actions
seem quite repetitive for staff . . . they like to see each resident as having ‘different needs’. I made
actions read slightly differently to make these palatable for staff. I talked to [staff champion] and
needed to adjust this action plan to make it more helpful for other staff to use.
TABLE 5 Residents with action plans and CBS incidence at three time points (n= 180)
CBS behavioura
Per cent displaying behaviour
Item chosen for action plan
from all with this behaviour
at time point 1 (%)
Time point 1:
baseline
Time point 2: post
staff training
Time point 3:
follow-up
Physical aggression 49.4 53.3 61.1 33.3
Verbal aggression 60.6 62.2 59.4 17.0
Self-harm 6.1 6.7 6.1 8.3
Shouting 64.4 54.4 61.7 18.4
Screaming 34.4 30.0 35.6 14.8
Perseveration 61.1 24.4 46.1 9.1
Wandering 50.6 41.1 43.3 21.6
Restlessness 61.7 40.0 54.4 11.1
Lack of motivation 60.6 43.9 65.0 11.4
Clinging 27.2 17.8 27.2 12.5
Interfering with other people 35.6 26.7 32.8 14.6
Pilfering/hoarding 24.4 18.9 22.2 11.8
Suspiciousness 36.7 21.7 32.8 10.3
Manipulative 11.1 6.7 8.3 8.3
Lack of self-care 77.2 50.6 88.9 5.5
Spitting 11.1 8.9 10.0 6.3
Faecal smearing 17.2 13.3 20.0 12.5
Inappropriate urination 16.7 11.7 13.9 19.0
Stripping 18.3 11.7 16.7 0.0
Inappropriate sexual
behaviour
3.9 5.0 5.0 33.3
Sleep problems 35.8 29.4 30.7 7.5
Non-compliance 54.4 41.7 56.7 21.3
Dangerous behaviour 9.4 3.3 10.6 0.0
Demands attention 31.7 20.0 36.7 11.1
Lack of occupation 51.7 33.3 60.6 8.3
a Behaviours are listed in the table in the order in which they appear on the CBS.
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The decision support e-tool in the community
This version of the decision support e-tool was extensively tested for acceptability with 26 community
mental health practitioners between November and December 2011. They included CMHNs and others
from occupational therapy, social work and clinical psychology disciplines, across six specialist community
mental health NHS organisations in England. Prior to use of the e-tool, practitioners practised its logic
using the e-learning. They used the system with ‘anonymised cases’, in that they adapted information from
their current case to practice, but then ensured that for data protection reasons they did not include any
personal identifiable details.
In most cases, but not all, training occurred at the host NHS sponsor site in Yorkshire, allowing practitioners
from different parts of the country to discuss their experiences of providing care to families supporting
people with CB and dementia at home. Connectivity fluctuated across training sessions, depending on
internet speed at a given time or NHS location. For example, at one NHS trust, a thunderstorm delayed
use and overall speed was significantly slower than at the sponsor’s NHS site; and, at the sponsor site,
practitioners reported varying difficulties with connectivity and speed when using the e-learning course at
their own team location. Many practitioners reported that computer and internet use in their routine
practice was a predictable pressure on their work, stating connectivity and slow speeds as some common
difficulties. Overall, these internet experiences with the e-tool were not perceived as an obstacle to the
delivery of computer-assisted functional analysis-based interventions for their patients with dementia and
CB, by community mental health practitioners.
One practitioner felt that use of the e-tool did not add anything to their own practice:
Feels like it’s what I do a lot of already without technology to help me – but it’s a different way of
formulating. Glad it may help all therapists to work in the same way.
Occupational therapist 1
Overall, practitioners found the e-tool easy to use and understandable, and comments were positive:
Makes you think differently using functional analysis.
CMHN 1
This will help families to feel listened to and give therapists the tools to help decide what needs to be
focussed on.
Psychologist
Like the assessment summary as it gives the key relevant information all in one place rather than
trawling back through notes.
Occupational therapist 2
Glad it’s not lots of paperwork and glad it’s not just limited to medical interventions. Keen to reduce
reliance on meds that are not needed.
CMHTOP practitioner
Think I can use the videos and audio to help families see that they are not alone and we can
work together.
CMHN 2
Think the tool will fit in smoothly with work I do already.
CMHN 3
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It’s better than I expected, pulls all the information together, action plan printable. I like the format
and that the scoring is done for you.
CMHN 4
I like that it’s planning specific and evidenced.
CMHN 5
The behaviour checklist is helpful carer’s can complete whilst waiting and we can use it with the carer
to decide how to help.
Psychologist
The behaviour checklist is better than what we use . . . and its evidenced.
CMHN 5
This version of the e-tool was subsequently adapted to take into account the practitioners’ suggestions
for improvements, mainly aesthetics and clarifications on wording rather than content. A limitation to our
evaluation was that, although participants were trained in a small group setting by clinical experts from
the research team, using relevant cases from module 3, we did not take formal data on this aspect of the
training. However, our previous participatory workshops with teams (see Chapter 5) to introduce the study
suggested that practitioners were enthusiastic about the video material presented of real-life situations
in dementia care. Another limitation was that usability of this computerised system could not be fully
piloted in routine practice for two main reasons. First, we were impeded by the time required to make
arrangements with clinical information governance systems within individual NHS organisations. They were
under pressure to develop their own online clinical decision support tool,120 to train practitioners to cluster
patients in groups in preparation for the Payment by Results (PbR) initiative (see Chapter 5), which is
now mandated for all mental health NHS organisations in England.121,122 In particular, as was noted by
another study of online decision support software for mental health conditions,123 we had yet to resolve
complications such as security and privacy concerns with each NHS organisation. Second, the software
company was provided with a database of expert interventions, but there were delays in full population
of the system. Because of these impeding factors, although we fully investigated acceptability, we were
unable to conduct a feasibility study using the e-tool in the NHS within the time scale of our programme.
As noted earlier (see Methods), it was not possible for our clinical expert team to update and manage the
content of the e-tool, in order to reflect knowledge or resource updates relevant to action-planning.
However, some practitioners tested feasibility of our protocol to deliver functional analysis-based
interventions (biopsychosocial) for dementia with CB, within their own work with their patients and
families. During our consultations with them and their managers (March–May 2011, see Chapter 5) many
had realised that they had been overlooking potential cases for the functional analysis–based intervention
as a result of their misunderstandings about the nature of dementia and CB in family settings. This was at
a time of significant redesign of specialist dementia services across the NHS in England (see Chapter 5).
Consequently, some NHS organisations involved their memory clinic services in order to locate families that
might be suitable for the FamCare study. All CMHTsOP and memory clinics involved in the FamCare study
had access to clinical expertise with respect to medical (health) and psychosocial (the person with dementia
and the family) needs that were identified by the trained practitioner, through use of the functional
analysis (see Appendix 1, Box 9). Although practitioners did not have access to the e-tool, paper copies
were included in the therapist manual that was supplied during training.
Discussion
This chapter has outlined the development and field testing of a training and decision support intervention.
The main findings are threefold, the first located in community NHS settings and the others in the care
home context. These will be outlined next.
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In the context of specialist community services for the provision of support to people with dementia and
families at home, skilled professionals perceived the decision support e-tool for functional analysis-based
interventions as useful and relevant to their practice. In the past, this type of service to families was usually
provided by the CMHN, with support from a multidisciplinary team for older people.65 A potential strength
of our study, in terms of the NHS, is that the professionals were selected for this study by their managers
at a time when they and their organisations were being prepared for a nationally driven new financial
regime.122 The debate across these organisations was about which professional group should deliver this
type of support, and the present study recruited a range of professionals, including CMHNs. A potential
methodological weakness of this approach was that these professionals were both highly experienced and
motivated practitioners. It is out of the scope of our findings to comment on whether or not all qualified
practitioners with a remit for providing intervention for CB in dementia care at home would be as
enthusiastic about using the computer-assisted intervention in clinical practice. Kortteisto et al.124 noted
that all professional groups have their own perceived duties and practices, and that the perceived
usefulness of decision support systems can vary even between professional groups. This will undoubtedly
affect the motivation of practitioners to engage directly with the software and indirectly with the
intervention.
In the care home context, we overcame most of the commonly reported obstacles to e-learning, such as
access to computers, bandwidth and other factors related to the internet, provided funding to release staff to
engage in learning,73,104,113 and designed a course that was compatible with the learning styles of most care
staff. However, we failed to engage staff at the homes. Several optimal conditions for e-learning for staff
working in care homes can be recommended on the basis of this study.
First, management-led selection of staff champions to co-ordinate and support staff in the delivery of
interventions was seen as a way forward for most homes. If the goal of the care industry is to develop care
leaders for the future, our data suggest that champions will be selected from those who are younger, with
higher educational qualifications, and who have had previous dementia training, but are not necessarily
any different from other staff in their experience of use of computers (see Characteristics of staff
champions). There was some evidence that the method of training, combined with facilitation by the
specialist dementia care therapist, was important, perhaps in overcoming stigma attributable to perceived
low literacy, which is known to undermine communication with health-care professionals,125 and in this
case may also reduce access to training initiatives for some staff. For example, some staff made comments
such as ‘I enjoyed the training because I could listen and watch at the same time – this was important
because I have dyslexia’ or ‘I wish I had this teacher when I was at school’ (see Staff champion feedback).
Second, training allowed for the preferred option of delivery at an external site with some face-to-face
interaction with the specialist dementia care therapist and some group-based discussion.70,126 Although the
training was well received during the project, its take-up beyond the project was disappointing. It is
beyond the scope of these findings to offer robust evidence that the care home sector in England is ready
to fully embrace an electronic learning culture, on its own. However, the findings outlined in this chapter
provide some recommendations on how specialist dementia care therapists can assist care homes to use
this e-learning course as a means of sensitising staff to the case-specific elusive nature of CB in dementia,
and ways to approach effective responses. This is important as a recent review of e-learning in dementia
care, a study of 21 care staff and managers from three care homes in south-east England, observed that
staff were ‘unanimously enthusiastic about the potential for e-learning to help them’ deal with CB, using
video-clips of different examples.127 Sensitising staff to an understanding of case-specific causality of CB
and functional analysis-based interventions, through online training, did appear to have the power to help
staff to change or expand the way in which they perceive behaviour they find challenging (see Figure 2). A
previous pilot study of functional analysis-based intervention for CB, which used face-to-face workshops
for all care staff in three homes, noted a positive post-training effect at 4 months’ but not 12 months’
follow-up.63 The effect of the present e-learning course appears to be less sustained. Compared with the
4-month follow-up of the pilot study,63 the planned 4-month follow-up in this present study of 27 care
homes averaged 7.8 months, ranging from 5 to 11.5 months (see Figure 2). A study of decision support
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interventions in care homes104 noted that continued support of staff beyond the initial maintenance phases
of a study is of key importance. In the present study this is reflected in the time taken by the need for
external support on the assessment, on supporting implementation of action plans and for ‘booster’ visits
to the home.
Finally, the decision support e-tool allowed staff, with support from a specialist dementia care therapist,
to initially select one of the behaviours from the CBS107 to develop a functional analysis-based action plan
for a given resident; for two residents, staff, assisted by the specialist dementia care therapist, developed
action plans for two resident behaviours. Residents selected for intervention at baseline were required to
have four or more behaviours on the CBS107 at that time point. The effect of training on the perception
of staff (see Figure 2) may, to some extent, have influenced their choice of behaviour for developing an
action plan (see Table 4). For example, staff sometimes struggled to find challenges in residents that they
had previously reported as presenting with at least four behaviours that were challenging (see Figure 3
and Booster visits: feedback from the specialist dementia care therapist). In addition, highly prevalent
challenges around self-care, restlessness and perseveration in residents were not often chosen for attention
with an action plan (see Table 5). Of note is that restlessness and perseveration include descriptions of
pacing or physical agitation, which, together with challenges in assisting residents with self-care, are common
antecedents for episodes of aggression.49,128 Furthermore, poor experiences with other professionals, such as
a GP, may have undermined commitment to the action plans for some staff, as an intervention from another
study to address unmet need in people with dementia living in care homes suggests that, compared with
mental and social health, physical health needs (sensory loss, mobility and medication) were aspects that care
staff seemed motivated and able to meet with some success.129
Limitations
A limitation to our approach is that, apart from the paper workbook-based clinical checks of our e-tool,
it was not possible in the project time scale to validate the e-tool itself outside the CRT (see Chapter 3).
Reasons for time scale delays are documented in this chapter (see Changes to protocol: the ResCare trial
and Changes to protocol: the FamCare trial). In addition, it was also not possible to implement our original
plan to build into the action-planning cycle an iterative process that would enable staff to refine and
modify a resident’s action plan based on their findings from trying out the first set of actions. According to
the principles of a functional analysis approach to understanding behaviour,1 and our modelling of this in
clinical practice,13,68,69 an iterative ‘detective’ approach to problem-solving is usually required. Nor did our
time scale allow staff to receive assistance from the specialist dementia care therapist to target the range
of multiple behaviours, as often there are a number of behaviours that cause distress for the person living
with dementia and those supporting them. Moreover, neither the e-tool nor the specialist dementia care
therapist monitored detailed implementation of the action plan in the care homes. For example, although
clear strategies on contextual issues in the care home, such as assigning responsibility across shifts to
ensure that all staff took a consistent approach and time scales for specific aspects of the action plan
were documented, these were not actively monitored. A further limitation is that if the success (or not)
of the action plan is not reviewed then poor action plans may be implemented in the future. The
assumption underlying the decision support e-tool was that encouraging staff to ask ‘why’, to seek fuller
understanding of individuals and their behaviour, would lead to change in staff behaviour and perception.
Although the training may have contributed to a change in perception, the next stage – of recording
actions undertaken and the response – was not part of the e-tool as designed here. The intention was
that this aspect should fit with systems already in place in the care home, but this may be a limitation of
our approach.
Conclusions
Providing computers, internet facilities, access to a specialist dementia care therapist and backfill funding to
release staff to use the training facilities was not enough to engage most care home staff in e-learning.
Champions, who were nominated by the care home manager, attended an external centre to use e-learning
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in facilitated small groups. They were enthusiastic about its potential to help their colleagues support
residents with dementia and CB, but take-up by their colleagues was disappointing. The evidence from this
study suggests that the care home sector in England is probably not yet ready on its own to engage fully in
technology-driven education to assist staff to support people with dementia and CB. This study provides
knowledge about important preparatory actions to overcome known obstacles to e-learning as an education
method for care home staff who wish to engage in this. Care home organisations and their managers would
need to weigh up options such as whether staff would prefer to access e-learning at an external site, in
small groups facilitated by a dementia specialist, or if the care home environment would need to arrange
computer and internet facilities in the home; or a combination of these options. In contrast, providing
specialist community dementia practitioners in the NHS with some training and a computerised rule-based
system for making decisions about the most appropriate set of interventions in a given family setting,
described here as ‘functional analysis-based interventions’ to support people with dementia and CB at home,
shows promise. However, usability will depend on the success of collaboration between clinical experts, IT
advisers within individual NHS organisations and the software engineers, as well as financial resources.
Implications for the design of the care home (ResCare) and family care (FamCare)
studies: major design changes
Changes to protocol: the ResCare trial
Three main changes to the planned ResCare trial occurred: the delivery of the intervention (reasons for
which are described here in Chapter 2); associated implications for follow-up during the CRT (see Chapter 3);
and a process evaluation to throw light on the mechanisms for implementation of IT-based intervention in
care homes (see Chapter 4). These will be considered next.
Following an initial visit from an unblinded researcher to introduce the care staff to the intervention in the
experimental homes (initially these were senior staff who later were designated as champions), we had
originally proposed that they would then be left to complete the e-learning course themselves and then have
access to the computerised decision support tool within their care home. We envisaged providing some
support, including visits and telephone calls from the specialist dementia care therapist, where needed.
However, we soon found that staff champions’ other responsibilities within their care homes prevented them
from completing the e-learning. Instead, we offered the training course outside the care home environment,
where interruptions would be fewer. Furthermore, significant complications in the development and
functionality of the decision support e-tool, probably because of coding errors in software design, delayed
the start of the trial. The intervention phase consequently took longer than planned as a result of the
decision to train care staff at locations outside care homes and the extra input required from the specialist
dementia care therapist to apply the most suitable interventions using a poorly developed decision support
e-tool. Figure 2 demonstrates the effect of these intervention delivery obstacles on delays in the progress of
data collection from baseline to the first follow-up, which had been planned for 4 months post baseline.
Although data collection progressed well following adjustment to the intervention protocol, the planned
second follow-up at 12 months was dropped in order to complete the trial within the agreed timetable.
Chapter 3 therefore describes our CRT with follow-up at just one time point. An independent research
team was commissioned to study the process of implementing functional analysis-based interventions
using technology in care homes (see Chapter 4).
Changes to protocol: the FamCare trial
The aim of the FamCare trial was to test a computerised functional analysis-based intervention for use by
specialist community mental health practitioners who support people with dementia and their family carers
at home across England. The functional analysis-based decision support e-tool was developed by clinical
experts and software engineers for three reasons: (1) guidelines suggest that functional analysis is seen
as the intervention of choice for CB and dementia;12 (2) although our Cochrane review of the literature
suggested that this approach shows promise,82 there do not appear to have been any studies worldwide
that have comprehensively tested implementation of the approach in the wide range of settings that
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provide support for family carers of relatives with dementia and CB; and (3) an IMS would allow improved
knowledge on who to approach from the wide range of clinical experts and facilitate adherence to the
selection of case-specific interventions for use by practitioners who may not have regular access to the
range of clinical experts that can help to formulate key unmet need in a given case. This current chapter
has outlined the results of our field testing of the decision support e-tool, which was limited and required
further development. The community version of the decision support e-tool was not used in the planned
cluster randomised therapeutic study, as we were unable to proceed with the FamCare trial (see Chapter 5
and Appendices 2 and 3).
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Chapter 3 Challenge ResCare: a cluster
randomised trial of the clinical effectiveness and
cost-effectiveness of online training and decision
support for care home staff to deliver functional
analysis-based interventions for challenging behaviour
in dementia
Abstract
Aim
To evaluate the clinical effectiveness and cost-effectiveness relative to usual care of an online application to
enable care home staff to understand the function of CB in people with dementia and support them
accordingly.
Design and methods
A CRT that allocated 63 care homes in Yorkshire between intervention and usual care. The primary outcome
was the well-validated NPI using frequency and severity scores taken at 4 months to address the primary
research question, that is, whether or not the intervention reduces CB in dementia. Secondary outcome
measures (n = 21) monitored both residents and staff and included resident quality of life using the EuroQol-5
Dimensions (EQ-5D) self-reported and proxy versions. The basic statistical model for effectiveness analysed
follow-up scores by treatment group; corresponding baseline scores; and other covariates for both resident
and care home. Resources used by residents with CB were costed by adapting the Client Service Receipt
Inventory (CSRI) to focus on health and social care over 4 months; and assuming no marginal change in care
home resources, as these are less likely to change and more difficult to cost.
Results
Eight hundred and thirty-two residents (555 with CB) and 609 care staff at baseline were reduced to 658
(79%) residents [428 (77%) with CB] and 436 staff (72%) at follow-up. No participants reported any
serious adverse reactions (SARs) to the online intervention or to analogous activities in the control group.
Our primary outcome measure, the NPI, showed that the intervention reduced the frequency of NPSs by
0.60 relative to treatment as usual; however, as the 95% confidence interval (CI) from –1.18 to 2.38
includes zero, this finding was not statistically significant. Although the intervention also reduced the
severity of those symptoms by 0.45 (95% CI –1.03 to 1.93), this also lacked statistical significance.
Although 14 of the 21 secondary outcome measures showed positive effects of the intervention, none
reached statistical significance. Furthermore, the intervention generated little change in the prescription of
drugs relevant to dementia – notably antipsychotics (χ2 > 0.999), antidepressants (χ2 = 0.635), hypnotics
and anxiolytics (χ2 = 0.215), anticonvulsants (χ2 > 0.999) and the anti-dementia (such as the cholinesterase
inhibitors) drugs (χ2 > 0.999) or those for pain relief – that is, the opioids (χ2 = 0.399) and non-opioids
(χ2 = 0.996). Hence, there is no evidence that the intervention changed the care of CB in dementia.
Health- and social-care costs over 4 months did not differ significantly between groups (mean cost was
£331 less in the intervention group, with the bootstrapped 95% CI from –£927 to £272) and staff reports
of quality-adjusted life-years (QALYs) over 4 months differed little between groups. Hence, there is no
evidence that the online intervention was cost-effective.
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Conclusions
This computer-assisted intervention was neither clinically effective nor cost-effective. It comprised a
comprehensive interactive e-learning program, delivered with group discussion to facilitate case-specific
management of CB in dementia, and was followed by assisted decision support to provide case-specific
interventions for residents with dementia and clinically significant CB. It was not enough to reduce CB in
dementia in care homes.
Trial registration
The International Standard Randomised Controlled Trial Number (ISRCTN) is 02553381.
Introduction
The need for research on case-specific interventions for the management of CB and dementia in care
homes was outlined in Chapter 1. Using our Cochrane review, these were conceived as functional
analysis-based interventions (see Chapter 1). An online solution was adopted to make the approach
available to all care staff working in a home (see Chapter 1) and a mixed-methods study of the process of
delivery was described in Chapter 2. We learned that despite enthusiasm and significant support with
internet resources from the research team provided to all participating care homes, worksite-based
e-learning was not achievable. Specialist dementia care therapist support was appreciated by care staff in
the delivery of e-learning (see Chapter 2). Developing interventions with the decision support system also
required assistance from a specialist dementia care therapist (see Chapter 2). In this chapter the CRT of
effectiveness and cost-effectiveness of computerised functional analysis-based interventions for the
management of CB in care homes is described. The study was conducted across Yorkshire.
Research questions
l Does the experimental intervention described in Chapter 2 reduce CB in residents with dementia,
as measured by the frequency and severity scores of the NPI?
l Does the experimental intervention improve the experience of staff and the quality of life of residents
in care homes?
l Does the experimental intervention reduce the prescription of psychotropic medications and change the
usage of medications, such as analgesia for management of pain and laxatives for the management of
bowel movements?
l Is the experimental intervention cost-effective?
Methods
Design
This pragmatic CRT allocated participating care homes to two groups. The experimental (intervention)
group received a functional analysis-based intervention and the control group delivered ‘treatment as
usual’. Randomisation at care home level ensured that all recruited residents and care staff in each home
were allocated to either experimental or control group. Following consent procedures at a care home, a
Registered Clinical Trials Unit, the North Wales Organisation for Randomised Trials in Health (NWORTH),
undertook computerised randomisation remotely. The researchers who assessed participants were blind to
treatment allocation at baseline and follow-up.
Governance and study approvals
The York Research Ethics Committee (REC; reference number 09/H1311/29) approved this study in May 2009
(see Appendix 4). Details of amendments that were approved during the trial by the REC are also found in
Appendix 4. In April 2009 the Research and Development (R&D) Department at Humber NHS Foundation
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Trust confirmed its sponsorship of the trial and gave local research governance approval. Appendix 5
describes the management arrangements for this study, including patient and public involvement.
Changes to the protocol
Chapter 2 outlined reasons for changes to the ResCare trial, namely the decision not to go ahead with a
second follow-up assessment at 12 months.
The intervention
Ninety-two nominated champions from homes allocated to the experimental intervention received
e-learning (functional analysis training), usually away from their care homes. The purpose was to teach
them ‘detective’-like skills to improve their understanding of the ‘language’95 of common behaviours that
were seen as challenging. By using simulated case studies of varying complexity, filmed in a care home
setting, this course aimed to change or expand the way staff perceived and responded to resident
behaviour in their own care home. Staff champions also worked with a specialist dementia care therapist,
who used a decision support e-tool to develop action plans for a particular behaviour that was identified
by staff as challenging (see Chapter 2, Table 4). The ‘usual’ long-term care services and interventions that
were available to residents in control homes were also available to those in the experimental homes,
as we were evaluating the additional benefit of our e-learning course and decision support e-tool-assisted
intervention. Both control and experimental homes therefore had access to other training materials and
courses, as they would normally.
Study population
In July 2010 we invited all care homes in East Yorkshire, Hull and York with 25 or more beds (including
nursing care beds if available) listed on the Care Quality Commission (CQC) website (URL: www.cqc.org.uk/)
as old-age care homes to take part in the study. Based on data from a previous study,107 homes with 25 beds
or over were judged to be the smallest care home sample that could be included to achieve the numbers
of people with dementia and CB required per home to meet the sample size calculations of this CRT
(see Sample size). To ensure consistency in quality of care across the homes for this trial, we invited only
those that the CQC had rated as ‘good’ or excellent’ at the time. All types of homes were invited, including
those managed by local authorities, regional and national commercial chains and the not-for-profit sector
and small, independently run private homes. Recruitment of care homes began in October 2010, with
participants recruited between March 2011 and March 2012. Follow-up was completed in October 2012.
Eligibility criteria for residents
Inclusion criteria
l Resident lived in the recruited care home.
l Residents met the diagnostic criteria for dementia in the Diagnostic and Statistical Manual of Mental
Disorders-Fourth Edition (DSM-IV),130 and those in the ‘CB’ stratum were required to exhibit at least
four problems on the CBS.107 Of the residents who did not meet both the DSM-IV and CBS criteria, we
selected five residents at random from each home. They constituted the ‘other residents’ stratum and
included some residents with dementia and some with CB, but not with both.
Exclusion criteria
l Residents whose stay in the home was not, in the judgement of the home manager, likely to be long
term (e.g. those receiving respite care).
l Residents who were receiving palliative care.
l Residents who were unable to speak or understand English.
l Residents who were out of the home, for example in hospital, at baseline data collection.
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Sample size
Originally we planned to recruit 48 homes, expecting to recruit an average of 13 CB participants per home
and 624 in total. Mozley et al.,131 in a study carried out in the same locality as the ResCare trial, reported a
39% loss of care home participants over 12 months because of death, moving elsewhere or illness too
severe for follow-up. So we expected to lose two recruited CB residents (15%) per home over 4 months,
yielding a completed sample of 48 × 11 = 528 participants. Re-analysis of data from previous studies
suggested that intracluster correlation coefficients (ICCs) rarely exceed 0.03.131 We therefore judged that the
ICC would not exceed 0.03, and calculated that 528 CB completers would provide the same power as a
simple random sample of 528/[1 + 0.03 × (11 – 1)] = 406. Our original design had > 80% (85%) power
using a significance level of 5% to detect a difference in NPI scores equal to 0.3 of their population SD.
Though this difference is sometimes regarded as ‘small’, our research team and Programme Steering
Committee (PSC) judged that it was both clinically important and feasible. However, as the number of CB
residents per home was smaller than expected, we recruited 63 homes to the trial with the aim of achieving
63 × 7 = 441 CB completers, equivalent to a simple random sample of 441/[1 + 0.03 × (7 – 1)] = 374. Using
the increased number of care homes with the decreased number of residents in each care home still
achieves the > 80% (82%) power of the initial design to detect an effect size of 0.3.
Recruitment procedures
When appropriate, we approached the organisation owning the home for support and then contacted the
home manager to discuss the trial, including the implications of participating. We needed to recruit care
staff and residents through participating care homes. At this stage, 63 homes provided us with anonymised
data on CB, using the 25-item CBS incidence domain,107 for all their residents aged > 65 years (n = 2185).
This was in order for us to establish homes where CB was highly prevalent; these cross-sectional data
are referred to as the ‘screening data’. Next we began the process of seeking consent for all homes
simultaneously in order to seek permissions for residents who lacked capacity to consent to participate in
the study. Care home managers introduced research team members to staff, who introduced them to
residents. If residents were happy to talk, the researcher explained the study to potential participants,
provided information sheets and answered their questions.
Care homes then sent letters advising each resident’s main relative about the research, asking them to
inform the home manager or research team if they had any objections to being contacted by us. For
residents without capacity to consent, we explained the study to the relative, asked them to act as
personal consultees for the resident’s participation and answered their questions. We then asked those
willing to act as a consultee whether or not their relative would have wished to take part in this research
and to sign a consultee form. For residents with no key relative we approached an alternative consultee
(e.g. a solicitor or social worker).
We gave each resident notified to the research team a trial identification number, whether or not they
subsequently joined the study. This enabled us to document the flow of participants through the trial,
as required by the Consolidated Standards of Reporting Trials (CONSORT).132
Informed consent
In line with current guidance on the use of the Mental Capacity Act 2005,133 produced by the British
Psychological Society,134 we assumed that each person had the capacity to consent, and explained the
research in an accessible manner, increasing their likelihood of being able to consent for themselves. We
encouraged them to discuss the research with their family when appropriate and gave them as much time
as they needed before reaching a decision. Only after residents had been assessed for capacity in this way in
accordance with the Mental Capacity Act 2005,133 and they or their consultee had agreed that they would
take part, were residents eligible to participate in the trial. We treated consent as a continuing process
rather than a single decision, and discontinued interviewing whenever residents did not want to engage or
became distressed by the assessments.
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We also asked staff to consent to participate in the trial, both by answering questions about themselves
and by providing information about consented residents. We emphasised to all participants, both residents
and care staff, that choosing not to take part would not disadvantage them in any way. The resident’s GP
was also given information about the study and notified that their patient was participating.
Ethical arrangements
We know of no documented harmful effects of using functional analysis-orientated interventions to
manage CB. Nevertheless, we devised a trial-specific procedure for reporting serious adverse events (SAEs)
to the chief investigator. In addition to agreeing with care home managers that they would update us on
any changes to the residents’ circumstances, the researchers contacted each care home every month to
check on adverse events that might not have been reported to us. Criteria for judgement of whether or
not the event was deemed serious, or could be defined as an ‘untoward occurrence’ for the participant,
were as follows:
l resulted in death
l was life-threatening
l required hospitalisation or prolongation of existing hospitalisation
l resulted in persistent or significant disability or incapacity
l was considered medically significant by the investigators
l included alleged or suspected abuse or neglect, according to the protection of vulnerable adults
procedure agreed for the trial.
If so, the researcher completed a SAE reporting form for the chief investigator to assess whether that SAE
could have been related to the intervention or deemed as ‘unexpected’. We then reported any adjudged
intervention related or unexpected (or both a fortiori) to the REC, the trial Data Monitoring and Ethics
Committee (DMEC) and the sponsoring NHS trust R&D department, within 15 days.
Randomisation
Given the CRT design, in which the care home was the unit of randomisation, consent was obtained from
care home managers prior to computerised randomisation of care homes between the experimental and
control groups, undertaken remotely by NWORTH. Our plan was for randomisation to take place gradually,
home by home, once the consent process had been completed in each. However, this became problematic
at an early stage, as the lengthy process of setting up computers and internet facilities in experimental
homes (see Chapter 2) had not been anticipated. Thus, we needed to know which homes would contribute
to the experimental arm of the CRT in advance, to ensure that facilities were in place in order to commence
intervention as close to the baseline data collection point as possible. Therefore, we gained consent from
managers at all homes and began the process of randomisation early on. In order to not affect baseline
responses, as far as possible we communicated with managers, but not care staff, about technology
required for the intervention, and maintained blinding to the treatment condition for researchers who
collected the data.
Homes were randomised using two stratifying criteria:
1. ‘high or low CB’, namely whether more or less than 40% of residents had a CBS incidence score of
> 10 at screening
2. size of home in terms of registered beds, that is, small (25–39 beds), medium (40–49 beds) or large
(≥ 50 beds).
Blinding
As the intervention was pervasive, it was neither possible nor desirable to blind participating staff or
residents to homes allocated to the experimental or control group. Instead, the researchers responsible for
data collection remained blinded during collection of all baseline and follow-up assessments of care home
staff and residents. An unblinded researcher informed the care home manager of their allocation to the
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experimental or control group, and ensured that experimental homes had the IT equipment and adequate
internet (including broadband) facilities that were required for the intervention. An unblinded specialist
dementia care therapist then acted as facilitator, supporting staff champions in training and using the
decision support e-tool to develop action plans for target behaviours in CB residents identified by
care staff.
After follow-up data collection was complete in each home, and in order to take into account the quality
of blinding, the blinded researchers completed a perception sheet that asked them to predict the
treatment group to which that home had been allocated.
Data analysts applied an agreed analysis plan to the data set, which was blinded for treatment group with
anonymous codes.
Data collection
Our aim was to assess all participating residents at baseline and as close to 4 months as possible after that.
However, because of problems in delivering the intervention and associated change of plan (see Chapter 2,
Changes to protocol: the ResCare trial), follow-up in control homes ranged from 4 to 7 months after baseline
[mean 5.15 months (SD 1.31 months)]. In intervention homes, the range was from 5 to 11 months [mean
7.86 months (SD 1.48 months)]. To adjust for this significant difference (p < 0.001) and the potential resulting
bias, the agreed analysis plan was updated to use participants’ time to follow-up as a major covariate.
We conducted all interviews with residents and care staff in the care home and this usually took 2 or
3 days per home. In most homes, two researchers interviewed residents and care staff concurrently in
separate rooms. In larger homes more than two researchers sometimes worked at the same time; in
smaller homes mostly only one researcher conducted all the interviews. Second visits to complete
interviews were arranged, for example when participants became tired.
Measures
(See Appendix 6 for details of the instruments and their scoring methods.)
Primary outcome measure
The NPI135 is a validated measure based on interviewing an appropriate informant. It rates ‘frequency’,
‘severity’ and ‘caregiver distress’ for 12 CB categories: delusions, hallucinations, agitation or aggression,
depression or dysphoria, anxiety, elation or euphoria, apathy or indifference, disinhibition, irritability or
lability, aberrant motor behaviour, sleep and appetite or eating disorders. We addressed our primary
research question, that is, whether or not the experimental intervention reduces CB in dementia, by
analysing frequency and severity scores.
Secondary outcome measures
l Frequency and severity of CB in residents with dementia based on staff reports of a resident’s
behaviour, assessed using the Cohen–Mansfield Agitation Inventory (CMAI)136 and the CBS.107
l Emotional impact of, or reaction to, a resident’s CB for individual staff using the NPI caregiver distress
score; the CBS total challenge score; the Maslach Burnout Inventory (MBI);137 and the EQ-5D.138
The EQ-5D converts staff reports of their current dimensions of quality of life into a single preference-
based utility.
l Attitudes of individual staff towards people with dementia, assessed by the Approaches to Dementia
Questionnaire (ADQ).139
l Perceived effectiveness of individual staff in caring for people with dementia using the Self-Efficacy
Scale (SES),140 based on staff assessments of how effective they believe they are as a care worker.
l CSRI,141 adapted to estimate the health- and social-care resources, including medication, that each
resident with CB uses.
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l Residents’ quality of life using the EQ-5D (self-report and proxy), which is a valid measure in people
with mild to moderate dementia;142 and the Quality of Life in Alzheimer’s Disease (QoL-AD) self-report
and proxy.143
l Residents’ personal utility aggregated over time into QALYs estimated from the EQ-5D by using the
trapezium rule at baseline and follow-up.
In addition, we used the Clinical Dementia Rating (CDR)144 not as an outcome, but as a covariate for
analysis. During the course of the trial the research team also recorded organisational change, such as
change in manager or ownership, in each care home.
Table 6 shows the topics that were addressed, the measures used and whether or not the measure related
to the residents or the staff.
Data management
Data were collected in questionnaire packs by researchers, during interviews with participating care
home staff and residents, and from residents’ care home records, including the resident’s Medication
Administration Record for their prescribed medication. Questionnaires were scanned into Verity Cardiff
Teleform (Teleform Desktop V10.4.1; Cardiff Software, Inc., Vista, CA, USA), and were verified and
validated. Data were then exported into IBM SPSS Statistics version 19.0 (IBM Corporation, Armonk, NY,
USA) and SPSS was used to check data for inconsistencies, values out of range and missing data. All
corrections to the SPSS file were logged, along with the reason for each change. A 5% sample of each
type of questionnaire was checked against the final SPSS file to ensure consistency and to identify variables
needing further in-depth checking. For example, the medication data needed further checking against the
questionnaires, because numerous text fields in the recording form had increased the likelihood of human
and scanning error.
TABLE 6 The ResCare trial: outcome measures for participants
Topic Measure Participants
Behaviour NPI (frequency) CB residents
NPI (severity) CB residents
CBS (incidence) CB residents
CBS (frequency) CB residents
CBS (difficulty) CB residents
CMAI (frequency) CB residents
Emotions NPI (distress) CB residents
NPI (total score) CB residents
CBS (total score) All residents
MBI Staff
EQ-5D Staff
Attitude ADQ Staff
Self-efficacy SES Staff
Quality of life EQ-5Da All residents
QoL-ADa All residents
Resource use CSRI adapted CB residents
a Completed by resident where possible and also by care staff as proxy for the resident.
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Data analyses
The main statistical analyses applied SPSS version 20 (similar to version 19 in all relevant respects) to three
participant populations: all residents, those with CB and staff. Participants were compared by treatment
allocated (previously known as analysis by intention to treat) to draw pragmatic inferences about the real
world in which participants vary in their compliance with planned interventions. Health economic analyses
used SPSS version 19.
Missing data
The researchers endeavoured to collect as many data as they could. However, two types of missing data
were inevitable: missing items within a measure and missing time points. Missing items were attributable
to researcher error or participants declining to answer individual questions. When questionnaires had
recommended rules for managing such missing items, these were applied.
Several methods to maximise the available data were used. If a resident answered at least 75% of the
items for a given subscale, the subscale score was calculated pro rata. For staff-reported measures,
18 residents had missing items for the CBS at baseline and 12 had missing items for the NPI at follow-up.
The remaining staff-reported measures had missing items for four or fewer residents at both baseline
and follow-up. Imputations to three populations were applied: (1) outcomes for all residents (n = 832);
(2) outcomes for the residents with CB (n = 555); and (3) outcomes for all staff (n = 632). Data values were
imputed for residents who (1) still had missing values after using the method described above; (2) dropped
out; or (3) lived in a care home that withdrew from the study. Values were not imputed for 113 residents
who died from the ‘dropout group’ of 174 residents. This procedure was repeated five times to create five
sets of data with missing values replaced by imputed values.
The economic cost-effectiveness analyses did not impute missing costs, but used only cases with full cost
data. Imputation to replace missing data with statistical estimates is considered the usual procedure to use;
however, Briggs et al.145 outline different approaches to handling missing service use data, noting that
simpler methods such as complete-case analysis are acceptable in data sets with a small number of missing
data. In the ResCare trial, service use data were available for 428 out of the 474 residents with CB
(i.e. 90.3%) who were still alive at the end of the trial. We therefore used complete-case analysis.
For multiple imputations, the method of multivariate imputation by chained equations (MICE)146,147 was used
with a two-level modelling structure to capture the clustered trial design (residents in care homes within
allocated intervention). The software used for this method was ‘mice 2.9’ in R (The R Foundation for Statistical
Computing, Vienna, Austria).148 Before imputations, a missing value analysis was conducted to seek the level of
satisfaction on the assumption of missing at random. If variables that affected the missing mechanism were
identified, these were taken into account in imputation and analysis.149,150 After imputations, the convergence
and the marginal distributions of outcomes were investigated to ensure a healthy performance of the MICE
algorithm and plausible estimates. The few missing demographics (e.g. age, gender and previous housing)
were imputed from all other demographic variables as means from simple regressions, but adjusted when
necessary to ensure that imputed values fell within the range of observations. To impute missing outcomes at
baseline, we treated home characteristics and demographics as fixed effects, and care homes as random
effects. At follow-up we added the same outcome at baseline to the fixed effects, thus keeping care homes as
random effects and, again, ensuring that imputed outcomes fell within the range of observations.
Outliers
We checked the data of all outliers identified by statistical analysis, but found no reason to drop any from
the main data set. Health economic analysis identified one participant who spent 50 nights on a medical
ward; but, after sensitivity analysis to test the effect of removing that resident, we retained the full data set
for the main analysis.
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Interim analyses
No interim analyses were planned or requested by our DMEC.
Primary effectiveness analyses
The primary research question was: does the experimental intervention reduce CB in residents with
dementia, as measured by NPI frequency and severity scores?
Initially we used logistic regression to predict from the covariates measured at baseline whether or not
residents were missing at follow-up, and included good predictors of missing status in our main analysis.151
The NPI frequency and severity scores were analysed by multilevel modelling of follow-up scores; the
key factor was allocated group (intervention vs. control) and the main covariate was the corresponding
baseline score. Two multilevel models were tested: model I included only allocated group and the baseline
score; and model II extended this by adding the other baseline covariates. An adjustment for multiple
testing between the primary outcomes was not required because there was no significant difference and,
therefore, no change to the results would have been seen.
Two data sets for each resident population were used: the complete-case data set comprised those
residents who provided baseline and follow-up scores for the response variable; and the pooled data set
of scores imputed for participants’ missing responses at follow-up.
The baseline covariates for care homes were:
1. number of beds in the care home
2. proportion of residents in the care home with CBS incidence scores of > 10
3. type of care home: local authority, not for profit or private
4. the number of days between the baseline and follow-up measures
5. whether or not organisational change occurred between baseline and follow-up.
The baseline covariates for residents were:
1. age
2. gender
3. Clinical Dementia Rating-sum of the boxes (CDR-SB).144
Secondary effectiveness analyses
The secondary questions were:
l Does the experimental intervention improve the experience of staff and residents in care homes
as follows.
¢ Does it reduce the emotional impact of CB on care home staff?
¢ Does it give them a more positive and person-centred attitude to people with dementia?
¢ Does it improve their self-rated efficacy in caring for people with dementia?
¢ Does it improve quality of life of residents, including those without dementia?
¢ Does it reduce the number of psychotropic medications used by residents?
¢ Does it change the number of relief medications used by residents (e.g. for pain or constipation)?
The secondary outcome measures for residents with CB were NPI distress and total scores, CMAI score
and the number of psychotropic and relief drugs. For the ‘all residents group’, the secondary outcome
measures were CBS, EQ-5D and QoL-AD. For staff, the secondary outcome measures were MBI, EQ-5D,
ADQ and SES.
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Analysis of quantitative secondary outcomes used the same multilevel model as for the primary outcome
measures; the resulting significance levels were adjusted to correct for multiple testing. For staff, the
covariates were age, working hours per week and the corresponding baseline score.
Analysis of changes in the proportions of residents taking each medication by home used generalised linear
models with logit link function and covariates as follows: treatment group; type and size of home; proportion
of residents with a CBS incidence score of > 10 at screening; organisation change between baseline and
follow-up; time between baseline and follow-up; and corresponding baseline proportion. Again model I
included only treatment groups and baseline proportions; and model II included all the listed covariates.
Economic questions
The main economic question was: what is the incremental cost-effectiveness of the experimental
intervention relative to treatment as usual in improving CB in residents?
Other questions were as follows.
l Secondary question: what is the incremental cost–utility of the experimental intervention relative to
treatment as usual in improving the quality of life of residents?
l Tertiary question: what is the incremental cost-effectiveness of the experimental intervention relative to
treatment as usual in reducing emotional impact of CB on care home staff?
Economic analyses
Cost of the intervention
This was derived from the following: costs of developing the e-learning and decision support e-tool for
functional analysis in dementia, taken from invoices from the software engineering company to reflect the
direct costs of development; costs for equipment including computers, telephone lines and internet use
(see Chapter 2); and staff time spent on the e-learning course and in developing action plans. We annuitised
all these costs over 5 years, while allowing for staff turnover that would necessitate annual training.
Cost of health and social care
The research team used care home records to extract data for the adapted CSRI. These included residents’
contacts with primary and secondary health care, social care and voluntary services, but not care home fees,
as the intervention was neither designed nor likely to change these. Where possible, national unit costs
for 2012 were used to estimate the mean total cost of these extra services per resident.152,153 However,
medication costs for 2011154 were the latest available at the time of analysis. We did not discount these
service costs as the follow-up period was less than 12 months. Unit costs used in this study are detailed in
Appendix 7.
Economic evaluation
A public sector, multiagency perspective for the economic evaluation was adopted and the cost-effectiveness
analysis was conducted in accordance with the Medical Research Council (MRC)’s guidelines for the
evaluation of complex interventions,155 with a standard operating procedure for economic evaluations carried
out alongside RCTs.156 The main analysis was cost-effectiveness by treatment allocated, with cost per unit of
NPI as the criterion. Non-parametric bootstrapping with 1000 replications157 to quantify the uncertainty
associated with point estimates of cost-effectiveness ratios was used. Increasing the number of replications
to more than 1000 would have been unlikely to change the results, given the lack of significance noted in
the effectiveness study.
The cost–utility analysis was conducted using the EQ-5D completed by residents, or staff as proxies for
residents, to estimate differences between allocated treatments in residents’ QALYs. If the intervention
reduced staff stress, as measured by the MBI, we planned to undertake a secondary cost-effectiveness
analysis by treatment allocated, with cost per unit of MBI as the criterion.
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To explore whether or not results were robust to our costing assumptions, a sensitivity analysis was carried
out to test the effect of changing the staff who created the action plans, from the specialist dementia
research therapist to a senior care assistant. An analysis to check whether or not our economic findings
were sensitive to size of care home was also undertaken.
Results
Randomised allocation
Figure 4 shows the flow of care homes, staff and resident participants through the trial. In total, 111 care
homes were considered for inclusion in the trial, with 63 ultimately being randomised and 58 completing
baseline assessment. Table 7 shows the distribution of the 832 residents across the homes, with 555 in the
CB group and 277 in the ‘other residents’ group. The main reasons for the lack of baseline data for those
residents who were initially assessed for inclusion were withdrawal of care home, death, and non-selection
or unwillingness of residents. Baseline assessments were completed by 609 staff.
Of those who completed baseline data collection, in the intervention group there were 28 care homes,
420 residents (286 residents in the CB group and 134 in the other residents group) and 315 staff. In the
control group, there were 30 homes, 412 residents (269 residents in the CB group and 143 in the other
residents group) and 294 staff. A further 23 staff joined the study after baseline, mainly because some
original staff were not available at follow-up and these staff were asked by the manager to answer
questions about the residents in their place. Within the intervention homes, 92 staff trained as champions,
88 of whom completed study measures.
Dropouts
Seven homes withdrew from the study, five before baseline data collection and two after. Two homes
were lost to follow-up (22 residents at baseline), both from the intervention group: one withdrew after the
staff champions had completed the e-learning but before they had developed action plans, and the other
withdrew after action plans were completed. Another intervention home failed to identify any staff to act
as champions and, therefore, received no intervention, but provided data at follow-up, so these were
analysed by treatment allocated (17 residents at baseline and 12 at follow-up). No control homes dropped
out of the study between baseline and follow-up. Fifty-six homes were therefore followed up.
The dropout rate for the CB sample was 22.9%, with 428 of the initial 555 in the CB group completing
follow-up. This was higher than the original estimate of 15%, which was based on previous local studies.63,131
The ICCs from the NPI and CMAI data were between 0.03 and 0.06 (except for the NPI distress subscale;
see Table 25), and so were higher than the value of 0.03 used in the original sample size estimation. The
dropout rate in the other residents group, consisting of residents with dementia or with CB but not both,
was 17% and, therefore, closer to our original estimate of 15%.
Table 8 outlines reasons why residents dropped out, broken down by their group allocation. Death was
the most common reason, with 10.2% (n = 113) of the overall resident sample being lost to follow-up for
that reason.
The mean age of the 113 residents who died before follow-up was 87.85 years (SD 7.01 years) and the
mean age of survivors was 84.68 years (SD 7.58 years); 73% of those who died were female, as were
76% of survivors. There appeared to be little or no difference between those who died and those who
survived, except for the expected difference in age.
Logistic regression was carried out to identify any factors and covariates affecting the dropout rate, that is,
not just those who died. The factors included were gender, smoking status, size of care home, proportion
of CB, type of home, treatment group, whether or not there had been organisational change and CB/other
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• Not selected for study, n = 183
• Care home withdrew, n = 20
• No longer works at the home, n = 15
• Did not want to participate any more, n = 1
• Other, n = 7
• Not selected for study, n = 485
• Declined/unable to contact consultee, n = 391
• Participant died, n = 345
• Care home withdrew, n = 169
• Moved care homes, n = 72
• In hospital, n = 25
• In palliative care, n = 25
• In respite care, n = 11
• Returned home, n = 11
• Did not want to participate any more, n = 5
• Other/not specified, n = 15
Excluded prior to baseline
(SN, n = 226)
(RN, n = 1554)
• Declined to participate, n = 35
• Lack of co-operation/unable to 
   contact, n = 9
• Ineligible, n = 4
Excluded (HN, n = 48)
• New manager declined 
   participation, n = 3
• Manager thought research was 
   too long, n = 1
• Manager said insufficient 
   resources, n = 1
Excluded (HN, n = 5)
Assessed for eligibility 
[SN, n = 861 (staff);
RN, n = 2386 (residents)]
Homes 
approached
(HN, n = 111)
Entered study
after baseline 
(SN, n = 12)
Entered study
after baseline 
(SN, n = 11)
Baseline
completed
(HN, n = 58; 
SN, n = 609; 
RN, n = 832)
CB residents, n = 269
Other residents, n = 143
Control group
(HN, n = 30;
SN, n = 294;
RN, n = 412)
Intervention group
(HN, n = 28;
SN, n = 315;
RN, n = 420)
CB residents, n = 286
Other residents, n = 134
Follow-up 
completed
(HN, n = 56; 
SN, n = 436; 
RN, n = 658)
Follow-up completed
(HN, n = 30; SN, n = 245; RN, n = 355)
CB residents, n = 226
Other residents, n = 129
Follow-up completed
(HN, n = 26; SN, n = 191; RN, n = 303)
CB residents, n = 202
Other residents, n = 101
Consented 
and 
randomised
(HN, n = 63)
• No longer works at the home, n = 18
• Not available for interview, n = 40
• Other, n = 3
• Participant died
• Moved care home
• In hospital
Other
n = 11
n = 2
n = 1
CB
n = 31
n = 11
n = 1
Withdrawn from trial
(HN, n = 0; SN, n = 61)
(RN, n = 57)
• After intervention, home said 
   insufficient resources, n = 1
• After intervention, lack of 
   co-operation by home, n = 1
• Care home withdrew, n = 22
• No longer works at the home, n = 17
• Not available for interview, n = 94
• Other, n = 2
• Participant died
• Care home 
   withdrew
• Moved care home
• In hospital
• In palliative care
Other
n = 21
n = 10
n = 2
n = 0
n = 0
CB
n = 50
n = 20
n = 12
n = 1
n = 1
Withdrawn from trial
(HN, n = 2)
(SN, n = 135)
(RN, n = 117)
FIGURE 4 The ResCare trial: participant flow through the trial by treatment allocated. HN, home numbers;
RN, resident numbers; SN, staff numbers. Note that the loss of 43% (SN = 135) from the staff intervention group,
but only 21% (SN = 61) from the staff control group and 28% (RN = 117) and 14% (RN = 57), respectively, from the
resident group are both largely attributable to the difference in the period of follow-up.
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resident group. Covariates were age and length of time from baseline to follow-up. Based on the
174 residents who dropped out, the likelihood of dropout from the intervention group was increased by
living in a home with a larger number of beds; male gender; older age; and longer time between baseline
and follow-up (see Appendix 8, Table 71). The number of residents who dropped out of the intervention
group (n = 117) was double that of the control group (n = 57). However, this may be attributed to the
longer follow-up times in the intervention homes than those in the control homes because of the delays
encountered in training the staff champions following baseline data collection (see Chapter 2).
The dropout analysis, conducted as part of the primary effectiveness analysis, included 31 cases. This figure
was arrived at by excluding those residents who had died or whose care home had withdrawn, as these
were not considered to be random. Whether or not the resident was in the CB sample group was the only
factor found to affect dropout in this case, with these residents having a 2.8 times higher risk of dropout
than a resident from the other residents group.
Those who dropped out in the CB group alone (n = 127) were therefore examined further. The
proportions dropping out due to death in the intervention (50/64) and control (31/43) groups were
compared, excluding those in the care homes that withdrew from the study. No significant difference
between the proportions [χ2(1) = 0.51; p = 0.498] was found. Furthermore, no significant differences were
found when the CB dropout group was compared with those who remained in the study at follow-up on
baseline CBS, NPI and CMAI scores (Table 9).
Dropout was the reason why intervention (i.e. an action plan for a resident) was not provided for 87 residents
(30% of the original 286 residents with dementia and CB) from the intervention group. This was mainly
because the resident had died or the care home had withdrawn or declined the intervention (see Chapter 2,
Figure 3).
TABLE 7 The ResCare trial: resident group distribution per home
Residents
Distribution per home (N= 58 homes)
n Mean SD Minimum
First
quadrant Median
Third
quadrant Maximum
Total 832 14.34 4.84 6 11 15 16.75 28
CB group 555 9.57 4.81 1 6 10 12 23
Other residents group 277 4.78 0.68 2 5 5 5 6
TABLE 8 The ResCare trial: resident dropout rates by allocated group
Reason
Group, n (%)
Total, n (%) (N= 832)CB (N= 555) Other residents (N= 277)
Control
(N= 269)
Intervention
(N= 286)
Control
(N= 143)
Intervention
(N= 134)
Control
(N= 412)
Intervention
(N= 420)
Died 31 (11.5) 50 (17.5) 11 (7.7) 21 (15.7) 42 (10.2) 71 (16.9)
Moved care home 11 (4.1) 12 (4.2) 2 (1.4) 2 (1.5) 13 (3.2) 14 (3.3)
Palliative care/in hospital 1 (0.4) 2 (0.7) 1 (0.7) 0 2 (0.5) 2 (0.5)
Care home withdrew 0 20 (7.0) 0 10 (7.5) 0 30 (7.1)
Total 43 (16.0) 84 (29.4) 14 (9.8) 33 (24.6) 57 (13.8) 117 (27.9)
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Analysis of the staff who completed the baseline questionnaire (n = 609) showed that those who dropped
out were significantly younger [t(606) = 2.4; p = 0.015], with a mean age of 37.25 years (SD 13.45 years),
than those who remained at follow-up [mean age 40.02 years (SD 12.86 years)]. They had also worked
with older people for less time, though this difference was not statistically significant.
The most common reason for staff not being followed up was their lack of availability because of either
annual leave or sickness (Table 10). As with the figures for resident dropout, more staff dropped out in the
intervention homes than in the control homes, but this may again be explained by the longer duration to
follow-up in the intervention homes. After excluding the two homes that withdrew from the study, based
on the chi-squared/Fisher’s exact test, two factors appear to significantly influence staff dropout: working
in a large home and experiencing organisational change (see Appendix 8, Table 72).
Maintenance of ‘blind’ follow-up assessments
One or more researchers completed a blinding perception questionnaire for each of the 26 experimental
and 30 control homes at follow-up. Table 11 indicates that, when researchers were able to make a
judgement as to which group the care home had been allocated to, they were more likely to be correct
than incorrect in their prediction. However, they were certain of their judgement in only 27.4% of
instances, most of which were correct. In 41.2% of cases the researchers stated that the allocation could
have been ‘either group’ and in another 31.4% researchers only ‘thought they knew’, as opposed to
‘definitely knew’. Some unblinding at the follow-up assessment point may have occurred, but the
proportion of correct definite judgements remained low, at just under one-quarter, reflecting the
considerable remaining uncertainty.
TABLE 9 The ResCare trial: baseline measures for CB sample dropout group compared with CB sample retained
Measure
Dropout (n= 127) Completed follow-up (n= 428)
Mean score SD Mean score SD
CBS incidence 9.00 3.91 8.96 3.84
CBS frequency 28.48 13.08 27.68 13.06
CBS difficulty 15.15 10.92 14.61 10.79
CMAI 53.60 19.02 54.05 18.49
NPI incidence 4.99 2.25 4.78 2.40
NPI total (frequency × severity) 21.88 16.78 20.88 15.74
NPI distress 5.22 6.46 4.67 6.60
TABLE 10 The ResCare trial: staff dropout rates by allocated group
Reason for dropout
Group, n (%)
Control (N= 294) Intervention (N= 315)
Not available for interview 40 (13.6) 94 (29.8)
Care home withdrew from the study 0 22 (7.0)
No longer works at the home 18 (6.1) 17 (5.4)
Other 3 (1.0) 2 (0.6)
Total 61 (20.8) 135 (42.9)
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Descriptive analyses
The baseline descriptive data have been split into a number of tables describing the care homes (see Table 12),
the care home staff (see Tables 13–16) and the residents (see Tables 17–20).
Care home descriptives
As shown in Table 12, only 15.5% of care homes were local authority owned, which reflects Lievesley and
Crosby’s findings,158 noting that, since the NHS and Community Care Act of 1990,159 private sector care
homes have dramatically increased in number and local authority ownership has decreased. The homes in
this study were located in a mix of urban, suburban and rural areas, with the majority (63.8%) being
categorised as suburban. The suburban category was further split into ‘built up’ (typically more populated
areas that include a higher proportion of social housing) and ‘not built up’ (typically more private houses
and ‘green’ areas).
There appeared to be some differences in the care home characteristics between the two groups; most
notably, compared with control homes. The higher percentage of the intervention homes were in the
private sector and provided care without nursing (57.1% vs. 33.3%, respectively), a lower percentage
were in the private sector and provided care without nursing (7.1% vs. 16.7%) and a higher percentage
had undergone major organisational change during the study period (46.4% vs. 33.3%). However, none
of these differences or any of the other home demographics was statistically significant.
Staff descriptives
Table 13 outlines demographic information for ResCare trial staff participants. Our data are similar to those
from an analysis of the National Minimum Data Set for Social Care (NMDS-SC) in England, which includes
a sizeable proportion of all social care staff working in registered services. Nine out of 10 of the ResCare
trial participants were female, similar to findings of an 87% female dementia care workforce noted in
NMDS-SC dementia care workforce data.160 The NMDS-SC160 analysis also noted clear incremental mean
and median number of years working in the care sector as employee age rises, indicating that the vast
majority of older workers in the social care sector are continuing workers, rather than ‘new’ workers hired
recently. The ResCare trial participants had worked in their current care home for an average of 4.87 years
(SD 5.26 years) and with older people in general for 9.64 years (SD 8.27 years).
Overall, our sample is generally representative of this sector in England. Differences are noted in that part-time
work is common in social care, yet 84.5% of the ResCare trial participants worked ≥ 24 hours a week,
TABLE 11 The ResCare trial: breakdown of researcher perception of care home randomisation at follow-up
Researcher perception
Group, n (%)
Total, n (%)Control Intervention
I know this home is a . . . home
– incorrect
0 (0.0) 3 (6.3) 3 (2.9)
I think this home is a . . . home
– incorrect
6 (11.1) 4 (8.3) 10 (9.8)
This home could be either . . . 28 (51.9) 14 (29.2) 42 (41.2)
I think this home is a . . . home
– correct
11 (20.4) 11 (22.9) 22 (21.6)
I know this home is a . . . home
– correct
9 (16.7) 16 (33.3) 25 (24.5)
Total 54 48 102
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TABLE 12 The ResCare trial: demographic details of the care homes
Care home descriptive
Group, n (%)
Total, N (%) (n= 58)Control (N= 30) Intervention (N= 28)
Type
Local authority 7 (23.3) 2 (7.1) 9 (15.5)
Private without nursing care 10 (33.3) 16 (57.1) 26 (44.8)
Private with nursing care 5 (16.7) 2 (7.1) 7 (12.1)
Not for profit/voluntary/charity 8 (26.7) 8 (28.6) 16 (27.6)
Size of homea
Small (25–39 beds) 15 (50.0) 15 (53.6) 30 (51.7)
Medium (40–49 beds) 10 (33.3) 8 (28.6) 18 (31.0)
Large (50+ beds) 5 (16.7) 5 (17.9) 10 (17.2)
Location
Urban 4 (13.3) 7 (25.0) 11 (19.0)
Suburban (built up) 12 (40.0) 7 (25.0) 19 (32.8)
Suburban (not built up) 10 (33.3) 8 (28.6) 18 (31.0)
Rural 4 (13.3) 6 (21.4) 10 (17.2)
Proportion with CBS incidence score of > 10 (based on screening data)
< 0.4 25 (83.3) 24 (85.7) 49 (84.5)
≥ 0.4 5 (16.7) 4 (14.3) 9 (15.5)
Organisational change 10 (33.3) 13 (46.4) 23 (39.7)
a Homes with fewer than 25 beds were ineligible for the trial.
TABLE 13 The ResCare trial: demographic details of the care home staff at baseline
Staff descriptive
Group
Total (N= 609)Control (N= 294) Intervention (N= 315)
Missing (n) Mean (SD) Missing Mean (SD) Missing Mean (SD)
Working with older
people (years)
12 10.08 (8.82) 11 9.23 (7.71) 23 9.64 (8.27)
Working in current
care home (years)
12 4.77 (5.26) 12 4.95 (5.31) 24 4.87 (5.28)
Working hours per
week
15 34.34 (9.67) 11 33.78 (10.21) 26 34.05 (9.95)
Age left full-time
education (years)
16 16.90 (2.06) 13 16.61 (1.82) 29 16.75 (1.94)
Current age (years) 13 39.13 (13.49) 11 38.23 (12.75) 24 38.66 (13.11)
Gender (female) n= 265 (90.1%) n= 282 (89.5%) n = 547 (89.8%)
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with an overall mean of 34.05 hours per week (SD 9.95 hours) (see Table 13). Perhaps the full-time
workforce was more available to participate in the ResCare trial? The NMDS-SC data analysis160 showed
that workers in the age range of 50–75 years constitute nearly two-fifths of the whole care workforce and
nearly one-eighth of the total are aged between 60 and 75 years. The ResCare trial participants tended to
be younger, with only one-quarter aged > 50 years, and just 3.3% aged > 60 years (Table 14).
Participating staff were asked to provide details on their highest qualification (see Chapter 2, Table 2) and
about their computer and dementia training (Table 15). Not all staff chose to complete the questionnaire,
and for the 93% (n = 568) returned, not all items were completed. The NMDS-SC data analysis160 found
that for ‘highest qualification held’ there was a concentration around NVQ level 2 among dementia care
workers (the relevant qualifications at the time of the study), with relatively fewer dementia care workers
possessing higher-level qualifications than other social care staff. Staff participating in the ResCare trial held
a range of qualifications (see Chapter 2, Table 2): for 54%, the highest qualification level was equivalent to
NVQ level 2 or lower, but compared with the national picture the ResCare trial participants were more likely
to have higher-level qualifications and only 5%, compared with 9% in the national social care workforce,
held no qualifications. Approximately two-thirds of the ResCare trial staff had never received any computer
training and a striking 30.3% had never received any dementia training (see Table 15).
There were no noticeable differences in the demographics of the staff across the two treatment groups
(see Table 13), apart from the control group having a slightly greater percentage of staff with higher-level
qualifications than the staff in intervention homes (see Chapter 2, Table 2).
TABLE 14 The ResCare trial: age of care home staff broken down into groups
Age group (years) Baseline, n (%) (N= 609)a
16–19 25 (4.1)
20–29 174 (28.6)
30–39 97 (16.0)
40–49 159 (26.2)
50–59 133 (21.9)
60–69 18 (3.0)
70–79 2 (0.3)
a Data missing for 24 staff.
TABLE 15 The ResCare trial: previous training of care home staff
Previous training
Group, n (%)
Total, n (%) (N= 564)Control (N= 268) Intervention (N= 296)
Previous computer training
Yes 101 (37.7) 102 (34.5) 203 (36.0)
No 167 (62.3) 194 (65.5) 361 (64.0)
Previous dementia training (n= 269) (n = 295) (n= 564)
Yes 193 (71.7) 200 (67.8) 393 (69.7)
No 76 (28.3) 95 (32.2) 171 (30.3)
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The mean EQ-5D index value for staff at baseline was similar to the UK population norm of 0.91 (SD 0.16)
for the age bracket of 35–44 years.161 However, the mean staff EQ-5D visual analogue scale (VAS) was
slightly lower than the population norm of 86.56 (SD 13.79). The EQ-5D index is scored from –0.59 to 1
(worst health state to full health), and the EQ-5D VAS is scored from 0 to 100 (worst imaginable health
state to best imaginable health state), so the staff in this study had reasonable health at baseline (Table 16).
Staff attitudes to dementia were consistent with those reported by qualified nurses working in nursing
homes in one UK study,139 higher than a pilot study in care homes162 and also more positive than those
reported from a large US study,163 where the mean total score of direct care staff on the ADQ was 70.7
(SD 6.4), compared with our mean score of 75.16 (SD 7.04).
On the MBI, average scores showed relatively low levels of emotional exhaustion (Maslach Burnout
Inventory-Emotional Exhaustion; MBI-EE) and depersonalisation (Maslach Burnout Inventory-Depersonalisation;
MBI-DP) and high levels of personal accomplishment (Maslach Burnout Inventory-Personal Accomplishment;
MBI-PA) compared with norms. For the MBI, values greater than the cut-off points, indicating a high
degree of burnout137 are MBI-EE = 18, MBI-DP = 10 and MBI-PA = 33. Our sample reported lower MBI-DP
scores than with health-care workers in Africa,164 but were in line with a UK pilot study in care homes.162
Self-efficacy ratings were in line with the original participant sample, where this measure was used.140
Resident descriptives
Basic demographic details of the residents are detailed in Table 17. Overall, the mean age was 85.11 years
(SD 7.58 years), the majority of residents were female (75.7%) and almost half had been living in their
own privately owned home prior to moving to the care home. All residents eligible for the CB group had
dementia, which was checked using DSM-IV criteria. In the other residents group, 31.3% met the criteria
for dementia, but this group did not meet the eligibility criteria of at least four behaviours on the CBS
incidence measure. Overall, of the 832 residents in the study at baseline, 473 (56.9%) had a formal
diagnosis of dementia according to care home records. The CDR score for those in the CB group is shown
in Table 17, with the largest percentage of residents (49.2%) being rated as 3, that is, ‘severe dementia’.
TABLE 16 The ResCare trial: summary of outcomes measured on care home staff at baseline
Staff measure
Group
Total (n= 609)aControl (n= 294) Intervention (n= 315)
Mean score SD Mean score SD Mean score SD Range
EQ-5D index 0.92 0.14 0.91 0.16 0.92 0.15 0.12–1
EQ-5D VAS 84.82 13.07 82.90 14.36 83.84 13.77 10–100
ADQ 75.23 7.15 75.10 6.93 75.16 7.04 54–95
Hope 27.05 4.72 26.82 4.56 26.93 4.64 12–40
Person centred 48.18 4.12 48.28 3.98 48.23 4.05 37–55
MBI 21.82 15.51 20.27 14.58 21.03 15.05 0–84
Emotional exhaustion 13.31 11.43 12.31 10.40 12.80 10.92 0–49
Personal accomplishment 42.21 5.69 42.53 5.43 42.37 5.56 18–48
Depersonalisation 2.72 3.41 2.48 3.41 2.60 3.35 0–21
SES 54.18 7.36 53.71 7.36 53.94 7.54 25–63
a Data were missing for 11 participants for EQ-5D index and VAS, ADQ and MBI. In addition, data were missing for
12 participants for the SES.
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There was no noticeable difference in the demographics of the residents across the experimental
(intervention) and control groups.
As can be seen from Table 18, the quality-of-life self-report scores (EQ-5D and QoL-AD) were fairly similar
for the CB group and the other residents, with the CB group reporting a higher EQ-5D index and VAS
score. However, proxy reports on these measures showed lower scores for the CB group, reflecting the
contribution made by CB to proxy quality-of-life ratings.165
As shown in Table 19, by far the most common CBs exhibited by residents in the CB sample, as perceived
by care home staff, were lack of self-care, lack of motivation, shouting, restlessness, lack of occupation,
perseveration, verbal and physical aggression, non-compliance and wandering. This pattern was similar
in the other residents group, albeit in smaller proportions, as these were recruited randomly to have
dementia or CB but not both. In comparing the CB sample and the other residents, the greater complexity
of the CB sample can be seen. For example, for 8 of the 25 CBs (verbal aggression, shouting, perseveration,
restlessness, lack of motivation, non-compliance, lack of occupation and lack of self-care), the CB sample
percentage incidence scores suggested that those particular CBs were more likely to be present than not
present. There were no such occurrences in the other residents group. Another example of this complexity
was the higher percentage of CBS incidences of certain types of behaviour, such as faecal smearing, in the
CB sample.
Medication in the challenging behaviour group
In total, 3601 individually prescribed medications were recorded for the CB group, with a mean number of
6.82 medications (range 0–24 medications). This was lower than in a small study in 2008, in which an
average of 8.0 medications (range 1–17 medications) was reported for 119 residents in six homes.166 Males
had an average of 7.42 medications (range 1–24 medications) and females averaged 6.64 medications
(range 0–19 medications). For residents aged between 90 and 94 years the mean number of medications
was 7.02 (range 0–16 medications) and in those aged > 95 years (all female) the mean was 6.71
medications (range 0–17 medications). Six residents (1.08%) did not receive any medication.
TABLE 17 The ResCare trial: demographic details of the residents
Resident
descriptive
Residents, n (%)
Total by treatment
group, n (%) (N= 832) Total
sample,
n (%)
(N= 832)
CB sample (N= 555) Other (N= 277)
Control
(N= 269)
Intervention
(N= 286)
Control
(N= 143)
Intervention
(N= 134)
Control
(N= 412)
Intervention
(N= 420)
Gender (female) 208 (77.3) 223 (78.0) 102 (71.3) 97 (72.4) 310 (75.2) 320 (76.2) 630 (75.7)
DSM-IV criteria
for dementia met
269 (100) 286 (100) 45 (31.5) 42 (31.3) 314 (76.2) 328 (78.1) 642 (77.2)
CDR
0 2 (0.7) 2 (0.7) 4 (0.7)
0.5 6 (2.2) 12 (4.1) 18 (3.2)
1 36 (13.4) 52 (18.2) 88 (15.9)
2 79 (29.4) 90 (31.5) 169 (30.5)
3 145 (53.9) 128 (44.8) 273 (49.2)
Missing 1 (0.4) 2 (0.7) 3 (0.5)
Age (years),
mean (SD)
84.84 (7.59) 85.47 (7.27) 85.18 (7.62) 84.81 (8.17) 84.96 (7.60) 85.25 (7.56) 85.11 (7.58)
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Table 20 outlines the drug groups we recorded, showing medications that the residents were prescribed in
the 3 months before baseline and whether or not they were taking these for the full 3 months.
Of interest in the present study were care practices surrounding the prescription of some psychotropic
medications, pain relief and relief from discomfort due to constipation. Next we summarise key
observations of our baseline data (see Table 20) relating to the antipsychotics, hypnotics and anxiolytics
(including benzodiazepines/z-hypnotics, sometimes referred to as the B/Z/A drugs), antidepressants,
analgesics and laxatives.
Eighty-four residents (15.14%) were prescribed an antipsychotic, of which the atypical risperidone is the
only licensed antipsychotic for the management of serious behavioural symptoms in dementia. Risperidone
TABLE 18 The ResCare trial: summary of baseline outcomes by sample and treatment allocated
Resident measure
Residents, mean score (SD)
Total sample, mean score
(SD) (n= 832)CB sample (n= 555) Other (n= 277)
Control Intervention Control Intervention Control Intervention
CBS incidence 9.01 (3.84) 8.94 (3.85) 3.02 (2.90) 3.09 (2.41) 6.93 (4.55) 7.07 (4.40)
CBS frequency 28.03 (12.92) 27.55 (13.17) 8.87 (9.15) 8.34 (6.75) 21.38 (14.87) 21.42 (14.59)
CBS difficulty 14.73 (10.78) 14.55 (10.71) 4.08 (5.52) 4.11 (4.27) 11.03 (10.59) 11.22 (10.37)
CBS challenge
(frequency × difficulty)
46.67 (36.72) 46.06 (36.93) 12.02 (18.52) 11.36 (12.09) 34.64 (35.65) 34.99 (35.16)
EQ-5D index (proxy) 0.31 (0.32) 0.30 (0.34) 0.44 (0.32) 0.44 (0.39) 0.36 (0.33) 0.35 (0.36)
EQ-5D VAS (proxy) 57.05 (18.51) 52.03 (19.07) 66.36 (17.44) 62.63 (20.39) 60.28 (18.66) 55.42 (20.09)
QoL-AD (proxy) 29.46 (5.82) 29.38 (5.95) 34.62 (5.62) 34.85 (6.92) 31.25 (6.25) 31.12 (6.77)
EQ-5D index
(self-report)
0.64 (0.34) 0.69 (0.34) 0.47 (0.39) 0.56 (0.38) 0.57 (0.37) 0.63 (0.36)
EQ-5D VAS
(self-report)
70.67 (22.08) 73.52 (22.00) 64.40 (21.54) 68.05 (18.68) 67.50 (21.97) 70.66 (20.44)
QoL-AD (self-report) 33.61 (6.34) 36.08 (6.33) 34.37 (5.45) 35.84 (5.72) 33.97 (5.94) 35.96 (6.03)
NPI incidence 4.80 (2.34) 4.86 (2.40) – – – –
NPI frequency 12.66 (7.50) 12.12 (7.12) – – – –
NPI severity 7.97 (4.87) 7.55 (4.80) – – – –
NPI total
(frequency × severity)
22.28 (16.22) 20.06 (15.66) – – – –
NPI distress 4.82 (6.50) 4.77 (6.63) – – – –
CMAI total 53.30 (16.49) 54.61 (20.43) – – – –
CMAI physical:
aggressive
16.94 (7.79) 17.20 (9.47) – – – –
CMAI physical:
non-aggressive
19.29 (8.62) 19.55 (8.93) – – – –
CMAI verbal:
aggressive
5.49 (3.14) 5.68 (3.21) – – – –
CMAI verbal:
non-aggressive
11.58 (5.68) 12.13 (6.40) – – – –
CDR-SB 13.42 (3.49) 12.70 (3.81) – – – –
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was prescribed for just 14 residents (2.52%). Contrary to best practice, 38 residents (6.85%) were
prescribed a ‘typical antipsychotic’, of which the antipsychotic haloperidol accounted for 28 residents
(5.05%) (i.e. double that of the atypical risperidone). Where antipsychotic medication was prescribed to
those aged > 90 years, only two residents were treated with risperidone and seven had the atypical
antipsychotic quetiapine, a product that is not approved by the US Food and Drug Administration for
the treatment of behavioural problems in older people with dementia. Surprisingly, six residents aged
> 90 years were prescribed typical antipsychotics, despite the risk factors for adverse drug reactions.
Of those receiving at least one antipsychotic prescription, 91.67% (77 residents) were prescribed an
antipsychotic for 3 months or more.
The records showed that 111 residents (20%) were prescribed hypnotic and anxiolytic (B/Z/A) drugs.
Of these, 88.29% (98 residents) had prescriptions for over 3 months, that is, well over the recommended
guidance for prescription. Seventeen residents were prescribed benzodiazepines, despite being aged
> 90 years.
Furthermore, 189 residents (34.05%) were being treated with an antidepressant; for 87.83% this was
prescribed for over 3 months. Of these, 41 residents (7.39%) were prescribed a tricyclic, including
amitriptyline and 117 residents (21.08%) had a selective serotonin reuptake inhibitor (SSRI) or the
antidepressant mirtazapine. Fourteen residents were prescribed low-dose amitriptyline (≤ 25 mg) and three
had prescriptions for both the antidepressant citalopram and mirtazapine. Forty residents aged > 90 years
were prescribed an antidepressant of some description.
TABLE 20 The ResCare trial: frequencies by medication for the 3 months before baseline
Medication category
Baseline frequency of medication, n (%) (N= 555)
Not prescribed < 3 months Full 3 months (1 drug) Full 3 months (> 1 drug)
Antipsychotics 471 (84.9) 7 (1.3) 70 (12.6) 7 (1.3)
Atypical 506 (91.2) 1 (0.2) 46 (8.3) 2 (0.4)
Typical 517 (93.2) 6 (1.1) 29 (5.2) 3 (0.5)
Antidepressants 366 (65.9) 23 (4.1) 151 (27.2) 15 (2.7)
SSRI 438 (78.9) 16 (2.9) 97 (17.5) 4 (0.7)
Tricyclic 514 (92.6) 4 (0.7) 36 (6.5) 1 (0.2)
Other 516 (93.0) 4 (0.7) 33 (5.9) 2 (0.4)
Hypnotics and anxiolytics 443 (79.8) 13 (2.3) 91 (16.4) 8 (1.4)
B/Z/A 444 (80.0) 13 (2.3) 90 (16.2) 8 (1.4)
Non-benzodiazepines 554 (99.8) 0 (0.0) 1 (0.2) 0 (0.0)
Anticonvulsants 520 (93.7) 2 (0.4) 31 (5.6) 2 (0.4)
Dementia drugs 473 (85.2) 6 (1.1) 72 (13.0) 4 (0.7)
Acetylcholinesterase inhibitors 493 (88.8) 3 (0.5) 59 (10.6) 0 (0.0)
Cognitive enhancers 532 (95.9) 4 (0.7) 18 (3.2) 1 (0.2)
Pain relief 251 (45.2) 19 (3.4) 234 (42.2) 51 (9.2)
Opioid 436 (78.6) 15 (2.7) 91 (16.4) 13 (2.3)
Non-opioid 328 (59.1) 17 (3.1) 206 (37.1) 4 (0.7)
Laxatives 296 (53.3) 18 (3.2) 172 (31.0) 69 (12.4)
B/Z/A, benzodiazepines/z-hypnotics; SSRI, selective serotonin reuptake inhibitor.
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In relation to pain relief medication, 304 residents (54.77%), were prescribed some form of analgesia, of
whom 59 (10.63%) had co-codamol and 18 (3.24%) an oral non-steroidal anti-inflammatory drug. One
hundred and thirteen residents aged > 90 years were prescribed analgesics. Nearly half the resident group
(46.6%) was prescribed laxatives, of whom 80 were aged > 90 years.
Analysis of serious adverse events, reactions and unexpected reactions
Our rigorous procedure for identifying, validating and reporting SAEs uncovered no SARs and, therefore,
no suspected unexpected SARs.
Our analysis of SAEs focuses on the 58 homes and their 832 residents who completed baseline assessments.
The 28 intervention homes reported 80 SAEs, namely 59 in the 286 residents with CB (comprising 50 deaths,
seven hospital admissions and two instances of ‘persistent or significant disability’) and 21 deaths among
the 134 other residents. The 30 control homes reported 55 SAEs, namely 40 in the 269 residents with CB,
(comprising 31 deaths and nine hospital admissions) and 15 among the 143 other residents, comprising
11 deaths and four hospital admissions. As the 420 intervention residents were at risk for an average of
7.86 months, while the 412 control residents were so for an average of 5.15 months, the SAE rates per resident
per year were 0.291 in the intervention group and 0.311 in the control group. None of these comparisons is at
all close to reaching a statistically significant difference between the intervention and control groups.
Analyses of primary outcome measures
A residual analysis showed that the assumption of normality was acceptable for both NPI frequency and
severity. The relationship between the baseline and follow-up measures was similar across all the care
homes in both intervention and control groups, so there were no difficulties in using the models, outlined
in Methods, for the chosen analysis.
The sample size was 555 residents from the CB sample, and 81 deaths were excluded from the imputed
data sets. Fifty-seven care homes were included in the analysis because one home had only one resident in
the CB sample at baseline and did not subsequently complete follow-up measures.
Table 21 shows the NPI frequency scores at follow-up for those residents with measures at both baseline
and follow-up. There was only a small difference in the scores at follow-up. To be significant at the 5%
level, the 95% CI for the mean should not contain zero. Subsequently, because the CIs contain zero for
both models for the complete-case analysis, we found no significant difference between the intervention
and control groups. This non-significant finding was also found for the imputed data set.
TABLE 21 The ResCare trial: mean NPI frequency scores and differences at follow-up
Group
Follow-up,
mean score (SD)
Data set, mean difference in score (95% CI)
Complete case (N= 428)a Five imputations (N= 474)b
Model Ic Model IId Model Ic Model IId
Control (n = 226) 11.55 (6.92) 0.27
(–1.01 to 1.55)
0.59
(–1.21 to 2.39)
0.26
(–1.02 to 1.54)
0.60
(–1.18 to 2.38)
Intervention (n= 202) 11.65 (6.43)
a Number of homes = 55.
b Number of homes = 57.
c Adjusted for baseline and clustering (care home).
d Adjusted for baseline, clustering (care home) and covariates (number of beds, proportion of residents with a CBS
incidence score of > 10, home type, gender, age, CDR-SB, organisational change, and the number of days between
baseline and follow-up).
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Table 22 shows the results of the analysis of the NPI severity scores. Again, there was only a small
numerical difference between the intervention and control groups at follow-up. The results of fitting
models I and II, for both the complete case and multiple imputed data, again failed to find any of the
differences to be significant at the 5% level. In model II, we adjusted for the differential duration of
follow-up between the two groups, as this was included as a covariate.
In conclusion, the primary analysis did not demonstrate any evidence of differences between the two
treatment groups on the primary outcome measures of NPI frequency and severity. We therefore found no
evidence of an effect of the intervention.
Analyses of secondary outcome measures
To determine whether or not the experimental intervention improved staff experience and quality of life
for the residents living in the care homes, the following variables for the CB sample were used: NPI
distress, NPI total score and CMAI frequency. Variables for the whole resident sample were CBS frequency,
CBS total score, EQ-5D and QoL-AD. For the staff the following measures were used: MBI, ADQ, EQ-5D
and SES.
The same combination of two models (I and II) and two data sets (complete and pooled results of five
imputed data sets) were used for the secondary outcome measures.
A residual analysis showed that the assumption of normality was acceptable for all the variables, and as
the relationship between the baseline and follow-up measures was similar across all the care homes in
both treatment groups, there were no difficulties in using models I and II for the chosen analyses.
The CBS frequency showed that for model I there was almost a significant effect of the intervention for
the complete-case data, whereas the imputed data did find a significant effect. However, model II did not
confirm this effect (see Table 23 for the results of the secondary analyses). There was a significant effect
of the intervention in relation to the EQ-5D index for model II but not for model I. However, when the
correction for multiple comparisons was applied, the possible effect of treatment on EQ-5D index
disappeared. No significant effects of the intervention were found in the staff measures for either of
the models.
Data for the residents’ responses were not imputed, as there were so many missing data (only 376,
174 and 214 out of the total 832 residents answered the EQ-5D index, VAS and QoL-AD, respectively).
There were no significant effects.
TABLE 22 The ResCare trial: mean NPI severity scores and differences at follow-up
Group
Follow-up,
mean score (SD)
Data set, mean difference in score (95% CI)
Complete case (N= 424)a Five imputations (N= 474)b
Model Ic Model IId Model Ic Model IId
Control (n= 222) 7.25 (4.45) 0.27
(–0.67 to 1.21)
0.37
(–1.03 to 1.77)
0.30
(–0.76 to 1.36)
0.45
(–1.03 to 1.93)
Intervention (n= 202) 7.29 (4.44)
a Number of homes = 55.
b Number of homes = 57.
c Adjusted for baseline and clustering (care home).
d Adjusted for baseline, clustering (care home) and covariates (number of beds, proportion of residents with a CBS
incidence score of > 10, home type, gender, age, CDR-SB, organisational change, and the number of days between
baseline and follow-up).
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TABLE 23 The ResCare trial: secondary outcomes means and differences at follow-up
Measure
Data set, mean difference in score (95% CI)
Complete case Five imputations
Model Ia Model IIb Model Ia Model IIb
CB sample
NPI distress 0.72 (–0.58 to 2.02) –0.16 (–2.00 to 1.68) 0.71 (–0.51 to 1.93) 0.12 (–1.64 to 1.88)
NPI total 1.48 (–1.30 to 4.26) 0.23 (–5.77 to 6.23) 1.52 (–1.18 to 4.22) 0.18 (–3.68 to 4.04)
CMAI: physical/
aggressive
0.55 (–1.01 to 2.11) 0.75 (–1.55 to 3.05) 0.29 (–1.19 to 1.77) 0.39 (–1.77 to 2.55)
CMAI: physical/
non-aggressive
–0.60 (–2.10 to 0.9) 0.64 (–1.48 to 2.76) –0.41 (–1.91 to 1.09) 0.46 (–1.66 to 2.58)
CMAI: verbal/
aggressive
0.43 (–0.13 to 0.99) 0.66 (–0.16 to 1.48) 0.42 (–0.10 to 0.94) 0.60 (–0.16 to 1.36)
CMAI: verbal/
non-aggressive
0.71 (–0.49 to 1.91) 0.74 (–1.00 to 2.48) 0.67 (–0.67 to 2.01) 0.63 (–1.17 to 2.43)
All residents
CBS frequency 1.71 (–0.01 to 3.43) 0.93 (–1.67 to 3.53) 1.65 (0.03 to 3.27) 0.69 (–1.67 to 3.05)
CBS (frequency ×
difficulty)
4.30 (–0.76 to 9.36) –0.62 (–7.4 to 6.16) 4.17 (–0.69 to 9.03) –0.19 (–6.69 to 6.31)
EQ-5D index –0.001 (–0.06 to 0.059) 0.09 (0.01 to 0.17) –0.005 (–0.065 to 0.055) 0.08 (0.00 to 0.16)
EQ-5D VAS –2.53 (–1.43 to 0.85) 0.84 (–1.68 to 1.76) –2.83 (–1.65 to 0.99) 0.35 (–1.58 to 1.98)
QoL-AD –0.29 (–0.49 to 1.91) 0.04 (–1.00 to 2.48) –0.33 (–0.67 to 2.01) 0.20 (–1.17 to 2.43)
Model Ia Model IIc Model Ia Model IIc
All staff
MBI total 0.40 (–2.80 to 3.60) 1.28 (–3.60 to 6.16) 0.23 (–2.91 to 3.37) –0.07 (–4.73 to 4.59)
MBI-EE 0.08 (–2.10 to 2.26) 0.87 (–2.59 to 4.33) 0.16 (–2.18 to 2.50) 1.12 (–3.00 to 5.24)
MBI-PA –0.03 (–1.21 to 1.15) 0.20 (–1.44 to 1.84) –0.26 (–1.42 to 0.90) 0.04 (–1.54 to 1.62)
MBI-DP 0.32 (–0.34 to 0.98) 0.57 (–0.37 to 1.51) 0.07 (–0.57 to 0.71) 0.08 (–0.88 to 1.04)
ADQ total 0.18 (–1.04 to 1.40) 0.26 (–1.64 to 2.16) 0.14 (–1.10 to 1.38) 0.51 (–1.47 to 2.49)
ADQ hope –0.14 (–0.92 to 0.64) –0.11 (–1.35 to 1.13) 0.15 (–0.83 to 1.13) 0.28 (–0.96 to 1.52)
ADQ person centred 0.30 (–0.50 to 1.10) 0.48 (–0.68 to 1.64) –0.11 (–1.03 to 0.81) 0.28 (–1.16 to 1.72)
EQ-5D index –0.02 (–0.04 to 0.00) –0.01 (–0.05 to 0.03) –0.02 (–0.04 to 0.00) –0.01 (–0.07 to 0.05)
EQ-5D VAS –1.24 (–4.92 to 2.44) –1.38 (–7.20 to 4.44) –0.28 (–3.94 to 3.38) –2.29 (–7.61 to 3.03)
SES –0.76 (–1.88 to 0.36) –0.25 (–2.09 to 1.59) –0.41 (–1.79 to 0.97) 0.36 (–1.74 to 2.46)
a Adjusted for baseline and clustering (care home).
b Adjusted for baseline, clustering (care home) and covariates (number of beds, proportion of residents with a CBS
incidence score of > 10, home type, gender, age, CDR-SB, organisational change, and the number of days between
baseline and follow-up).
c Adjusted for baseline, clustering (care home) and covariates (number of beds, proportion of residents with a CBS
incidence score of > 10, home type, age, working hours per week, organisational change, and the number of days
between baseline and follow-up).
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Other significant covariates were CDR-SB affects CMAI verbal non-aggressive; the time between baseline
and follow-up affects EQ-5D index; and the group (CB or other residents group) affects CBS frequency and
total score, both EQ-5D measures and QoL-AD.
In conclusion, we did not show that the experimental intervention consistently affected any of the
secondary outcomes.
In order to address whether or not the intervention had an impact on the prescriptions of psychotropic
and pain/discomfort relief medication, a multilevel analysis as above for the binary outcome of whether or
not the resident was prescribed the drug was attempted. However, there were computational difficulties
because of the distribution not being normal, and so the preferred analysis could not be performed.
We then decided that the clustering effect was less important than the effect of the resident and so the
results of comparing those residents who changed medication between baseline and follow-up in the two
treatment groups are presented. This potentially results in an analysis that would find more significant
effects than would be found if the appropriate multilevel model was fitted. The medication information
was collected only for the CB sample and eight medication categories were of particular interest:
antipsychotics, antidepressants, hypnotics, anxiolytics, anticonvulsants, dementia drugs, pain relief
medication and laxatives.
Table 24 shows details of the residents who were present at both baseline and follow-up (n = 428) and
whether or not their medication was changed. The majority of residents were prescribed the medication
either at both baseline and follow-up, or at neither time point. Those residents whose medication changed
received it either at baseline and not at follow-up, or received it at follow-up but not at baseline. Using
only the change figures and comparing them between the two treatment groups, a chi-squared test to
compare the proportion found no significant differences between the intervention and control groups.
In conclusion, we found no evidence of changes in the prescription of medication between the intervention
and control groups.
Effect sizes
The effect sizes found were not as large as had been expected when the study was designed, and the
largest effect sizes in this study did not occur for the measures that had been expected. Table 25 presents
the effect size in two ways: (1) the naive effect size is calculated as the difference between the change
from baseline to follow-up (follow-up – baseline) between the two groups (intervention group – control
group) divided by the pooled SD of the change; and (2) the effect size with clustering taking account of
the clustering in model I.
In summary, the effect sizes do not approach the 0.3 value that was used for designing the study.
The majority of values are < 0.2, which is usually classified as a small effect size. For the staff-reported
residents’ measures the maximum naive effect size is 0.277 for the CDR-SB and with clustering the value
for the CDR-SB shows a similar value of 0.215. For the resident-reported residents measures the effect size
with clustering value for the QoL-AD is 0.236, but this is not mirrored by the naive effect size value of
0.114. For the staff measures, the effect size with clustering value for the SES is 0.151, but again this is
not mirrored by the naive effect size value of 0.098.
Intraclass correlation coefficients
The intraclass correlation coefficients values were calculated from model I output and were found to be of
the same magnitude as had been expected when the study was designed assuming a value of 0.03.
Dose effect of the intervention
As we found no evidence of effect of the intervention, we carried out an investigation of the ‘dose effect’.
The dose was measured by two home-level outcomes: the number of action plans expressed as a
proportion of the number of CB residents per home and the number of champions per home. These two
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TABLE 25 The ResCare trial: effect sizes and intraclass correlation coefficients
Measure Naive effect size Effect size with clustering ICC with clustering
CBS
Incidence 0.075 0.116 0.018
Frequency 0.140 0.173 0.010
Difficulty 0.099 0.168 0.056
Challenge (frequency × difficulty) 0.117 0.172 0.045
EQ-5D (proxy)
Index –0.008 –0.006 0.095
VAS 0.002 –0.111 0.058
QoL-AD (proxy) –0.033 –0.058 0.081
NPI
Incidence –0.102 –0.066 0.028
Frequency 0.053 0.045 0.016
Severity 0.078 0.068 0.046
Total (frequency × severity) 0.161 0.116 0.017
Distress 0.095 0.154 0.114
CMAI
Physical (aggressive) 0.083 0.087 0.059
Physical (non-aggressive) –0.103 –0.086 0.021
Verbal (aggressive) 0.134 0.188 0.046
Verbal (non-aggressive) 0.085 0.148 0.054
Total 0.016 0.045 0.023
CDR-SB 0.277 0.215 0.087
EQ-5D (self-report)
Index 0.042 0.164 0.051
VAS –0.179 –0.235 0.138
QoL-AD (self-report) 0.114 0.236 0.000
Staff data
EQ-5D
Index –0.071 –0.112 0.004
VAS 0.043 0.019 0.000
ADQ 0.051 0.039 0.088
Hope –0.059 –0.044 0.057
Person-centred 0.133 0.095 0.056
MBI 0.059 0.036 0.135
MBI-EE 0.040 0.010 0.114
MBI-PA 0.001 –0.007 0.067
MBI-DP 0.121 0.107 0.017
SES –0.098 –0.151 0.014
CHALLENGE RESCARE: A CLUSTER RANDOMISED TRIAL
NIHR Journals Library www.journalslibrary.nihr.ac.uk
62
measures were included in models I and II, replacing the treatment groups, to investigate the intervention
effect. The number of inpatient days was an additional response besides the primary outcome variables of
NPI frequency and severity. For each of the responses, two models were fitted and both considered the
clustering. Model 1 included the dose measures and baseline measure of the response. This was to test
significant changes of the response caused by the dose measures (the intervention) before adjusting for
other factors and covariates. Model 2 added other factors and covariates. At the individual level these
were age, gender and baseline measure, and at the home level they were size of home, proportion of
residents with a CBS incidence score of > 10, care home type, organisation change, and length of time
between baseline and follow-up.
In summary, the proportion of action plans did not affect the NPI frequency significantly according to
either model. (See Appendix 9, Tables 73 and 74, for the results of models 1 and 2, respectively, for NPI
frequency, Tables 75 and 76 for NPI severity and Tables 77 and 78 for the number of inpatient days.)
We found borderline evidence in model 2 that the NPI severity was affected by the number of champions,
but this evidence was not strong. The dose measures showed significant effects on the NPI severity using
the data after the 25% missing rule, but this was not then confirmed using the pooled results from the
imputed data sets. Likewise, the dose measures did not affect the number of inpatient days significantly
according to either of the models.
One might have expected that when the number of champions was higher, the NPI severity would have
been found to be lower. However, this was not the case: when the number of champions was higher, the
NPI severity was also higher. One explanation for this might be that where the NPI severity was higher, the
home manager sent more staff to be trained as champions.
Further analysis of residents with inpatient stays
As a point of interest, a further analysis of residents with inpatient stays (medical, surgical, other and
mixed) compared with those without any inpatient stays was conducted. The NPI frequency and severity,
and the CBS frequency × difficulty scores of the residents were visually compared. Box plots were used to
summarise those with no inpatient stays, whereas dot plots summarised those with inpatient stays (see
Appendix 10, Figures 17–21). There was no visually apparent difference in the three measures between
baseline and follow-up or between those with or without hospital inpatient stays. In relation to the cost of
medication in the 4 months up to follow-up, the median costs were similar across all the groups. There
was nothing to suggest that those residents with inpatient stays, irrespective of treatment group, were in
any way different from those who had no inpatient stays during the study.
Economic analyses
Characteristics of the economic sample
At baseline 555 residents with CB and dementia were randomised (intervention, n = 286; control, n = 269).
Follow-up data were available for 428 residents (intervention, n = 202; control, n = 226). Full service use
data were available for all 428, so the economic sample size matched the effectiveness sample size. Staff
report of the primary outcome measure, the NPI score, was available for all 428 residents at baseline,
and for 422 residents at follow-up. The six missing NPI scores were imputed. There were no significant
differences between the intervention and control groups with regard to demographic characteristics and
the mean cost of service use in the 3 months preceding baseline of the 428 residents for whom both
baseline and follow-up data were available (Table 26).
Cost of the e-learning and decision support e-tool package
Table 27 summarises the costs of the ResCare trial intervention. The software development cost was
£89,873; however, this did not include costs of staff time incurred by the ResCare trial team developing
the e-learning and decision support e-tool package content and subsequent checking. It is anticipated that
the package would need to be redeveloped every 5 years. With an assumed discount rate of 3.5%, this is
an annuitised cost of £19,905 over 5 years, and a cost of £6635 over 4 months. An unexpected cost was
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
63
for the installation of computer and telephone equipment in some care homes. The total cost for the
additional equipment was £17,455. Annuitising this cost over 5 years at a discount rate of 3.5% leads to
an annual cost of £3866 for equipment, which is £1289 over 4 months.
Training sessions were delivered by one specialist dementia care therapist to groups of up to 10 care home
staff. Most of the training sessions took place away from the care homes. Staff costs for training, including
venue hire, travel and backfill, were £15,658. It was assumed that because of staff turnover, training
would need to be on an annual basis, so spreading the cost over 4 months leads to a total training cost of
£5219 for the trial period. Action-planning included information-gathering, and creation and dissemination
of action plans. The cost for action-planning over 4 months was £28,004.
The total intervention cost was £150,990. After annuitising costs of software and equipment over 5 years,
and training over 1 year, the cost for the 4-month trial period was £41,147. Dividing this cost over the
286 residents randomised to the intervention at baseline results in a mean intervention cost per resident of £144.
TABLE 26 The ResCare trial: baseline characteristics of the economic sample
Characteristic
Group, n (%)
Control (N= 226) Intervention (N= 202)
Resident gender (female) 176 (77.9) 161 (79.7)
Resident age (years) group
60–69 9 (4.0) 8 (4.0)
70–79 39 (17.3) 33 (16.3)
80–89 126 (55.8) 107 (53.0)
90–99 48 (21.2) 52 (25.7)
≥ 100 4 (1.8) 2 (1.0)
Group, mean (SD)
Resident age (years) 84.60 (7.51) 84.97 (7.43)
NPI total score 21.89 (15.99) 19.95 (15.46)
EQ-5D (proxy) score 0.32 (0.31)a 0.34 (0.34)b
EQ-5D (self-report) score 0.66 (0.33)c 0.72 (0.32)d
QoL-AD (proxy) score 29.75 (5.87)e 29.64 (6.07)f
QoL-AD (self-report) score 33.84 (6.31)
g
35.84 (6.63)h
CMAI score 53.65 (17.31) 54.57 (19.82)i
CBS score 45.99 (37.53) 45.73 (35.96)
Cost (£) of community-based service usei 171.57 (210.67) 169.16 (244.57)
Cost (£) of hospital-based service usej 365.87 (2102.23) 437.96 (2294.18)
Cost (£) of medicationj 257.50 (438.34) 210.27 (285.29)
a n= 224.
b n= 201.
c n= 125.
d n= 81.
e n= 216.
f n= 197.
g n= 101.
h n= 64.
i n= 201.
j Costs refer to the 3 months preceding baseline.
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Cost of health- and social-care service use
(See Appendix 7 for the national unit costs of health services used in the calculations.)
Tables 28 and 29 provide details of service use in the 3 months before baseline for all residents in the two
treatment groups (n = 555) for whom baseline data were collected. The mean overall cost per resident
of community-based service use in the intervention group was £160.61 (SD £216.62) and in the control
group was £195.52 (SD £227.34), a difference of £34.91. Across the whole sample the overall mean cost
for community-based services per resident was £177.53 (SD £222.37). By far the largest cost in both
groups was for GP services. In relation to hospital services, the intervention group had higher overall mean
costs than the control group [i.e. £552.05 (SD £2587.44) compared with £441.23 (SD £2234.80), which is
a difference of £110.82]. Across the whole sample the overall mean cost for hospital services per resident
was £498.34 (SD £2423.50), and the largest proportion of the costs across both groups was for medical
inpatient stays.
Table 30 lists the various groups of medications that the residents were prescribed in the 3 months before
baseline. Those residents in the control group had a higher mean cost [£254.12 (SD £412.60)] than those
in the intervention group [£222.93 (SD £338.01)], a difference overall of £31.19. There was no significant
difference between the intervention and control groups for total medication costs at baseline or follow-up.
Across the whole sample, the overall mean cost of medications per resident was £238.05 (SD £375.99).
Adding together community-based services, hospital services and medications gives a total of £913.92 per
resident for the 3 months before baseline. It should be noted that care home fees are not included.
TABLE 27 The ResCare trial: cost of the intervention
Cost category
Cost (£)
Salary Travela Total For 4 months
e-Learning and decision support e-tool package development 89,873.00
Development subtotal 89,873.00 6635.00
Equipment for care homes 17,455.39
Equipment subtotal 17,455.39 1288.68
Training: therapist and care home staff 10,065.05 2539.10 12,604.15
Backfill to cover staff attending training 2295.66 2295.66
Training: venue hire 757.87
Training subtotal 15,657.68 5219.23
Information gathering: therapist and care home staff 4549.38 1900.81 6450.19
Information inputting: therapist 4507.45 127.75 4635.20
Action-planning: therapist 11,078.34 0 11,078.34
Disseminating action plans:b therapist and care home staff 2820.33 1052.66 3872.99
Follow-up booster visits: therapist and care home staff 1313.09 564.66 1877.75
Other administration: therapist and care home staff 43.48 45.66 89.14
Action-planning subtotal 28,003.61 28,003.61
Total intervention cost 150,989.68 41,146.91
a Travel time includes the cost of staff time and a mileage allowance rate of 40 pence per mile.
b Dissemination of action plans includes failed attempts at delivery (e.g. where scheduled meetings were cancelled).
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Table 31 shows the frequency and total mean costs of service use by the intervention and control groups,
subdivided into primary care, secondary care and medication for the 4 months up to follow-up. For a
more detailed breakdown of the services in each category, see Appendix 11. One resident in the control
group received 50 nights of medical inpatient care during the trial (aged 100 years and had a fall that
required leg pinning), which resulted in the mean costs of hospital service use for the control group being
almost double that of the intervention group; however, this was not a statistically significant difference.
Mann–Whitney U-tests showed no significant differences in overall service use costs between the
intervention and control groups, with a mean cost of £974.85 (SD £1601.40) per resident in the intervention
group and £1305.51 (SD £3752.74) per resident in the control group (difference in mean costs of –£331,
bootstrapped 95% CI of –£927 to £272).
Cost-effectiveness and cost–utility analysis
Follow-up data collection occurred approximately 4 months post intervention; however, due to problems
implementing the intervention in some care homes, the length of time between baseline and follow-up was
longer than anticipated. To account for the differential timing, it was assumed that the NPI and EQ-5D
changed linearly over time and individuals’ outcome changes were adjusted to 4 months. This adjustment
TABLE 28 The ResCare trial: community-based service use for the 3 months before baseline (per resident)
Service
Group
Difference in
mean cost (£)
(intervention –
control)
Control (n= 269) Intervention (n= 286)
Mean
frequency
(SD)
Mean cost (£)
(SD)
Mean
frequency
(SD)
Mean cost (£)
(SD)
District nurse 1.79 (6.07) 30.62 (82.55) 2.16 (7.24) 38.82 (128.63) 8.20
GP 1.74 (2.18) 137.58 (179.53) 1.27 (1.73) 88.35 (139.88) –49.23
Practice nurse 0.06 (0.47) 0.87 (6.58) 0.17 (0.74) 2.31 (11.31) 1.44
Health visitor 0.01 (0.09) 0.13 (1.53) 0 0 –0.13
Community psychiatrist 0.02 (0.16) 3.04 (29.70) 0.02 (0.19) 2.69 (25.69) –0.35
Psychologist 0.00 (0.06) 0.25 (4.15) 0.00 (0.06) 0.24 (4.02) –0.01
CMHN/CMHT 0.12 (0.67) 4.15 (31.38) 0.10 (0.44) 2.46 (11.30) –1.69
Physiotherapist 0.03 (0.25) 0.48 (3.88) 0.12 (0.76) 1.19 (7.48) 0.71
Occupational therapist 0 0 0.05 (0.38) 0.40 (2.78) 0.40
Chiropodist 0.77 (0.87) 7.74 (10.11) 0.55 (0.91) 6.04 (11.11) –1.70
Dietitian 0.13 (0.50) 1.39 (5.57) 0.13 (0.46) 1.50 (5.41) 0.11
Dentist 0.05 (0.31) 1.32 (7.77) 0.06 (0.31) 1.50 (7.93) 0.18
Optician 0.11 (0.36) 2.31 (7.44) 0.09 (0.31) 1.81 (6.35) –0.50
Social worker 0.02 (0.15) 1.33 (9.35) 0.05 (0.27) 2.19 (12.70) 0.86
Speech and language therapist 0.03 (0.16) 0.45 (3.52) 0.03 (0.17) 0.53 (3.63) 0.08
Specialist nurse 0.01 (0.14) 0.26 (3.01) 0.01 (0.10) 0.20 (2.28) –0.06
Falls team 0.05 (0.44) 0.86 (7.92) 0.03 (0.21) 0.39 (2.63) –0.47
Emergency care practitioner 0.06 (0.35) 1.63 (11.61) 0.13 (0.48) 2.61 (9.85) 0.98
Other 0.02 (0.17) 1.10 (9.00) 0.03 (0.23) 7.37 (55.43) 6.27
Total 5.02 (7.29) 195.52 (227.34) 5.01 (8.08) 160.61 (216.62) –34.91
CMHT, community mental health team.
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meant that our analysis of the data kept closely to our original analysis plan. As shown in Table 32, over
4 months the mean cost per resident in the intervention group was £187 less than the mean cost per
resident in the control group (bootstrapped 95% CI of –£744 to £300). For the cost-effectiveness analysis,
we reverse scored the total NPI so that an increased score indicated an improvement. NPI total scores range
from 0 to 144 points. Residents in the control group had improved their mean NPI score by 2.90 points
more than residents in the intervention group (bootstrapped 95% CI of –0.60 to 5.09). No significant
difference between groups was found in NPI severity or NPI frequency score in the primary effectiveness
analysis; however, the economic analysis used raw change scores and did not include variables accounting
for clustering or other characteristics. This was because we adopted a bootstrapping approach to the
analysis, and, as there was a very low intraclass correlation between homes, clustering was not seen as
necessary. The main base-case economic analysis produced an incremental cost-effectiveness ratio (ICER) of
£64 per NPI point improvement (95% bootstrapped CI of £14 to £303). There is no NICE-recommended
threshold for a 1-point improvement on the NPI; however, we extrapolated from the £20,000–30,000
per QALY gain threshold that an equivalent threshold for the NPI would be approximately £140–210 per
1-point improvement on the NPI (which has a range of 0–144 points). Figure 5 shows the cost-effectiveness
plane with 1000 bootstrapped ICER estimates. The majority of plots (75%) fell in the south-west quadrant
of the effectiveness plane, where the intervention is less costly and less effective than the control.
The cost–utility analysis showed a different picture. When repeating the analysis using QALY area
under the curve values, calculated using UK tariffs for the EQ-5D completed by staff as proxies for the
residents, the intervention group had a QALY gain of 0.01 (equivalent to 3.65 days) larger than the
control group (95% bootstrapped CI of –0.01 to 0.02). Figure 6 shows that the majority of the plots in
the cost-effectiveness plane fell in the south-east quadrant, where the intervention is less costly and more
effective than the control. Using resident self-reported QALY values (Figure 7), the majority of plots in
the cost-effectiveness plane fell between the north-east and south-east quadrants, indicating that the
intervention was slightly more effective than the control.
As can be seen in Figure 8, the probability that the intervention is cost-effective at a threshold of £30,000
per full NPI improvement is only 11% when the NPI is used as the measure of effect. The probability that
the intervention is cost-effective at a threshold of £30,000 is much higher when the unit of effect is the
QALY. In Figure 9 it can be seen that there is a 77% probability of cost-effectiveness at a threshold of
£30,000 per QALY using proxy values, and in Figure 10 there is a 90% probability that the intervention is
TABLE 29 The ResCare trial: hospital use for the 3 months before baseline (per resident)
Service
Group
Difference in
mean cost (£)
(intervention –
control)
Control (n= 269) Intervention (n= 286)
Mean
frequency
(SD)
Mean cost (£)
(SD)
Mean
frequency
(SD)
Mean cost (£)
(SD)
Surgical inpatient ward 0.07 (1.16) 63.64 (1043.76) 0.01 (0.12) 6.30 (106.55) –57.34
Medical inpatient ward 0.35 (1.83) 318.20 (1646.94) 0.47 (2.70) 422.15 (2434.79) 103.95
Other inpatient ward 0.05 (0.52) 46.89 (464.64) 0.13 (1.00) 113.41 (901.74) 66.52
Outpatient service 0.08 (0.33) 2.34 (9.93) 0.08 (0.38) 2.52 (11.51) 0.18
A&E 0.01 (0.09) 1.03 (11.88) 0.02 (0.14) 2.90 (19.81) 1.87
Day hospital 0.10 (0.35) 9.13 (31.59) 0.05 (0.24) 4.77 (21.70) –4.36
Total 441.23 (2234.80) 552.05 (2587.44) 110.82
Note
Frequency refers to nights for inpatients and attendances for all others.
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TABLE 32 The ResCare trial: cost-effectiveness analysis
Measure
Incremental
ICER point estimate
(£) (bootstrapped
95% CI)
Probability intervention
is cost-effective at
Cost (£)
(bootstrapped
95% CI)
Effect
(bootstrapped
95% CI)
£20,000 per
full unit of
effect (%)
£30,000 per
full unit of
effect (%)
Main analysis
NPI proxy (n = 428) –187
(–744 to 300)
–2.90
(–5.09 to 0.60)
64 (14 to 303) 0 0
QALY proxy (n = 428) –187
(–744 to 303)
0.01
(–0.01 to 0.02)
N/A: intervention less
costly and more
effective
76 77
QALY self-report (n = 206) –72
(–1085 to 714)
0.02
(0.00 to 0.05)
N/A: intervention less
costly and more
effective
85 90
Subgroup analysis
25–39 beds (small) (n= 188) –595
(–1963 to 477)
–2.28
(–4.97 to 0.47)
261 (44 to 1953) 6 6
40–49 beds (medium)
(n = 148)
49
(–318 to 419)
–3.24
(–6.77 to 0.60)
N/A: control less costly
and more effective
5 5
≥ 50 beds (large) (n = 92) –86
(–885 to 617)
–3.81
(–8.80 to 0.94)
23 (14 to 344) 7 7
Sensitivity analysis
Staff cost: action-planning
done by senior care assistant
(n = 428)
–242
(–776 to 269)
–2.90
(–4.95 to 0.68)
83 (17 to 327) 1 1
Removing secondary care costs
(n = 428)
115
(–7 to 230)
–2.90
(–5.21 to –0.81)
N/A: control less costly
and more effective
1 1
Removing outlier in control
group (n= 427)
14
(–79 to 674)
–2.91
(–5.13 to –0.71)
N/A: control less costly
and more effective
1 1
N/A, not applicable.
TABLE 31 The ResCare trial: resource use and costs in the 4 months up to follow-up
Service
Group
Mean difference in
cost (£) (intervention –
control) (95% CI
bootstrapped)
Control (n= 226) Intervention (n= 202)
Mean
frequencya
(SD)
Mean
cost (£) (SD)
Mean
frequencya
(SD)
Mean
cost (£) (SD)
Primary care
total
116.06 (119.12) 257.92 (310.16) 137.84 (151.21) 277.89 (302.22) 19.97
(–39.22 to 81.38)
Secondary care
total
0.95 (4.05) 663.37 (3634.81) 0.59 (1.81) 362.08 (1544.66) –301.29
(–924.05 to 160.61)
Medication total 7.47 (3.84) 384.21 (655.88) 7.87 (4.06) 334.88 (386.97) –49.33
(–153.39 to 51.60)
Total service use 1305.51 (3752.74) 974.85 (1601.40) –330.66
(–926.87 to 272.10)
a Frequency denotes minutes for primary care services and number of prescriptions for medication. For secondary care,
it denotes number of days for inpatient services and number of visits for outpatient services and A&E.
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FIGURE 8 The ResCare trial: cost-effectiveness acceptability curve for NPI.
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FIGURE 9 The ResCare trial: cost-effectiveness acceptability curve for proxy-scored EQ-5D.
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FIGURE 10 The ResCare trial: cost-effectiveness acceptability curve for self-rated EQ-5D.
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cost-effective at a threshold of £30,000 per QALY when using residents’ self-reported values. The issue is
to what extent these two health measures (NPI as a dementia-specific measure and EQ-5D as a generic
health-related quality-of-life measure) are in any way comparable. We have concerns for both the NPI and
EQ-5D with regard to relating differences in costs to extremely small differences in outcomes, which may
not be of clinical significance.
Subgroup analysis
A subgroup analysis (see Table 32) was conducted on the size of care home. The resident in the control
group who had spent 50 nights in hospital was in the smallest category of care home size, which led to a
larger difference in mean costs between groups in this category than in the main analysis. The difference
in mean NPI scores between groups was the largest in the large care homes, with residents in the control
group in large homes having greater improvements in their NPI scores.
Sensitivity analysis
The ResCare trial was a pragmatic RCT. During the trial the specialist dementia care therapist created
action plans for residents with CBs and worked alongside the care home staff to deliver the plans. The
intervention (i.e. the action plans) could, in theory, be developed and delivered by a care home staff
champion. Therefore, a sensitivity analysis was conducted using senior care assistant wages instead of the
specialist therapist’s wages for the creation of action plans, and the specialist therapist time removed from
action plan dissemination costs. The only input from a specialist therapist in this scenario was for training
and booster visits. The intervention cost per resident in this scenario fell from £144 to £90. The ICER
increased from £64 to £83 per NPI point gained.
Two post hoc sensitivity analyses were conducted to explore the effect that the resident in the control
group, who spent 50 nights in inpatient care had on the analyses: one analysis on all participants without
secondary care costs and the other with the outlier resident removed completely. In both cases the control
group had lower mean costs than the intervention group and a greater improvement in NPI scores, so the
control condition dominated (see Table 32).
Cost-effectiveness of the e-learning and decision support e-tool as a means of reducing
care home staff stress
Effect size for the range of measures for care home staff was negligible, leading to a conclusion that
the e-learning and decision support e-tool package did not reduce care home staff stress. During the
development of the ResCare trial, care home staff indicated that they were not willing to give personal
information on their own health- and social-care resource use. We were therefore unable to undertake a
secondary exploratory cost-effectiveness analysis using one of the carer stress measures as an effectiveness
measure and relating this to their service use.
Discussion
Summary of findings
This is the largest study in the UK to date (December 2016) of an intervention for the management of
dementia and clinically significant CB in care homes. Two thousand one hundred and eighty-five residents
aged > 65 years living in 63 care homes were screened for CB. Homes were then stratified across treatment
conditions for high versus low proportions of clinically significant CB. Within the cluster randomised study
design, 555 residents with dementia and CB (the CB sample) and 609 staff were recruited to this study.
In the intervention homes, 92 staff champions, nominated by their manager, attended training and
co-ordinated delivery of action plans for the management of residents with dementia and CB in their home.
There were no significant demographic differences between the residents and staff in the two treatment
groups. Comparison of the two groups on the primary measure of NPI (incidence and severity scores)
failed to find significant differences that could be attributed to the intervention. This was true for both
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‘complete cases’ and those derived by imputing scores for residents who dropped out but did not die, as
well as for all of the resident and staff secondary measures, including comparisons of medications that
were prescribed for residents. Post hoc analyses found that the proportion of action plans delivered within
this intervention in a given home did not affect the NPI scores. There was borderline evidence that the
number of champions who received training and contributed to delivery of action plans was associated
with an increased NPI severity score. This finding was not examined qualitatively post hoc, but training may
have contributed in part. For example, improved observation of communications through behavioural
expressions by the resident (see content of e-learning in Chapter 2 and Appendix 1) could have enhanced
staff observations of resident behaviour or, conversely, post-intervention completion of the NPI interview
may have triggered staff awareness of resident communication of their severe distress through behaviour.
Comparisons of health- and social-care costs, over and above care home costs, did not differ between
groups over 4 months. However, cost–utility analysis indicated that residents in the intervention group had
higher QALYs at the 4-month follow-up than those in the control group.
Limitations and implications for research
There are a number of limitations to design of the study and delivery of the intervention, some of which
were unavoidable. We did not conduct extensive feasibility checks, as recommended by the MRC in
its framework for complex interventions.155 For example, we did not survey stakeholder homes prior
to inclusion into the study on the availability of computer equipment and opportunities for e-learning
(including space for staff to do this) prior to planning the CRT, as we were keen to offer the intervention
as widely as possible in the real world of the range of care home settings; nor did we test and validate
the e-tool prior to its inclusion in the CRT, as difficulties with the engineers delayed progress of the study.
Therefore, the CRT was perhaps premature in relation to the e-tool, which required a more thorough
developmental process. Furthermore, we did not evaluate whether or not action plans were being
implemented or limit our experimental group data collection to staff (champions) who had attended
training and were charged with co-ordinating delivery of the action plans in the home. Finally, although
we did not collect data on ethnicity of staff or their migrant status in respect of the national picture,
the dementia care workforce includes many migrant workers, and it is likely that the care homes in the
ResCare trial were not atypical. Hussein and Manthorpe160 reported that the dementia workforce contains
significantly more non-British workers (19.1% vs. 15.3%) than other parts of the care workforce. Non-UK
workers among the dementia workforce are most commonly from the Philippines (17%) followed, equally,
by Poland and India (10.8%). This may have an influence on training and staff practices, but this study was
not designed to investigate these.
Potential contributing factors to the non-significant results of this intervention on CB outcomes in care
homes will be considered next.
First, we examine the design of this intervention. Functional analysis-based approaches to intervention for
CB and dementia were developed from modelling167 studies of face-to-face staff training workshops for
dementia and CB,63 single case studies of functional analysis-based interventions in care homes,13,68,69 and
our description of this intervention outlined in our Cochrane review82 (see also Chapter 1). The content of
the range of supportive investigations and interventions for the management of CB and dementia was
derived from Dementia: A NICE–SCIE Guideline on Supporting People with Dementia and their Carers in
Health and Social Care (p. 210).12 A functional analysis approach offered a systematic means of choosing
the most appropriate interventions and testing these out in a given case. In order to widen its impact for
future delivery in the present intervention, we additionally conceived an ICT solution for both staff training
and intervention planning (see Chapter 2). The ICT solution comprised an e-learning course and a decision
support IMS (the e-tool), to develop case-specific functional analysis-based action plans for residents with
dementia and clinically significant CB. To this we added support from a specialist dementia care therapist,
as this is seen as an important component of delivery in an individualised case-specific intervention such as
this.82 After we had adapted the delivery of staff training to care workers’ need for facilitated learning
away from their work environment, this was well received (see Chapter 2). However, the action-planning
process required a significant time commitment from the specialist dementia care therapist to interact with
CHALLENGE RESCARE: A CLUSTER RANDOMISED TRIAL
NIHR Journals Library www.journalslibrary.nihr.ac.uk
74
the e-tool, rather than supporting care home staff to use the iterative approach that is common in
functional analysis-based interventions in dementia (see Chapter 2). This study was not designed to
compare therapist-supported functional analysis-based interventions with the present ‘ICT-plus-therapist’
intervention described in Chapter 2. Our aspirations to widen the scope for the delivery of functional
analysis-based interventions using ICT may have undermined any potential robust conclusions about
use of this promising168 approach to intervention in care homes. A review of computerised clinical decision
support systems suggests that these may improve practitioner performance but, to date, the effects on
patient outcomes are understudied or inconsistent.169 The present study found that the decision support
software was not enough to impact on resident or staff outcomes. In contrast, an earlier study, FITS
(Focused Intervention Training and Support), demonstrated good impact on prescribing practice with the
use of bespoke interventions delivered by trained therapists working intensively with a small number of
care homes.27 A trained therapist is usually required for such an intervention,82 as a key skill in working in
this area is the ability to be flexible and have the capability to alter care plans as new needs arise, meaning
that the process remains iterative, but the functional analytical skills remain at the core of the plan. Future
research with decision support software could explore the feasibility of training specialist dementia care
therapists in working with care homes to deliver interventions for the management of dementia and
clinically significant CB.
Second, this study adds to knowledge about staff training in care home settings. Our e-learning course,
with its training on how to deal with common CB using simulated ‘real-world’ scenarios in the care home
setting, is what was advocated in a recent focus group study of e-learning with 21 stakeholders in south
London.127 In the present study almost one-third of care home staff had never had any dementia training,
let alone specialist training on the management of CB in dementia, which was the focus of our e-learning
course. Staff champions were positive about the case-specific individualisation of the approach to dealing
with CB and the qualities of the specialist dementia care therapist who facilitated the e-learning course
(see Chapter 2). However, our findings indicate that, whatever delivery method is used, training alone is
insufficient in its impact on the lives of residents with dementia and CB; future research needs to
incorporate a sustained period of joint working and supervision with a trained dementia professional.60,170
This conclusion stands true even for a course such as ours which, in contrast to many which are not
empirically based,170 was informed by the growing evidence on case-specific understandings and
intervention for CB13 and also on the NICE–SCIE guidance12 (see Chapters 1 and 2).
Third, organisational factors associated with engagement of care homes impacted on delivery of the
intervention. For example, even in the context of providing extra arrangements to deliver the training away
from the care home at no financial cost to the home, additional courses had to be arranged, as some
homes struggled to send their staff to pre-arranged training (see Chapter 2), whereas homes with high NPI
scores nominated more staff champions to support the intervention, suggesting that engagement with our
e-intervention would be better focused on homes where there are more residents with CB, as staff may be
more aware of their learning needs171 in the management of dementia with CB. Moreover, at the start of
the intervention two homes dropped out and a third large facility failed to engage with the intervention at
all. In contrast, no control homes were lost to the study. Organisational commitment to an intervention such
as this is an important consideration for future research. Barriers to delivery of the intervention to reduce
antipsychotics in the FITS implementation study included unclear communication across management levels
and values and ethos that contradicted the intervention approach.84 Other studies have noted that staff
perceptions of empowerment are important in the provision of individualised care;172 values and beliefs
that guide behaviour in an organisation can have an impact on depressive symptoms in nursing home
residents;173 and the impact of training initiatives on staff confidence and standards of care is often
dependent on strong leadership and the home culture.174 We will now consider our findings in the context
of fidelity and adherence to the intervention.
Fidelity and adherence to the intervention
Our intervention was designed to empower staff to access clinical expertise for the management of
dementia and CB, using a broad view of training that was complemented by an IMS to develop action
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plans (the decision support e-tool) and access to a specialist dementia care therapist. A study of training
in decision-making using the internet in primary care practices also noted disappointing use of the
resource.175 In the present study we can conclude that the effects of training nominated staff champions
did not diffuse to non-exposed staff in the homes. This may have been attributable to our unavoidable
need to depart from our original plan (see Chapter 2) and deploy research therapists to actively work
with staff to gather data for the e-tool, and a specialist dementia care therapist to assist with developing
the action plans. It is possible that active intercession of the therapists may have increased feelings of
dependency among the staff champions and reduced their sense of ownership of the action plans,
which in turn may have reduced the likelihood of them providing leadership in driving forward the steps
associated with the intervention. However, a more likely explanation is associated with our proposed
mechanism of change, which we will consider next.
The proposed mechanism of change envisaged was that once staff champions had completed the
e-learning course, and produced an idiographic action plan for a resident using the decision support tool,
they would use the action plan for a given resident. Furthermore, we envisaged that the bespoke training
would be used to improve their own approaches and interactive skills and the action plans would further
guide them to try solutions to meet the residents’ needs and also to facilitate informed approaches of their
colleagues. To achieve the latter, the staff champions needed to be able to influence and motivate their
colleagues to work differently and consistently in accordance with the action plan. It was also thought
that in those homes in which staff champions operated in this facilitative manner, there would be
improvements in residents’ quality of life, staff attitudes and other secondary outcomes. Limiting factors
to behaviour change in staff champions include lack of practice in delivering the intervention, as 30% of
the residents in the CB intervention group did not receive an action plan (see Chapter 2); no specific
component of support or training given to assist them to implement the action plans and/or disseminate
their new knowledge to their colleagues; different grades and experiential backgrounds, where some may
have been unable within the hierarchy of the home culture to speak up and share insights with their
colleagues; the low ‘dosage’ of the intervention in terms of the small percentage of staff champions in
each home, the lack of relevant and ongoing supervision, particularly over the implementation phase of
the action plan; and the experiences of the specialist dementia care therapist, who provided the perhaps
crucial time required to mentor and support staff to implement the action plans, with interaction with the
e-tool. This may have also undermined the expert clinical role of the specialist therapist who was cast into
a different, more technical role with time taken to troubleshoot computer problems. Therefore, just one
action plan was developed for most of the 199 residents, even though residents often displayed more
than one CB, which may or may not have been related to each other. In understanding the barriers to
integration of internet-based instruction by nurse trainers or other experts working in care homes, Irvine
et al.73 note that the technological role can undermine comfort levels of some clinical experts involved in
training, even if they are frequent internet users.
The lack of effect on prescribing practices was particularly disappointing. Our baseline data on prescribing
practices indicated that these are contrary to emerging clinical recommendations for antipsychotic use in
dementia105,112,176,177 and clinical guidelines advocating benzodiazepines prescription for no longer than
28 days.178 The action plans for such residents would have signposted staff to seek a review of these from
the resident’s GP or a psychiatrist, at a time when high-level NHS targets for the reduction of antipsychotics
in dementia care were emerging.112 Such action plans would have also recommended clinical risk–benefit
evaluation for the high use of benzodiazepines, hypnotics and anxiolytics (B/Z/A products) given the
cautionary guidelines associated with adverse effects of these in older people.178
It may be that staff working in care homes were unable to persuade other professionals, for example the
GP, to assist with action plans such as review of drugs, as attitudes of professionals, including physicians
and psychiatrists, to the management of dementia and CB can vary.179,180 Indeed, there is some evidence
from process notes (see Chapter 2) that the ‘unofficial hierarchy’ that was noted in a study of care
home staff and physician interactions104 may have undermined implementation of these action plans.
Variability in the culture of some homes, with respect to antipsychotic use,181 could have also contributed.
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The unwillingness of nurses and GPs to discontinue use of antipsychotics has been noted as a significant
barrier to changed practice182 where the authors suggest that these barriers may be overcome with more
complex multidisciplinary interventions. The FITS implementation study used the equivalent of specialist
dementia care therapists to demonstrate impact on prescribing practices, but only in organisations with
commitment to this type of intervention.84
The fidelity of the intervention could have additionally been compromised by the needs of the
specialist dementia care therapist who supported delivery. Although a percentage of action plans
were checked by the clinical expert team, this may not have been enough, particularly for the residents
who had presentations of severe CB. Routine access by the therapist to the clinical expert team was not
incorporated into the planned intervention here. Where care homes are committed to provide care to
residents with dementia and clinically significant CB, future cost–benefit evaluation is warranted. However,
this will need to include in-reach by a trained dementia care therapist. However, care will be needed to
ensure that trained dementia care therapists have access to clinical experts, as one of the lessons learned
from integrating IMS into clinical practice is that experts operate at a higher level of complexity,183 and
residents with dementia and clinically significant CB often have significant comorbid health conditions184
and live in a complex environment reflecting a system of varying cultures and practices in a care home.
This type of cost–benefit study for a training intervention such as this would need to take into account the
level of ‘scaffolding’,185,186 such as supervision, mentorship and access to clinical experts needed for
the specialist dementia therapist, as well as that provided by the therapist to staff in care homes, as
confidence in ongoing management of CB can vary. For example, the relevance of scaffolding new
learning was demonstrated empirically in a study of experienced cognitive–behavioural therapy therapists
who, following training, demonstrated an early dip in therapy performance, because of an initial
undermining of confidence and requirements of the participants to change existing ways of working
before further training and support raised their levels of competence.187 An alternative investigation of
‘dose’ could be to explore substituting many product champions for an in-home specialist dementia care
therapist, as our study appears to suggest that this low dose is not effective but that a higher dose, with
access to clinical expertise, may be more effective in the management of dementia and clinically significant
CB in care homes. For statistical examination of dose effect, our indices were necessarily limited. We were
unable to capture the extent to which action plans were implemented and any resulting changes in CB.
The likelihood is that many action plans were implemented only partially, if at all, and the good practice of
reviewing and adapting plans in the light of the response to the initial set of actions could not be followed
through. Future studies need to document each step on the putative pathway to change and allow for
longer follow-up, in order to allow the intervention to become embedded in the care home. This was the
case in all of the three care home intervention studies in our Cochrane review,82 where the intervention
phase was 4, 6 or 10 months, with specialist support following training to support staff in implementing
care plans described as occurring weekly or twice weekly.
Health economics findings
The health economic analyses did not identify any significant difference in service use by residents between
the intervention and control arms over the follow-up period (health, social care and medicines, excluding
residential costs). Although it was possible to calculate an ICER of £64 (95% CI £14 to £303) per 1-point
improvement on the NPI, this is difficult to interpret as there is no agreed threshold of societal willingness to
pay for such an improvement. In general, the lack of evidence for effectiveness in the trial is not compensated
for by any difference in costs. The cost–utility analysis appeared to support the intervention, in that, using
EQ-5D as a source of utility weights, the intervention dominated the control group, that is, it was more
effective and less costly than usual care. There was a 77% probability that the intervention could be
cost-effective at a payer threshold of £30,000. However, the mean QALY gain for the intervention group,
as compared with the control group, was only 0.01 and so this finding must be treated with caution.
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Conclusions
This study has high ecological validity as, once randomisation had occurred, all care staff and high CBS
scoring residents in good-quality care homes were eligible for participation. Thus, the results obtained
from our project have direct applicability to clinical services, which is in contrast to the findings obtained
from the more selective exploratory types of study.188 No evidence was identified for the effectiveness of
the intervention as implemented, but as the trial progressed it was evident that the tools and resources
developed were not sufficient to embed a functional analysis approach in care homes. We cannot then
draw conclusions from this trial regarding the effectiveness of using e-learning and decision support
software for functional analysis-based interventions, because of the factors associated with implementation
error.189 An implementation error refers to findings that cannot be interpreted as either effective or
ineffective in a pragmatic trial, because inadequate attention has been given to intervention fidelity by staff
who deliver the new intervention.189 In this chapter we have outlined some of the factors associated with
fidelity that we encountered in our study. These can inform the design of future research on case-specific
functional analysis-based interventions for the management of CB in dementia in care homes. In the next
chapter, the contextual and process factors that are key to successful implementation of e-learning and
decision support software in care homes are explored in depth.
This trial adds further evidence to the literature that suggests that training, in itself, is not enough to
change dementia care practice. The next step for future applied research such as this could examine the
effectiveness and cost-effectiveness of this training programme for clinically significant CB in dementia
supplemented with ‘in-reach’ support from a specialist dementia therapist.190 However, given the
elusiveness of the syndrome and the iterative nature of functional analysis-based intervention for residents
with dementia and clinically significant CB, the therapist will need access to clinical experts from the
disciplines of psychiatry, geriatric medicine and psychology. This may not necessarily take more contact
time with the home than was used in the current study.26
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Chapter 4 Challenge ResCare: a process
evaluation of the implementation of e-tools for the
management of dementia with challenging behaviour
in care homes
Abstract
Aim
To understand key implementation processes for delivery of e-learning and computer-assisted decision
support (e-tools) for the management of CB and dementia, including perceived and actual barriers
to delivery.
Methods
We used the normalisation process theory (NPT) and framework analysis to re-analyse data from the
ResCare trial and examine how innovations may become embedded in everyday work. Barriers to, and
facilitators of, change in care homes were studied by considering ‘process problems’ in social care settings;
and ‘structural problems’ affecting the integration of new systems into those settings. Following analysis of
contextual data collected during the trial for the intervention homes, a typology of ‘organisational cultures’
for computer-assisted intervention was developed. From this, four ‘case study’ homes were extracted and
seven (managers, senior care staff and care assistants), from a sample of 14 participants, were interviewed
individually; and a specialist dementia care intervention therapist and a research nurse who collected data
during the study were interviewed together. Nine additional qualitative interviews with care home staff
included those from the control group, and three focus groups using nominal group techniques with a
maximum variation sample (n = 22) of wider stakeholders provided opportunities to consider how far the
findings of the ResCare trial resonated with their experiences and how they interpreted the trial and
its findings.
Results
Three explanatory themes for the findings of the ResCare trial emerged: variation in care home managers’
trust of their staff; variation in the extent to which managers commissioned training; and variation in
cultures of training and practices within care homes. The findings also suggest that care homes are not
ideal environments for implementing new approaches, but implementation can be feasible, in smaller care
homes and in those with less hierarchical structures.
Conclusions
The implementation of interventions for the management of CB and dementia, using specialist NHS
support and resources, depends on the readiness of care homes to invest in innovation. Capable leadership
and collective willingness are also important. The toolkit developed for implementing online interventions
in care homes has scope for informing future practice innovations and research.
Introduction
The need for research on case-specific tailored interventions for the management of CB and dementia in
care homes was outlined in Chapter 1. These were described as ‘functional analysis-based interventions’
(see Chapter 1). An online solution was adopted to make the approach available to all care staff working in
a home (see Chapter 1) and a mixed-methods study of the process of delivery was described in Chapter 2.
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The findings of the CRT of computerised functional analysis-based intervention to tailor case-specific support
for the management of CB in care homes were described in Chapter 3. In order to make recommendations
for how e-learning, computerised and related individually tailored interventions for the management of
CB can become embedded in care home settings, key implementation processes are examined in this
present chapter.
Studying implementation processes from findings of the ResCare trial
Normalisation process theory is a relatively recently developed method to assist understanding(s) of how
new effective ways of working or service improvements may become a ‘normal’ part of daily practice.191
It has particular strengths in the systematic use of data from complex interventions192 to gain a deeper
understanding of the contextual processes involved in delivery of an intervention. By systematically
capturing the many human processes at work, when individuals and groups encounter a new set of
practices or aspirations to improve service innovations, it allows clear specification of the processes of
implementation that can then inform the transfer of the innovation into routine practice.
Normalisation process theory is used in the present investigation as a way of understanding and describing
the processes that inhibited or promoted a functional analysis of the causes and consequences of CB in
care home residents. Using the theory-based approach provided by NPT and its sociological ‘toolkit’ to
understand implementation, we focused on the dynamic, rather than the linear, processes that affected
how an innovative approach to training and delivery of functional analysis-based interventions for CB in
dementia may become embedded in everyday work in care homes.
There are several ways of using NPT to investigate implementation. Some of these have been developed
in care homes193 and have also been used to inform computer-assisted decision support systems in the
NHS.194 In this present study we adopted a retrospective approach, following completion of the ResCare
trial (see Chapters 2 and 3), as some implementation variables may have changed during the course of the
trial. For example, in a journal dedicated to practitioners, including care home staff and managers in the
UK, Flint and Cream127 conclude that there is a pressing need for e-learning programs to manage CB in
dementia. Other efforts made in the social care sector to improve care homes’ access to IT have also been
recommended for consideration by employers, who have to balance the time staff spend on training
against the demands of their work and personal commitments;195 and websites, such as that of the SCIE,
have begun investment in dementia management video-assisted demonstration and training resources.196
In this chapter we report the evaluation that explored the processes at work when people and groups
encounter, and seek to embed, a new set of practices or ways of doing things.191,197 We used process data
collected during the trial and also asked a sample of those involved in the study to reflect, with the benefit
of hindsight, on the processes of the trial. In addition, during stakeholder consultations, we asked those
who had not been engaged in the intervention, or in the trial, to think about the findings of the study and
how these might relate to their own current practice or service.
Normalisation process theory was used to address two important problems commonly encountered when
attempting to translate an intervention or service improvement into practice:
1. process problems – about the ‘implementation’ of new ways of thinking, acting and organising in
health and social care
2. structural problems – about the ‘integration’ of new systems of practice into existing organisational and
professional settings.
Normalisation process theory is built around a set of four core constructs and specific components that
represent ‘generative’ mechanisms of social action, namely the different kinds of work that people do as
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they seek to implement; for example, the findings of a trial of a complex intervention.192 These are the
ways that people make sense of the work entailed in implementing and integrating a complex intervention
(coherence); how they engage with this work (cognitive participation); how they enact it (collective action);
and how they appraise its effects (reflexive monitoring).198
The present study builds on other recent research conducted in health care, and, to a lesser extent,
in social care settings,193,199–202 in which NPT as a conceptual framework has been used to understand the
implementation of complex interventions,203 such as the ResCare intervention trial outlined in Chapters 2
and 3. It additionally outlines stakeholder contributions to the knowledge base, in which they discussed and
refined the combined findings from the ResCare trial, including those described in Chapters 2 and 3 and
from NPT analysis.
Methods
Normalisation process theory can be used at various points in the research cycle including, as here, to
re-analyse data from a completed project and to collect new information from those in positions to make
observations about findings. We used NPT and framework analysis to link and integrate two sets of data.
The first drew from existing qualitative and quantitative process data collected during the ResCare trial;
the second was supplementary qualitative data from semistructured interviews and a group discussion
collected on completion of the ResCare trial. Thus, NPT was used iteratively to:
1. Examine already collected materials and data from homes (collected by the ResCare trial team) to
identify and link the following data sets:
i. contextual features of care home types and characteristics (Box 2)
ii. implementation process data
iii. implementation outcomes data (Box 3).
2. Develop a typology of the organisational ‘cultures’ of care homes in which the computer-assisted
intervention for reducing CB among people with dementia was delivered. This involved refining and
validating the synthesis from point 1 above through additional qualitative data collection, using
accounts and updated experiences of the ResCare trial research team (e.g. research nurse, programme
manager, intervention therapist and IT engineer).
3. Examine interview data from a sample of four intervention case study homes that were selected on the
basis of analysis of the typology for computer-assisted intervention that was developed (see point 2
above), to gain a fuller understanding of implementation processes. This incorporated approaches to
identify perceived, as well as actual, barriers to implementation.
4. Engage with a wider group of stakeholders to gain a fuller understanding of the findings and of
implementation processes. This used stakeholder interviews and a modified nominal group discussion.
Participants were asked to comment on the typology of implementation that emerged from further
analysis of the data (see points 1–3, above), and about information derived from contact with study
participants. The latter comprised data from interviews with staff sourced from the ResCare trial homes,
addressing stages of implementation, homes in which implementation went smoothly and where it
did not, and perspectives from the control group of homes, where the intervention did not take place.
Normalisation process theory was used retrospectively and deductively in three ways: first, to inform, guide
and structure the way in which we collected additional data using interview guides; second, to code and
interpret data against the core construct components of NPT; and, third, to inform the way in which we
drew conclusions.199 We also drew on principles of constant comparison204 to inform data collection and
analysis, in order to inductively identify any other processes which facilitated or inhibited implementation,
and which have been overlooked through a priori application of NPT modelling on its own.
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Participants: intervention case study homes
Four candidate intervention case study homes were identified from within the emerging typology of 27
intervention homes by researchers (JK and FP) who were independent of the original ResCare trial. This
sample represents approximately 14% of intervention homes and was chosen to best represent the range of
contextual factors and implementation processes identified from our analysis of existing data (see Table 33).
These included home size, ownership and reported ease of implementation across a range of enabling and
disabling implementation processes. All four candidate homes agreed to support the implementation study
data collection. We aimed to speak to managers and any staff who attended staff champion training from
these case study homes. These additional qualitative data were collected between May and June 2013 by a
researcher (JK), unknown to, and independent of, the original research project team. The ResCare trial
programme manager (CH) contacted homes to find out who was still employed at the home and available
for interview; their contact details were then passed on to the researchers. Interviews were conducted over
the telephone, electronically recorded and transcribed verbatim. Topic guides were informed by NPT205 and
revised iteratively to explore further matters that emerged as important in the initial analysis. Telephone
interviews took between 20 and 50 minutes each.
Reflecting the difficulties experienced by the original research team in contacting care homes, potential
participants were often hard to contact, and scheduling interviews proved to be similarly problematic.
Care home staff would often schedule dates and times with the researchers, but would later be unavailable.
BOX 3 The ResCare trial: process and outcome data sources relating to implementing the intervention
l Researcher-completed questionnaire records of perceptions of helpfulness of staff when visiting, ease of
access to staff/data/interview space (some questionnaires completed post study).
l Study administrative database, researcher (minimal) comments on accessing homes.
l Researcher (minimal) notes/comments on individual homes.
l Intervention therapist’s notes.
l Programme manager’s notes on communication with care home managers.
l IT engineer’s notes on homes.
l Focus group transcript: research team discussion of implementing the technology/training in homes and
off-site [facilitated by AH (author, Doctor of Philosophy)].
l Reasons care homes withdrew (recorded by research team).
l Champions’ evaluation of e-learning (summary of evaluation forms completed).
l Care staff learning styles questionnaire (summary of data).
l Research team’s perceived receptivity of homes to e-learning and e-tool.
l Data detailing organisational change within care homes over the course of the trial.
BOX 2 The ResCare trial: contextual data sources for care homes where the ResCare trial intervention occurred
l Cover sheet for each care home (working records for the trial), including numbers of residents, staff,
staff turnover, management, etc. In addition, information relating to the attempts to contact homes and
researchers’ comments.
l Computer/broadband information for homes (collected in initial IT scoping exercise).
l Spreadsheet of data classifying care homes by type of ownership (local authority, private, not-for-profit
sector), sole ownership/chains, care homes with and without nursing care, experimental or control,
geographical region, numbers of beds (small/medium/large), proportion of CB in care home (high/low).
l Care staff demographics (e.g. age, gender, age left education, how long working with older people).
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A research nurse, who was involved in data collection during the trial, and the specialist dementia care
(intervention) therapist were also interviewed face to face, together, by the researcher (JK), to discuss
specific homes. Transcripts were not returned to participants for comment and/or correction, as this was
deemed unnecessary for a study of a non-personal nature, and would incur significant delays. Julia Keenan
led the analysis to identify salient themes and issues; both Julia Keenan and Fiona Poland independently
coded and discussed a subsample of four interviews to develop the initial coding frame, which was largely
deductive, as informed by NPT, but tailored to the context of the ResCare trial.
Participants: stakeholders
We aimed to recruit a qualitative maximum variation sample of participants and so, in addition to the case
study homes that were sourced from intervention homes (see Participants: intervention case study homes),
we expanded our enquiry to participants from the other ResCare trial intervention homes (that were not
used as case studies) and control homes; stakeholders from localities where the trial had been carried out;
and wider stakeholders from other parts of England. These diverse participant groups are here referred to
as ‘stakeholders’. Use of qualitative methodology meant that no sample size was determined in advance
for the wider stakeholder group discussion. Instead, individuals with a broad variety of relevant experiences
working in different agencies, and others with personal interest in dementia care, were approached and
recruited. They included:
1. care home managers and care home workers from different parts of England
2. professionals with experience of supporting care home residents and working with care home staff
3. people with experience of training and professional education
4. people with experience of service improvement (including regulators, inspectors, complaints work),
described here as ‘service improvers’
5. lay people who had reflected on their personal experiences of visiting and scrutinising care homes
as relatives, or friends of residents; and
6. professionals with experience of purchasing places in care homes on behalf of local authorities
(commissioners and senior managers).
Recruitment and data collection ceased when thematic saturation was achieved, that is, when no new
themes appeared to be emerging from the data.
Two further researchers who were independent of the original research project (JM and KS) invited 22
stakeholders to a discussion event, which comprised a facilitated meeting involving three discussion groups
that used modified nominal group techniques. This was held in London, in April 2013. We (JM and KS) further
interviewed nine others in person or over the telephone between June and July 2013. Topic guides were
informed by findings from the ResCare trial to include development of the intervention (see Chapter 2), the
CRT (see Chapter 3) and the case studies that were used during NPT process investigation. These were
tailored to stakeholder participants’ knowledge and role, where stakeholders considered whether or not
our findings ‘rang true’ (see section Interview topic guides). Stakeholder interviews and discussions at the
facilitated meeting were recorded in note form. These data were anonymised and then analysed thematically.
Two researchers (JM and KS) undertook the analysis to identify salient themes and issues. Again, transcripts
were not returned to participants for comment and/or correction, as this was deemed unnecessary for a study
of a non-personal nature, and would incur significant delays.
Interview topic guides
Semistructured tailored topic guides were developed to explore the research questions posed in the case
study interviews with managers and care staff (Boxes 4 and 5), facilitated meeting and in the subsequent
interviews. The topic guides were discussed with members of the programme steering group, which
included a person with dementia, and the wider research team. The case study topic guides were closely
informed by NPT constructs and components, but tailored to the individual characteristics of the care home
and interviewee role in relation to the ResCare trial.
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For practitioners and other experts, the interview schedules were tailored to the activities of the specific
agency or professional group being interviewed, whereas for family carers, their expressed experiences of
managing CB themselves and their observations of care home practice and staffing were both potential
sources of information and of their views. The topics covered included:
1. Do the findings of the ResCare trial (summarised), and about implementing an e-learning/e-tool for care
home staff (described), and the introduction of functional analysis approached for planning (explained),
‘ring true’ in your experience?
2. Thinking of homes you have worked with or visited, does our typology for computer-assisted
interventions (explained) help anticipate and explain these challenges for implementing e-learning/e-tool
and functional analysis?
3. What other barriers might be relevant to consider?
4. What potential resources/enablers might be relevant to consider?
BOX 4 The ResCare trial: interview guide for case study interviews with care home managers
What did your home hope to get out of taking part in the ResCare trial? Who decided that your home should
take part? . . . Feelings about this?
From your point of view, what did you understand as being the purpose of the research? . . . Was CB among
residents with dementia a priority for you at the time, or not?
Was it clear when you joined the research what staff and resources would be involved and what you were all
being asked to do? What was your role in all this? Was there someone in your home who was responsible for
co-ordinating or leading the research activity?
Were the relevant staff/owners ‘on board’ with the e-learning and the care planning?
Did people want to be involved? Did you have to do any extra work to get people involved? See it as part of
their job? How were staff/champions identified to take part?
How did this type of e-learning compare to the usual ways in which you train your staff? Probe perceived
learner confidence with IT/education levels. How far had care staff received any previous training to understand
CB in residents with dementia? How did the new care planning process (e-tool) compare with your home’s
existing care plans?
In your opinion, what were the difficulties encountered in making the intervention run well? What needed to
be in place in your home in order to make the intervention run well? What did you have to do (differently) to
make this work?
How do you feel staff got on with the e-learning/action-planning? How far did they get the support (time,
resources) they needed to complete training and formulate action plans (with confidence)? How were the new
action plans used?
How did you judge whether or not the e-learning or action-planning made a difference to residents or staff in
dealing with CB? Did you discuss whether or not it was working? Did you get any feedback along the way on
how staff managed or performed with the e-learning or with the action-planning? Do you feel this e-learning
and action-planning made a difference? Do you feel it made dealing with CB easier or more laborious?
Has anything changed in the day-to-day way you deal with CB in residents with dementia as a result of this
intervention? Better/worse? Why?
CHALLENGE RESCARE: A PROCESS EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
84
Ethical considerations
In line with other parts of the trial, data reported in this chapter were collected with informed consent
and participants were assured of anonymity. To help reduce the risk of bias, the interviews were conducted by
researchers who had not been part of the trial as the participants may have wished to give socially acceptable
answers to members of the trial research team. Each case study home was assigned a pseudonym, chosen to
avoid the name of any actual UK care home at the time.
Data analyses
The first phase of analysis involved close reading and re-reading of various overarching and home-specific
data sources, related to the process and outcomes of implementing the intervention. These sources were then
manually coded (by JK and FP) so as to identify barriers to, and facilitators of, successful implementation, and
then to identify the main (sequential) mechanisms of implementation (see the example outlined in Figure 11).
These mechanisms, in conjunction with context data (see Box 2), were used to identify potential factors
affecting barriers to, or facilitators of, implementation; and to develop a typology for intervention homes
BOX 5 The ResCare trial: interview guide for case study interviews with care staff
What did you hope to get out of taking part in the ResCare trial? Who invited you to take part? . . . Feelings
about this.
From your point of view, what did you understand as being the purpose of the research? . . . Was CB among
residents with dementia a priority for you at the time, or not?
Was it clear when you joined the study what would be involved and what people in the home were being
asked to do? What was your role in all this?
Was there someone in your home who was responsible for co-ordinating or leading the research?
Were the relevant staff/owners ‘on board’ with the e-learning and the care planning? Did people want to be
involved? See it as part of their job?
How did this type of e-learning compare to the usual ways in which you are trained? Probe perceived learner
confidence with IT/education levels. Have you received any other previous training to help you understand and
deal with CB in residents with dementia? How did the new action-planning process (e-tool) compare with your
home’s existing care plans?
How did you find the e-learning/action-planning? Did you get the right support (time, resources) needed to
complete training and formulate action plans (with confidence)? How were the action plans actually used?
In your opinion, were there any problems in your home in implementing the e-learning and action-planning
tool? What did you have to do (differently) to make this work?
Did you ever discuss with other colleagues in your home whether or not the e-learning or action-planning
made a difference to residents or staff in dealing with CB? Did you get any feedback along the way on how
you did with the e-learning or with the action-planning? Do you feel it made a difference? Do you feel it made
dealing with CB in residents with dementia easier or harder?
Has anything changed in the day-to-day way you deal with CB in residents with dementia as a result of taking
part in this project? What? (Care planning, understanding CB?) Better/worse? Why?
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according to whether they provided an enabling or disabling environment for each of these mechanisms.
Of the 28 intervention homes in the main study, 27 received the intervention; one home failed to engage
with the intervention and one dropped out following intervention (see Chapter 3), so no trial follow-up data
were available for this home. Where supporting data were unclear, making initial assignment of a home
to an ‘enabling’ or ‘disabling’ environmental category difficult, a note was made, and clarification was
achieved in April 2013 during consensus discussions with the research team. NVivo 8 (QSR International,
Cambridge, MA, USA) was used to manage the systematic coding of existing and supplementary qualitative
data. Participants in any interviews completed for this chapter did not provide feedback on the findings,
but the findings from the case study intervention homes’ interviews were shared with the stakeholder
group and their reflections recorded as part of the modified nominal group.
Results
Two aspects of our inquiry are outlined in this section: first, those that took part in the intervention study
that were included as case study data; and, second, those described as ‘stakeholders’. This group included
wider stakeholders from the localities of the trial and also across England, staff at homes that took part
in the intervention but were not sourced as case studies and staff in control homes who did not receive
the intervention, apart from the offer of free access to the e-learning course if they wished.
First, we report the findings of the study of intervention homes using NPT and framework analysis206,207
by presenting a descriptive typology for all intervention homes, and descriptive data for case study
homes. This is followed by a description of the factors that influenced implementation of the intervention,
described according to the four NPT constructs: coherence; cognitive participation; collective action; and
reflexive monitoring. Interpretation of NPT analysis, relating to requirements for implementation, is outlined
in Figure 12.
Next, we present the thematic findings of our stakeholder interviews and group discussions, in terms of
whether or not our approach to training and functional analysis ‘rang true’ with those not involved in the
intervention; whether or not identified enablers and facilitators of implementation are applicable to other
parts of the country; and whether or not the problems with and barriers to implementation would be
applicable to other homes and areas across England.
Finally, findings on uptake of resources available and how decisions are made about who delivers
interventions are outlined.
Care home’s ability to 
‘bridge IT gap’ to ensure 
web-based training can 
run in home
Care home’s ability to 
lead implementation; to 
co-ordinate people and 
resources, to communicate 
purpose of research to 
staff, and keep staff
’on board’
1. Building IT capacity for e-training/tool
2. Intervention leadership and management
Care home’s receptivity to 
web-based learning and 
care action-planning, and 
ability to protect training 
time and support 
development of the 
intervention
3. Training culture 
FIGURE 11 The ResCare trial: mechanisms of implementation taken from the analysis of process and outcome data
from the ResCare trial.
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Implementation of the intervention in homes
Descriptives: typology for all intervention homes
An overview of the implementation process and outcomes across intervention homes is presented within
a descriptive typology of care homes (Table 33). The top part of the table shows single homes and the
bottom part shows homes that are part of a chain or larger company. The typology of homes is structured
according to implementation mechanisms illustrating the three implementation mechanisms (shown as
columns in Figure 11): IT (connectivity, equipment and building IT capacity); research and intervention
leadership and management; and training culture.
For the first implementation mechanism associated with IT, most single, privately owned independent
homes, even when running without modern IT systems before the intervention, could facilitate the
required upgrades to run the intervention; only one of the nine single intervention homes (home 1111)
struggled here. For the 18 homes that were part of a larger chain or company, just over one-third,
struggled at this first hurdle, of having the IT in place in order to deliver the intervention.
The second implementation mechanism associated with enabling or disabling leadership and management
environments was equally prevalent across both single homes and homes owned by a chain or larger
company. Within homes experiencing changing ownership or management during the trial (shown as
codes within the table footnotes), some homes coped better than others in leading the research, with a
change of manager sometimes helping the research to progress.
For the final implementation mechanism associated with training culture in homes the picture was also mixed.
As can be seen from Table 33, across the intervention homes, all three implementation mechanisms were
‘enabling’. These were rated as ‘good’ for implementation by the original research team in six homes. Two
homes were rated as ‘disabling’, across all three mechanisms, and these were also described as ‘challenging’
by the original research team. Finally, a sizeable cluster of a ‘challenging’ care homes were deemed
‘enabling’ for IT, yet ‘disabling’ in both leadership and training culture.
Internet provider 
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Management style: 
responsive, open to 
reflection and change
Benefits and innovation of  
intervention understood 
Implementation processes 
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Champions identified at 
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effect change
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2.
 R
es
ea
rc
h
 a
n
d
 in
te
rv
en
ti
o
n
 le
ad
er
sh
ip
 a
n
d
 m
an
ag
em
en
t
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protected
Staff trusted to use 
internet responsibly
Learner concerns 
regarding e-learning
(such as confidence) 
addressed
High-quality trainer 
support in place
Support to produce 
action plans using e-tool
Action plans valued, 
reflected on and refined 
if needed (with support 
from a specialist 
dementia therapist)
3.
 T
ra
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g
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u
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u
re
FIGURE 12 The ResCare trial: what needs to be in place to support implementation, as identified by NPT analysis.
PC, personal computer.
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Descriptives: intervention home case studies
Each of the four case study homes was assigned a pseudonym. Their operational contexts are shown in
Table 34.
To reflect the variety within the intervention homes overall, three case study homes were part of a care
group and one was a single privately owned home. We included a small, medium and large care home
(with different staffing structures and cultures), and one of the case study homes selected was a care
home with nursing (Careful Place). We included homes that had dedicated or specific dementia floors/units
for residents. Finally, geographical location and urban or rural setting were likely to influence the pool of
available labour and staff turnover, as well as the culture of care; so these were also taken into account.
Fourteen case study home staff (at least one from each home) were identified as potential participants, of
whom seven agreed to be interviewed: three managers and four care assistants or senior care assistants
(Table 35).
The therapist leading the intervention and a research nurse employed throughout the research process
were also interviewed together to discuss implementation in these homes.
TABLE 33 The ResCare trial: typology of intervention group care homes according to implementation mechanisms
Ownership IT
Leadership/
management
Training
culture
Homes (n= 27) (research team rating –
implementing the research trial)
Single home (private or charity/
voluntary owned)
Enabling Enabling Enabling 1038 (good); 1004a (good); 1028a (good)
Disabling 1016b (average)
Disabling Enabling 1098 (average)
Disabling 1073 (challenging); 1093 (average); 1069a
(challenging)
Disabling Enabling Enabling
Disabling 1111 (average)
Disabling Enabling
Disabling
Care group home (private,
charity/voluntary or local
authority owned)
Enabling Enabling Enabling 1108c (good); 1066c (good); 1015 (good)
Disabling 1043a (challenging); 1072 (average)
Disabling Enabling 1048 (average); 1001c (good); 1079a,c
(average)
Disabling 1078c (challenging); 1013c,f (challenging);
1103a,d (challenging); 1027 (challenging);
1062 (challenging)
Disabling Enabling Enabling
Disabling 1082 (average); 1105a,e (average)
Disabling Enabling 1085e (average)
Disabling 1087 (challenging); 1106a (challenging)
a New manager put in place during trial.
b Home owned by another (group of two).
c New company took over during trial.
d Investigation took place during trial.
e Council reshuffle during trial, dropped out of study following intervention.
Note
Home IDs in bold were those selected for implementation case studies.
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Factors influencing implementation of the intervention
Analysis of four NPT-framed factors (i.e. coherence, cognitive participation, collective action and reflexive
monitoring) revealed that these varied in their influence during implementation of the intervention.
These are described below.
Coherence: making sense of implementing the research and intervention
One emerging finding from the analysis of interviews with care home managers, and for some other
staff who attended the training, was that, despite their reported initial enthusiasm for the research and
intervention, after allocation to the intervention group and taking part in the research, they struggled to
define the unique aim of the intervention. Beyond the novelty of it being specifically about dementia and
CB and its delivery by electronic means, none of the three managers interviewed saw the intervention as
being about a biopsychological case-specific approach for dementia and CB.
TABLE 35 The ResCare trial: case study care home staff interviewed
Staff
Care home pseudonym
Happy Haven Careful Place Home Court Lifelong Lodge
Number of
potential care staff
participants (grade)
n= 3 (one manager
and two senior care
assistants)
n = 3 (one manager
and two care
assistants)
n= 5 (one manager, two
senior care assistants and
two care assistants)
n= 3 (one manager
and care assistants)
Changes in
personnel since
intervention
No change One care assistant
on maternity leave
Manager stepped down,
but in home once a week
to train staff; one senior
care assistant now acting
manager, one left the
home and one unable to
be released
One care assistant
went on long-term
leave after training
Number of actual
participants
n= 3 (one manager
and two senior care
assistants)
n = 1 (one manager) n= 1 (one care assistant) n= 2 (one manager
and one care assistant)
TABLE 34 The ResCare trial: overview of the context for case study homes
Care home pseudonym
Happy Haven Careful Place Home Court Lifelong Lodge
Single privately owned care
home
Private (group) care home
with nursing care
Private (group) care home Not-for-profit (group)
care home
Mixed client group: organic
and functional mental health
problems
Registered for those with
dementia and for those with
physical disability
Registered for those with
dementia and for those
with physical disability
Registered for those with
dementia
Small home (29 beds,
27 full-time staffa)
Medium-sized home
(45 beds, 12 full-time staff)a
Large home (82 beds) Small home (30 beds,
37 full-time staff)a
Urban area. Home adjoined
converted houses, bit ‘run
down’
Suburban – not built up.
Converted nurses’ home
within own grounds
Suburban – not built up.
Staff work on one side of
the home or the other
Semi-rural/village location.
‘Not a spacious home’
Home run on ‘relaxed family
basis’, staff members related
‘Cottage hospital’ feel.
Care staff described like
‘shop floor girls’
Designated ‘floor’ for
dementia
Specific dementia unit
a Staff numbers described as full-time equivalents: complete figures are not available for Home Court.
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Indeed, the approach was not felt to be entirely new to some homes, but, significantly, no one envisaged it as
implementing a somewhat specialised approach to systematically deliver tailored case-specific support or
functional analysis-based interventions for the management of CB in the home. Care staff interviewed
recollected that the training had addressed ‘thinking about how they [resident] see things’ (Lifelong Lodge,
care assistant), the ways in which staff interpreted, understood and could more productively address what
might be seen as CB. However, they did not understand themselves as being champions taking forward and
modelling the way they understood and supported residents with CB within a cascaded learning approach.
Coherence, that is, how people make sense of the intervention, was vulnerable to fragmentation over the
course of the research. This appeared to be the result of the dynamic nature of the research content since,
in reality, care homes could be involved in several service improvement initiatives simultaneously:
. . . you know they might have had a patient survey, or they might have had a little university project
going on, or they might have been contacted by some audit department, or, . . . changes of
management and staff and stuff, so I think they do forget.
PA4 research team focus group
The impact of this within-sector dynamism on maintaining coherence was to some extent foreseen and
anticipated by the research team. However, the length of the research process, the gaps created between
contact, data collection and intervention activities within individual homes and the necessary implementation
changes to the study (Box 6) worked against maintaining coherence. The research team saw this as leading
to a considerable increase in workload, as they had to ‘start all over again’ with subsequent contacts.
From the perspectives of care home staff tasked with leading the interventions, they did not see these
different components as part of a larger project. Such fragmentation threatened care home managers’
willingness and ability to participate; and was an even greater threat in care homes operating under pressure.
Managers also described fragmentation as a result of several ‘different researchers’ coming into the home
at different stages such as those who were there for the purposes of data collection and those who were
there to assist with the intervention. The result of this was:
We never got to really form any kind of relationship with the team that was actually doing it.
Careful Place, manager
Finally, the threat of fragmentation to care staff making sense of the intervention arose from changes
having to be made in the research process and intervention. The e-tool could not produce the
individualised action plans as envisaged without significant additional staff input.
One manager expressed confusion about why the IT equipment from the research was still in the home,
having forgotten the original (modified) plan for the intervention to run independently in the homes.
Thus, a final significant barrier to coherence was lack of communal specification, within each home,
when people who were important to the intervention had lost understanding of its aims and processes.
BOX 6 The ResCare trial: key changes made to the implementation process by the research team
l A shift from the e-learning/e-tool in homes running independently without a therapist through a
champions/cascade learning model – to delivering e-learning to champions in classes off-site, delivered by a
skilled therapist and providing therapist support for action-planning.
l The e-tool module of the intervention, initially designed to deliver individualised action plans – demanded
therapist support and much more input with the therapist from champions in care homes than was
originally envisaged.
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Poor communal specification caused the largest implementation problem in two key areas. The first area
was when care staff identified as champions did not understand the intervention’s specific purpose and
nature. The second area concerned the need to supply or boost homes’ IT and broadband provision to
sufficient levels in order to run the intervention. This was needed to realise the original plan of installing
and running the e-learning and e-tool in homes, and to gain the necessary permissions to undertake this
work. The research team had sought the agreement of care home owners. These were either heads of
groups of privately owned or not-for-profit or local authority-owned care homes or owners or owner/
managers of individual care homes. Sometimes permissions from others were required, such as training
directors or regional/national company directors or when working with an organisation’s external IT
department or an organisation’s outsourced IT provider. This convoluted process of gaining communal
understanding and authorisations from different people in the care home system, often located at different
sites and often not very contactable, further contributed to a lack of coherence. Staff knowledge of IT
systems varied across case study homes, but IT installation was deemed to be relatively straightforward.
Thus, we can conclude that lack of a coherent understanding of the intervention and research process
clearly impacted on the willingness of care home staff to fully engage with or ‘buy into’ the intervention,
leading to one manager expressing disappointment:
. . . it was very exciting to be able to be picked to take part in it you know, especially as I said at the
time it was . . . the timing was right. But I was disappointed with how it progressed.
Careful Place, manager
The lack of coherence was a particular threat in homes operating in conditions of uncertainty, and in those
with more hierarchical staffing structures or homes that were part of a larger group. This suggests that
smaller homes may be more amenable to the changes needed for implementation of interventions for
dementia with CB. The ‘real’ and ‘ideal’ conditions193,199 for making sense of the intervention are
summarised in Table 36.
TABLE 36 The ResCare trial: coherence; real and ideal conditions for making sense of the research and intervention
Conditions
Strategies to promote coherenceReal Ideal
Care home staff struggled to define
the unique aim of this research:
implementing functional analysis across
the home
Recognition of what the research and
intervention were trying to deliver
Promote the intervention as a
psychosocial framework for CB in
dementia, rather than focusing on its
novel delivery
Coherence vulnerable to fragmentation
over the course of the research process
Maintained understanding of the
stages of research and intervention
implementation
Provide a regularly updated
user-friendly timeline to show key
research milestones
Circulate regular newsletter with
research updates and photographs of
new research staff
Care staff sent for training not
understanding themselves as
champions within a cascaded learning
approach
Owners and IT departments did not
understand their role in upgrading
homes’ IT and broadband provision
All relevant parties know what the
intervention is; and what it requires
of them
Create a diagram/poster describing
each staff role in implementation
Explain/cascade learning model and
identify support for champions
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Cognitive participation: investing in implementing the intervention
Cognitive participation, according to NPT, refers to how people engaged with the research process and
the intervention. Data were analysed in terms of the barriers to individual and collective investment in
delivering interventions for dementia and CB. These were:
l a manager or other senior member of staff not taking responsibility for initiating and maintaining
participation in each home; or not being supported in this role
l managers being ‘told to take part’, leading to tokenistic engagement
l managers and care staff resisting the research and intervention.
Embedding innovations requires that key participants drive implementation forward. Not surprisingly,
the most important person identified within care homes by the research team to lead implementation
was the manager, and it was evident that the manager who ‘invested’ in, or was personally committed to,
the research could make a huge difference to implementation. Managers were widely deemed to be
more likely to lead participation if they had gained a greater sense of coherence about the research,
by themselves engaging in it and showing others through their actions, such as by taking part in data
collection (questionnaires), or, more powerfully, as a small number did, choosing to attend the training
themselves. For the six homes whose managers attended training, three were rated as being ‘good’ in
terms of implementation by the research team, two were rated as ‘average’, and only one as ‘challenging’:
. . . the managers that have been involved in answering questionnaires that have been more hands-on
managers have also been much, much easier to work with as well, because they’ve just got it,
whereas the managers that have been very distant and we don’t really see, and don’t have any
involvement, have been more of a struggle.
PA1 research team focus group
In their focus group discussion, the research team acknowledged ‘in hindsight we should have probably
got all managers to come before we then got their staff to come’. This is certainly borne out in the analysis
of the case study interviews for this process evaluation; the only manager (Happy Haven) interviewed who
attended the training was surprised at its high quality, despite some prior reservations about the quality of
learning associated with e-learning.
Having a named manager invested in the research was essential for facilitating implementation, even when
aspects were delegated to senior care staff, but that manager also needed to be supported by owners, or
their senior organisational managers or directors. Having a supportive key person to promote implementation
related to having a collective coherent understanding of the research and intervention. It also now leads us to
question how homes initially understood and engaged with the research.
When managers had been ‘told to take part’ by their senior management, this had, on occasion, impacted
adversely on their willingness to participate; some were accordingly perceived as resisting by stalling the
researchers and/or being ‘a bit stubborn’ (researcher) throughout the process, or engaging only in token form.
In their eagerness to access free training, it was felt that some care homes had signed up without fully
thinking through or appreciating what would be required in order to implement the intervention. This is
seen in the data collated by the research team describing their perceived receptivity of each home for
both the e-learning and the e-tool (separately) on a scale of 1 to 3 (low to high), which strongly indicated
that homes in general were more receptive to the e-learning than to the e-tool. Although this made
relationships particularly difficult with managers when sorting out IT capacity within each home to enable
it to use the computer-assisted intervention, the IT engineer had sympathy for care home managers, who
often had poor knowledge of their existing systems and infrastructure.
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Thus, managers of homes that were part of a chain or larger company expressed some resistance to taking
part in this or any other research, whatever its aims. Other specific reasons managers and care staff had
for resisting investing in the research and intervention included:
l concerns that care staff could not be trusted to do e-learning on computers in the home because they
could not be trusted to access the internet responsibly
l scepticism towards e-learning and the quality of learning delivered through such means
l concerns that older care staff might lack the necessary experience or confidence to undertake training
on an IT platform
l belief that some staff (in low-paid, transitory jobs) did not want to learn.
Managers’ greatest initial concerns were about broadband internet being put in for the research, and that
staff would be accessing the internet in work time for other purposes.
Of the four case study care homes, at least one (Careful Place) had routinely used e-learning for more
procedural updates prior to our study, but all managers interviewed expressed doubts about delivering
effective training around dementia or CB, or even personalised care, through an e-learning platform.
Similarly, managers were more commonly concerned that some older staff would lack confidence with IT
platforms. This was the case for one of the older members of care staff at Happy Haven, who was one
of a handful who arrived at training not knowing that it was e-learning they had been nominated for.
Others felt that having the specialist dementia care therapist available and present to lead training was
helpful. The specialist dementia care therapist describes some less confident staff ‘sitting on their hands’
and needing reassurance and support to interact with the computer. Finally, there was evidence of some
reluctance on the part of staff selected to attend training and act as champions to do anything other than
attend the training. This could have been because they had not been told anything about the important
aspect of the intervention involving delivery of case-specific action plans. Some care staff also had concerns
over data protection and governance, such as inputting residents’ personal information onto an IT platform
‘in view of others’.
In this theme, several facilitators for staff investment relating to implementation of interventions in the
care home were found. A facilitator of implementation was having a named, contactable manager to lead
and drive implementation by providing support to staff champions. This was an important mechanism
for change, as they had close interaction with the specialist dementia care therapist. Another facilitator
was access to, and interaction with, the specialist dementia care therapist,82 who, for the purposes of
implementation, can be described here as a ‘service improver’. In the real world of NHS provision for people
with dementia with CB living in care homes, this role can be conceived as an equivalent of an ‘in-reach’
specialist NHS dementia therapist.82 In order to facilitate delivery of the components of the biopsychosocial
approaches underpinning functional analysis-based interventions in care homes,97 this role of ‘service
improver’, provided by a specialist dementia care therapist, should allow for a therapist who has additional
formal arrangements for access to, and clinical support from, a multidisciplinary team.97,186 Real and ideal
conditions for fostering the engagement of care homes and strategies to facilitate investment are
summarised in Table 37.
Collective action: enacting the work required for implementing research and
the intervention
Home managers were largely responsible for the practical work of co-ordinating resources to ensure that:
l the research team could collect data from residents and care staff
l the appropriate staff were identified for training as champions
l the staff were scheduled to attend training and given time to develop and implement care plans
without this undermining the routine running of the home.
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Champions also had a central role in enacting the intervention through co-producing and implementing
the CB action plans, but there were five barriers identified to enacting the implementation of functional
analysis in care homes. These will be outlined next.
First, longitudinal data collected by the research team document various contacts made with individual
care homes over the process of the research to initiate and support implementation, and evidence
difficulties for researchers in getting in touch with care homes. Telephone calls were the only fruitful way
of contacting homes and different homes had different cultures/policies about staff availability to take
calls, if they were at work. Absent owners were the most difficult people to reach.
A second barrier, evident in the majority of homes, was that senior staff or managers struggled to co-ordinate
staffing to support and enact the research or intervention. The research team tried hard to be flexible and
unobtrusive when collecting data in homes; however, this flexibility inevitably incurred difficulties and delays.
Staff absences, shift patterns and turnover aside, by far the most significant barrier to managers committing to
releasing staff to take part were competing service pressures – when carers would be scheduled to meet with
the research team and then called back into service to meet residents’ needs:
. . . It was demands on time; it was like ‘Oh how much longer are you going to be?’ ‘We need you to
come and help with bathing,’ or you know, lunch, or somebody’s come to see someone, can you
come and deal with it, so there were constant interruptions, nobody was, and they were feeling
almost as if ‘I’ve got to rush, I’ve got to rush’.
PA2 focus group
The changes made to (1) deliver e-learning off-site; (2) have a therapist lead the training; (3) deliver the
action-planning; and (4) offer to compensate care homes to release staff were appreciated by managers
interviewed, although some still complained about sending staff away from the home. Even supportive
managers, such as the one at Happy Haven, who managed to schedule all the time and staff required,
felt that in hindsight the home should have claimed more money back:
. . . I probably short-changed ourselves to what [staff] we actually did provide to be honest. But if we
was to do anything like that again, I’d just have a separate diary for the days the people come in
because they’d cancel and then we’d reschedule and all like this but obviously I’d already got them
staff members in.
Happy Haven, manager
TABLE 37 The ResCare trial: cognitive participation – real and ideal conditions for investing in the research and
computer-assisted intervention
Conditions
Strategies to promote cognitive
participationReal Ideal
Lack of supported leadership for
implementation
Key individuals take a lead role in
creating and sustaining momentum for
implementation
Active support from owners or care
group managers to support managers in
leadership role
Payment for managers to
co-ordinate implementation
Provide guidance on role of ‘service
improver’ and avenues for support
Scepticism towards e-learning Care homes understand this e-learning
package as based on realistic scenarios,
with interactive, problem-solving
components and continuous feedback
Managers to undertake training
before/with staff
Share positive feedback from those
who have already completed
training
Concerns about staff accessing training
and using the internet irresponsibly
Care homes trust staff to access internet
responsibly for training purposes only
Reassure managers that access
to other sites can be blocked,
if concerned
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A more general concern was that managers were seen as unhappy with the amount of staff time
implementation would take, irrespective of whether or not it was being paid for by the research team.
Many of the managers did not actually claim back the money to cover staff time. From the manager’s
point of view, it is burdensome to arrange cover from existing staff to co-ordinate this leave on top of
existing training demands:
. . . we don’t have the amount of free staff I suppose, for a better word, to be able to . . . you know,
with all the staff training, I mean believe me we have a huge staff training matrix what we have to
deliver in a year anyway, [. . .] And if staff aren’t always easy to pin down to say ‘can you do extra
shifts to cover the shifts’, that makes it quite difficult really.
Lifelong Lodge, manager
Another barrier was that managers frequently sent inappropriate staff to be trained as champions. Interviews
suggested that managers had a strategy for selecting staff for training, but that this was perhaps wrong for the
intervention. In Lifelong Lodge, for example, priority was sensibly given to selecting full-time over part-time
staff to champion the intervention. However, the therapist’s notes reveal that it had taken several months to
get to the stage where the manager at Lifelong Lodge released these staff for training, of whom one was quite
junior and another had a booked hospital admission for a knee operation the week after training, and would
be off work for a significant period of time. Only one champion actually took part in the action-planning side
of the intervention in this home and she was too junior to be able to enact the medications part of the care
action plans for residents. More junior staff were usually keen, but they were more likely to complete entries
in a resident’s day book than be fully involved in writing individualised care plans within the home, nor did
they have a sufficient understanding of residents’ medications to fully engage with care action-planning.
Conversely, there were also issues, depending on homes’ staffing structures, when senior staff were distanced
from residents and their day-to-day care needs, personalities and life histories:
. . . if you think about it, you’ve got this gap between people writing care plans and people doing the
work, so [. . .] it’s not really ideally going to work with just like you know, one person being a bit more
senior and they do care planning but don’t do hands-on stuff because you’re not getting that depth
of information there. And certainly you know, it’s difficult to then sort of have a prescription of an
action plan almost.
Therapist
Thus, in homes with a gap between those doing care planning and those with in-depth knowledge of the
person with dementia it can make it difficult to implement this intervention on a one-carer-to-one-resident
basis. Across the case study homes there were also differences in how care plans were routinely written and
used by those sent to train as champions. In Lifelong Lodge the day seniors and manager write the care plans:
. . . I’m just doing that myself now and updating the care plans and risk assessments and making sure
that staff are aware that changes have happened [. . .] she [carer 1] does not take over any care plans
or risk assessments . . . they write a daily life record on what’s happened on her shift but . . .
Lifelong Lodge manager
Right and that feeds into the care plan does it, that daily life record or . . .?
Researcher
No, no . . . they’re writing care plans every day but they don’t probably review the changes and . . .
they get told back in handover you know, at the beginning of each shift really but it wouldn’t be that
they would go look at a care plan and read it thoroughly every shift you know, that doesn’t happen
really at all. [. . .] No, I mean major changes or things what are affecting people day by day are
changes where they would get given verbally at handover and then like I say it’s left to the senior
team to write the care plans.
Lifelong Lodge manager
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This is confirmed by the champion from this home, who also noted that neither champion at this home
was routinely involved in writing care plans.
Finally, in this section, our NPT analysis in respect of collective action and enacting the research/intervention
revealed that a major barrier to implementation was that staff were not given time to develop action plans
with the therapist in the homes. The research nurse subsequently felt that this part of the intervention was
initially thought to be much more straightforward, that the e-tool would simply produce individualised care
action plans; and homes had bought in and signed up to participate on this understanding:
To be fair, right at the very beginning, we told them that this tool . . . there’d be like three trainings
[modules] and then the fourth one would write you a care plan. And then it ends up that [Therapist]’s
going in with them. So they were hoping to just do that [e-learning] and out comes this piece of
paper with like [. . .] and they don’t have to check it because that’s dead right because computer’s
done it. [. . .] So they weren’t expecting to spend a lot of time with you [. . .] Press a few buttons and
there’s your answer.
Research nurse
However, from the perspective of the research team, if care action plans were to be fine-grained enough
to impact on levels of CB, quite detailed information about the person with dementia was required. Once
the therapist actually got into the home, champions often were not allowed enough extra time to develop
these action plans, and:
. . . a lot of people have had to do a lot of stuff in their own time, and you know, whether they’re
prepared to do that or not has made a difference.
Therapist
This was particularly the case at Home Court, where the champion took the main role in providing
information about the CB residents for action-planning. This senior care assistant did not appear to see
this as a problem and had previously attended training on her non-working days.
To summarise, the five barriers identified above are:
1. difficulties for researchers in getting in touch with care homes
2. managers struggling to co-ordinate staffing to support the research or intervention
3. managers selecting inappropriate staff for training as champions
4. different staffing models within homes sometimes meaning that champions did not have sufficiently
detailed knowledge of, or a working relationship with, those residents with dementia to effectively
implement care action plans
5. managers not providing adequate time or support for care staff to co-produce action plans.
These barriers were addressed by the research team and steps were taken to work around these problems
with care homes, with the consequence of significant delays and additional costs. The real and ideal
conditions for implementation and strategies to promote the enactment of interventions in care homes are
summarised in Table 38.
Table 39 provides an overview of findings across the four case study homes with respect to the collective
action processes of implementing the intervention.
Reflexive monitoring: appraising the effects of implementing the research
process and intervention
To successfully embed interventions for CB in residents with dementia, care home staff needed to review
their experiences of implementing it and, if necessary, adapt their practice to suit local circumstances and
individual residents. Key examples of reflexive monitoring are seen through the changes made by the
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TABLE 38 The ResCare trial: collective action – real and ideal conditions to promote the enactment of the research
and intervention
Conditions
Strategies to promote collective
actionReal Ideal
Managers struggled to co-ordinate
staffing to support research or
intervention
Managers are supported with
appropriate resources and funds to
release staff for implementation
Discuss with managers how best to
support releasing staff and provide
funding
Managers selecting inappropriate staff
for training as champions
Careful, strategic consideration given
to which staff members are sent to
train as champions
Discuss with managers which staff
would be best placed to effectively
champion implementing the
intervention across the home
Different staffing structures/models
meant that champions might lack
sufficiently detailed knowledge of, or a
working relationship with, residents
with CB to effectively implement care
action plans
Consideration given to how care
homes’ existing care planning
processes relate to those of the
intervention
Assess each home’s staffing structure
with respect to care planning and tailor
training/action-planning accordingly
Redesign action-planning e-tool to be
used collaboratively by more than one
member of staff
Managers not providing adequate time
or support for care staff to produce
action plans
Dedicated and protected time to
produce care action plans
Discuss with managers how best to
support releasing staff and provide
funding
TABLE 39 The ResCare trial: collective action processes of implementation in case study homes
Process
Care home pseudonym
Happy Haven Careful Place Home Court Lifelong Lodge
IT provisioning
(engineer’s report)
Installation ‘straight-
forward’
Installation easy and
aided by the staff,
‘one of the best’
Installation
‘straightforward, but
Wi-Fi connection is
not secure . . . no one
was bothered’
Installation
‘straightforward’,
dispute between
manager (wanted
wireless) and internal IT
department who did not
Staff knowledge
of IT systems
‘Poor’ ‘Excellent’ ‘Non-existent’ ‘Good’
Service
improvement
leadership/
management
Manager well
established
Difficult to contact,
but ‘very keen’ to
implement training and
tool
Manager ‘a very
experienced nurse’,
enthusiastic and
eager to be involved,
but extremely busy
and difficult to get
hold of
Manager keen but
has ‘fixed ideas’
about how home
should be run and
residents cared for
Manager busy and
difficult to get hold of
Manager very keen to
access hard-to-find CB
dementia training
Administrator makes it
difficult to contact
manager or senior staff
For research:
baseline and
follow-up
Manager led strong
communal buy-in to
help with research
Manager available to
help researchers, staff
available on rota
Staff informed, but
unprepared for
research team and
intervention – all very
busy, no private
space in which to
conduct research
Manager did not
know about needing
to see medication
records/care plans.
Staff informed that
researchers were
coming, but unaware
of the study
Manager rigid about
visits not being before
14.00
Care staff on rota for
researchers at baseline
but not follow-up –
unsure as to purpose of
research
continued
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research team to adapt implementation, such as responding to difficulties about installing computers in
homes, providing financial resources to release staff for training and arranging more training events with
smaller groups to help some managers who were unable to release staff as planned. However, there were
barriers to reflexive monitoring within the homes themselves. These were:
l lack of any systematic feedback on the impacts of the intervention on residents with dementia from
the research team, because the trial was ongoing
l positive feedback from staff who attended training not being shared with managers
l lack of momentum and support for staff to share and embed learning and change their practices.
TABLE 39 The ResCare trial: collective action processes of implementation in case study homes (continued )
Process
Care home pseudonym
Happy Haven Careful Place Home Court Lifelong Lodge
For intervention Champions understood
purpose of the
training/tool
Champions did not
know about action-
planning following
e-learning
Champions did not
know about action-
planning following
e-learning
Manager unaware of
action plan aspect of
research. Champion
unaware of their role in
this
Training culture
and management
Manager requested
and attended training
him/herself. No
problems scheduling
staff for research and
intervention
Manager struggled
to release staff to
attend training or
complete action
plans because of
staff shortages
and/or sickness
Manager had initially
only allocated one
staff member for the
entire study. Took
several months to
access staff to train as
champions
Staff shortages
prevented release of
staff from duties for
training
Took several months to
access staff to train as
champions. Manager
found it difficult to
arrange staff to cover
shifts
Manager noted that
some staff in care sector
do not want to develop
their skills
Champions Two senior care
assistants, one ‘initially
fearful of using
computer’, but both
‘quickly grasped the
concept of functional
analysis’
Champions not
ordinarily involved in
writing care plans
Champions able to
discuss intervention
and supported to do
action plans in work
time
Champions question
extent of their
involvement in action-
planning
Two fairly young,
but very keen and
IT literate care
assistants
Champions not
suitably qualified to
complete action
plans for medication
(care home with
nursing)
Champions not
ordinarily involved in
writing care plans
Two senior care staff,
two care assistants.
Senior staff ‘took the
main role in providing
information about the
CB residents for care
action-planning’
Champions not
ordinarily involved in
writing care plans
Champions did action
plan in their own
time, but not likely to
be supported
implementing action
plans
Two care assistants, one
who was about to go
on a planned period of
leave. Other champion
too junior to access
medication information
Champions not
ordinarily involved in
writing care plans
Care staff not allowed
to take telephone calls
other than at 14.15
Champions not allowed
to contact trainer or get
help with action plans in
work time – did this in
their own time
Information provided
was patchy and difficult
to access from senior
staff
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Case study care home managers were aware that the nature of the research design meant that they
would not get to know the outcomes of the study (in terms of impacts of the intervention on measured
levels of CB among people with dementia) until data had been analysed and the study had ended, but
managers at Careful Place and Lifelong Lodge reflected that they felt short-changed in that they had not
yet had what they understood as feedback from the research team since data collection had been
completed, as described below:
. . . it would have been nice to have had some general feedback you know, to say well the trial’s now
finished you know and a general summary at a location.
Careful Place, manager
The manager at Happy Haven, however, recognised that she had received informal feedback along the
way and that more formal findings would be coming. Intervention care homes in the study were written to
after data collection and thanked and offered three free additional licences (active for 3 months), a
certificate and a free place at a dissemination conference.
In terms of appraisals of therapist-led e-learning training, all staff interviewed who had attended training
felt that it had exceeded their expectations. This supports the findings of the evaluative questionnaires
completed by those who attended training. An aspect of the intervention judged as particularly good was
that the e-learning:
. . . wasn’t as complicated on the computers as I’d thought [it would be].
Happy Haven, care staff 1
Most noted was the package providing a much more active and engaging learning experience, which
related well to their own experiences of working with people with dementia:
I’m more of a hands-on, ‘let me read it, let me do it’, than having someone just sit there and go on
and on and on and on for hours. And then say to you ‘Take a test’ or something, [. . .] it kept your
mind going [. . .] some of them scenarios that we did I just thought oh that is so like so and so where
I work.
Home Court, care staff 1
Also valued was that the e-learning process gave the learner instant feedback on their understanding:
. . . it made you think ‘Oh, oh yeah, I get it’; do you know what I mean? We put in what we would
have done but then the computer told you the correct way.
Happy Haven, care staff 2
Some staff were more effusive in their praise than others, whereas on a basic level the relatively junior
champion sent from Lifelong Lodge reflected that:
. . . it does open your eyes a bit.
Others were clear about the specific value the learning added in terms of improving individualised care:
. . . where before you just thought like everybody was the same, dementia was . . . but it was
explained better and everybody’s is not the same.
Happy Haven, care staff 2
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These individual responses corroborate the therapist’s notes on which champions in each home performed
and engaged best with the process – in that these staff could offer a more detailed account of what they
learned. The manager from this care home who attended training remarked that:
. . . if it had widely been available, I certainly would have sent more staff on it.
Champions who attended training and completed care action plans appraised its perceived impact on
practice in lukewarm ways in interview. Although the impacts could be interpreted as being fairly
profound, the intervention prompted some subtle changes, which were perceived to have stayed with
staff, as in these comments:
No, I don’t think I’ve changed anything on the way I deal with things. I think it just makes you more
aware [. . .] you know, if a situation arises, I think it just gives you a better insight into it, on how to
deal with it.
Happy Haven, care staff 1
I don’t know how to explain it really. Something pops up in the back of your mind what you learnt
and you do like tend to deal with it differently.
Lifelong Lodge, care staff
. . . it did work sometimes and it still works now sometimes but you just have to find what kind of
mood they’re in that day and maybe that one won’t work today but you go and you try it tomorrow
and it works fantastically.
Home Court, care staff
When probed, these champions could provide illustrative examples of the intervention in practice as follows:
Just the way you calm them down and things like that, like your tone of voice.
Lifelong Lodge, care staff
Just things like trying to go along with a resident when the resident’s sort of maybe going off on a
tangent about their mum or dad or something . . . just to listen and agree [. . .] just things like that
instead of constantly battling with them and trying to explain that they actually live here.
Home Court, care staff
Similarly, subtle examples were noted by the therapist when she had returned to homes. One example was
the reduction in the number of falls experienced by one resident. Following training, staff had noticed that
the resident had difficulty differentiating between a counterpane and the carpet. They changed to
counterpane and there were no further falls at this location again.
Given the overwhelmingly positive feedback about the e-learning experience from care staff, it is surprising
to find that the two managers interviewed in case study homes who did not attend training saw little
value in what staff had learned:
. . . when I spoke to the staff, they said well they didn’t really get a lot out of it and it was kind
of dismissed.
Careful Place, manager
And how does that compare to their reaction to other sorts of training or would you expect . . .?
Researcher
No they’d . . . you know, like they’ve just done an end-of-life course and dignity in the home and
things like that and their reactions to those were quite positive.
Careful Place, manager
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Only the manager at Happy Haven, who had attended training herself and thought that it had been useful
for staff, gave any feedback on the perceived impact of the action plans at her home on levels of CB
among people with dementia. Furthermore, the therapist’s notes mention that it had been fed back to her
that the project action plans had received praise and been identified as being extremely good, in terms of
both clarity and person-centred individuality, by the CQC team during their recent audit; the manager in
this more recent interview evaluates them differently:
. . . I think it was more like the problem areas, if things was more sort of like . . . we learnt more about
the person and sort of like what their conditions was [. . .] [therapist] gave a lot of insight into that
which helped staff, rather than more of the individualised . . . we already had it really in the care plans.
Happy Haven, manager
. . . Because we’re not a home that have got a lot of challenging behaviour to other care homes but I
saw it more as that we could help like the project develop [. . .] The staff did get something out of it
but I think the project got more out of us than we did.
Happy Haven, manager
Again, this reflection that the intervention might have a greater impact on homes or individual residents
with higher pre-existing levels of CB should be considered when looking at recommendations for
wider implementation.
Interviews with care staff also revealed few existing mechanisms through which champions could share
learning with colleagues within the home who had not attended training. In smaller, family-run care
homes (Happy Haven), some wider dissemination could be achieved informally and through general
face-to-face interactions and a staff comments folder. Staff in larger homes also mentioned being able to
discuss and so to reflect with other staff who had attended training and were still employed at the home.
However, the lack of formal support either within the home or from the research team to help champions
to embed the intervention was seen as a weakness by the therapist:
I think again, what normally happens when something’s like an incremental sort of development
thing, if somebody else comes along and shows you what they’re looking at, what type of things that
they’re judging it on and then bit by bit you sort of can do that yourself and you learn to judge
yourself don’t you and evaluate for yourself.
Therapist
The research team ran out of time to embed the intervention, as it was hard to address and overcome the
initial barriers to delivery within the time scale of the CRT.
For care staff, the experience of becoming champions led to fresh insights, and better strategies, to
improve the individualised care of residents exhibiting CB. Champions in smaller, less hierarchical homes
could share these insights informally with other care staff.
However, overall, there was little feedback to managers who had not attended training about the use of
systematically formulated case-specific approaches for managing dementia and CB and ways in which
support could be delivered in the context of a given care home. Therefore, there was inadequate support
from managers or the research team to further develop and embed a functional analysis approach to the
management of residents with dementia and CB. Understanding of real compared with ideal conditions is
required to enable staff to evaluate and adapt case-specific interventions for dementia and CB. These
should also suit local strategies to facilitate reflexive monitoring and are summarised in Table 40.
Table 41 provides an overview of the outcomes of implementation in the four case study homes. From
this and the other data, Figure 12 summarises what needs to be in place to support implementation in
individual homes, as identified by NPT analysis.
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Thematic findings from wider stakeholder interviews and groups
The transcripts of interviews with the stakeholder group further informed our findings on implementation,
and supplemented the interviews with participants in the experimental and control arms of the trial. In this
section, data derived from this second source of enquiry (i.e. the stakeholder group involving interviews
with staff from experimental homes who received the intervention; those from control homes who did
not receive the intervention, but were offered free access to the e-learning course if they wished; and a
discussion group with stakeholders from across the country) are described. These stakeholder interviews
TABLE 40 The ResCare trial: reflexive monitoring – real and ideal conditions for appraising the intervention
Conditions
Strategies to promote reflexive
monitoringReal Ideal
Lack of systematic feedback on
intervention impacts on levels of CB
Lack of momentum and support for
staff to share and embed learning and
change practice
Research team provides feedback of
results to managers and care staff to
allow them to reflect on and, if
necessary, reconfigure implementation
(functional analysis-based interventions),
with support
To plan a development phase within
the research process
Run reflective sessions within homes to
evaluate and modify implementation
Positive feedback from staff attending
training not shared with managers
Managers informed of staff’s
assessments of the e-learning
Questionnaire findings from those
attending e-learning shared with
managers
TABLE 41 The ResCare trial: overview of the outcomes of implementation in case study homes
Care home pseudonym
Happy Haven Careful Place Home Court Lifelong Lodge
‘Good’ ‘Average’ ‘Average’ ‘Challenging’
Action plans ‘well
received in the home’
Manager and
champions keen to
access the tool ‘in
house’ and be involved
in future research
Manager feels that care
staff did not feed back
much about training
Engagement limited by
‘autocratic management style’ –
staff wanting to continue with
old practices
Manager feels that care staff
did not feed back much about
training
Management style: ‘extremely
autocratic’
Home not open to changing
care practices provided
Manager more focused on
successfully meeting audited
standards
Manager showed CQC
team the care action
plans during recent
audit
Both champions feel
that they now deal with
CB differently
Staff more task
orientated to ensure
physical care needs are
addressed to high
standard
Both champions feel that they
now deal with CB differently
Action plans produced were
basic, but well received by
champion
Champion feels that they now
deal with CB differently
One champion went on
to become ‘small
change agent’
‘More than web-based
training required to
change practice’
Champion was subsequently
successful in gaining promotion
to oversee dementia care floor
‘It is unlikely that web-based
training or action-planning
tools would make any impact
at this time as basic systems
warrant a complete overhaul’
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and discussions gave rise to potentially generalisable themes, as a wide group of participants were involved
(see Methods). The research questions we addressed with stakeholders were as follows.
1. Did the findings of the ResCare trial ‘ring true’ with others not involved in the study?
2. Were the enablers and facilitators found from the case study enquiry applicable to other areas of
the country?
3. Were the identified problems and barriers applicable to other areas?
For the purposes of this chapter, overarching themes are presented and between-group differences are
highlighted. Initials used for illustrative quotations of key findings are pseudonyms and do not reflect those
of the participant.
Training and functional analysis: ‘ringing true’?
Overall, there was general agreement among stakeholders that much could be done to improve the quality
of life of care home residents, especially people with dementia and CB. One experienced trainer and
professional educator, whose work covers different parts of the UK, observed:
I think many care homes could improve their support for people who are distressed, confused, angry
and expressing how they feel in a huge number of ways. I think the way they prepare staff. The way
they help staff to even think about what’s happening for that person and what is their emotional
experience like and how is that linked to the way that they would behave?
MD
Many of those interviewed had experience of training care home staff or were professionals who visited
care home residents for assessment, provision of clinical care or treatment, or to offer staff advice about
care practices. However, concern was expressed by some stakeholders that not all training was necessarily
helpful. An experienced trainer and professional educator reflected on their experience:
I’ve seen lots of very poor examples, particularly from external professionals coming in who maybe
have a general sense of, well, I know what the tasks that care assistant does in a day. But [they] seem
to have no insight into where those people are coming from as non-professionals. They [care home
workers] haven’t taken three years out to do training [like nurses or occupational therapists].
MJD
Mixed views emerged around the optimum venue for training. Some stakeholders were not surprised to
hear of the ResCare trial findings that staff often preferred to undertake training outside their work
environment. For example, one stakeholder drew on their broad experience of training (over 25 years) to
argue that training needs to relate to the individual’s experience and yet should be challenging:
I would say they definitely prefer to be trained outside their place of work, usually with others doing
the same work but in different locations/situations – so they can learn from others’ experiences.
Without a shadow of a doubt the training that is most effective falls into two categories, the first is
using actual real live case stories of those in need and illustrating how they were supported/helped by
the [care home worker]. The second is using more challenging training that in effect places the learner
in the same position as those they seek to support. I use exercises that have the effect of making the
learner vulnerable and in need of support so they can really ‘feel’ what it is like to be in this position.
These can only be used when the Trainer has achieved a strong rapport and very high level of trust
within the group of trainees.
PK
This last point reflects the importance expressed by some other participants that a trainer has a key
interpersonal role in addressing dynamics and different responses to the emotions that may surface during
training. This was something that many commented on, and reflected trial participants’ positive views of
the skills of the trainer who facilitated our e-learning course (see Chapter 2).
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However, the view of one care home manager from the experimental arm of the ResCare trial was very
different. They thought that training at an ‘out-of-home’ venue was often seen as a ‘jolly away from work’
for many of the staff and found that friends tended to go along together, and that their learning was
therefore limited. This manager preferred training to be within the home itself. Similarly, an experienced
trainer thought that staff might like to leave the care home for training, but that the benefits of this were
more to convey to staff that they were valued:
It doesn’t surprise me at all. It’s a completely different change of context and yes, I suppose my
experience would be much more about saying, we value our people as a member of staff and people
feel that value. In terms of changing people’s skills, confidence, I’m not sure that it addresses that
at all.
MJD
A service improver argued that the effects of training were hard to evidence, but that improving staff
morale was valuable for care workers and did have a positive effect on practice. They added that in
thinking about the wider dementia care services and training the workforce, it could be easier to arrange
training for care home staff rather than home care staff ‘where it’s much harder to get people in same
place at same time’ (SF).
In contrast, a care home worker (experimental home) who had undertaken the ResCare trial training away
from the work location felt that it had been beneficial, for reasons that related to learning with colleagues:
. . . away day . . . helps you get away from everyday work stress . . . [had gone with a couple of
friends/colleagues] . . . you have that support when you’re back in the care home to ask questions and
like, you know.
CD
In their view, the training had been very good:
I liked the training; I learnt things I hadn’t known before. Maybe I would have learnt it on the job
anyway, but it was good to have a day to do it.
CD
Similarly, a care home manager (experimental home) thought that the ‘out-of-home’ venue worked quite
well; if staff were able to go away together, they would learn together, and could then ‘bounce ideas off
one another’ on their return. Another care home worker said that they had enjoyed the training and the
e-learning program as part of the ResCare trial – in their view the trainer was very enthusiastic and ‘taught
very well’. They appreciated having a full day for this, but realised that it must have been difficult for the
rest of the staff in the care home to cover their shift.
There was an alternative view that a full day was too long and did not reflect what we know about adult
learning. One trainer interviewed thought that:
What works best in training is probably a basic outline plus simple case examples – short ongoing
sessions comprising revision plus a new aspect each time.
RJ
This trainer suspected that concentration among care staff was often limited and that 15-minute-long
at-work sessions were more suitable. They also noted that there seemed to be a much broader range of
ability among ‘hands-on’ care staff than among managers, and concluded that opportunities for refresher
and repeat sessions should be available for those who needed or wanted them.
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Moreover, the value of formal training on its own was not universally accepted. One care worker, working
in a control home in the ResCare trial, did not think that there was a need for training because, in their
experience:
Just talking about patients with challenging behaviour at case meetings or in the staff room is good,
as it helps us get a better understanding of that person . . . it was good to meet the team . . . I was
given time to think about the residents when they asked questions and filled in their paperwork . . .
just talking about the residents when they [research team] came each time gave me ideas . . .
EF
Although they were not able to comment on the training offered, they thought that discussion with
someone with expertise would be more effective:
I’m sure that the training is good, but I can see why that [talking with a specialist dementia CB
practitioner] would work.
EF
How this might work was outlined by a manager of a care home that had been part of the experimental
arm of the ResCare trial. They described the study as ‘fitting in’ the home and had found that the trained
champion was able to answer questions raised by other members of staff. Training without extra support
afterwards was not generally seen to be a good investment, and one part of training that appeared to be
strongly supported by some interview participants was the desirability of more senior staff (senior care
workers or shift leaders) to model good practice ‘on the floor’:
It’s not only about training. For me, the best services are where you have, whoever the shift leader is,
a good knowledge of the people and individuals concerned and the way they feel and how their
illness or their degeneration of whatever it is affect the way they behave. They are the role model and
they will guide that. They will suggest. They will encourage. They will question.
MD
However, a care home manager who expressed their belief in a ‘train the trainers’ model did not think a
single champion who could be referred to for all questions was particularly helpful owing to high staff
turnover, but that training someone who could regularly cascade this to all other staff in the home was
more useful. In their view, sending all staff on training was not always possible, and they expected all staff
to be competent in addressing some things like management of CB.
What seemed to emerge in these discussions was a nuanced view of training and learning. Training may
make a difference in the short term, if it encourages more material discussion across the team about real
incidents and events. It is here that it seemed to be seen as useful in terms of encouraging openness and
discussion about the practice that actually happens in a care home. ‘Ringing true’ or a sense of authenticity
about service improvement seemed to be a barometer by which the interventions were gauged.
Enablers and facilitators
One service improver commented that training should not have to be argued to be cost-effective, being
confident that ‘the big facilitator is that training leads to improved staff morale and job satisfaction’.
Similarly, one of the care home managers suggested that training providers would be well received by care
homes if they were able to promise refresher training every year, which would incentivise care homes to
invest in training. They added:
Most managers have now come to accept that one-off sessions are futile, and without the offer of
second phase, when things are likely to have changed, managers see little point in training events.
MJA
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Turning to the ResCare trial development of a championing role in each care home, one manager
expressed surprise that having a specialist CB practitioner did not work, as they felt that it had been useful
in practice. Unfortunately, they reported that most of the staff whom the practitioner had engaged with
had subsequently left, being replaced by younger and more junior staff who found training of this sort
harder to understand. This manager described how some of these new staff did not understand some of
the basics of care home training (such as how to manage restraint and aggression, for example, through
breakaway training), and that they themselves had to explain this to the staff.
In contrast, several reflected that some care home staff were not ‘empty vessels’, but with experience they
had accumulated substantial skills that were not always acknowledged or respected. For example, a care
assistant, working in a control home in the ResCare trial, felt that speaking to others about the topic was
helpful as it made them realise how much they actually knew but had not been utilising or had not
considered previously. In their view, more intensive training would have been better, as it was about an
area that was of particular interest. Similarly, another care home worker had overall enjoyed the ResCare
trial training as it had given them the confidence to do what they had known all along, but did not know
if it was correct or not – it ‘gave a grounding’.
This contrasted with the view of a former regulator who noted that one enabler of promoting training was
when a regulator can insist on staff being trained to do their job. In their experience:
Care homes get away with doing what is mandatory. Issues like dignity, nutrition, and so on, are seen
as ‘add ons’ and there is reluctance to release staff for this. I have been commissioned to provide
training for care home workers on completing care plans as they had been pulled up by the CQC.
[Locally] I have tried engaging with care homes to attend free training and the response was zero.
So . . . unless there is evidence of poor practice the regulator can insist only so much. The essential
standards only talk about the ‘suitability of staff’ so if the care homes can prove they are meeting this
standard by some means CQC will probably have to be satisfied.
ER
Similarly, a local authority manager spoke of the limits of regulation and inspection in prompting training.
They pointed to the differences between their role and that of NHS commissioners:
As a purchaser – I use that word because we buy – we don’t actively commission residential care; by
and large we are really just a major funder [of people’s fees] we do not currently require a suite of
training. We obviously require that providers are registered with CQC and they in turn will check the
training records. At the moment, that is as far as we go.
NP
This local authority manager envisaged some changes, as the local authority was working more closely
with the local Clinical Commissioning Group to possibly develop a dementia staff competency framework,
with validated training attached. In addition, there were aspirations that staff termed dementia care
‘mappers’ (having attended a course on dementia care mapping) might be able to identify specific training
needs among a staff group. As a result, if there were severe problems, the contracts monitoring team in
the local authority would be able to check if the care home’s staff had undertaken training and thus might
be able to block new placements (those paid for by the local authority) until specific training had been
undertaken. All this was at the planning stage and would represent considerable management investment,
and possibly could be open to questions about infringements of choice.
The stakeholder interview data show that it is important to think about the interactions of content,
methods, timing, location and venue of training in order to draw conclusions about its effects. There were
several views that the sustainability of current training was limited, partly because of high staff turnover
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and reorganisation in care homes, but also because of changes in ownership and management. A trainer
and professional educator commented:
I’ve worked with many teams who have lots of training – 3 day[s’] training or even more. I’m not sure
that that’s reflected in what I see in their practice 6 months later, 12 months later and so, if it is a
training that you go away to and you are taught almost in a classroom setting, then I’m not sure a
year later that I see the results of that training any more.
MD
Care homes being commercial organisations in the main, even if not for profit, their managers often
adopted an economic perspective in discussions of training investment. One care home manager, for
example, noted the presence of other preoccupations for managers: ‘There are only so many hours in
the day’. They were uncertain as to how care homes could be incentivised to participate in training and
e-learning, thinking that this could be over-reliant on one person – ‘sometimes need a champion in the
home, but this has to be the manager as they make decisions’. This manager noted that having a champion
should help, but that high staff turnover made it hard for managers to decide on investing in a champion
who might then decide to leave in a few months. Like many care home managers and other stakeholders,
they described high staff turnover as a major problem: hence specific topic training took a lower priority as
recruiting new staff, inducting them, and training them for basic care became more important.
In the context of these pressures, a service improver and researcher commented that smaller care homes
seemed to benefit from the establishment of a care home or social care-focused organisation that could
offer staff opportunities that they could not purchase or arrange by themselves. In the region where they
had recently facilitated a learning set for care home managers, such an independent organisation had
been financially supported by the local authority, which was able to recommend that some managers
might find certain training ‘useful’ when concerns had been raised about their home’s performance.
Problems and barriers
This dissonance between professional expectations and the reality of care staff’s experience and prior skills
was expressed as a barrier to receiving professional advice and adopting decision support tools for
planning care. In this section we explore stakeholders’ views on care plans. Several commented that
detailed care plans were not commonly found in care homes. One manager said:
They are not used ‘on the floor’ and the subtle nuances of how you respond to [a situation of CB].
You end up with things like, ‘please respond sensitively to X’s [resident’s] aggression’. What on earth
does that mean? It’s about getting skilled people to role model that to show people; actually this
[care planning] works.
MD
Furthermore, although there might be several professionals going in and out of a care home, it seemed
to require taking a deliberate decision to respond to a situation where the level of distress was getting
beyond the ability of a care home to cope. There seemed no agreement over who should take the lead to
challenge, and to say ‘What’s going wrong?’. Part of the explanation offered by one trainer was the lack
of a culture of teamworking in some homes:
I still work with teams who don’t meet. They never have a staff meeting. There is no time at all for
more skilled perhaps senior staff to be asking those questions. What happened this week? How did it
go? I still work with teams that never do that.
MJD
One of the care home managers interviewed ascribed a lack of interest in taking on further activity as a
result of some care homes’ economic, and other, uncertainties. This feeling of being under siege arose
from the general impression of several changes in the care home sector in recent years, with the recession
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and the Southern Cross ‘fiasco’ (closure/break-up of a chain of 750 care homes in England 2011, including
some that were part of the present study). As a result of general austerity and reductions in local authority
expenditure, managers were managing budgets more carefully, and the first expense line to go could be
training: ‘Some feel there is no use for it, or not much use, shall I say’. Another care home manager in the
ResCare trial control group, although expressing disappointment that they did not have more training, or
had not been offered the e-learning provided to the experimental group, considered that ‘we wouldn’t
have had time for that anyway [laughs]!’ At an extreme, although voiced by more than one stakeholder,
was the view that some care homes were not engaged with policies and strategies about training.
Further barriers raised by a minority of stakeholders were connected with suspicions that e-learning might
be adopted as a cost-saving measure. One trainer thought that employers might start to say:
Can you do this in your own time? You all have access to the internet now at home and it will be
good for you and your career if you can say you have completed these modules and so some staff will
and some staff won’t.
MD
There were other views, that, although it might be theoretically possible to do e-learning at work, shifts
were often short staffed and for some staff the ability to switch from care work to computer study would
be ‘mentally difficult’, even if they were not interrupted. Others had observed almost a feeling of ‘distrust
across some organisations or an anxiety about staff not being on the shop floor’, which would mean that
sitting by a computer could be seen as avoiding work or the ‘difficult’ residents.
For one former regulator, its impression was that, in the current state of the public sector economic climate,
care homes would do only what was mandatory and had been identified as a requirement by the CQC:
Unfortunately any non-mandatory training is seen as a luxury and in the current financial climate is not
something they would do willingly.
ER
Others too were pessimistic about regulation’s potential to improve training uptake:
By chance I’ve studied a few compliance [CQC] reports in the last month. Very, very little mention of
training, if the word training in there at all. Even where I would perhaps have identified a training
need in relation to an issue that was described. That’s not my experience; I haven’t seen a lot
emphasis on that.
DM
However, this did not reflect the stakeholders’ realisation of care homes’ changing customer base, with
more residents having high levels of disability. One care home manager felt that ‘selling’ training to junior
staff was hard because many initially thought that all people with dementia were ‘nice little grannies just
watching TV’. Initially, new staff rarely expected to encounter CB, but they quickly realised it was common.
In this manager’s experience this ‘frightens a lot of the younger ones’. Just to get staff ‘to read the care
plan’ gave them some confidence that the problem was not their fault. They felt that more discussions and
demonstrations, as well as training around management of CB, could do nothing but good. One care
home worker from the control group of the ResCare trial said that she had liked having someone:
. . . professional and experienced in challenging behaviour to talk to – it made me appreciate how
difficult some of this is.
IJ
The emotional impact of being ‘on the floor’ and being expected to manage CB was communicated by
several stakeholders. One added that having someone to talk to made them confident to approach other
senior members of staff with any later queries.
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Resources and implementation
There were several reasons why the offer of free e-learning licences to the care homes following the
ResCare trial was not seized on (see Chapter 2). One care home manager thought that the free licences
were not taken up because many younger staff members were being protective of their work–life balance
– ‘few are willing to stay late, even if overtime is paid’. Another, in the control group of the ResCare trial,
found that taking part in the study had been valuable – ‘everyone is talking about challenging behaviour
right now’ – but had mainly found it ‘helpful to have someone [the data collection research team] to talk
to about the residents’. This manager thought that free licences, which could enable staff to do the
training in their own time, should work, and confessed surprise that they had not been taken up.
It was the personal expert approach that seemed to have left a lasting legacy.
One of the care home workers interviewed thought that refresher training would be necessary, ‘as things
change so often’. Their expectations for this were not high. By refresher training they meant having
someone to remind them about what they had learnt, perhaps to talk to on an annual basis, even over
the telephone or during a visit to the care home, rather than having to go along to another day of
training ‘like the first aid courses you do’. However, this person seemed little engaged with professional
development and could not offer a view about the free licences, other than speculating ‘maybe the
manager had other priorities, or didn’t realise it was free or something’. This lack of knowledge was
expressed by other care home workers, illustrating the point to be made below that training decisions
were largely the business of managers and that front-line care staff felt that they had no role in such
decisions and plans. Placing this in context, a trainer thought that many care homes and care home staff
were used to abiding by statutory minimum training requirements and added that taking up training in the
form of an internet package is ‘not the way they are used to working. It is unusual and it would be new
and different’. They further noted that managers would have to free staff from their work and would not
necessarily be able to map what staff were doing, a point already discussed above when reflecting on the
surveillance of staff in care homes and the limits of trust in the home.
Making decisions
In this section, we report one of the underpinning themes around innovation in care home practice.
Who makes decisions about investment and staff time proved to be a helpful diagnostic aid when thinking
about system change, which is in effect what the ResCare trial was investigating. Training, for example,
was seen by almost all stakeholders as a subject that the manager made decisions about. This was because
it necessitated authorisation of expenditure, it affected the resource of staff time, and it was an area
where there was some discretion in choosing to go beyond minimum requirements or not. Both managers
and their staff agreed that the manager ‘managed’ training. They were described as sometimes shopping
around, for example for a ‘knowledgeable good trainer, with appropriate credentials’. However, one care
home manager prided themself on being a prudent purchaser, noting, for example, their view that the
language used in training needs to be in ‘layman’s’ terms, as specialist knowledge tended to go ‘over the
heads’ of younger, less experienced staff. In the experience of a former regulator, managers often
‘shopped locally’ for training as it was cheaper.
There were very few examples of care home staff feeling that they could influence training purchasing.
One care home worker in the control group commented that they would have liked more training, but
‘X [name of manager] is in charge, I do what s/he says’. For some of the care homes that were owned by
large corporate providers, their managers’ discretion about purchasing training was minimal. One of these,
a manager of a care home in the experimental arm of the ResCare trial, commented that in their care
home’s company, the national training manager decided whether or not specific training was required
across all homes, and then ‘every home has to have it’. This manager expressed surprise that free licences
from ResCare were not taken up, but seemed to have passed on responsibility for training to head office:
‘I leave that to the training department’.
Those who were familiar with the world of the corporate care home described how there was little
discretion over the training that homes provided for staff. The exception to this was when something had
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to be commissioned quickly as a response to some failing or perceived problem. Such prompts could
emerge from various directions.
The economy of care home systems was often used by stakeholders to explain why care homes operated
as they did. For some homes, aspirations to develop training could evaporate if there was no money left in
the annual training budget. However, as commented by an experienced trainer interviewed, training could
also be part of the marketing budget, or viewed as such:
There is certainly more of (that) – we are marketing ourselves as having this specialism and this specific
expertise and therefore everybody will be trained in that . . . That is the way we will sell ourselves.
MD
There was a mix of views expressed about the potential for training during times when care homes were
preoccupied with other changes. Generally, it was agreed that during substantial changes (such as change
of management or ownership), there would be turmoil and worry about its possible impact. However,
changed ownership, management or a new manager was seen to be likely to want to introduce new
things to establish their authority. One regulator interviewed commented:
New face – new initiatives are more acceptable than old face – new initiatives – if you know what
I mean.
ER
A trainer reported being brought on board at the time of a company takeover of a care home when the
new managers were keen to ‘brand’ their new acquisition:
I’ve come across services which will say, we bought up that service and I’ve visited those services with
corporate managers and they have said, we are now putting them on board with our dementia
methodology whatever it is. Therefore, the staff are now beginning that route of training, so we will start
with the managers and then . . . it’s bringing them on board once that company has been subsumed.
MJD
Discussion
The ResCare trial intervention aimed to change ways of thinking and acting in relation to CB and dementia
in care homes, rather than to introduce any materially new organisational systems or technologies. The
strength of this comprehensive process evaluation, which was embedded within the CRT (see Chapter 3),
is its value in enabling us to gain a deeper understanding of the context in which the interventions were
used, and to identify ways in which they may be implemented within routine practice in the longer term.189
Thus, we were able to identify serious limiting factors to implementation and facilitators that can inform
practice in care homes. The additional findings from wider stakeholder interviews and discussions allowed
us to confirm or explain many of the main ResCare trial findings and the in-depth case study reflections.
First, we note that despite limitations to delivery, some intervention-related changes were found to become
embedded in practice, in the ways in which care staff understood, responded to and reflected on such CBs.
This finding can be interpreted in two ways. On the one hand, despite the problems noted, some, but not
all, aspects of training had translated into everyday thinking and practices. On the other hand, these
changes were subtle. They were therefore at risk of being underestimated and undifferentiated in the care
home environment, as they could be easily absorbed within common sense ideas of ‘getting to know
residents better’ or within pre-existing systems for individualised care planning at some homes. This was not
our intention when developing the training and intervention approach. Our aim was to assist staff to focus
on a more systematic questioning approach to understand the potential causes of the person’s behaviour,
and to thus learn to respond to need in the person with dementia and CB. Based on this functional analysis
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approach to understanding unmet need in a resident, they could then access timely help from the NHS if
necessary. It may be that staff in our sample had similar challenges to those in the USA with respect to
finding mental health support for a resident,208 although, at the time of this study, they had access to the
specialist dementia care therapist who was working with champions to deliver action plans. More probable
is the fact that the dosage or intensity of the intervention as a whole was not enough to change staff
behaviour and their responses to resident distress. Additionally, as noted previously (see process notes in
Chapter 2, Booster visits: feedback from the specialist dementia care therapist and Chapter 3, Discussion),
others, such as the resident’s GP, may not have responded positively to their requests for assistance, thus
undermining the efficacy of care staff as change agents, in the timely management of dementia and CB in
care homes.
Second, we found that the most important person identified for successful implementation was the home
manager. Thus, key to organisational readiness209 for implementation of a new intervention are the
qualities and capabilities of the home manager, in leading and supporting others in the home. Managers
having an open attitude and a willingness to engage in research and service improvement were found to
be key contributors to successful implementation. Managerial support was also highlighted as important
for the delivery of interventions in care home settings in a successful intervention in Australia210 and in an
implementation study of the FITS care home intervention in the UK.84 Staff perceptions of empowerment
within their work environment can exert considerable influence on the delivery of individualised care,172
which is also a prerequisite for case-specific intervention in dementia and CB. Disappointingly in our case
studies, we found examples of managers who were unable to value their ‘staff champions’ by providing
encouragement to use the resources, such as the technology and training opportunities we provided. This
rang true for the wider stakeholder group, which also pinpointed a tension whereby some managers felt
that they needed to observe staff activity to ensure that work is being done, with the feeling among staff
that they cannot be trusted, or that their own work and experience are insufficiently valued.
Low commitment to training as a priority for staff development may also be attributable to a sense of a
transient workforce. One report found that 31% of care workers leave in their first year.211 Moreover, high
staff turnover was seen as a significant barrier to sustainability of our specialist NHS innovation by our
stakeholder group, as, in reality, much energy was directed at recruitment, induction and training in
basic care activity. Organisational commitment has been shown to be an important predictor in staff
turnover,212 relevant also to the complex systems operating in the care home setting.213 If, for example,
as a consequence of turnover in the workforce, new senior staff employed are unaware that there is a
training and intervention methodology available to support residents with dementia and CB, they too will
be unable to sustain delivery of interventions to meet the changing needs of residents not because they
are disinclined, but because they ‘don’t know what they don’t know’.
Relevant to this is our earlier observation, that our intervention may have become embedded into
‘common sense ideas and practice’, in which staff champions had not fully appreciated the importance of
searching for the potential cause or causes of the person’s varying communication of distress due to
unmet need. This was our planned mechanism for change in staff behaviour, as our training was designed
to engender a more skilled approach involving empathic curiosity214,215 and a ‘detective approach’ to
discovering unmet need in the resident who met the diagnostic criteria for both dementia and CB. Indeed,
even for existing staff, although intervention champions could identify ways in which functional analysis
in part may have become embedded in their own practice, there was little evidence to suggest that this
had transferred to other staff in case study homes. This can be explained by different perspectives from
stakeholders. They point to the emotional labour of working ‘on the floor’ with people who are distressed
and how training and coaching may be useful in providing staff with confidence, resilience and the skill to
recognise that they too need support. They highlighted the tendency for members of staff to feel excluded
from discussions about training and their lack of involvement in any self-assessment of their own needs,
those of the team or shift, or the home generally. This is akin to the phenomenon of working in teams but
not as a team,216 in which there may be a disconnect between structure and function of the workers.
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Team climate in not-for-profit homes has been shown to moderate staff well-being,217 and recent reports
have pointed to the inter-relationship between the well-being of patients and residents and the well-being
of care and nursing staff.218 Moreover, positive staff experiences of their managers’ leadership are critical
to workforce retention,219 thus demonstrating that the care industry may be undermined by a vicious circle
where managers are overwhelmed with dealing with high turnover and staff cannot be retained because
of the limited encouragements made by their managers. Consistent with the international literature,
our study also demonstrates that leadership in care homes remains key to the sustainability of service
improvements in care homes,219–221 with additional benefits to stabilisation in the workforce.222 Also
consistent with the literature,223 supervision from a specialist was seen as important, but in this case
care is needed to avoid the negative effects on staff of reduced supervision and support from their own
managers in the home.224 Organisational investment in improving leadership and management skills is
therefore recommended for staff productivity, stability and good resident outcomes.225
Third, home size is a factor to consider, as, unlike a study carried out over a decade ago in the USA,226
implementation of this intervention was easier to achieve in smaller homes and in those with less
hierarchical structures or inflexible managerial styles. To effect change in larger homes in particular,
stakeholders noted that this would require a more significant critical mass of senior staff to be trained as
champions and then to be made available in sufficient numbers across shifts. This would necessitate a
major investment in training for the dementia care home workforce, as levels of training are low overall160
and, as noted previously, high turnover in the industry could dilute such investment, particularly within a
context of no clear infrastructure for career development or pay benefits. The potential for large care
homes to provide greater autonomy by having small units within them may be one way to encourage
more personalised care and support for residents, but this is beyond the scope of this present study.
As noted previously, it would also be necessary to address matters of manager support and leadership in
the wider organisation.
Fourth, our typology identified homes where the culture of training seemed to be enabling or disabling.
The picture here was mixed, in respect of leadership and training culture, as, even across the homes that
had a change in ownership and/or management during the study, some coped better than others in
leading the research and also in implementing the intervention. This could be in spite or because of, such
changes in leadership, and stakeholders agreed that opportunities could arise from adversity. The typology
of the organisational ‘training cultures’ for care homes provided a useful overview of, and entry point into,
the implementation process and outcomes across intervention homes. This typology highlighted the
importance of knowledge of home ownership as particularly important in building IT capacity for the
intervention and in commissioning training. Likewise, the typology illustrated which intervention homes
had an enabling or disabling environment with respect to research or intervention and management or
leadership. These might be related to other pressures or the need to improve quality.
It was no surprise to stakeholders that the implementation of the intervention was inconsistent across care
homes, because it proved to be difficult to build a collective understanding of, and thus investment in,
the intervention and research process. This was exemplified by the difficulties encountered in upgrading
IT/broadband to the standard required to run the intervention within homes. This may be a transitory
phenomenon, as there is likely to be further investment in the sector as IT becomes much more common
in private and public spheres. Sharing emerging research outcome findings with care homes during the
implementation would have biased the study. However, because of the lack of time and resources
to fully implement the intervention, there were relatively few observable benefits and very little reflexive
monitoring within care homes themselves. The lack of perceived benefit is a predictable barrier to
implementation.193,227
Some care homes proved keen to access CB dementia training for staff, and could be further persuaded of
the possibility of improving personalised care through e-learning. This implementation study, however,
underlines the importance of achieving better consensus about the potential benefits of functional analysis
for addressing different levels of CB, as some staff may not see the use of psychosocial interventions for
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dementia and CB as part of their job.228 Not only those working in care homes, but those who are ‘in and
out of their doors’ such as medical practitioners, district (community) nurses, mental health practitioners
and social workers, would have to display collective willingness and openness to culture change, if they
are to persuade those at the frontline of care that residents may benefit from this type of biopsychosocial
intervention. This may be because challenges exist in sustaining care innovations because of differing
perspectives of what constitutes good care.229 This can only be further exacerbated as people with
dementia and CB represent a more complex group than those who have dementia but do not present
with CB, or those without dementia living in care homes. People with dementia with CB often require
skilled, case-specific interventions that are more than just ‘good care’, when support to meet their needs
may need to draw help from a range of professional disciplines. Senior care home staff therefore need to
remain actively engaged in improving their knowledge, skills and confidence230 to allow them to know
when to access help from others in the care system, before unmet need in residents escalates to the point
of causing harm or reaching a level of perceived crisis.
Overall, it was difficult to maintain individual and collective coherence and investment over the relatively
short time frame of the research, especially given the dynamic nature of this sector. Implementation
changes made by the research team, such as delivering training off-site with the support of a trained
therapist, were largely successful. However, implementation was inconsistent, largely because resources
required to ‘enact’ the intervention were underestimated and because managers under pressure struggled
to release senior staff, who were seen as best placed to act as champions, to complete training and
undertake care action-planning. This was noted even where homes accepted the offer of backfill costs to
release staff for training, when some staff continued to worry about the increased overload on their
colleagues, suggesting that, even when free training is on offer, with backfill costs covered, the quality of
care provided by other staff, sometimes sourced from an agency, appears to remain a concern for some
care workers. Within implementation in case study homes, more was achieved where particular staff made
personal commitments and sacrifices to undertake the extra communication work required to support
collective coherence.
The data from the stakeholder interviews confirmed that the heterogeneity of care homes and ‘one size’
training is not likely to flourish. The data suggested that approaches to training need to consider factors
beyond the training’s content, venue, format and timing. Care homes were portrayed as places that
change in some respects, but also have great continuity. As the stakeholders and case study homes
described, ‘customers’ were changing, staff moved and could be replaced by staff with different
experiences and expectations, the economy of care homes was changing and investments were being
scrutinised for their profits. However, many care home staff were seen, in this changing landscape, as
being committed to their jobs where they lived and worked within their local communities. Additionally,
their employers were regarded as perhaps being less often subject to the vagaries of reorganisation than
other employers in society at large. Finally, managers were described as exercising some degree of control
over a given home, to the extent that some were described as ‘autocratic’.
Limitations to this evaluation
This process evaluation had its limitations. First, the retrospective nature of this exercise meant that there
may have been some inaccurate recall by participants over time. Second, although the sample of case
study homes was diverse, implementation barriers may have been missed, as staff members who did not
attend the training as champions and who would have views about whether learning was shared or
cascaded through care homes were not interviewed in large numbers. Third, the sample of stakeholders
interviewed may have been tempted to overgeneralise, or to report their own opinions about training and
care homes.
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Conclusions
Overall, our combined data from the case studies and stakeholder consultations, which were examined in
the light of the literature, suggest that the ResCare trial findings appear to be transferable across other
settings in England. Although care homes had been initially keen to access training and intervention for the
management of dementia with CB, and the potentially unique benefits of a care home-wide functional
analysis-based approach to CB were evident to many stakeholders, these benefits were not sufficiently
evident to participating care homes. It may be that many homes were not ready for the higher level of
systematic work that is required for the management of dementia and clinically significant CB in care homes.
Three key factors are identified for successful implementation. These factors relate particularly to leadership
and management, home size and staff turnover, and continued availability and timely use of support and
supervision from external professionals. The first two factors appear to reflect potential indicators of
organisational readiness209 and commitment. Our study was close to the real world of care homes and
pre-dated National Institute for Health Research (NIHR) initiatives, such as Enabling Research In Care
Homes (URL: www.enrich.nihr.ac.uk/). Such initiatives may help to develop the capacity of managers over
time by fostering positive engagement between them and researchers within the care home setting.
However, in applied research such as this, where the aspiration is for implementation in the real world of
the variety of contexts of care settings, these ‘research-rich innovations’ may not provide the environment
for a full understanding of what is needed for implementation. Moreover, research teams are not always
the same, and our findings suggest that staff and managers can lose track with researchers, such as those
involved in data collection and those who may be delivering an intervention. Improved communication to
enhance a shared understanding between researchers, managers and staff is key to the success of studies
such as this. However, as we demonstrate, this is not always easy to achieve given the pressures of lack of
time experienced by some managers and care staff.
In the short term, NHS-led training and support initiatives in care homes have a greater likelihood of
sustainability in smaller homes, where risks of poor coherence and turnover may be reduced, particularly if
leadership is relatively strong or leadership support is also offered. However, systems to monitor the effects
of the intervention on the frequency and levels of CB among residents would need to be developed for
homes, to ascertain any benefits of taking up the new practice.
Finally, implementing an e-learning program and decision support e-tool by itself, without the support of
trainers and the professional support networks from primary and secondary care, was seen to be unlikely
to achieve relevant organisational change within homes. This was confirmed by the lack of up-to-date
knowledge about the current training requirements within the care home sector among almost all who
were interviewed, apart from care home managers and care home trainers with relevant expertise. The
publication of Dementia Core Skills Education and Training Framework in 2015,231 subsequent to our
research, may have some influence, but this remains to be evaluated. Plans to change the technical
regulations that control qualifications in social care (the new Regulated Qualification Framework) may
already overtake this development as these will enable care providers to choose a variety of training
awards and tailor them to their needs. Again, these changes will need to be evaluated. Our present
research suggests that there has been little sustained engagement of NHS professionals within care homes.
New recommendations,232,233 that those interested in a nursing career should gain a year’s work experience
in a care home may go some way to improve mutual interprofessional and intersectoral learning about
what is needed to change current approaches to managing dementia with CB in care homes, but this is
not a solution to more widespread problems.
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Chapter 5 Challenge FamCare: a naturalistic study
of people with dementia and challenging behaviour
living at home and their carers
Abstract
Aim
To describe the characteristics and resource use over 6 months of a cohort of people with dementia and
CB living at home, and their carers, referred to specialist NHS services across England; and to elicit
stakeholder views on CB service provision and the findings from the cohort study.
Design and methods
Cohort study of people with dementia referred for CB to six NHS mental health organisations. Participants
were people who met the diagnostic criteria for dementia and CB and their carers (dyads). The primary
outcome measure was the RMBPC at baseline, 2 and 6 months; and the extent and cost of formal and
informal care – using an adapted CSRI and NHS records of contacts with specialist mental health
practitioners. Secondary measures included quality of life for the person with dementia and the family
carer; and distress, guilt, mood and coping (sense of competence) in the family carer. Stakeholders
debated emerging findings.
Results
Over 15 months we recruited 157 dyads (154 included family carers), in which 61% of people with
dementia had mild dementia with clinically significant CB; we followed up 126 and 117 dyads at 2 and
6 months, respectively. Dyads received an average of nine contacts from mental health practitioners over
6 months, but there was little overall change in levels of CB. Increased contact with practitioners
significantly reduced levels of guilt (p = 0.016) among carers. There was significant variation in trends for
CB among dyads, but no stable clusters of those who improved, remained the same or deteriorated over
time were identified. Family carers estimated that they devoted a mean of 112 hours a week to providing
care at baseline, rising, though not significantly, to 129 hours at 6 months. They contributed over 80% of
the total estimated cost of care. Stakeholder consultations revealed concerns about the equity of access to
CB services for these carers.
Conclusions
People living at home with mild dementia can present with clinically significant CB. CB fluctuates for some,
even over a short 6-month period. Families require trained practitioners, irrespective of where dementia
service pathways are located, to systematically assess their varied needs and provide timely patient-specific
interventions. Commissioning practice should reconsider the priority given to specialist assistance for
families experiencing CB.
Trial registration
The ISRCTN is 58876649.
Introduction
Two-thirds of people with dementia in the UK live in the community in their own homes, supported by
family and friends. One study notes that informal care accounts for £12B, that is, over half of the annual
£23B cost of dementia to the UK economy,234 although a more recent study, published in 2014, estimates
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the current annual spend as £26B, with families shouldering two-thirds (£17.6B) of this themselves, either
in unpaid care (£11.6M) or through paying for care.235 The costs of BPSD in family care settings in other
countries such as North America and Israel have been estimated,21,236,237 but these are not known in the
UK: the assumption is that, by taking action to address the causes, there will be a reduction in carer stress,
thus reducing carers’ reliance on services and delaying breakdown of care at home (p. 7).238
Addressing the complex causal mix of multiple aetiologies is not straightforward and the elusiveness of the
syndrome is outlined in Chapter 1. The important contribution of ‘context’ in the management of CB,
such as the way others in the environment respond to BPSD, is emphasised by the term ‘behaviour that
challenges’ (p. 210),12 and also calls for a reconceptualisation of BPSD to take account of its impact on
the family carer.239 The Cochrane review on the management of CB in family care settings, which was
conducted as part of the present programme (see Chapter 1), also notes the importance of the family
context, as 85% of effective interventions incorporated an element of psychological support for the carer.82
There is a growing empirical rationale for better understanding of the relationship between family context
and CB. For example, studies note that frequent BPSD are not necessarily the most challenging for family
carers;47 the carer’s own characteristics, such as their coping strategies, independent of dementia severity
or other patient factors, can contribute to aggressiveness51 and other BPSD;240 carer responses to BPSD are
likely to be influenced by social and cultural setting, and may vary;241 and how the carer accepts their
situation and manages dementia-related problems can influence the course of BPSD.52 This may be why,
even when families receive professional support, two-thirds indicate an unmet need associated with how
to deal with BPSD.85 A second systematic review, conducted as part of the present programme, used a
meta-ethnographic synthesis to understand why the impact of BPSD in family settings varied from carer to
carer.86 This noted that some reasons for variation in family responses to BPSD were their sense of a
‘declining relationship’; or misunderstandings about their relative’s behaviour, which were perceived as
transgressions against social norms, or underlying beliefs that dementia would inevitably undermine the
humanity of their relative.
Rationale for and background to the present study
What is not clear from the literature outlined above is the extent of the variation of carer characteristics
and their reports of BPSD.242 This is an important clinical question given our definition of CB in dementia
(see Chapter 1) that takes into account distress in both the person with dementia and/or the carer to
provide interventions for the management of dementia and CB (see Chapter 2). What is also unknown is
whether or not current health- and social-care support, provided early on in the development of CB, that
is, while the person with dementia is living at home and the family has been referred to specialist services
for mental health support for the management of dementia and CB, makes any difference over time to
family carers.
The present longitudinal study was conducted in specialist NHS mental health organisations across
England, where the delivery of specialist services for people with dementia and CB was co-ordinated by
CMHNs working within specialist multidisciplinary CMHTsOP. During the course of this study, changes
within some of the organisations resulted in extending this remit to other professionals, such as
occupational therapists, working in these CMHTsOP (see Appendix 2). In this chapter, we describe
professionals who deliver specialist NHS mental health support as specialist mental health ‘practitioners’.
Additionally, the terms ‘carer’ and ‘family carer’ are used interchangeably in place of ‘informal carer’,
as only three participant dyads did not include family members.
This study explores, in detail, the noted variation in carer responses to behaviour in the person with
dementia. We examine whether or not it is possible to determine subgroups of carers who might improve,
remain stable or worsen in terms of their stress, coping and quality of life. We also examine the impact of
the support delivered by specialist mental health practitioners; and the extent of health- and social-care
service support over time.
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Finally, we examine stakeholder views about CB service provision and the findings from the cohort study.
Changes to protocol
Mental health practitioners were trained to use functional analysis-orientated interventions for CB in
people living at home with their family, with a decision support system (see Chapter 2). Appendix 2
outlines detailed changes to the FamCare trial protocol, from a planned CRT to a controlled feasibility trial
and then to the present observational naturalistic cohort study.
This was because recruitment to the study across all NHS organisations was slow and we could not
therefore proceed with an intervention study. Prior to the study, all organisations had provided estimates
of participant recruitment potential based on their recorded figures for performance of the CMHTOP in
previous years. Reasons for slow recruitment were as follows.
1. The mental health NHS organisations were in the final preparatory year for the PbR initiative121 and all
practitioners were engaged for the first time in using online electronic systems for the assessment and
clustering of ‘need’243 for every new patient. Many community mental health services for older people
were undergoing redesign,244 in a context of widespread uncertainty,245,246 which could be bewildering
and disruptive for some,247,248 whereas others continued to try and make sense of this in their practice.249
2. Triggered by the National Dementia Strategy of 2009250 was the growing national move towards
dementia-specific services, with early diagnosis of dementia carried out in memory clinics or Memory
Assessment Services (MASs). During this study period, some NHS organisations delivered all mental
health services to older people within the CMHTsOP, others had memory clinics for diagnosis and
management of early dementia, with the CMHTsOP providing support to older people with dementia
later in the pathway, and yet others were redesigning services to develop either MAS provision within
their CMHTOP or new memory clinics. This may have affected thresholds for acceptance as a case by
the CMHTOP. At the start of recruitment in August 2010, continuing for an average of 31 weeks
(SD 6.00 weeks; range 14–46 weeks), 33 CMHTsOP across seven NHS organisations received 5360 new
referrals (see Appendix 3, Table 66), of which only 452 (8.4%) patients were potentially eligible for
recruitment to this study of dementia and CB in family settings (see Appendix 3, Table 66). About
one-quarter (25.8%) of new cases, that is, 1385 people referred for specialist mental health care, were
not accepted by the CMHTOP (see Appendix 3, Table 67). They could therefore not be approached by
the research team, as to be eligible for the study the referral had to be accepted by the CMHTsOP.
The criterion of recruitment through CMHTsOP was extended to include redesigned CMHTOP services,
in which new MASs and memory clinics were emerging in some NHS trusts. Consequently, 16.6% of
the FamCare study cohort was recruited from MASs and memory clinics.
3. In 2011/12 the contract for delivering services in one NHS trust was in the process of transfer to
another NHS organisation; the reorganisation of roles and responsibilities in this NHS trust resulted in
withdrawal of all five of their CMHTsOP from the FamCare study. Although not directly affecting this
study, but in order to provide context for this organisation with its five CMHTsOP, we further observed
that recommissioning of services for the locality covering this NHS trust occurred for a second time in
2014 with transfer to yet another NHS organisation in 2015.
Research questions
The main aims of this study were to investigate the following questions in respect of people with dementia
and CB, living at home, supported by a carer:
1. Do levels of reported CB, and carer reaction to this, change over time as measured by the frequency
and reaction domains of the RMBPC?111
2. Does the level of support offered by usual care, determined by the number of specialist mental health
care service contacts and time spent with the family, influence CB, family coping and/or quality of life of
people with dementia and their family carer?
3. What are the predictors of change in CB, measured by the frequency and reaction domains of the
RMBPC and the NPI total and distress domains?
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4. What are the patterns of health- and social-care service use and associated costs?
5. What are the estimated costs of informal family care?
6. What are the patterns and costs of prescribing medications?
7. What are the total costs of services, informal care and medication?
An additional aim was to elicit the views of stakeholders in relation to CB service provision in dementia
care and the findings from the cohort study.
Methods
Design
A cohort of people with dementia and CB and their carers who were referred to 28 CMHTsOP in six NHS
organisations was followed up over a 6-month period. The information collected focused specifically
on CB in family care settings, the stress experienced by family carers, the quality of life of people with
dementia and their carers and the range, frequency and cost of health- and social-care services (including
prescriptions) accessed by participants recruited to the study.
A participatory design development process used consultations with practitioners and managers across the
NHS organisations. At the end of data collection, emerging findings were discussed in groups at two
further consultation meetings with a wider group of stakeholders. These occurred in July 2013 in two cities
in northern England.
Governance and study approvals
Ethics permissions for the protocol and subsequent changes were applied for and granted by the York REC
(REC reference number 09/H1311/28), and later Leeds West REC when York ceased to exist, between
March 2009 and October 2013 (see Appendix 12).
Confirmation that Humber NHS Foundation Trust would sponsor the trial was provided in April 2009
by the trust’s R&D department. Site-specific approvals for the participating NHS sites were also obtained
from all seven of the original participating NHS organisations’ R&D departments, before commencing
local recruitment.
For a description of the management arrangements for this study, see Appendix 5.
Study population
Six community mental health NHS organisations in England were involved in the cohort study: Greater
Manchester West, Grimsby, Humber, North East London, Oxford and Buckinghamshire, and Sheffield.
Of these, Grimsby was a specialist mental health social enterprise and the rest were specialist community
mental health NHS trusts. One NHS trust, consisting of five CMHTsOP, withdrew prior to data collection
for this study because of the transfer of its contract for services to another NHS trust. However, this NHS
trust provided data prior to its withdrawal to inform our review of all new referrals to CMHTsOP (see
Appendix 3) and for our iterative consultations of practitioners and managers (see Design). The CMHTsOP
were considered to be broadly representative of the national picture; a mixture of rural and city locations,
spread geographically across the country and from a mix of affluent and deprived areas. Researchers
undertaking data collection were based in NHS mental health services. Within all study sites, the
researchers visited each of the CMHTsOP to introduce the study, explain the eligibility criteria, and to
collaborate with practitioners to apply these criteria for study recruitment. Recruitment commenced in
August 2010 and ended in October 2011, with follow-up data collection continuing until July 2012.
Eligibility criteria
The criteria applied at the point of recruitment are detailed below.
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Inclusion criteria
l Had been reported with dementia.
l Lived at home.
l Had a family (or friend) carer.
l Fulfilled the diagnostic criteria for dementia using the DSM-IV.130
l Fulfilled the behavioural criteria for CB, that is, an incidence score of at least five, from a maximum of
24 on the RMBPC.111 The index for clinically significant CB, set at five on this measure, was based on
our longstanding routine use of this measure in clinical practice, where, at the first point of contact,
families presented as significantly upset when they reported at least five items on this measure as
having occurred one or two times or more in the past week.
Exclusion criteria
l Living in residential care at the time of recruitment.
l Being in the palliative stage of disease at the time of recruitment.
l Not being able to speak or understand English.
Sample size
Each of the six NHS organisations expected to recruit at least 30 dyads and, therefore, this convenience
sample had a target of 180 dyads (person with dementia and their carer). Evidence from a previous
relevant study65 suggested that approximately 40% of participants with dementia living at home may
be lost to follow-up over a period of 6 months because of death, movement to other accommodation or
care settings, or illness being too severe to allow for completion of follow-up assessments. If this loss was
evenly spread, then 13% of recruited participants, that is, 24 out of the 180 dyads, would be lost by
2 months and 72 by 6 months, leaving a total sample of 108 by the end of the study.
Recruitment procedures
Community mental health teams for older people were asked to approach every new patient referred to
them who potentially met the inclusion criteria. Each new patient notified to the research team was
allocated a study identification number, whether or not they consented to take part in the FamCare study,
or subsequently met the inclusion criteria. This enabled documentation of the flow of participants through
each of the stages, as specified in the CONSORT statement.251
Where agreed with team leaders, a member of the CMHTOP contacted the patient or carer who had been
referred to them to explain the study and to ask permission to pass their contact details to the research
team. When permission was given, a member of the research team then arranged to visit the person with
dementia and their carer to explain the study further, provide information leaflets if not received already,
and obtain written consent.
Informed consent
The MRC’s recommended ‘cluster representation mechanism’ (CRM) was adopted for this study. A CRM
is an individual, body or mechanism that represents the interests of a cluster, a gatekeeper. In this study,
the clusters were the mental health teams and so the team leaders for each were deemed to be the
gatekeeper. This accords with the MRC’s guidance that the CRM must be independent of the research
team so that they can act in good faith in the interests of the cluster. They had the right to exclude or
withdraw the cluster from the trial at any time and to exclude or withdraw individual patients. Patients
and family carers who met the inclusion criteria, and were referred to those teams, were approached for
consent to be included in the study.
Participants had at least 24 hours to consider taking part in the study. In line with the British Psychological
Society’s guidance on the Mental Capacity Act of 2015,134 we assumed that each person had the capacity
to consent, and explained the research in an accessible manner, increasing their likelihood of being able to
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consent for themselves. For each dyad, separate informed consent was sought from the person with
dementia and their carer. If the person with dementia was judged to be unable to provide informed consent,
then the carer was asked to act as a personal consultee and to indicate whether or not they believed the
person would wish to take part. It was made clear to participants that there would be no disadvantage to
them if they chose not to participate. Only after people had been assessed for capacity in accordance with
the Mental Capacity Act 2005,133 and they or their consultee had agreed that they would take part, were
they eligible to participate in the study.
We treated consent as a continuing process rather than a single decision, and discontinued interviewing
whenever participants indicated either verbally or in any other way that they did not want to engage,
or when they became distressed by the assessments.
Ethical arrangements
Our original design of FamCare, as a trial of functional analysis, included a procedure for reporting SAEs
to the chief investigator. On converting the trial to a cohort study, this procedure was no longer necessary,
given that interviewing participants with the selected questionnaires carried very little risk of a SAE.
Nonetheless, we continued to abide by other ethical obligations, such as being aware of potential
safeguarding concerns.
Data collection procedures
After initial baseline data collection, there were two follow-up periods of data collection for this cohort study,
at 2 and 6 months. For the first follow-up this ranged from 1.80 to 4.40 months (mean 2.44 months, SD
0.54 months) and for the second follow-up it was 5.77 to 9.50 months (mean 6.55 months, SD 0.72 months).
All interviews were conducted in the home of the person with dementia or their carer, unless they
specifically requested an alternative location. The questionnaire measures were arranged into booklets,
which facilitated their ease of delivery during the interviews. If a participant became tired, or if it was
requested by participants or deemed appropriate by the researcher, an interview was occasionally broken
off part-way through and then continued on another day.
As well as the data collected from participants themselves via interview, the number, type and duration of
mental health practitioner contacts were also collected from internal patient administration systems, for the
full period that participants were in the study. This was from baseline to the first follow-up and then from
first follow-up to the second final time point.
Measures
(See Appendix 6 for details of the instruments and their scoring methods.)
Primary outcome measures
The primary outcome measures were the RMBPC frequency and RMBPC reaction, for the sample of
persons with dementia and their carers, respectively.
This is a 24-item carer report of observable behavioural problems in the person with dementia living at home.
These are known to be of concern to family members and the measure has been widely used in family care
studies.82 It provides one total score and three subscales for problems (memory related, depression and
disruptive behaviours) and parallel scores for carer reaction. The frequency dimension, which represents the
rate of occurrence of individual behaviours, is seen as a measure of day-to-day problems taken from the
perspective of the family carer. Scores vary from zero to four, with a low frequency score indicating that
the behaviour arises infrequently and a high score indicating that it arises very frequently. The RMBPC has
a second domain relating to the caregiver’s reaction to the reported problem, that is, how ‘bothered or
upset’ the caregiver is as a result of the person’s behaviour, rated on a Likert scale from zero to four, with a
lower score indicating lower burden. The RMBPC is completed as a structured interview, usually requiring a
maximum of 15 minutes of interview time.
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Secondary outcome measures
l Frequency and severity of BPSD assessed, using the NPI, with its caregiver distress domain.135
l Emotional impact of CB on carers, using the NPI distress score, where carers report how distressing they
find a given BPSD; the 17-item Guilt Scale (GS);252 the Hospital Anxiety and Depression Scale (HADS);253
and the General Health Questionnaire-12 items (GHQ-12).254
l Coping and effectiveness in caring for someone with CB, using the Short Sense of Competence
Questionnaire (SSCQ),255 and the Relative Stress Scale (RSS),256 which measures stress specific to
dementia caregiving.
l Quality of life of the person with dementia, using the EQ-5D with its index and VAS scorings,138 in which
participants are able to indicate their health; the QoL-AD143 and the ICEpop CAPability measure for
Older people (ICECAP-O),257 where those people who are able to can report on their perceived quality
of life (for EQ-5D and QoL-AD the carers also provide their perception of the person with dementia’s
quality of life – proxy report); and the quality of the relationship, assessed by both the person with
dementia and their carer using the Quality of Caregiver/Patient Relationship (QCPR) scale.258
l Quality of life of the carer, using the EQ-5D (index scoring), ICECAP-O and QCPR.
l Costs in relation to CB, using the adapted CSRI,141 to establish the level of health- and social-care
services and medication being accessed for the couple.
l Specialist mental health service contacts: data were collected retrospectively from patient administration
systems about the number, and duration, of contacts with all mental health practitioners over the
6-month period in which participants were in the study.
In addition, we used the CDR-SB,144 not itself an outcome measure, as a covariate when analysing
outcomes. Table 42 shows the topics we addressed, the measures we used and the subjects to whom
they relate.
TABLE 42 The FamCare study: outcome measures
Topic Measure Subjects
Behaviour RMBPC (frequency) Person with dementia
RMBPC (incidence) Person with dementia
Emotions RMBPC (reaction) Carer
NPI (distress) Carer
NPI (total score) Person with dementia
GHQ-12 Carer
HADS Carer
GS Carer
Coping and effectiveness SSCQ Carer
RSS Carer
Quality of life EQ-5Da Person with dementia and carer
QoL-ADa Person with dementia
QCPR scale Person with dementia and carer
ICECAP-O Person with dementia and carer
Resource use CSRI Person with dementia and carer
Contacts with specialist mental health services staff Person with dementia and carer
a Completed by the person with dementia, where possible, and also by the carer as a proxy for the person with dementia,
as well as the carer answering for themselves.
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Data management
Data for the study were collected in questionnaire packs completed by researchers with the person with
dementia and their carer. For further details in relation to scanning and data verification see Chapter 3,
Data management.
Data analyses
The main statistical analyses for the study applied SPSS version 20 to two participant populations: people
with dementia and their carers. Health economic analyses used SPSS version 19.
Missing data
The researchers endeavoured to collect as many data as they could. However, some missing data were
inevitable (see Chapter 3, Missing data, for an explanation of the methods used to maximise the available
data). We did not impute data for the six people with dementia who died during the study. The first
follow-up data sets were imputed simultaneously based on the demographics and corresponding baseline
measure. The second follow-up data sets were imputed using demographics and the corresponding
measure at baseline and first follow-up.
Outliers
We re-checked the data of all outliers identified during statistical analyses of the cohort, but found no
reason to drop any from the data set.
Research question 1
Do levels of reported CB, and carer reaction to this, change over time as measured by the frequency and
reaction domains of the RMBPC?
Initially, a linear mixed model (LMM) approach to the analysis of repeated measures was used to assess
whether or not there was a significant change in the measures over the three time points. The covariates
were baseline measures, NHS organisation, gender, age, carer type and CDR-SB.
As no significant changes were observed, we used a cluster analysis to examine if there were participants
who were improving, remaining stable or declining, as measured by the RMBPC frequency and reaction
over time. The RMBPC measures were summarised using orthogonal polynomial transformations, and linear
and quadratic means.259 We planned to use different methods of cluster analysis260 on the orthogonal
polynomial transformations using those participants with complete data for the RMBPC. If relevant clusters
were found, then, for those without complete RMBPC data, we planned to assign them to the cluster they
were most similar to, using all available baseline data. The stability of the clustering was assessed by
comparing the results from the method described above with those obtained from the fully imputed RMBPC
values. We also planned a logistic regression analysis to identify baseline measures that predicted the cluster
to which a participant belonged.
Research question 2
Does the level of support offered by usual care, determined by the number of specialist mental health care
service contacts and time spent with the family, influence CB, family coping and/or quality of life of people
with dementia and their family carer?
The levels of support were measured by the number and length of total contacts with the specialist mental
health practitioners during the full period that participants were in the study, that is, between their baseline
and first follow-up interviews, and between their first and second follow-up interviews (this measurement of
‘contact’ was taken from the NHS organisation patient administration electronic record and should not be
confused with the CSRI data collected during the participant interviews and used in the health economic
analyses). The contact data were used to determine their effect on the response measures in a LMM; the
response at the two follow-ups were the response measure, the number and duration of contacts were the
predictor, and baseline and first follow-up measures acted as the covariate. The response measures here
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were the primary measures of RMBPC frequency and reaction. The secondary measures were NPI total; for
the person with dementia the EQ-5D, using both index and VAS methods, and the QoL-AD; and for the
carers they were the GS and the SSCQ.
Research question 3
What are the predictors of change in CB, measured by the frequency and reaction domains of the RMBPC;
and the NPI total and distress domains?
The four ‘behaviour’ response measures of RMBPC frequency and reaction, NPI total and distress were
further analysed to determine whether or not predictors of change could be identified. We assessed the
baseline measures and demographic variables (e.g. NHS organisation, gender, age, carer type, CDR-SB) for
inclusion in the LMM used for question 1. The effect of any identified clusters from research question 1
was also included in the analysis. The assumptions of the model were assessed and, where they did not
hold, we used transformations of the data to find the most appropriate model. A sensitivity analysis of the
imputation results was also conducted.
The missing status of participants was categorised into three groups: complete, monotone missing (dropouts)
and non-monotone missing (those who missed first follow-up, but returned for second follow-up). We used
logistic regression to assess whether or not the missing status could be predicted from any of the factors and
covariates measured at baseline. The variables that were identified to affect the missing status were included
in the above models.261
Economic research questions
Research question 4
What are the patterns of health- and social-care service use and associated costs for people living at home
with dementia and CB and their carers?
Research question 5
What are the estimated costs of informal family care?
Research question 6
What are the patterns and costs of prescribing medications?
Research question 7
What are the total costs of services, informal care and medication?
To address the economic questions, questions 4–7, the following methods were used:
First, we interviewed carers (unpaid family or a friend) in order to complete an adapted CSRI141 to record
the person’s (with dementia) contacts with community and hospital-based health- and social-care services.
They also completed a CSRI for their own contacts and we collected information of prescribed medication
extracted from prescriptions held at home for both parties. As described in Chapter 3, we used national
unit costs for 2012 and medication costs for 2011.
Second, we categorised the types of services accessed into broad groups: community-based health care,
community mental health services, hospital care, social care services and other. This was done to gain a
picture of the general pattern of services being accessed by community-dwelling people with dementia
and CB, and their family carers. Where possible, we also noted contacts with voluntary sector support
services, but these proved very difficult to cost. When looking at prescribed medications, we paid particular
attention to drugs prescribed for dementia and CB management, such as antipsychotics, sedatives,
antidepressants and anxiolytics, and also drugs for pain management and associated polypharmacy
(e.g. drugs to manage bowel movements).
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Third, and finally, carers (unpaid family or a friend) were asked to estimate the number of hours spent
each week accompanying or caring for the person with dementia. They were also asked how many hours
per day they were able to leave the person with dementia unattended. We used two approaches to value
this time. First, valuing this time at the replacement cost of hiring a home care worker to replace unpaid
carer time; and, second, using a minimum wage value from 2012 for the carers’ time. We did not
differentiate between replacement costs and opportunity costs, unlike the recent Alzheimer’s Society
report of 2014,235 in which opportunity costs were applied for activities such as hobbies and leisure that a
carer might need to give up to support their relative. Instead we treated all hours accompanying or caring
for the person with dementia as the same. Many carers were spouses (59.6%) and/or retired (68.4%) and
we are aware of the view that assigning a cost to informal care detracts from the perspectives of some
carers, who may feel a duty or desire to support their relative with dementia.
Consultations with stakeholders
Two levels of consultation were conducted in order to examine how older people with dementia and CB
and their carers received specialist support, and whether or not the process and outcomes of the current
FamCare cohort study rang true with stakeholders. In both types of consultation we used a nominal group
technique, in which facilitated group discussions were structured around topics relevant to CB in a person
with dementia living at home, and their carers. Nominal group techniques have become popular for
structuring and focusing understandings in group discussions and in analysing health-care problems to
bridge the gap between researchers and practitioners.262,263
Our practitioner consultations occurred at the participating NHS organisations, early on in the data collection
period (March to May 2011). We explored the different perspectives of specialist community mental health
practitioners and managers on identification of need, and responses to, referrals of people with dementia
and CB living at home, by their specialist mental health services for older people. This occurred at five of
the seven participating NHS organisations, in which our initial 33 CMHTsOP were located (see Appendix 3).
These discussions were facilitated by the chief investigator, programme manager and principal investigators
at each organisation. They involved managers and practitioners, such as CMHNs, support workers and those
from occupational therapy, clinical psychology, old age psychiatry, physiotherapy and social work. First,
facilitators outlined the emerging data relating to the spread of patient referrals from our examination of
every new referral from CMHTsOP (for final data see Appendix 3, Table 66); next, findings from the evidence
base and the rationale for our proposed intervention were outlined. We used video-clips and audio-clips
to demonstrate real-life presentations of CB in family settings from module 3 (see Appendix 1), such as
examples of repeated questioning, accusations, ‘wanting to go home when living in one’s own home’
that could result in miscommunications and conflict between the carer and their relative. Then we asked
practitioners of all disciplines to identify three of their recent cases of a ‘typical’ patient with ‘no CB, some
CB and severe CB’. For each of these they completed two common measures of CB in dementia, in family
settings.264 These were the RMBPC111 and NPI with its caregiver distress domain135 (see Appendix 6). Finally,
in order to examine identification of need, and responses to referrals of people with dementia and CB living
at home, practitioners discussed their findings in terms of where people with dementia and CB might be
located in their service pathways.
On the basis of data from the initial discussions between March and May 2011, additional facilitated
group discussions were held at three organisations between May and October 2011.
A semistructured tailored topic guide was used as follows.
1. How can specialist mental health practitioners identify people with dementia and CB who are living at
home, to provide timely support to prevent escalation of CB and distress?
2. What are the contextual obstacles to providing timely support to people with dementia and CB living at
home, and their family carer?
3. How might these be overcome in their local setting?
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4. What particular supportive strategies or interventions might be used to prevent escalation of upset or
distress, for those families who live with dementia and CB and present with low, medium or high levels
of CB measured by the RMBPC and NPI measures?
These discussions were recorded in note form; these data were anonymised, then analysed thematically.
Two researchers undertook the analysis to identify salient themes, which were then used in the second
consultation with a wider stakeholder group, which we outline next.
The second ‘stakeholder’ consultation occurred in July 2013 on the completion of data collection and
analysis of the cohort study. We invited stakeholders to a discussion event at each of two study sites.
Invitations were sent to service providers, commissioners, lay people and families with current and past
experience of caring for a relative with dementia. They were provided with a summary of the combined
findings of the referrals to CMHTsOP (see Appendix 3); themes and related quotations from the systematic
review, using meta-ethnographic synthesis to understand why the impact of BPSD in family settings varied
from carer to carer;86 the findings of the present cohort study, which was designed to examine whether or
not there are subgroups of carers who might improve, remain stable or worsen, including findings of the
support offered to them by specialist mental health practitioners; and the salient themes that arose from
the first set of ‘practitioner’ consultations. A total of six facilitated discussion groups were held at these
two events, where stakeholders considered these data from the perspective of the wider context of access
to, and delivery of, interventions for people with dementia with CB and their family carers.
Field notes and tape-recordings were taken and transcribed. Two researchers iteratively checked and
re-checked the analyses and emerging themes. Checking ceased when thematic saturation was achieved,
that is, when no new themes appeared to be emerging from the combined data. The present chapter
outlines the findings of this second ‘stakeholder’ consultation.
Results
Recruitment to the study
In total, 289 dyads were considered for inclusion in the study, with 157 completing baseline assessment.
Figure 13 shows the flow of participants through the study. Our consultations with practitioners and
managers resulted in an awareness of their misunderstandings about the nature of CB in dementia in
family care settings; and in-depth discussion to consider where potential participants might be located in
their services.
Consequently, 16.6% were recruited from MASs or memory clinics, as from March 2011 two trusts
decided to extend recruitment to within their memory clinics as follows.
1. From May 2011 onwards, one trust, which was redesigning services to develop new memory clinics,
recruited 60% of their total contribution to the FamCare study cohort from memory clinics.
2. From October 2011 a second trust, which had two longstanding memory clinics, recruited 28% of its
contribution to the FamCare study cohort from one memory clinic.
Of the 132 participants who agreed for their details to be passed to the research team, but then dropped
out prior to baseline data collection, 99 (34.3% of the total considered) declined to participate when
contacted by researchers. Reasons for this are summarised in Appendix 13. This information suggests that
some of the most distressed participant dyads had excluded themselves from this research programme
that was specifically designed to help people such as them who may have been distressed because of
dementia symptoms.
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Follow-up dropout rates
In total, 126 dyads completed the 2-month (first) follow-up, 117 completed the 6-month (second) follow-up
and, as three dyads had missed the first follow-up, there were 114 for whom data were collected at all three
time points. Therefore, 20% (n = 31) of the initial 157 were lost to follow-up at 2 months; 10% out of 126
(n = 12) were further lost at the second follow-up, and with the three participants who were not observed
at all the time points, by the end of the study there were 27% (n = 43) incomplete cases. Three dyads
who were lost to follow-up at 2 months returned to the study at second follow-up. Therefore, the overall
dropout rate was 25.5%, much less than the 40% predicted at the outset.
Descriptive data
Tables 43 and 44 outline the demographic characteristics of participants. Of the carers recruited to the
study, 70.7% were living together with the person with dementia in the same household, 74.5% owned
their own homes and most (64.3%) were retired (see Table 43). The majority of the people with dementia
were female (59.2%), as were the majority of carers (70.7%). The mean age of people with dementia
was 80.34 years (SD 7.66 years) and of carers it was 66.13 years (SD 13.06 years). The most common
relationship between dyads (see Table 44) was spousal (52.9%).
Referred to the study
(n = 289)
Baseline assessment
(n = 157)
First follow-up 
assessment completed
(n = 126)
Available for second 
follow-up assessment
(n = 129)
Second follow-up 
assessment completed
(n = 117)
Skipped first 
follow-up assessment
(n = 3)
Excluded
(n = 132)
• Declined, n = 99
• Study closed, n = 14
• Ineligible, n = 8
• Gone/going into care home, n = 4
• Ill health, n = 3
• Inappropriate referral, n = 1
• Unable to contact, n = 1
• Moved out of area, n = 1
• Not specified, n = 1
Withdrawn from the study
(n = 28)
• No longer wished to participate, n = 7
• Unable to contact, n = 7
• Gone/going into care home, n = 5
• Ill health, n = 4
• Participant died, n = 4
• Not specified, n = 1
Withdrawn from the study
(n = 12)
• No longer wished to participate, n = 3
• Gone/going into care home, n = 2
• Unable to contact, n = 2
• Ill health, n = 2
• Participant died, n = 2
• Safeguarding adults risk concern, n = 1
FIGURE 13 The FamCare study: participant flow through the study.
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As shown in Table 45, although all participants met the criteria for dementia using the DSM-IV, a very
small number (n = 5) at baseline assessment were rated by the researchers as falling within the ‘no
cognitive impairment’ range on the CDR. At the opposite end of the spectrum, there were relatively few
(n = 14) who were scored as having severe dementia.
In the autumn of 2014 the Alzheimer’s Society published an update of its 2007 study on the social and
economic impact of dementia in the UK.235 It did not identify any further UK evidence on the distribution
of dementia by severity compared with its estimates in the 2007 Dementia UK: The Full Report265 and,
therefore, concluded that estimates for dementia severity remained relevant as follows: 55.4% mild
dementia, 32.1% moderate dementia and 12.5% severe dementia. Based on the CDR, the proportions in
each group are very similar to those we found in the present FamCare study (see Table 45).
Examination of change over the 6 months of the study (Table 46) indicates that most people either stayed
the same or moved up to the next level of severity on the CDR.
TABLE 43 The FamCare study: demographic characteristics
Characteristic (N= 157) Person with dementia, n (%) Carer, n (%)
Gender: female 93 (59.2) 111 (70.7)
Accommodation
Owner 117 (74.5) 117 (74.5)
Privately rented 12 (7.6) 9 (5.7)
Housing association/local authority 18 (11.5) 15 (9.6)
Sheltered accommodation 5 (3.2) 1 (0.6)
Live with friend/relative 5 (3.2) 4 (2.5)
Not answered – 11 (7.0)
Employment status
Paid/self-employed – 39 (24.8)
Unemployed – 13 (8.3)
Homemaker – 4 (2.5)
Retired – 101 (64.3)
Mean (SD) Mean (SD)
Age (years) 80.34 (7.66) 66.13 (13.06)
Age left full-time education (years) 15.82 (5.00) 16.59 (2.81)
TABLE 44 The FamCare study: relationship to the person with dementia and whether or not they live together
Relationship
Living together (N= 111) Not living together (N= 46) Total (N= 157)
n % n % n %
Spouse 81 73.0 2 4.3 83 52.9
Son/daughter (including in-law) 28 25.2 40 87.0 68 43.3
Other relative 1 0.9 2 4.3 3 1.9
Other (e.g. friend/neighbour) 1 0.9 2 4.3 3 1.9
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Reported problems at baseline
The RMBPC ratings of the daily concerns of carers show that the most commonly reported problems cited
by carers (Table 47) were associated with forgetfulness, including asking the same question and misplacing
things. These can be triggers for escalation of upset and other CB in families who have not learned how to
respond effectively; the least common ones were destroying property and threatening to hurt themselves
or others.
Main outcomes over time
Table 48 outlines the outcome measures at each time point. From the sample of 157 participants with
dementia, 122 completed some of the self-report measures at baseline.
The average NPI composite score (see Table 48) of 25.75 (SD 19.17) at baseline is strikingly high and is
comparable to that found in smaller studies conducted in Spain240 and Australia.266 There was no discernible
change over the 6 months on this measure, or on the RMBPC, which was our primary outcome measure.
The self-reported baseline QoL-AD score averaged at 37.2 (SD 5.3), comparable to values from the
REMCARE (REMiniscence groups for people with dementia and their family CAREgivers) study of reminiscence
therapy for community-dwelling people with dementia and their carers,267 in which the intervention group
average score was 37.5 (SD 5.32) and the control group average score was 37.0 (SD 5.35). As with the
REMCARE study,267 carer (proxy) ratings of quality of life of the person with dementia were lower than
self-reported ratings, providing further support for the view that patient and proxy ratings of quality of life
TABLE 45 The FamCare study: summary of CDR score over time (all participants)
CDR score
Time point
Baseline (N= 157) First follow-up (N= 126) Second follow-up (N= 109)a
n % n % n %
0: no cognitive impairment 5 3.2 3 2.4 6 5.5
0.5: very mild dementia 35 22.3 29 23.0 18 16.5
1: mild 59 37.6 45 35.7 39 35.8
2: moderate 44 28.0 30 23.8 28 25.7
3: severe 14 8.9 19 15.1 18 16.5
a CDR data for eight people at second follow-up were excluded because of a suspected interviewer error.
TABLE 46 The FamCare study: change in CDR score over 6 months (n= 109)
CDR score at second follow-upa
0 0.5 1 2 3
CDR score at baseline
0 1 3 0 0 0
0.5 4 12 14 1 0
1 1 2 21 12 3
2 0 1 4 14 10
3 0 0 0 1 5
a CDR data for eight people at the second follow-up were excluded because of a suspected interviewer error.
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in people with dementia do not concur with each other;268 perhaps adding weight to findings from another
study of BPSD that families may be more aware. FamCare study participants with dementia had a mean
EQ-5D index self-reported score of 0.71 (SD 0.28) and carers had a mean self-reported index score of
0.81 (SD 0.21). These values were similar to those found in the REMCARE study.267 Self-reported scores for
participants with dementia were also similar to the age-matched UK general population norms.161 Although
not statistically significant, carers aged ≥ 75 years had a slightly higher average EQ-5D index score (mean
0.79, SD 0.23) than the general population aged ≥ 75 years (mean 0.73, SD 0.27), but younger carers had
a slightly lower than normal average EQ-5D index; in the age group of 45–54 years, the average carer
EQ-5D index was 0.81 (SD 0.24), compared with the population norm of 0.85 (SD 0.25).
TABLE 47 The FamCare study: summary of the RMBPC baseline scores of the 24 items
RMBPC (N= 157)
Incidence Frequencya Reactionb
n % Mean SD Mean SD
Trouble remembering recent events 154 98.1 3.65 0.71 1.55 1.26
Forgetting what day it is 149 94.9 3.53 0.92 0.97 1.08
Asking the same question 141 89.8 3.57 0.78 1.69 1.09
Losing or misplacing things 131 83.4 3.28 0.97 1.47 1.16
Difficulty concentrating on a task 117 74.5 3.35 0.97 1.39 1.18
Appears anxious or worried 116 73.9 2.88 1.09 2.17 1.08
Appears sad or depressed 109 69.4 2.65 1.16 2.22 1.13
Starting but not finishing things 99 63.1 3.27 1.18 1.24 1.29
Arguing, irritability, complaining 91 58.0 2.55 1.10 1.84 1.16
Awaking carer/other family at night 71 45.2 2.69 1.38 2.69 1.61
Comments about feeling worthless/burden 70 44.6 1.97 1.06 1.96 1.21
Trouble remembering significant past events 70 44.6 2.88 1.43 1.55 1.58
Crying and tearfulness 68 43.3 2.12 1.09 2.40 1.09
Expressing feelings of hopelessness/sadness about the future 66 42.0 2.29 1.08 1.94 1.23
Aggressive to others verbally 52 33.1 1.73 1.01 2.42 1.13
Talking about feeling lonely 49 31.2 2.19 1.14 2.23 1.05
Doing things that embarrass you 46 29.3 2.00 1.15 2.09 1.35
Commenting about death of self or others 45 28.7 1.82 1.05 2.53 1.37
Engaging in behaviour dangerous to self or others 31 19.7 1.94 1.09 2.94 1.09
Talking loudly and rapidly 23 14.6 2.96 1.22 1.52 1.24
Comments about feeling like a failure/not having
worthwhile accomplishments
17 10.8 2.59 2.12 2.29 2.05
Threats to hurt others 10 6.4 1.80 1.23 3.40 1.07
Threats to hurt oneself 8 5.1 1.75 0.89 3.63 1.06
Destroying property 6 3.8 2.00 1.53 2.83 1.60
a Frequency ranges from ‘never’ (0) to ‘daily or more often’ (4).
b Caregiver’s reaction (how much the behaviour bothers them) is rated from ‘not at all’ (0) to ‘extremely’ (4).
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TABLE 48 The FamCare study: values for main outcome measures at each time point
Measure
Time point
Baseline (n= 157) First follow-up (n= 126) Second follow-up (n= 117)
Missing Mean SD Missing Mean SD Missing Mean SD
RMBPC incidence 0 11.08 3.49 0 10.65 3.50 1 10.76 3.73
Memory related 0 5.48 1.09 0 5.45 1.18 1 5.61 1.12
Depression 0 3.49 2.32 0 3.08 2.21 0 3.13 2.21
Disruptive 0 2.10 1.68 0 2.12 1.67 0 2.09 1.81
RMBPC frequency 1 31.66 11.97 1 30.21 11.00 2 31.27 12.03
Memory related 1 18.59 5.36 1 18.65 5.28 2 19.32 5.38
Depression 0 8.22 6.68 0 7.26 6.33 0 7.28 6.18
Disruptive 0 4.83 4.58 0 4.43 3.94 0 4.64 4.68
RMBPC reaction 1 19.99 12.31 8 17.31 12.47 0 18.71 13.68
Memory related 1 7.64 5.32 8 6.86 4.96 0 7.62 5.45
Depression 0 7.58 6.83 1 5.79 6.30 0 6.46 6.86
Disruptive 0 4.71 4.80 1 4.52 5.08 0 4.62 5.23
NPI incidence 0 5.35 2.65 0 5.03 2.67 0 5.30 2.85
NPI total (frequency × severity) 0 25.75 19.17 0 24.21 20.14 0 24.21 19.42
NPI distress 0 13.37 9.65 0 11.58 9.44 0 12.37 9.31
EQ-5D index (self-report) 40 0.71 0.28 39 0.78 0.23 43 0.81 0.22
EQ-5D VAS (self-report) 40 68.16 20.23 40 89.80 140.53 44 84.69 109.14
EQ-5D index (proxy) 0 0.47 0.32 0 0.53 0.33 1 0.49 0.33
EQ-5D VAS (proxy) 0 52.86 20.78 0 56.25 20.58 0 54.32 21.61
EQ-5D index (carer) 0 0.81 0.21 1 0.78 0.25 0 0.80 0.23
EQ-5D VAS (carer) 0 74.64 18.06 0 74.81 18.43 0 74.91 16.88
QoL-AD (self-report) 41 37.21 5.26 41 37.43 5.64 44 37.01 5.94
QoL-AD (proxy) 1 29.73 5.91 2 30.79 5.97 1 30.09 6.40
SSCQ 0 24.77 5.97 0 24.74 5.53 0 24.99 5.51
ICECAP-O index (person with
dementia)
42 0.47 0.21 40 0.45 0.21 45 0.46 0.23
ICECAP-O index (carer) 0 0.57 0.26 0 0.52 0.28 0 0.52 0.25
GHQ-12 0 13.86 5.01 0 12.56 4.86 0 12.41 5.24
HADS total 0 9.62 6.50 1 9.06 6.31 0 9.07 6.07
HADS anxiety 0 5.66 4.04 1 5.26 3.91 0 4.91 3.90
HADS depression 0 3.97 3.28 1 3.79 3.36 0 4.15 3.20
QCPR total (person with
dementia)
42 58.23 6.38 40 57.44 7.20 45 56.58 8.13
QCPR warmth 40 34.51 3.62 39 34.01 4.26 44 33.53 4.13
QCPR criticism 42 23.70 3.47 40 23.47 3.58 45 23.06 4.57
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Prescribed medication 3 months prior to baseline
Table 49 outlines the various groups of medications that people with dementia and their carers were
prescribed in the 3 months before baseline, whether or not they were taking them for the full 3 months and
whether they were on one or more medication in a category. From this, we can see that 8.9% (n = 14) of
people with dementia were taking at least one antipsychotic at some point in the 3 months before baseline,
21.6% (n = 34) antidepressants and 6.3% (n = 10) hypnotics and anxiolytics (B/Z/A drugs). Furthermore,
29.9% (n = 47) were prescribed dementia drugs. Baseline data in Table 49 cover an important period
between August 2010 and October 2011. This period follows the publication in October 2009 of the
landmark report commissioned by the Department of Health, The Use of Antipsychotic Medication for
People with Dementia: Time for Action,112 which recommended that reduction of the use of antipsychotics
in dementia should be a clinical governance priority for primary and secondary care. Its author estimated
that this could be done safely over a 36-month period. In March 2011, the Prescribing Observatory for
Mental Health (POMH-UK) programme conducted an audit-based quality improvement programme of
prescribing in dementia care within 54 specialist NHS organisations.269 This noted that 64% of people with
dementia lived at home and, of this group, 9.6% were prescribed an antipsychotic. Our data, which were
taken from patient prescriptions rather than from audits carried out by staff within their organisation – and
where some but not all NHS organisations had participated in the POMH-UK audit – show that 91% of our
sample were not prescribed an antipsychotic and thus concur with the POMH-UK data. Disappointingly, the
quality of prescribing was suboptimal, as very few people had been taking an antipsychotic for less than
3 months. This may be because participants had been managed in primary care prior to referral to specialist
services for CB, and primary care physicians may be less confident about withdrawing patients from
antipsychotics than their colleagues in secondary care.269 Similar to other studies, a large number of
participants with dementia (i.e. around 20%) were prescribed at least one antidepressant, but our data note
a low likelihood of discontinuing in 3 months, despite evidence indicating limited or no benefit in the
management of depression in dementia.270,271 This pattern of suboptimal prescribing for the hypnotics and
anxiolytic (B/Z/A) drugs is also seen, as 6.4% of participants continued with prescription for 3 months or
more, contrary to guidelines advocating benzodiazepine prescription for no longer than 28 days.178
Contacts with practitioners from the community mental health teams for older people
for treatment
During the study, dyads continued with their treatment as usual and as such were contacted by specialist
mental health services such as psychiatrists, psychologists and other mental health practitioners (such
as CMHNs, occupational therapists, physiotherapists and support workers). Data were collected for
157 participants between baseline and first follow-up (2 months) and 129 between first and second follow-ups
(4 months) in the six NHS organisations from which baseline data were collected. There were 20 (of the 157)
dyads that had no contacts at all with specialist mental health care services during the period in which they
were in the study. Table 50 summarises the total number, length (minutes) and type of contacts during the
TABLE 48 The FamCare study: values for main outcome measures at each time point (continued )
Measure
Time point
Baseline (n= 157) First follow-up (n= 126) Second follow-up (n= 117)
Missing Mean SD Missing Mean SD Missing Mean SD
QCPR total (carer) 0 53.03 8.71 0 53.13 9.03 0 53.25 9.01
QCPR warmth 0 31.73 5.10 0 31.70 5.27 0 31.66 5.09
QCPR criticism 0 21.30 4.48 0 21.43 4.52 0 21.59 4.81
GS 1 6.08 5.02 0 4.84 4.31 0 5.25 4.94
RSS total 0 20.38 10.45 1 18.04 10.60 0 18.02 10.58
CDR-SB 0 7.96 4.25 0 8.20 4.76 0 8.00 5.11
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two time periods. The most common were face-to-face contacts, with 116 of the 157 dyads having this type
in the first period and 94 out of 129 in the second period.
As shown in Table 51, mental health practitioners, such as CMHNs or occupational therapists, accounted for
the majority of contacts with dyads (i.e. almost two-thirds of our sample). Dyads had the fewest contacts with
psychologists, with just 7.6% receiving a contact with them during the first time period and 6.2% during the
second. The percentage of dyads receiving each type of contact was similar between the two time periods.
As seen in Table 51, the average number of contacts per month with a mental health practitioner (rather
than across each of the two periods) was 1.22 contacts (SD 1.60 contacts) per dyad in the first time
period, dropping to 0.71 contacts (SD 0.92 contacts) per month in the second time period. The mean
number and length of contacts per month with mental health practitioners, psychiatrists and psychologists
decreased between the two time periods. At the same time, the mean number and length of support
worker contacts per month increased, in accordance with reports of an increased reliance on practitioners
without professional registration working in CMHTsOP in England.272 Overall (Table 52), the average
contact time with mental health services across the 6 months was just over 9 hours (mean 559.71 minutes,
range 0–5490 minutes), and the total number of contacts was nine (mean 8.78 contacts, range 0–57 contacts).
Dropout analysis
Baseline data were used to identify the factors that could be used as the predictors for dropouts from our
study. The demographic variables considered were participant’s age, participant’s gender, relationship
TABLE 50 The FamCare study: summary of number and total length of specialist mental health service contacts
with dyads by contact type
Contact type
Time period
Baseline to first follow-up
(2-month period; n= 157)
First to second follow-up
(4-month period; n= 129)
n Mean SD n Mean SD
Face to face
Number 116 3.60 3.86 94 5.50 6.72
Length (minutes)a 235.83 320.81 375.68 659.15
Telephone
Number 53 2.36 2.02 42 2.57 2.12
Length (minutes)a 34.49 32.80 36.02 31.26
Group
Number 7 3.57 2.94 7 5.29 5.56
Length (minutes)a 461.43 646.93 950.29 1344.77
Not specified
Number 4 1.50 0.58 5 1.00 0.00
Length (minutes)a 65.00 41.23 41.00 20.12
Other
Number 2 1.00 0.00 3 1.33 0.58
Length (minutes)a 52.50 10.61 41.67 32.53
Zero contacts 35 30
a The length indicates the total duration (in minutes) of the contact received during the time period.
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between participant and carer, whether or not participant and carer are living together and NHS
organisation. Other demographic variables could have been included, but, because of a large number of
missing values, they were not considered; for example, the time that the person with dementia is left alone
per day was excluded because 29% of values were missing. Only the baseline information was used in the
model to predict the dropouts. Other key predictors involved RMBPC incidence, frequency and reaction
total scores, NPI incidence, frequency, severity and distress scores, EQ-5D index and VAS of participants
with dementia, QoL-AD score, SSCQ, ICECAP-O, GHQ-12, HADS, QCPR, GS, RSS and CDR-SB.
A chi-squared test was used to explore the relationships between dropouts and demographic variables.
If the expected value of one cell was smaller than five, then Fisher’s exact test was used instead of the
chi-squared test. It was found that age, NHS organisation, relationship and CDR had a significant impact
on the number of dropouts.
Logistic regression was used to identify the predictors for the dropouts at second follow-up. The factors
and covariates were selected by the forward (Wald) selection method and this was implemented by the
SPSS logistic program. The sensitivity analysis used the data after applying the 25% missing rule on the
subscales/scales, as well as five imputed data sets from the multiple imputations. The predictors contained
two sets of variables: demographic factors and questionnaire measures. All the selected models agreed
that participant’s age and NHS organisation were two significant factors affecting the number of dropouts.
As a result, the final model included two variables: age and NHS organisation. Applying this model on the
original data showed that increasing age of the participant increases the chance of dropout by 10%
(95% CI 4% to 16%). NHS organisation 1 [exp (β) = 0.25, standard error (SE) (β) = 0.83] and organisation
2 [exp (β) = 0.77, SE (β) = 0.63] had lower dropout rates than NHS organisation 3. NHS organisation
4 [exp (β) = 1.48, SE (β) = 0.58] had a 48% higher dropout rate. NHS organisation 5 [exp (β) = 2.11,
SE (β) = 0.78] had over twice as high a chance to dropout than NHS organisation 3, although organisation
6 [exp (β) = 3.27, SE (β) = 0.61] had over three times more dropouts than organisation 3.
Research question 1
Do levels of reported CB, and carer reaction to this, change over time as measured by the frequency and
reaction domains of the RMBPC?
As noted previously, the primary outcome measures were the RMBPC frequency and RMBPC reaction for
the sample of people with dementia and carers, respectively.
TABLE 52 The FamCare study: summary of the number and total length of specialist mental health service contacts
per dyad by profession across 6 months
Profession
Baseline to second follow-up (6 month period; n= 129)
Total
number of
contactsa
Per cent of
dyads (%)
Mean (SD)
[range] number
of contacts
Total length
of contacts
(minutes)b
Mean (SD) [range] total
length of contacts
Mental health practitionerc 677 99 5.25 (5.51) [0–25] 36,648 284.09 (413.93) [0–2281]
Psychiatrist 119 62 0.922 (1.31) [0–6] 5736 44.47 (72.57) [0–536]
Psychologist 47 14 0.36 (1.45) [0–10] 5195 40.27 (251.42) [0–2160]
Support worker 289 27 2.24 (6.96) [0–45] 24,623 190.88 (638.12) [0–4005]
Zero contacts 16
Total 1132 8.78 (10.49) [0–57] 72,202 559.71 (970.94) [0–5490]
a If there were no contacts, this was recorded as zero.
b The length indicates the total duration (in minutes) of contact received during the time period.
c Includes mental health nurses, physiotherapists and occupational therapists.
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Results for the linear mixed-model analysis
Analysis was performed on three versions of the data set: the observed data with no imputations of
missing items or missing time points; after using the 25% missing item rule; and missing values replaced
by five imputed values. The basic analysis used a LMM to analyse the repeated measurements made at
baseline, first follow-up and second follow-up. An extended analysis included covariates in the LMM.
The assumptions of the LMM were assessed. They held for RMBPC frequency but a 0.4 power
transformation was needed for the RMBPC reaction.
Time was included in the model as both a fixed and a random effect. The fixed effect of time showed whether
or not there was a trend among the whole group, whereas the random effect of time showed whether or
not there was variation among the participants in their trend. In the basic LMM, the fixed effects of time
combining five imputations were not significant for RMBPC frequency or for RMBPC reaction. The same
general findings were found for the other versions of the data set, as shown in Table 53.
As for the basic model, the extended model included time as both a fixed and random effect. However, we
now also included the effects of the participant’s age and gender; the carer’s age, gender and relationship;
NHS organisation; whether or not the dyad lives together; carer’s job type; and CDR-SB. Carer’s gender and
CDR-SB were consistently found across the three versions of the data as predictors of RMBPC frequency,
whereas, for RMBPC reaction, the carer’s age was also a predictor. There was no significant change in
RMBPC frequency or reaction over time. The significant results are shown in Tables 54 and 55.
TABLE 53 Estimates and test results of time as a fixed effect on five imputed data sets
Imputation
RMBPC frequency RMBPC reaction
β SE t (p-value) β SE t (p-value)
After 25% missing rule 0.009 0.027 0.333 (0.740) –0.040 0.033 –1.242 (0.215)
1 –0.004 0.026 –0.169 (0.866) –0.039 0.028 –1.38 (0.168)
2 0.009 0.023 0.383 (0.702) –0.032 0.028 –1.136 (0.257)
3 0.019 0.024 0.808 (0.420) 0.010 0.030 0.329 (0.743)
4 0.028 0.023 1.207 (0.228) –0.031 0.030 –1.056 (0.292)
5 0.009 0.024 0.375 (0.708) 0.007 0.030 –0.236 (0.813)
Pooled 0.012 0.027 0.442 (0.660) –0.017 0.002 –0.440 (0.665)
TABLE 54 Selected model for RMBPC Box–Cox-transformed frequency applied on available cases, data after
25% missing rule and five imputations
Imputation
Carer’s gender CDR-SB
β (SE) t (p-value) β (SE) t (p-value)
After 25% missing rule –0.75 (0.31) –2.40 (0.018) 0.17 (0.03) 4.99 (< 0.001)
1 –0.81 (0.29) –2.77 (0.006) 0.15 (0.03) 4.85 (< 0.001)
2 –0.80 (0.30) –2.62 (0.010) 0.16 (0.03) 4.82 (< 0.001)
3 –0.88 (0.29) –3.00 (0.003) 0.17 (0.03) 5.37 (< 0.001)
4 –0.88 (0.30) –2.96 (0.004) 0.17 (0.03) 5.19 (< 0.001)
5 –0.69 (0.31) –2.25 (0.026) 0.16 (0.03) 4.79 (< 0.001)
Pooled –0.81 (0.31) –2.61 (0.010) 0.16 (0.03) 4.86 (< 0.001)
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In conclusion, there was no significant trend for either RMBPC frequency or reaction. However, there was
evidence of significant variation among participants in their trends for both RMBPC frequency and reaction.
Carer’s gender (female) and CDR-SB affected the trend for RMBPC frequency and carer’s age, gender
(female) and CDR-SB affected the trend for RMBPC reaction, meaning that female carers had lower
predicted scores than males in their reported frequency of, and coping with, CB. As there was no significant
change over time, a cluster analysis was performed.
Results for the cluster analysis
Four commonly used methods of cluster analysis were used: hierarchical clustering with complete, single or
Ward’s linkage, and k-means clustering. The data used were the mean, linear and quadratic orthogonal
polynomial transformation of the RMBPC frequency and reaction scores. These transformations were chosen
so that participants following different response patterns over time could be identified. The expectation was
that the three clusters would represent those participants whose condition improved over time, those who
stayed the same and those who got worse. To assess stability of the findings, the analyses were run on
those with complete data (n = 82), after application of the 25% missing rule (n = 104) and for the five full
imputations (n = 157). The clustering with Ward’s linkage tended to find three clusters for all versions of the
data, but only 25 (16%), three (2%) and five (3%) participants were consistently in the same improving,
stable and worse clusters.
In conclusion, no stable clusters were able to identify participants who could be described as improvers,
those who were stable or those who got worse. As no stable clusters were identified, no logistic regression
was subsequently used to identify the clusters from the baseline measures.
Research question 2
Does the level of support offered by usual care, determined by the number of specialist mental health-care
service contacts and time spent with the family, influence CB, family coping and/or quality of life of people
with dementia and their family carer?
In order to determine whether or not the level of support provided by specialist mental health-care services
influenced CB, family coping and/or the quality of life of people with dementia and their carer, the number
and length of total contacts with these services were measured.
We assessed whether or not the number and total length (duration) of specialist mental health service
contacts between baseline and the first follow-up and between the first follow-up and second follow-up
(see Table 51) predicted the value of each response variable at the later time point. To do this, we co-varied
for the effect of the response variable, that is, the number and total length of contacts at the earlier time
point. The stability of the results was assessed using the complete data set, after using the 25% missing rule
TABLE 55 Selected model for Box–Cox-transformed RMBPC reaction applied on available cases, data after
25% missing rule and five imputations
Imputation (n= 157)
Carer’s gender Carer’s age CDR-SB
β (SE) t (p-value) β (SE) t (p-value) β (SE) t (p-value)
After 25% missing rule –0.94 (0.35) –2.72 (0.007) –0.03 (0.01) –2.23 (0.027) 0.08 (0.04) 2.10 (0.038)
1 –0.84 (0.34) –2.46 (0.015) –0.03 (0.01) –2.33 (0.021) 0.08 (0.04) 2.06 (0.041)
2 –0.90 (0.34) –2.62 (0.010) –0.03 (0.01) –2.23 (0.027) 0.07 (0.04) 2.01 (0.046)
3 –1.05 (0.34) –3.04 (0.003) –0.03 (0.01) –2.52 (0.013) 0.07 (0.04) 2.02 (0.046)
4 –1.07 (0.34) –3.18 (0.002) –0.03 (0.01) –2.28 (0.024) 0.08 (0.04) 2.34 (0.020)
5 –1.00 (0.35) –2.90 (0.004) –0.03 (0.01) –2.45 (0.015) 0.08 (0.04) 2.21 (0.029)
Pooled –0.97 (0.36) –2.71 (0.008) –0.03 (0.01) –2.34 (0.021) 0.08 (0.04) 2.11 (0.037)
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and the pooled results from the five imputations. The assumptions of the analyses were found to hold for
measures as follows: RMBPC frequency and reaction; proxy EQ-5D index and VAS; QoL-AD; and, for carers,
the GS and SSCQ.
Table 56 shows the coefficients, SE and associated p-value for the relationship between the response
variable and each of the number and length of mental health service contacts (‘N_contact’ and
‘L_contact’), the value of the response variable at the time point prior to the period (‘previous’), the time
period (‘period’) and the three interactions between the covariates and the period factor. The results from
the five pooled imputations are summarised giving the minimum and maximum coefficient (β), the
minimum and maximum observed SE and the number of times out of five that the coefficient was
significant. It was found that the number of contacts was a significant (p < 0.05) predictor of RMBPC
frequency and proxy EQ-5D VAS, whereas the total length of contacts predicted the carer GS score
(p < 0.05). These findings were found in at least four of the five imputed data sets. For all three responses
there were significant effects of the response at the previous time point period, and the interaction
TABLE 56 Relationship between mental health service contacts and outcome measures: analysis for the model
using time as a random effect within participant and fixed effects as shown
Measure
Data after 25% missing rule Summary of five imputations
Number
of times
p< 0.05β SE p-value
Minimum
β
Maximum
β
Minimum
SE
Maximum
SE
RMBPC frequency
N_contact 0.62 0.27 0.023 0.53 0.59 0.23 0.25 5
L_contact –0.006 0.003 0.074 –0.006 –0.005 0.003 0.003 1
Previous 0.68 0.06 < 0.001 0.65 0.69 0.05 0.05 5
Period –6.76 3.38 0.048 –8.88 –6.31 3.07 3.17 5
N_contact × period 0.13 0.47 0.779 –0.07 0.17 0.43 0.45 0
L_contact × period 0.001 0.01 0.827 0.00 0.02 0.006 0.01 0
Previous × period 0.23 0.11 0.032 0.2 0.32 0.09 0.1 5
RMBPC reaction
N_contact –0.03 0.08 0.68 –0.109 –0.033 0.071 0.074 0
L_contact 0.002 0.001 0.1 0.001 0.002 0.001 0.001 0
Previous 0.10 0.02 < 0.001 0.109 0.118 0.014 0.015 5
Period 0.34 0.45 0.45 0.148 0.368 0.443 0.477 0
N_contact × period 0.12 0.11 0.29 0.106 0.187 0.108 0.112 0
L_contact × period –0.003 0.001 0.07 –0.003 –0.003 0.001 0.002 2
Previous × period 0.01 0.02 0.62 0.007 0.019 0.02 0.021 0
EQ-5D index (proxy)
N_contact –0.02 0.01 0.08 –0.025 –0.013 0.008 0.009 3
L_contact 0.00 0 0.15 0 0 0 0 1
Previous 0.69 0.07 < 0.001 0.659 0.711 0.062 0.067 5
Period –0.2 0.08 0.01 –0.237 –0.08 0.062 0.067 4
N_contact × period 0.01 0.01 0.62 0.002 0.014 0.013 0.014 0
L_contact × period 0.00 0 0.57 0 0 0 0 0
Previous × period 0.25 0.11 0.022 0.118 0.302 0.098 0.103 3
CHALLENGE FAMCARE: A NATURALISTIC STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
138
TABLE 56 Relationship between mental health service contacts and outcome measures: analysis for the model
using time as a random effect within participant and fixed effects as shown (continued )
Measure
Data after 25% missing rule Summary of five imputations
Number
of times
p< 0.05β SE p-value
Minimum
β
Maximum
β
Minimum
SE
Maximum
SE
EQ-5D VAS (proxy)
N_contact –1.47 0.65 0.027 –1.63 –1.012 0.59 0.634 4
L_contact 0.01 0.65 0.13 0.009 0.012 0.007 0.008 0
Previous 0.44 0.07 < 0.001 0.362 0.464 0.067 0.072 5
Period –31.5 8.45 < 0.001 –36.79 –28.89 6.95 7.512 5
N_contact × period 2.49 1.13 0.03 2.08 2.718 1.024 1.114 4
L_contact × period –0.02 0.01 0.11 –0.024 –0.022 0.014 0.016 0
Previous × period 0.46 0.13 < 0.001 0.388 0.583 0.109 0.119 5
QoL-AD
N_contact –0.17 0.13 0.21 –0.18 –0.099 0.114 0.129 0
L_contact 0.00 0 0.8 0 0.001 0.001 0.002 0
Previous 0.74 0.06 < 0.001 0.699 0.801 0.051 0.055 5
Period –12.68 3.34 < 0.001 –19.53 –8.131 2.88 3.138 5
N_contact × period –0.03 0.23 0.92 –0.008 0.064 0.211 0.23 0
L_contact × period 0.00 0 0.99 –0.001 0 0.003 0.003 0
Previous × period 0.38 0.11 < 0.001 0.232 0.585 0.093 0.1 5
GS
N_contact 0.20 0.12 0.092 0.115 0.23 0.097 0.117 2
L_contact –0.003 0.001 0.016 –0.004 –0.003 0.001 0.001 4
Previous 0.55 0.06 < 0.001 0.529 0.597 0.052 0.061 5
Period –2.15 1 0.03 –2.821 –1.295 0.861 0.948 3
N_contact × period –0.04 0.22 0.86 –0.166 0.057 0.19 0.221 0
L_contact × period 0.001 0.003 0.77 0 0.001 0.003 0.003 0
Previous × period 0.63 0.13 < 0.001 0.463 0.725 0.105 0.113 5
SSCQ
N_contact 0.13 0.13 0.32 0.016 0.195 0.109 0.117 0
L_contact 0.00 0 0.46 –0.002 0 0.001 0.001 0
Previous 0.68 0.05 < 0.001 0.632 0.72 0.047 0.05 5
Period –7.23 2.62 0.01 –9.883 –3.868 2.293 2.431 4
N_contact × period –0.22 0.22 0.32 –0.421 –0.031 0.194 0.211 1
L_contact × period 0.00 0 0.44 0.001 0.003 0.003 0.003 0
Previous × period 0.32 0.1 < 0.001 0.207 0.429 0.088 0.092 4
L_contact, the length of contact; N_contact, the number of mental health service contacts; period, the time period, baseline
to first follow-up coded 0, first to second follow-up coded 1; previous, the value of the response variable at the previous
time point.
Note
Coefficients are given along with their SE for the unimputed data. For the five imputations a summary is given of range of
coefficient and SE and the number of times it was significant out of the five imputations.
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between the period and the response at the previous time point, indicating that the way dyads performed
initially on a given measure affected how they continued to perform on that measure.
In conclusion, the number of contacts was a significant predictor of RMBPC frequency (p = 0.023) and for
proxy EQ-5D VAS (p = 0.027), that is, the quality of life of the person with dementia reported by the carer.
The coefficient was positive for RMBPC frequency and negative for the proxy EQ-5D VAS, suggesting that,
where more mental health contacts were provided to dyads, those carers reported more CB and also
reported lower ratings of quality of life for their relative with dementia. This may be because mental health
service practitioners have more contact with families when they notice them as having more CB. The total
length of contacts was a significant (p = 0.016) predictor of guilt among carers. As the coefficient was
negative, this showed that the greater the total duration of contact by the practitioner, the lower the levels
of GS in the family carer. When comparing the first time period with the second time period to examine
whether or not the timing of contacts (earlier vs. later) made any difference to the outcomes measured,
significant effects were noted for RMBPC frequency (coefficient = 0.23; p = 0.0382), GS (coefficient = 0.63;
p < 0.001), SSCQ (coefficient = 0.32; p ≤ 0.0021), proxy EQ-5D VAS (coefficient = 0.46; p < 0.001), proxy
EQ-5D index (coefficient = 0.25; p = 0.0224) and the QoL-AD (coefficient = 0.38; p < 0.001). The direction
of these coefficients is difficult to interpret, so no definitive conclusions can be reached on the timing of
contacts over this 6-month period.
Research question 3
What are the predictors of change in CB, measured by the frequency and reaction domains of the RMBPC;
and the NPI total and distress domains?
This analysis looked at whether or not predictors of change in CB could be determined. Here, CB was
measured by four responses: the frequency and reaction domains of the RMBPC and the NPI total and
distress domains.
As stable clusters could not be identified in the primary analyses, they could not be included in this
analysis. Table 57 shows the changes across the three time periods after the 25% missing rule had been
applied to the data. The change between baseline and second follow-up was analysed using backward
regression analysis (see Appendix 14), with the potential predictors being demographic variables (person
with dementia’s age and gender, carer’s age and gender, relationship, whether or not the dyad is living
together, carer’s job type and baseline CDR-SB), and the mean of the baseline and second follow-up
measures (RMBPC incidence, frequency and reaction, NPI total and distress, EQ-5D index and VAS of
participants and carers, QoL-AD, SSCQ, ICECAP-O, GHQ-12 HADS, QCPR, GS and RSS). The mean of the
baseline and second follow-up measure is included as a predictor to account for the expected relationship
between the change over time and the mean over time; the predictors of change after the level of the
response has been accounted for are being looked for here.
TABLE 57 The FamCare study: summary of reported behaviour changes across time
Measure
First follow-up – baseline
(N= 126)
Second follow-up – first
follow-up (N= 114)
Second follow-up –
baseline (N= 117)
n Mean SD n Mean SD n Mean SD
RMBPC frequency 124 –0.42 8.46 111 0.58 8.83 114 0.70 9.83
RMBPC reaction 118 –2.12 11.02 106 1.37 11.04 116 –0.02 11.52
NPI total 126 –0.43 15.69 114 0.16 15.10 117 –0.51 18.81
NPI distress 126 –1.29 8.06 114 0.78 7.36 117 –0.26 9.02
Note
Above uses data after the 25% missing rule.
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For all four responses, the mean of the baseline and second follow-up measures was found to predict the
change between baseline and follow-up. Carer gender predicted RMBPC frequency, and both NPI total
score and distress (see Appendix 14). No other predictor variables were consistently found across the data
set using the five imputed data sets, showing that there are no other stable predictors of change. Male
carers showed the larger decrease in the measures.
Economic analyses
Characteristics of the sample
Table 58 shows the baseline characteristics of dyads for whom data at all the time points were collected
(n = 114). For the purposes of the main health and care economic analyses we used only the data from
this sample, rather than the full available sample at each of the time points.
Service use at baseline
Full service use frequencies and costs for the 114 participants available at all time points are presented
in Appendix 15 and for the whole cohort that were available at each of the individual time points in
Appendix 16. For the 114 at baseline, when carers were asked to recall the person with dementia’s
contacts with health- and social-care services using the CSRI, 71.9% of people with dementia in the
FamCare study had seen a GP, 71.1% had seen a CMHN and 19.3% had seen a social worker in the
previous 3 months. Twenty per cent of participants with dementia had seen a community-based old age
psychiatrist over the preceding 3 months. Contacts with hospital services, including A&E admission and
overnight stays, were infrequent. These patterns were similar for the full baseline cohort of 157 and the
114 dyads for which data were available for all three time points.
When asked to recall type and frequency of services accessed, 52.6% of family carers had themselves
accessed the GP in the preceding 3 months and 24.6% had seen a practice nurse. A social worker had
separately been seen by 3.2% of family carers. Use of hospital services was low; 18.4% of family carers
had themselves visited outpatient clinics.
Research question 4
What are the patterns of health- and social-care service use and associated costs?
Figures 14 and 15 provide a snapshot of the proportions of people with dementia and their carers
accessing selected services over the study period. High proportions of both participants with dementia
and their carers saw a GP over the study period. The proportions of contacts with a GP that took place at
home, rather than at the GP surgery, increased from 8.3% at baseline to 27.7% at the second follow-up.
In order to be able to explore patterns of service use and costs over commensurate study periods,
we converted these into monthly frequencies and monthly mean costs. Table 59 shows mean monthly
frequencies of health- and social-care contacts at each time point for dyads interviewed at all time points
(n = 114), and Table 60 shows mean monthly costs. For a more detailed breakdown of the health- and
social-care categories for people with dementia and carers see Appendix 17.
Service use across community- and hospital-based health- and social-care services was low for both
participants with dementia and carers across the study period.
During the 3 months before baseline, one (0.9%) person with dementia and 28 (24.6%) carers recorded
no contacts with community-based health- and social-care services. This increased to five (4.4%) people
with dementia and 36 (31.6%) carers for the 2 months between baseline and the first follow-up. During
the 4 months between the first and second follow-ups, six (5.3%) people with dementia and 29 (25.4%)
carers recorded no contacts with community-based health- and social-care services.
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TABLE 58 The FamCare study: baseline characteristics of people with dementia and their family carers
Descriptive Person with dementia (N= 114) Carer (N= 114)
Gender (female), n (%) 63 (55.3) 77 (67.5)
Age group (years), n (%)
30–39 – 1 (0.9)
40–49 – 10 (8.8)
50–59 – 20 (17.5)
60–69 12 (10.5) 34 (29.8)
70–79 48 (42.1) 28 (24.6)
80–89 44 (38.6) 19 (16.7)
90–99 10 (8.8) 2 (1.8)
Mean (SD) 79.33 (7.48) 67.46 (12.63)
Relationship to person with dementia, n (%)
Spouse – 68 (59.6)
Son/daughter (including in-law) – 40 (35.1)
Other relative – 4 (3.5)
Other (e.g. friend/neighbour) – 2 (1.8)
Carer employment status, n (%):
Paid employment – 28 (24.6)
Unemployed – 6 (5.3)
Homemaker – 2 (1.8)
Retired – 78 (68.4)
NPI total score: mean (SD) 24.8 (19.1) –
EQ-5D index (proxy), mean (SD) 0.51 (0.31) –
EQ-5D index (self-report), mean (SD) 0.75 (0.24)a 0.80 (0.23)
EQ-5D VAS (proxy), mean (SD) 52.9 (20.78) –
EQ-5D VAS (self-report), mean (SD) 69.91 (17.94)a 73.72 (18.21)
QoL-AD (proxy), mean (SD) 30.36 (5.73) –
QoL-AD (self-report), mean (SD) 37.38 (4.99)b –
SSCQ, mean (SD) – 24.9 (6.10)
GHQ-12, mean (SD) – 13.8 (4.80)
HADS, mean (SD) – 9.1 (6.08)
QCPR, mean (SD) 57.81 (6.56)a 52.9 (9.01)
GS, mean (SD) – 5.7 (4.39)
RSS, mean (SD) – 19.2 (10.12)
a n= 86.
b n= 85.
Note
Participants with data at all three time points only.
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FIGURE 14 The FamCare study: proportion of people with dementia accessing selected services at each time
point (n= 114).
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FIGURE 15 The FamCare study: proportion of carers accessing selected services at each time point (n= 114).
TABLE 59 The FamCare study: mean monthly frequencies of health- and social-care services at each time point
Service
Time point, mean monthly frequencya (SD)
Person with dementia (n= 114) Carer (n= 114)
Baseline
First
follow-up
Second
follow-up Baseline
First
follow-up
Second
follow-up
Community health care,
excluding mental health
1.40 (1.62) 1.14 (1.45) 1.58 (4.27) 0.55 (0.64) 0.54 (0.70) 0.53 (0.87)
Community mental
health services
0.57 (0.73) 0.58 (0.75) 0.37 (0.98) 0.04 (0.24) 0.03 (0.16) 0.07 (0.39)
Hospital services 0.59 (1.39) 0.70 (2.87) 0.83 (2.19) 0.18 (0.38) 0.23 (0.89) 0.28 (0.91)
Social care services,
including day care
4.99 (13.59) 6.30 (14.83) 8.19 (18.83) 0.10 (0.79) 0.09 (0.55) 0.04 (0.33)
Otherb 0.63 (2.95) 0.39 (2.62) 0.32 (1.97) 0.14 (0.26) 0.22 (0.44) 0.11 (0.21)
Mean monthly service
use
8.19 (15.69) 9.13 (15.20) 10.87 (19.65) 1.03 (1.32) 1.10 (1.69) 1.04 (1.52)
a Frequency denotes number of visits, except in the case of inpatient services when it is the number of days.
b Other includes dentist, optician, Meals on Wheels, alternative therapists, general medical specialists, adult family
placements, memory clinics and chiropractors.
Note
Participants interviewed at all three time points only.
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When looking at community-based health service use for dyads, the average number of contacts with
a GP during the 3 months before baseline was three. There were 37 dyads with higher than average GP
contacts (i.e. four or more contacts). These high GP-using dyads had an average of 11 contacts with
community-based health- and social-care services, excluding GPs; dyads with three or fewer GP contacts
had an average of 22 contacts with other services.
The cost of social care was higher than the cost of community health care (excluding mental health
services) for participants with dementia (see Table 60), because participants used these services more
often. The main driver of costs in this category was the costs of the home care worker (see Appendix 17,
Table 108), with participants having an average of 2.72 (SD 12.69) contacts per month at baseline,
increasing to 5.52 (SD 17.80) contacts per month at second follow-up. Care attendants other than social
care staff were also seen regularly, with an average monthly frequency of 0.75 (SD 4.20) contacts per
month at baseline, increasing to 0.99 (SD 5.22) contacts per month at second follow-up.
Conversely, carers had higher community health-care costs than social care costs (see Table 60). Mean
social worker care costs per carer were minimal and decreased over the study period. Only 3.5% of carers
had seen a social worker in the 3 months preceding baseline, which is a considerably lower proportion
than the 19.3% of participants with dementia who saw a social worker. It may be, of course, that the
carers and their relatives were seen together by social workers at their own request.
Research question 5
What are the estimated costs of informal family care?
Over two-thirds of the carers were living with the person with dementia. Resident carers were asked how
many hours they felt that they could leave the person with dementia alone for in a typical day. The
majority of carers responded ‘not at all’ or ‘an hour or two’. The numbers of hours per week spent in
TABLE 60 The FamCare study: mean monthly costs of health- and social-care contacts at each time point (excluding
informal care and prescribing costs)
Service
Time point, mean monthly cost (£) (SD)
Person with dementia (n= 114) Carer (n= 114)
Baseline First follow-up
Second
follow-up Baseline
First
follow-up
Second
follow-up
Community
health care,
excluding
mental health
58.05 (57.54) 43.45 (63.41) 57.19 (136.88) 34.40 (69.37) 28.01 (45.75) 27.57 (51.36)
Community
mental health
services
60.10 (220.48) 53.63 (90.82) 17.44 (57.55) 4.30 (26.61) 1.82 (10.46) 4.60 (24.41)
Hospital services 214.07 (753.75) 210.26 (1117.22) 147.17 (627.12) 48.30 (235.72) 31.91 (185.06) 102.04 (466.30)
Social care
services,
including day
care
106.40 (247.65) 137.59 (299.45) 163.11 (334.67) 6.10 (41.27) 6.01 (47.55) 1.29 (6.33)
Othera 12.17 (41.10) 6.13 (19.13) 4.03 (12.42) 3.43 (6.26) 10.47 (57.86) 3.20 (7.87)
Mean monthly
service use costs
453.33 (877.99) 451.06 (1150.31) 388.95 (748.37) 96.96 (255.04) 78.21 (231.76) 138.70 (478.13)
a Other includes Meals on Wheels, dentists, opticians and alternative therapists.
Note
Participants interviewed at all three time points only.
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caring for the person with dementia are shown in Table 61. At baseline, resident carers spent an average
of 112.15 (SD 58.48) hours per week caring (approximately 16 hours per day), compared with 21.71
(SD 33.54) hours per week (approximately 3 hours per day) spent by carers who did not live with the
person with dementia. At the first follow-up, the average number of hours spent caring had increased
slightly for resident carers and dropped for non-resident carers. At the second follow-up, the average
number of hours spent caring had increased for both resident and non-resident carers.
Over the period, the estimated average weekly time devoted to care by families was 112 hours at baseline,
rising to 129 hours at 6 months.
Table 62 shows the costs of care if the hours spent by carers in our cohort were undertaken by a paid
home care worker at the rate of £23 per hour of face-to-face contact,153 this reflecting the cost of the total
service and not the amount paid to an individual home care worker. Here we refer to these costs as
‘replacement costs’. Across resident and non-resident carers, the average weekly cost of care per person
was £2070 at baseline, rising to £2234 at the 6-month follow-up. If the minimum wage (£6.19 per hour
in 2012) is used, instead, to estimate unpaid carer time, weekly costs per person at baseline are lower,
at £557, rising to £601 at 6 months.
Overall, based on figures in Table 62, the estimated annual costs at baseline, costed at paid home care
worker rates of £23 an hour, were £107,640 (£2070 per week); and, costed at the minimum wage rate
of £6.19 per hour, these were £28,969 (£557.10 per week). At the 6-month follow-up these rose to
£116,168 (£2234 per week) at paid home carer rates and £31,263 (£601.21 per week) at minimum
wage rates.
The costs of family care accounted for 80.6% of the total costs of health and social care for people with
dementia living in the community.
Comparable to our findings are those of the Alzheimer’s Research Trust in 2010, which reported estimated
costs of unpaid carer time at 86% of the total costs of health and social care.234 The Alzheimer’s Society, in
its recent update (2014) of its report of 2007,235 also estimated costs of family care for people with dementia
living at home and estimated unpaid carer time at 74.9% of total costs. Unlike our method of costing, the
Alzheimer’s Society assigned ‘replacement costs’ for unpaid care equal to the total organisational cost of
employing a professional carer (at £19 per hour) for help with personal care activities, and ‘opportunity costs’
to represent the value to individual carers of any activities they can no longer take part in (such as paid work,
housework, leisure activities and caring for children), while ‘supervising’ or ensuring that the person with
dementia is safe and comfortable. For the FamCare study, we used replacement costs for all care, not just
the personal care activities. The Alzheimer’s Society study reported the average annual cost of informal care
to be £19,714, £32,237 and £33,482 for people with mild, moderate and severe dementia, respectively.
Compared with this, our FamCare study annual estimated costs at the paid home care worker rate of £23,153
for people living at home with additional CB, was, at baseline, £107,640 (£2070 per week; see Table 62);
costed at the minimum wage rate of £6.19 per hour, this fell to £28,969 (£557.10 per week; see Table 62).
The method we used in the FamCare study would be expected to produce cost estimates that are higher
than would be the case if none or only a proportion of the opportunity costs were applied, although, for our
purposes of understanding costings for informal care, we have discussed these at the minimum wage rate
rather than at the higher rate for paid home care. The authors of the Alzheimer’s Society study note that,
should all unpaid hours of care become paid care, at the cost of a paid home care worker, uptake by
carers would be unlikely.235 However, the costings of informal care are not straightforward, as personal
circumstances and motivations within families may vary and are therefore hard to operationalise and
measure. For example, an adult family member of the person with dementia may take annual leave, or retire
or give up paid employment to support well-being in their relative. For these families, this not unsubstantial
contribution is perhaps a justifiable cost consideration, in addition to the more stringent calculation of
replacement costs for ‘help with personal care activities’.
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Later we will return to the issue of whether or not an understanding of the true costs of the experience of
some families in supporting a person with dementia and CB can be measured, using estimates of either or
both replacement and opportunity costs. Irrespective of the method of costing, our findings note that, for
this cohort of people with dementia and significant CB, cost estimates associated with informal care
provided by family members and friends, at 80.6% of the total costs of care, significantly dwarf those
provided by health- and social-care services.
The number of nights spent by participants with dementia in alternative accommodation was also
examined (see Appendix 18). The majority of participants did not live elsewhere during the study period.
At baseline, only 2.6% (n = 3) had spent time in a care home during the previous 3 months; this increased
to 11.4% (n = 13) at 6 months. The mean number of nights per month in a care home increased from
0.12 (SD 0.80) per participant at baseline to 1.47 (SD 5.47) per participant at 6 months.
Type of care home (i.e. private sector or local authority funded) was not specified. The average cost of
residential care in 2012 was £545 per resident per week for private sector residential homes and £1030
per resident per week for local authority homes.153 In comparison, private sector care homes with nursing
cost an average of £758 per resident per week. Assuming that all residential care in the FamCare study
occurred in private sector care homes, the mean cost of combined residential and nursing care home use
was £9 per participant per month at baseline. This increased to £31 per participant per month at first
follow-up and £131 per participant per month at second follow-up. However, this increase is largely
caused by a few users, rather than a general trend towards everyone using a bit more respite or short
break care. In the 3 months before baseline, three people (2.6%) with dementia had used respite services
in a care home. At the second follow-up, this had increased to 13 (11.4%). Of the 13, eight had spent
at least 1 month in respite care, with two of these spending 90 nights in respite care over the previous
4 months. Additionally, it is worth noting that 7 out of the 43 who dropped out of the study moved into
a care home over the study period. The reasons for this are unclear, but could include deterioration in the
patient’s condition or a reduction in ability of the family carer to provide support.
Research question 6
What are the patterns and costs of prescribing medications?
Table 63 shows medication usage for people with dementia and carers, over the 6-month period.
To examine patterns of prescribing and change over time, a McNemar’s test was performed for those
participants with dementia and their carers who had a change in their prescription between baseline and
the second follow-up. The only changes noted related to the person with dementia, when prescriptions for
dementia drugs increased and use of non-opioid pain relief decreased. No other drug categories changed
significantly.
The total cost of prescribing for people with dementia who were interviewed at all time points in this
cohort (n = 114) was £70,029 over the 6-month period. The pro rata prescribing costs were estimated to
be over £93,000, with an estimated cost per year per participant with dementia of £819 (SD £693); these
costs were more than double that of the carer. Acetylcholinesterase inhibitors represented the highest
prescribing cost for any individual medication category. For a breakdown of the prescribing costs for the
3 months before baseline for the whole sample (n = 157) of people with dementia for whom data were
available at baseline, see Appendix 19.
Table 64 shows the mean cost of prescriptions per dyad (person with dementia and carer) per time point
for each drug category of interest. Figure 16 shows the average number of participants with dementia
prescribed each drug category per time point, and the mean cost per participant per month. In this cohort,
prescribing expenditure over 9 months for people with dementia was highest for dementia drugs, that is,
acetylcholinesterase inhibitors (£30,466), and, for some, cognitive enhancers (£2448). The drug group
accounting for the next highest prescribing expenditure was ‘Other’ medications (£29,692). Unsurprisingly,
given the age of the cohort, costs related to opioid analgesia were relatively high (£3588).
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The average cost of prescribing per month per person with dementia varied slightly between time points
[baseline: £61.61 (SD £64.60); first follow-up: £71.23 (SD £80.09); and second follow-up: £71.76
(SD £67.14)], but was more than double that of carers at each time point [baseline: £25.89 (SD £48.26);
first follow-up: £30.59 (SD £60.30); and second follow-up: £28.96 (SD £52.10)], with the main difference
in prescribing costs, not surprisingly, relating to carers not being prescribed an acetylcholinesterase
inhibitor, a cognitive enhancer or an antipsychotic. The total cost of prescribing for carers in this cohort
(n = 114) was £29,036, with ‘other’ medications (£23,654) and opioid analgesia (£3825) accounting for
the highest prescribing expenditure.
Research question 7
What are the total costs of services, informal care and medication?
Table 65 summarises the total costs for the 114 people with dementia available at all time points. The
mean annual cost of community-based service use (including day care) and hospital-based service use for
each participant with dementia prorated is £5076. Participants had low use of respite services, but we
calculated this additional service at £676 per person per year. Our estimate of the annual cost of unpaid
carer time, using minimum wage (£6.19), is £27,369 per participant when using weekly means prorated
up across the sample of 114 (see Table 65); this is as opposed to the actual data available at each time
point used in Table 62. Our estimate of the mean annual cost of care per person with dementia with CB is
£33,941 (SD £19,268), of which the majority of the costs are borne by family carers.
TABLE 63 The FamCare study: frequencies for medication changes between baseline and second follow-up
Categorya
Prescription frequency
McNemar’s
test p-value
At baseline and
second follow-up,
n (%)
Not at all,
n (%)
At baseline but not
second follow-up,
n (%)
Not at baseline, but
at second follow-up,
n (%)
Person with dementia
Antipsychotics 8 (6.8) 105 (89.7) 2 (1.7) 2 (1.7) > 0.999
Antidepressants 22 (18.8) 87 (74.4) 2 (1.7) 6 (5.1) 0.289
Hypnotics and
anxiolytics
5 (4.3) 108 (92.3) 1 (0.9) 3 (2.6) 0.617
Anticonvulsants 2 (1.7) 112 (95.7) 1 (0.9) 2 (1.7) > 0.999
Dementia drugs 35 (29.9) 53 (45.3) 4 (3.4) 25 (21.4) < 0.001
Pain relief: opioid 8 (6.8) 102 (87.2) 4 (3.4) 3 (2.6) > 0.999
Pain relief:
non-opioid
7 (6.0) 97 (82.9) 11 (9.4) 2 (1.7) 0.027
Laxatives 7 (6.0) 105 (89.7) 2 (1.7) 3 (2.6) > 0.999
Carer
Antipsychotics 0 (0) 117 (100) 0 (0) 0 (0)
Antidepressants 10 (8.5) 102 (87.2) 1 (0.9) 4 (3.4) 0.371
Hypnotics and
anxiolytics
2 (1.7) 113 (96.6) 1 (0.9) 1 (0.9) > 0.999
Anticonvulsants 1 (0.9) 116 (99.1) 0 (0) 0 (0)
Pain relief: opioid 10 (8.5) 102 (87.2) 3 (2.6) 2 (1.7) > 0.999
Pain relief:
non-opioid
3 (2.6) 108 (92.3) 3 (2.6) 3 (2.6) > 0.999
Laxatives 2 (1.7) 114 (97.4) 0 (0) 1 (0.9) > 0.999
a n= 117.
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We also compared our findings with those of the Alzheimer’s Research Trust 2010 report234 and the
Alzheimer’s Society 2007 report (which was updated in 2014).265 The Alzheimer’s Research Trust 2010
report234 estimated the total annual cost of dementia to the economy as £23B. This report did not
estimate the cost per person, but provided a breakdown of the allocation of costs between health care
attached to GPs, nurse contacts, hospital use and prescribing costs; residential care; and ‘non-health or
social care’ which referred to carer time, mortality and morbidity. Our findings, that family care accounts
for a considerable proportion of the total costs for people with dementia living in the community, concur
with those noted in the Alzheimer’s Research Trust 2010 report.234 Its estimated cost of unpaid carer time
accounted for 86% of the total costs and is comparable to our findings of 80.6% for this cohort of people
with dementia and clinically significant CB. The Alzheimer’s Society’s Dementia UK report of 2007,265 gave
estimates of costs of care for people with dementia living in the community, stratified by disease severity.
Annual costs reported by the authors in 2007 for mild, moderate and severe dementia were estimated at
an average of £16,689, £25,877 and £37,473, respectively. The increase in cost as the disease progresses
probably reflects the additional services required to manage the condition, including additional time from
TABLE 64 The FamCare study: average monthly medication costs for participant dyads
Category
Time point, mean (SD) monthly cost (£) per participant
People with dementia (n= 114) Carers (n= 114)
At baseline
At first
follow-up
At second
follow-up At baseline
At first
follow-up
At second
follow-up
Antipsychotics
Atypical antipsychotics 1.51 (6.73) 2.05 (8.31) 1.48 (7.13) – – –
Typical antipsychotics 0.15 (1.14) 0.57 (6.07) 0.35 (3.78) – – –
Hypnotics and anxiolytics
B/Z/A drugs 0.22 (1.02) 0.22 (0.96) 0.18 (0.76) 0.03 (0.22) 0.01 (0.07) 0.04 (0.23)
Non-B/Z/A drugs – – – – – –
Antidepressants
SSRI 0.36 (1.41) 0.35 (1.46) 0.37 (1.40) 1.10 (5.25) 0.42 (2.23) 0.48 (2.49)
Tricyclic 0.52 (4.72) 0.30 (2.39) 0.29 (2.39) 0.01 (0.08) 0.07 (0.53) 0.03 (0.16)
Other 0.16 (0.67) 0.13 (0.59) 0.12 (0.55) 0.47 (3.56) 0.21 (2.25) 0.21 (2.25)
Anticonvulsants 0.14 (0.88) 0.15 (0.90) 0.09 (0.68) 0.13 (1.37) 0.29 (3.08) 0.03 (0.34)
Dementia drugs
Acetylcholinesterase
inhibitors
23.75 (39.98) 29.70 (41.63) 34.08 (44.05) – – –
Cognitive enhancers 2.03 (15.44) 1.31 (8.42) 3.20 (12.74) – – –
Pain relief
Opioida 4.53 (31.62) 7.94 (50.84) 0.51 (2.22) 3.32 (17.07) 5.37 (28.53) 3.22 (22.98)
Non-opioid 0.39 (1.24) 0.42 (1.53) 0.21 (0.92) 0.13 (0.77) 0.47 (1.68) 0.23 (1.20)
Laxatives 0.31 (1.45) 0.27 (1.30) 0.29 (1.19) 0.09 (0.81) 0.15 (1.02) 0.12 (0.99)
Otherb 27.46 (38.85) 27.83 (40.81) 30.61 (45.68) 20.62 (40.44) 23.61 (46.91) 24.60 (46.14)
No medication – – – – – –
Total 61.61 (64.60) 71.23 (80.09) 71.76 (67.14) 25.89 (48.26) 30.59 (60.30) 28.96 (52.10)
a Co-codamol is listed under opioid.
b All other medication categories are not of specific interest.
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family carers. Even accounting for inflation to 2012 prices, our estimate of £33,941 per person per year is
comparable to the estimates of 2007.
However, the Alzheimer’s Society’s 2014 update,235 which reported 2012/13 costs, noted that the direct
costs of health and social care, that is, excluding informal care and prescribing costs, in 2012/13 were
very different from those in 2005/6; the annual average for people with mild dementia living at home in
2012/13 was lower at £5872 than 2005/6 when these were £8634; the corresponding figures for people
with moderate dementia were similar at £10,467 in 2012/13 compared with £10,039 in 2005/6; and those
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FIGURE 16 The FamCare study: mean number of participants with dementia prescribed each medication category
and mean cost per participant per month (n= 114). Note that the number is averaged over all three time points
and ‘other’ medications have been excluded.
TABLE 65 The FamCare study: mean annual costs of care for people with dementia with CB
Cost categorya
Cost (£)
Total over 9-month
period
Pro rata
total
Pro rata per
participant
Service use (community care, social care, day care and
hospital use)
434,016 578,688 5076 (6525)
Informal (family) careb 2,340,080 3,120,107 27,369 (18,288)
Residential and nursing respite care 57,848 77,130 676 (2147)
Prescribing 70,029 93,371 819 (693)
Total costs 2,901,972 3,869,296 33,941 (19,268)
a n= 114.
b Informal care is costed using the minimum wage (2012) in this scenario.
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for severe dementia were much higher at £21,579 in 2012/13 than £12,037 in 2005/6. The Alzheimer’s
Society’s data were collected at one time point and we therefore compare these data with our baseline
FamCare study data: our estimated annual cost of caring for people with dementia and significant CB at
home is £5440 per participant, with a monthly cost of £453.33 (see Table 60). In our cohort 63.1% of
patients had mild dementia, 28% had moderate dementia and 8.9% had severe dementia.
From these data, we can see that the direct health- and social-care costs (excluding informal care and
prescribing costs) of supporting people with dementia and significant levels of CB at home are lower than
any of those for the range of people with dementia, of any severity, that were noted by the Alzheimer’s
Society in its 2014 update of the health- and social-care costs of dementia.235
Consultation with stakeholders
In the first set of consultations, in which different perspectives of CB among people with dementia were
explored with 83 specialist community mental health practitioners and their managers from participating
NHS organisations, it emerged that there was limited knowledge about the prevalence and impact of
CB among people with dementia living in community settings; or where and how the families caring for
such individuals might be supported by local NHS community mental health services. For example, many
practitioners felt that their service may have missed potential cases of clinically significant CB (measured by
the RMBPC111 and the NPI135) for inclusion in our trial during early evaluations of referral to them or their
initial interviews. Reasons put forward for this were that some carers could have under-reported CB and
more detailed interviewing may have helped; or some carers may have appeared to be over-reacting to
minor changes in their relative; and many felt that their service protocols lacked a structured assessment
tool for CB. One NHS trust had tried the NPI,135 but non-medical practitioners had found this unhelpful in
their work with family carers, so this was not used routinely. Some practitioners also indicated surprise that
families with a score of five on the RMBPC111 or one on the NPI135,273 qualified as a case for clinically
significant CB in dementia.
Salient themes from the first five sets of consultations with practitioners were followed by thematic analysis
of data from two further discussion events held with the wider stakeholders in July 2013. Stakeholders
attending included HealthWatch and other advocacy representatives (n = 3), carers and former carers
(n = 6), commissioners of social care services (n = 10), voluntary sector organisations (n = 6) (such as the
Alzheimer’s Society, Mind, British Red Cross and Age UK), other community-based health-care practitioners
and managers (n = 11) and NHS commissioners (n = 2). A person with dementia, who was a member of
the Programme Steering Group, also attended.
These diverse participant groups are here referred to as ‘stakeholders’. Use of qualitative methodology
meant that no sample size was determined in advance for the wider stakeholder group discussion. Instead,
individuals with a broad variety of relevant experiences working in different agencies, and others with a
personal interest in dementia care, were approached and recruited by the research team. Their travel costs
and any carer costs were met by the study.
Topic guides were informed by the emerging findings from the FamCare study data, but were tailored to
stakeholder participants’ knowledge and role. Questions and discussion topics were devised to explore
whether or not our findings ‘rang true’ with the wider stakeholder group.
A realist evaluation approach274 was used to synthesise the data from the combined groups in order to
obtain a comprehensive picture of the contexts within which practitioners worked, the mechanisms which
promoted or impeded changes, and the consequent outcomes for family carers supporting people with
dementia with CB. Realist evaluation was chosen as it addresses the immediate priorities of empirical
qualitative research, can be adapted to the research aims, addresses substantive issues and contributes to
policy and practice development, rather than aiming for methodological purity.275 Both consultation events
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were facilitated by members of the research team, who provided emerging results from the FamCare study
fieldwork and asked those attending to debate the findings for their face validity and to offer some
interpretations of the findings in the context of practice or service use. Both events were organised in
‘café style’, with tables around which mixed groups could debate the emerging findings. Members of the
research team and their colleagues kept notes of the points made and these records were produced as
non-verbatim transcripts and then analysed to consider within- and between-group themes. In order to
protect confidentiality, all quotations are referred to anonymously and personal details have been redacted.
Consultation with stakeholders: findings
Changes in the NHS and local authorities in England, as they became dominated by reactions to the
commissioning imperatives, were a common theme among the overarching reasons given by stakeholders
as to why systematic, case-specific interventions for people with dementia and CB living at home and their
families could not be accessed or delivered. Commissioning activity entailed prioritisation of new service
models to respond to national imperatives, such as the National Dementia Strategy’s250 emphasis on early
diagnosis and reductions in the use of antipsychotic medications in dementia. Other broader contextual
factors concerned planning around implementation of the controversial Health and Social Care Act
2012,276 which in particular redefined the roles of GPs in England, and the financial pressures affecting
local authorities and their contracts with the voluntary sector. Managers and practitioners also noted how
new imperatives affected their services’ priorities and, as a consequence, some reorganisation was taking
place or was mooted. Issues relating to practice and the way services are organised were found.
First, two areas of specific importance in delivering timely support for dementia with CB at home were
identified as relevant to the present study. These were timely recognition of the problems and effective
responses to them. Second, two particular imperatives were identified as profoundly affecting what
dementia services were able to offer to family carers. These were pressures to avoid hospital admission or
for rapid hospital discharge, and early diagnosis of dementia. These are outlined next.
Timely recognition and responses to challenging behaviour
There were some reflections that primary prevention measures to address the risk of CB could be effective
if they were properly resourced, and some of these ‘low-level’ interventions were seen as applicable and
acceptable to family carers:
Well we are creating peer support groups . . . people are lonely . . .
Voluntary sector worker
We help carers to cope with minor problems like forgetting, putting the kettle in the fridge . . .
Specialist CMHN J
However, many practitioners perceived that the problem remained that family carers did not always see CB
as sufficiently difficult to justify seeking help, and that they often had little confidence that help would be
forthcoming if they did raise such difficulties. Some carers were thought to see behavioural symptoms as
something that were only ‘deserving’ of help if they included physical aggression or similar, whereas other
practitioners themselves classed some symptoms as not ‘real’ CB:
[Carers are] . . . surprised that CB can include clinging, not letting carer out of sight, non-stop questioning.
CMHN G
CB . . . well I thought it was all about behavioural problems . . . aggression, wandering,
hallucinations . . .
Specialist CMHN J
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It’s not real CB . . . [s/he] can’t help forgetting . . . it’s [XXX the carer] who is demanding . . . [s/he]
doesn’t seem able to accept dementia . . . I tried to explain to [him/her] that it’s the dementia [s/he the
person with dementia] just can’t help it . . . not sure [s/he the carer] took this on board . . .
CMHN E
Several practitioners identified deficiencies in current services that needed to be addressed so that carers
could cope better with CB symptoms. Such ideas were concentrated around the need for early identification
of CB and work with carers to recognise that CB symptoms were becoming difficult to manage:
We need to know how to identify early . . . before there are huge problems . . . like who are the carers
who may not cope.
Dementia nurse specialist
The short checklist . . . of problems that we were given during training helps . . . I can go though it
with the carer and well . . . they admit to things a bit . . .
CMHN G
Carers say they are coping with low-level CB . . . repeated questioning . . . but I don’t think they are . . .
Voluntary sector carer advice worker
Carers don’t share information with family . . . wife doesn’t want to tell kids that husband is
incontinent/hitting her as it’s their Dad. Doesn’t want to burden them.
Former carer
Such ideas about timely identification were confirmed by some carers and former carers reflecting on their
own situations:
You don’t like to admit . . . too early that it’s difficult . . . even to yourself . . . s/he was still
independent . . . dressing . . . going for the newspaper . . . to the bank . . . but then s/he would think
I was his/her mother.
Former carer
I went to the clinic . . . s/he was upset that I was there . . . but I had to take him/her . . . They asked me
if s/he had any problems . . . couldn’t dress him/herself, or shop and cook or if s/he had ever been
aggressive . . . I didn’t like to say the small things . . . s/he does nothing all day . . . stopped going to
church things since his/her fall . . . always ringing me up to ask about the pension . . . losing money
and thinks I have taken it . . . well I was relieved when we left . . . the clinic . . . I didn’t want to
complain about my dad/mum.
Daughter
It’s the small things in life . . . incessant checking . . . putting things in the wrong place and we spend
hours looking . . . or always harping on and on about the same things . . . looking for [his/her] dead
brother . . . not aggressive or anything and she still knows me . . .
Carer
Many practitioners were optimistic that skilled support, accessed in a timely way, could be effective in
supporting carers to manage CB if it is addressed early on:
Carers need skilling up and support to practice strategies that may work . . . not just tips and pointers . . .
NHS psychologist
The CPNs [CMHNs] should show them [the carers] how to deal with the person . . . they may be
accusing them [carers] of stealing or taking their property . . .
Social worker
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The effectiveness of this was confirmed by a small group of carers who felt that they had been listened to;
that evaluation of their needs had been comprehensive and helped them to understand and thus cope
with their relative with dementia’s behaviour:
It was quite good for me . . . at the clinic . . . they asked me questions and filled in a form . . . when I
next saw the nurse I was able to tell them more . . . I noticed things more by the next week . . . not a
problem or anything . . . but silly things like clothes not being changed . . . quite smelly . . . s/he got
upset and pushed me away when I tried to help him/her with a change of clothes.
Carer
S/he was trying to leave the house by the window at night . . . everyone was worried but we . . . the
psychologist at the clinic and I discovered it was only because it looked like a toilet door . . . s/he needs
to go a lot . . . to the toilet I mean . . . at night.
Carer
In contrast, recognition of CB too late meant that breakdown of care could occur or crises develop where
there were very few options for acceptable resolution:
. . . a lot of pressure to ‘put her’ into a care home.
Former carer
I went to the memory clinic . . . [XXX the person with dementia] blamed me . . . refused to return . . . my
[son/daughter] told me to wait and not go to the clinic . . . I didn’t say . . . [XXX the person with dementia]
was just not the person I knew . . . irritable, quieter, getting aggressive . . . I mean s/he shouted at
me . . . we never shout or argue . . . finally my GP arranged it all [move to care home] with social services
and he/she [XXX the person with dementia] then didn’t know me when I visited . . . called me by my
daughter’s name once . . . I still feel guilty now after all this time . . . but [XXX the person with dementia]
never really hit me . . . or anything like that . . . I couldn’t manage anymore. It was making me ill . . .
Former carer
Hospital pressures and early dementia diagnosis
From different sectors, there were accounts of responding to the demands to avoid hospital admissions or
to ensure that discharges were not delayed, as the following comments illustrate.
First, was the ‘hospital admission’ imperative:
We have to keep people out of hospitals so we need to work in care homes . . . that’s where people
with dementia and CB are making demands on us.
NHS manager D
We have to concentrate on re-enablement now . . . this may be an opportunity but we have to work
this out locally . . . rehabilitation means different things to different people it seems.
Local authority commissioner
We have to reconfigure our rapid response dementia team which worked in one part of the trust . . .
NHS manager N
Second, comments were made about the new priorities given in dementia services to early diagnosis, to
the extent that these commanded professional and managerial attention:
We have to get people through the service and diagnose dementia . . . the anti-dementia drugs . . .
perhaps some brief other intervention is all we can manage at targets of 600–800 a year . . .
NHS psychiatrist
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In contrast, many of the carers participating, and some practitioners working outside the NHS, interpreted
such re-engineering of services as cuts to carers’ support and a withdrawal from preventative work:
My nurse [CMHN] who came occasionally had to discharge me . . . she said to ask the doctor to
re-refer me if I needed . . . maybe it’s the cuts in the health service.
Former carer
I rang the carers centre . . . they were very nice and we talked a lot . . . they told me I should ask my
doctor to refer my [husband/wife] and me to the CPN [CMHN] . . . but the nurse had told me to go to
the carers centre if I needed to . . .
Carer
I was lucky . . . they still have me on the books at the clinic . . . I know that I can phone but I don’t
often . . . shame they stop doing this now.
Carer
I would like to help carers look after people with dementia at home . . . usually it’s too late and we get
called in to help arrange for a care home.
Social worker
Stakeholder consultation: summary
The stakeholder discussions provide a context to the data reported earlier in this chapter and help to explain
some of the apparent dissonance between high levels of need among family carers and their uncertain
focus in services. When we compared the views of managers, practitioners and carers, some different
perspectives emerged between those whose role was to deliver broad strategic aims (such as hospital
discharge or admission avoidance, or early dementia diagnosis) and those who were more concerned
about the implications of commissioners’ and government decisions for their own organisation and the
people they were supporting. High thresholds for service access and high levels of CB were a prime
example of a self-excluding explanation of why carers felt that they were not deserving of interventions to
prevent escalation of CB at home. Across participants there was some cynicism that the purpose of early
recognition of dementia and service reorganisation was seen as more about driving down costs than
creating improvements. There was a strong theme among those who were optimistic about functional
analysis or similar interventions to minimise the impact of CB. This was that early or timely recognition
should be applied to CB symptoms and not just to the diagnostic recognition of dementia. Both practitioners
and carers voiced concerns that high thresholds for accessing specialist support led to carers not seeing
their situation as ‘deserving’ of help, with the risk of care breakdown and distress. In their view effective
responses to CB need to start early on with recognition of the risks; practitioners and advocates should
develop strategies to encourage carers to accept such interventions; and services should publicise their
availability before escalation of family distress precipitates a crisis or breakdown of care at home.
Discussion
This is, as far as we know, the first naturalistic observational cohort study in family settings across England
since publication of the National Dementia Strategy of 2009.250 A previous longitudinal study of
Alzheimer’s Disease in London and the Southeast Region (LASER-AD)277 of England reported in 2005.
In these studies participants with other dementia subtypes were excluded; they lived in both care homes
and at home; and those with and without clinically significant BPSD were included. In our FamCare study
cohort, index participants met the diagnostic criteria for both dementia and clinically significant CB, and
family carers also participated. The FamCare study was conducted between August 2010 and July 2012
across England, at a time of major contextual changes in the delivery of NHS and social care services. Some
of these were widespread considerations about the Health and Social Care Act 2012;276 introduction of
PbR in NHS mental health organisations;121 and financial pressures affecting the amount of social care
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commissioned by local authorities. Also, stimulated by work associated with the National Dementia
Strategy,177 there were several reports or guidance about dementia care from the Department of Health
and campaigning groups such as the Alzheimer’s Society. These included, for example, those about the
prescribing of antipsychotics in dementia care; mental health care in acute general hospitals; end-of-life
care; workforce needs; and calls for more and better support to maintain independence in people with
dementia living at home.112,176,278–281 The FamCare study is also one of the first recent in-depth studies in
England investigating the range and cost of health- and social-care services accessed by this group of
people with dementia and significant CB, and their family carer. Our participatory design development
process,282 using stakeholder consultations, provides a realistic understanding of, and potentially
trustworthy conclusions about, the access to, and delivery of, support to families and community-dwelling
people with dementia and CB.
Next we will examine our findings in terms of the recognition and management of CB in dementia in
family settings, by specialist mental health services for older people, and discuss our health economics
findings.
Recognition of dementia and challenging behaviour in family settings
Delivery of support by NHS mental health organisations, to people with dementia and CB living at home,
and their family carers, was difficult to examine. They were hard to locate within the records of the
organisations (see Appendix 3). From 5360 referrals to 33 CMHTsOP over a 7-month period, in seven NHS
organisations, only 8.4% of people who were living at home with potential dementia were accepted by
the teams, for evaluation or assessment. The present study provides new detailed data on the type of
referrals that are received by CMHTsOP in England, and how these are managed by teams. Practitioners
and managers in the teams and organisations were surprised by these findings, as their perception was
that their work was predominantly with people with dementia. Just under one-quarter (22%) of new
referrals to CMHTsOP were in respect of people living in a care home (see Appendix 3, Table 66).
Research suggests that only 38% of people with dementia live in a care home.235 The present study did
not set out to understand in-reach services by CMHTsOP to care homes, much of which is reported to
operate informally.283 Our interest was in the management of dementia and CB in family care settings.
Our data confirm the findings of another study of 15 CMHTsOP carried out in different locations from
those of the present study, during a similar period, between October 2010 and June 2011. The authors,
like us, note a weighting within CMHTsOP towards cases where the individual has a functional mental
health problem, rather than dementia conditions.284 Wilberforce et al.284 also note a huge variation of
practices in CMHTsOP in England, similar to the findings of their literature review of 2008, which
concluded that there was patchy evidence for CMHTsOP practices, compared with policy and practice
guidance.285 Our examination of every new case referred to 33 CMHTsOP suggests that only a very small
part of work accepted by CMHTsOP focuses on supporting new cases of people with dementia and family
carers at home. This, combined with the stakeholder consultations, confirms that the majority of people
with dementia living in their own homes, and potentially requiring specialist NHS mental health care, may
not be found using services provided by CMHTsOP. Thus, people with dementia with developing CB, and
their family carers, may be deprived of timely support to prevent escalation of their concerns and distress,
because they are not recognised early enough by services and offered support.
Management of dementia and challenging behaviour in family settings
Our examination of every new referral to CMHTsOP noted that, in the 7-month period, 61.5% (852 cases)
were referred, prior to evaluation by the team, on to memory clinics (see Appendix 3, Table 67). Indeed,
our observational 6-month cohort study of 157 dyads living at home with dementia and CB recruited
16.6% of participants with dementia and CB from memory clinics, with the rest from CMHTsOP.
Consultation with 83 practitioners and managers in participating NHS organisations noted views that, at
the points of referral services, some may have missed potential cases of people with dementia and CB,
because of the lack of a structured assessment with thresholds for clinically significant CB combined with
under-reporting of CB by the family carer, early on. Additional stakeholder findings point to the carers
themselves not knowing when they should ask for help.
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Although dyads in this cohort varied considerably in their CB, statistical analysis could not identify
subgroups that improved, were stable or deteriorated over time. This finding provides further confirmation
of our rationale of the elusiveness of the syndrome (see Chapter 1) and the complexity of symptoms,277
and it also lends further support for our rationale (see Chapter 1), that the treatment approach of choice,
for this particular group involves, case-specific interventions to address the cause(s) of behaviour, unmet
need in the person and needs of the family carer.
Specialist practitioners (not all with professional registration) had, on average, nine contacts with participants
with dementia and CB. These took the form of face-to-face support for the majority (116 dyads), but 12.7%
of dyads had no contact with a practitioner at all over the 6 months following their referral to specialist
mental health services for CB. As 16.6% of this cohort were being seen in memory clinics, it is fair to
assume that some of these contacts would have focused on diagnostics and review for the dementia
symptom-modifying medications. Over one-quarter (26.1%) of people with dementia and clinically
significant CB were already in receipt of a dementia-related medication such as an acetylcholinesterase
inhibitor or cognitive enhancer, prior to referral for CB to specialist CMHTsOP (see Table 49). Over the
6 months, prescriptions of these medications, and the associated costs, increased (see Tables 63 and 64):
the acetylcholinesterase inhibitors represented the highest prescribing cost (£30,466) for any individual
medication category. Disappointingly, the quality of prescribing practice for the antipsychotics was
suboptimal, despite policy and best practice initiatives for judicious use of these, which include, as a
minimum, regular review and a maximum treatment period of 12 weeks.59,112 Very few participants had
been on an antipsychotic for less than 3 months prior to referral (see Table 49). There was no change over
6 months in antipsychotic prescription (see Table 63). Additionally, the noted high use of antidepressants
prior to referral (see Table 49) did not change over the 6 months, despite studies showing that they are of
little or no benefit;270,271 nor was there a change in hypnotic (B/Z/A) prescription (see Table 63). Moreover,
in the past, people with dementia were more likely to be given antipsychotics than analgesics,46 but there is
emerging evidence for the effectiveness of analgesics in reducing agitation in dementia.35 In our study, we
may not have captured the use of self-administered medications, such as paracetamol. However, the overall
use of analgesics is surprisingly low for a cohort of this age, among whom comorbid conditions are likely to
be common. We did not examine participant case notes to determine the content of interventions offered
by specialist mental health practitioners, but these findings have the potential to undermine the view that
specialist psychiatric teams are better than primary care at withdrawing antipsychotics.286
Overall, support from practitioners over the 6 months did not have an impact on the strikingly high levels
of BPSD, measured by the NPI or the RMBPC (see Table 48), at baseline. This is consistent with the
LASER-AD study of over a decade ago,277 whose authors noted no association between psychiatric
treatment and outcome of BPSD, and no change in NPI scores. Our findings of mental health support
conclude that, although supportive contact with a practitioner may help families feel less guilty, this was
not enough for a sustained management approach to reduce measurable CB in this group. Families need
to be helped to learn to identify triggers266 of ‘behaviours that challenge’, including their own interactions
with their relative; and practitioners need to support them on an ongoing basis, to modify these triggers
and thus reduce their own distress. Specialist practitioners working from multidisciplinary CMHTsOP or
memory services also need, when relevant, to collaborate with the GP to address unmet health needs.
For example, our Cochrane review82 included a study by Gitlin et al.,287 who used this type of approach
in a randomised controlled study. Their treatment involved up to 11 home or telephone contacts over
16 weeks, including investigating health needs (such as taking blood and urine for tests when relevant);
they reported significant reductions in CB, including carer upset, as well as improvements in carer confidence.
In our cohort of people with dementia and clinically significant CB, 87.3% were recorded as being in
receipt of specialist multidisciplinary mental health care. In an earlier trial,65 in which CMHNsOP working in
multidisciplinary dementia-specific community mental health teams (CMHTs) were trained to apply a
functional analysis approach in family settings, a positive impact on CB was noted. There are a number
of possible explanations for these disappointing findings of both suboptimal prescribing and no change
in levels of CB when families received an average of nine practitioner contacts over a 6-month period.
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First, practitioners may not have the skill set needed to recognise and treat people with dementia and CB,
as their work appeared to be weighted towards people without dementia; they accepted only a very small
group of potential cases of dementia for evaluation, often referring people onwards without evaluation
(see Appendix 3). However, even in specialist mental health nursing services that do not focus specifically
on the management of CB at home, family needs may be missed.288 Second, the multidisciplinary teams
may not have had access to the range of professionals; for example, old age psychiatrists or geriatricians
can provide expertise for medical concerns, psychologists can provide expertise in maintaining the
micro-skills needed to formulate psychological needs, including those of the care,187 and social workers
may also have perspectives about family need and resources. An obstacle to delivery of interventions for
dementia with CB may have therefore been the absence of particular professional expertise. It is hard to
see why some prescribing practices were suboptimal, as old age psychiatrists were always available in
these services; it may be that some practitioners may have been working ‘in silos’272 and that the timing of
access of available professional expertise by the practitioner may have been an obstacle to the evaluation
for, and delivery of, some interventions for CB. The sometimes hidden ‘scaffolding’185,186 that practitioners
require for the delivery of these types of interventions is implicit in most successful applications of
case-specific dementia care interventions,289 including those for CB.26,50 Routine supervision and support
from skilled professionals with relevant expertise are therefore particularly important for the management
of dementia with CB at home.
Our programme of work has brought together manualised tools for the assessment and recognition and
management of people with dementia and clinically significant CB in family settings. These tools can assist
practitioners to detect unmet health, psychological and carer need. The tools were viewed by specialist
community mental health practitioners as helpful as well as both feasible and acceptable for use. They
valued the systematic structure for assessment and decision-making to meet the needs of families who live
with or closely support a person with dementia and CB (see Chapter 2). This is important, as practitioners
have different requirements for decision-making about treatment in dementia care, compared with other
long-term conditions.290
Health economics
This study set out to identify the frequency of health- and social-care service use and associated costs for
people with dementia and CB living at home. It included community-based health- and social-care service
use, prescribed medication, hospital use, day care, respite services and unpaid carer time.
The highest mean monthly use of mental health services for people with dementia occurred in the 3 months
before baseline. This is unsurprising, as a recent referral to a mental health team was an eligibility criterion
for the FamCare study. The costs of mean monthly mental health services were two-thirds lower by the
second follow-up. Community-based health-care costs, excluding mental health services, did not vary
considerably over time. However, the increase over the 6 months in the proportions of GP home visits, and
corresponding decrease in visits to the GP surgery by patients or carers, is interesting. We did not collect
detailed information that might explain this change in practice by the GP; it could reflect reduced
independence or increased distress in dyads over time or perhaps increased attention for those prescribed
an acetylcholinesterase inhibitor,291 as prescriptions for these drugs also increased over the study period.
Annual prescribing costs for the individuals with dementia were more than double those of family carers,
with acetylcholinesterase inhibitors, cognitive enhancers and antipsychotic prescriptions accounting for
most of this difference. Social care use from formal sources, including day care, increased for people with
dementia over the study period. For carers, local authority social care use remained low throughout the
study. Social care, such as home care, is a major support for family carers, although it is not always seen as
a service to them, as the ‘user’, such as the person with dementia who is provided with home or day care,
is seen as the focus of intervention.292
Two striking findings arise from our data of the costs of care for people with dementia and significant CB
living at home. First is the level of contribution borne by family carers, which accounted for 80.6% of the
total costs for this group. Second is the economic assumption that increases in cost are determined by
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dementia severity, defined as mild, moderate or severe. What this economic assumption can overlook are
the costly challenges of BPSD, which are common at the earliest stages of dementia and can be persistent in
the first year of a dementia diagnosis; they are also associated with depression in carers and high costs later
in the caregiving career.235,239,293 In the present cohort, we found high levels of BPSD, even though 63.1%
were categorised as having mild dementia. High levels of BPSD among people with mild dementia have also
been noted by others.294 In our cohort, the overall monthly health- and social-care costs were £2828 (mean
annual cost £33,941; see Table 65, with all informal care costed at minimum wage); this is comparable to
the costs quoted in the Alzheimer’s Society 2014 update235 for all disease severity levels of £29,298. The
authors235 also noted costs of £25,723 for mild, £42,841 for moderate and £55,197 for severe dementia.
In addition, they reported that since 2007 there has been a reduction in the level of formal care support for
people with mild dementia and a sizeable increase in support for people with severe dementia, consistent
with efforts to support people at home rather than in a care home. This change in focus may, according
to the authors, reflect the tightening of health- and social-care budgets over this period. However, an
alternative hypothesis based on our observation of low response by CMHTsOP to referrals of people with
dementia, and lack of impact on BPSD over time, may also be attributable to the perception that mild
dementia reflects less complexity and associated low need in families.
Health economics: consideration of financial benefits for family carers
Two-thirds of people with dementia live at home, with one-third of these living on their own.295 The
FamCare study cohort was representative of this finding, with 70.7% of participants living with someone
who described themselves as a carer. As such a high proportion of the cost of dementia is borne by family
carers, it is relevant to consider the adequacy of financial benefits available. In the UK, attendance
allowance is paid directly to individuals aged ≥ 65 years with physical or mental disabilities to help with
personal care costs. The allowance rate for 2014/15 was capped at £82.30 per week (URL: www.gov.uk/
attendance-allowance/overview, accessed 17 July 2015), which would pay for less than 4 hours of a
home care worker’s time (costed at £23 per hour to include employment costs). Additionally, a carer’s
allowance of £62.10 per week is available for people who spend a minimum of 35 hours per week caring
(URL: www.gov.uk/carers-allowance/overview, accessed 17 July 2015). However, the carer’s allowance is
taxable and is affected by the level of other benefits received, for example the state pension. The majority of
carers in the FamCare study were retired, and unlikely to be eligible for the full carer’s allowance after their
pension was taken into account. Carers in receipt of the full carer’s allowance would be able to purchase less
than 3 hours of a home care worker’s time, although for some it may be commensurate with employment
and its associated costs. However, these observations should be considered in the context of the views
outlined previously, that families may provide care to their relative out of duty or desire, and that, should all
unpaid hours of care become paid care, uptake by many carers would be unlikely.235
Limitations
This study was conducted across England, including the south-east, southern Midlands, the north-west,
Lincolnshire and Yorkshire. However, one important limitation to the generalisability of our findings is the lack
of data on ethnicity and migration status from within our cohort of participants or from the workforce within
the 33 CMHTsOP across the country. All but one of the 26 practitioners who were trained to use functional
analysis-based interventions were from white British backgrounds and none was from Asian ethnicities.
This observation is consistent with the observations of a study by Hussein and Manthorpe.292 They note that
there are wide local variations in diversity among the dementia workforce. In our consultations we recruited
more diverse stakeholders to help redress this limitation. Similarly, we did not collect information on
socioeconomic status. Such data are rarely collected and analysed in dementia research, but would be useful
to the understanding of family and individual resource decisions and priorities.
A second, unavoidable, limitation is consideration of those who did not wish to join our study and the
consequent loss of potentially the most distressed families to this cohort investigation (see Appendix 13).
A third limitation is that it was not possible to conduct the planned CRT of the intervention (see Chapter 5,
Changes to protocol, and Appendix 2).
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A fourth limitation is that recruitment from the MAS and memory clinic (16.6% of the cohort) began later
in the recruitment period, after workshops had been conducted with stakeholders in NHS organisations.
We do not have data on how many of the 61.5% (852 cases) that were referred on by the CMHTsOP
to memory services (see Appendix 3, Table 67) might have met our criteria of dementia with clinically
significant CB. However, the present study has developed tools for specialist services to use in CMHTsOP,
MASs, memory clinics and other commissioned services for the recognition and management of dementia
with CB in family settings.
Conclusions
Implications for services
Fundamental questions arise from these data. These are about the limited access regarding equity of
support from specialist services, for family carers living with a person with dementia who also has clinically
significant CB, compared with other groups of carers providing support. We did not collect comparative
data for other groups, but this study provides baseline cost data, for the purposes of such comparisons.
This 6-month cohort study notes that over 80% of the total costs of care were borne by family carers, and
over two-thirds of the carers were living with the person with dementia. Co-resident carers reduce the risk
of breakdown of care at home,296 thus justifying their need for higher priority to timely evaluation and
support with CB, by specialist and other services.
A better understanding of views about equity of specialist mental health support for older people without
dementia297 may explain our observations of the flow of new referrals to CMHTsOP, in which 1385 of these
were not accepted for any assessment by the teams. Of these, we would argue that 61.5% were probably
referred for dementia symptoms, as they were signposted on, prior to any evaluation, to memory clinics (see
Appendix 3). A new feature of our findings is the context of delivery of diagnosis, and the redirection of
investment towards memory clinics and MASs. This appears to have resulted in a perverse consequence of
creating a new care gap298 between diagnosis and support, when symptoms of CB are high. The image of a
pathway299 appears difficult to justify when there is a stark break between initial contacts and later interventions.
Our practitioner workshops of 83 multiprofessional practitioners combined with our stakeholder interviews,
which included carers, service managers, practitioners, advocates and commissioners of health- and
social-care services, concluded that effective responses to CB need to start early on with recognition of
the risks; practitioners and advocates should develop strategies to encourage carers to accept such
interventions; and services should publicise their accessibility and availability in order to avoid escalation of
family distress, which then precipitates breakdown of care at home. Although diagnosing dementia has
been the ‘dementia challenge’ for services until recently, these findings suggest that providing families with
evidence-informed specialist support to manage CB at home could be the challenge for the next 5 years.
Specialist mental health NHS organisations in England now have a formal framework of grouping needs
of people with dementia within the PbR programme,121 and the initiative has been rolled out. Dementia
cases are clustered into four groups, namely ‘clusters 18–21’, where it is anticipated resources will follow
complexity of need. These stakeholder contributions therefore have scope to guide commissioning practice
for services for dementia with clinically significant CB, to provide assistance for family carers.
Implications for practice
Another important finding is confirmation of the variability over time in a cohort, in which index participants
met diagnostic criteria for dementia and CB. This highlights the need for a skilled community-based
workforce to co-ordinate and deliver case-specific support to people with dementia and CB living at home,
taking into account their health, psychological status, family context and social capital, at any given time.
The circumstance of the family carers, in an increasingly diverse society, is a key to understanding what can
be achieved in terms of preventing escalation of CB at home, to the point of crisis. Our study provides
an evidence-informed framework with appropriate tools for such an approach, particularly about the
family context. For example, we have field tested two common outcome measures used in research with
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potential for use in routine practice,264 namely the RMBPC and the NPI. The RMBPC is a short self-report
measure completed by family carers where score of five and above was capable of detecting high levels of
BPSD on the NPI. Some non-medical practitioner stakeholders had discontinued their use of the NPI, but the
RMBPC may be a useful tool in assisting practitioners early on in their assessments to target their support
towards dementia with clinically significant CB; it is a self-report carer measure that can be then evaluated
by specialist practitioners of all professional disciplines, irrespective of whether they work in memory clinics
or CMHTsOP, or in other integrated services. By harnessing a more focused approach to the practice, and
delivery, of case-specific interventions for people with dementia and CB living at home, trained dementia
practitioners or ‘therapists’, perhaps described as ‘dementia behaviour therapists’, can use this framework
to make rational decisions about care and treatment plans, about which they can then have greater
confidence of their efficacy. They will also need to draw on expertise from their multidisciplinary team
and wider care providers where relevant, to co-ordinate and deliver sustained ongoing interventions for the
management of dementia with CB at home.
Implications for research
In the present cohort, high levels of BPSD were observed even though 63.1% were categorised as having
mild dementia. This is consistent with findings from Finland, noting BPSD in 76.5% of people with mild
Alzheimer’s disease.294 BPSD in community-dwelling people with dementia can be severe throughout the
course of the condition.300,301 Longitudinal studies are needed to improve our understanding of the
characteristics of people with mild dementia with CB, changes in BPSD over time and what interventions
might moderate CB to reduce distress for them, their families and others. Our findings add support to
recommendations from studies carried out in other counties for a focused structured assessment of BPSD
before deciding on treatment, even in mild dementia,294 and timely recognition with adequate professional
support.300 Future applied research studies such as ours will need careful longitudinal evaluation of
specialised individualised interventions for home-dwelling people with clinically significant CB, early on
following diagnosis of dementia. Given the gaps in knowledge about the management of CB in family
settings which have been noted in an independent review of progress of the National Dementia Strategy of
2009 (pp. 3, 68 and 69),302 the changing landscape of commissioned dementia care in England and the
findings from our stakeholder consultation, there is scope, using outputs and tools from the FamCare study,
for a future study of the delivery of case-specific interventions for CB in family settings. This could have an
impact on NHS, and other services for this group, in the next 2–4 years.
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Chapter 6 Discussion: overview of key findings
from Challenge Demcare and implications for future
research and practice
Overview of Challenge Demcare
Background to the programme
The aim of this programme was to study the management of CB in people with dementia living at home
and in care homes. The phenomena associated with CB in dementia are referred to as NPSs or BPSD.
These concepts acknowledge the psychological suffering in people with dementia, but they are limited in
their reach. First, they root the phenomena solely in the dementia when other factors such as undetected
pain and discomfort35 may contribute to an episode of CB; and, second, they take no account of the
environmental context in which the behaviour occurs, such as when an episode of aggression is precipitated
by the way care is carried out38 or by how a carer perceives a behaviour and responds to it.48–50
Therefore, we defined CB as ‘a manifestation of distress or suffering for the person with dementia or of
distress in a carer or others, thus threatening the quality of life of one or both parties’.
Overall, two related but distinct programmes of work were planned, with development work leading to
two CRTs. These were set within the real world of care homes in England’s largest county of Yorkshire;
and in seven large NHS mental health organisations across England, with 33 mental health teams that
were commissioned to provide care to people with dementia and CB living at home. The first CRT (The
ResCare trial) examined an individualised intervention consisting of e-learning and e-tool decision support
for ‘action plans’ to assist staff working in care homes in the management of people with dementia and
clinically significant CB, with an embedded process evaluation. The second (the FamCare trial) aimed to
assist specialist community mental health practitioners working with families to deliver such interventions
for people with dementia and clinically significant CB living in their own homes; and to evaluate this within
a CRT.
Background to the intervention
The aim of the intervention was to assist practitioners who support families and care home staff to respond
effectively to CB. It was refined from the behaviour management literature and outlined in Dementia: A
NICE–SCIE Guideline on Supporting People with Dementia and their Carers in Health and Social Care as
‘behavioural and functional analysis conducted by professionals with specific skills, in conjunction with carers
and care workers’ (p. 260).12 This biopsychosocial approach to assessment, analysis and the testing of
interventions for CB in dementia, which we describe as functional analysis-based interventions,82 is also
known as individualised formulation-led interventions for CB in dementia care.97,186,303,304 They are usually
algorithmic to enhance case specificity62 and are delivered by trained practitioners who have access to
knowledge and expertise from other professionals such as psychiatrists, geriatricians and experienced
psychologists.15,26,27,50,97 A trained therapist is usually required for such an intervention,82 as a key skill in
working in this area is the ability to be flexible and have the capability to alter care plans as new needs arise,
meaning that the process remains iterative but the functional analytical skills remain at the core of the plan.
A review of computerised clinical decision support systems suggests that these may improve practitioner
performance, but to date the effects on patient outcomes are understudied or inconsistent.169 The present
study found that the decision support software was not enough to impact on resident or staff outcomes.
In contrast, an earlier study, FITS, demonstrated good impact on prescribing practice with the use of bespoke
interventions delivered by trained therapists working intensively with a small number of care homes. The
practitioner works with staff, families or other carers to test out the most appropriate strategies and adjust
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these where required, to reduce CB in dementia.1,65–69 In Germany they are delivered through ‘case
conferences’,305–309 in England this approach is best known as the Newcastle model for the management of
CB,97,186 and others simply use practitioners supported by specialists working in multidisciplinary teams to
deliver formulated biopsychosocial case-specific support to staff in care homes.26 The Newcastle clinical
protocols grew out of the FITS RCT.310 The FITS study was one of the three care home interventions that
contributed to our Cochrane review of functional analysis-based interventions for the management
of CB in dementia.82 Many of these formulaic clinical innovations have been conducted in care home
settings,97,186,303,304 often growing out of experience by dedicated clinical teams.60
Rationale for the intervention
Previous work,63 and more recent studies,97,311 demonstrated the successful use of algorithm-based
protocols in the management of CB in care homes. One of the most recent studies311 used a pencil-and-
paper workbook format in care homes. The workbook, using functional analysis, was evaluated favourably
in an Australian RCT311 with four conditions: clinical protocol alone; clinical protocol, plus extra clinical
support; extra clinical support alone, plus a workshop on CB; and treatment as usual. All conditions
showed an improvement on at least one measure (behavioural frequency; perceived disruptiveness; carer
stress; carer attitude). However, the clinical protocol plus clinical support was most effective, and the only
condition to maintain the majority of its effects at follow-up.
We were interested in determining whether or not the training provided within the e-learning modules
would permit staff to utilise clinical protocols effectively with minimal supervision and support. In essence
we were building on preliminary work in the dementia literature that had separately demonstrated the
value of clinical algorithms,63,97,311 and current interest in and the use of e-tool technology,70–76 as care staff
appeared enthusiastic about access to e-learning dementia care opportunities.127 If successful we would
have produced a cost-effective programme that enabled staff to assess problematic presentations; identify
causes and underlying needs; develop appropriate care plans; and, based on the learning from the earlier
training modules, execute the plans effectively, with minimal external supervision. Hence, in order to widen
the scope for delivery of interventions for the management of CB in dementia, it seemed appropriate to
develop an online application of intervention algorithms based on functional analysis.
Chapter outline
This final chapter summarises key findings from our ResCare trial and the FamCare observational study,
including our data on prescribing, utilisation of our innovative tools in care homes and our study of the
management of dementia and CB in people living at home. The tools were based on a functional analytic
approach to individualising interventions for people with dementia and CB, with added attention to
strategies to meet the needs of the environment and the caregiving system. Functional analysis is
recommended by Dementia: A NICE–SCIE Guideline on Supporting People with Dementia and their Carers
in Health and Social Care12 and is also seen as a promising method for the management of dementia with
CB in our updated Cochrane review.82 We will examine why it was not as effective as previous care home
studies that did not include state-of-the-art, user-friendly technology.
We will also consider the limitations of our studies; discuss improvements for research methodology; and
compare key data from care home (the ResCare trial) and family (the FamCare observational study)
settings, to gain a deeper understanding about CB in dementia, and implications for its management in
these two settings.
Finally, we will review the findings and conclusions of the ResCare trial (see Chapters 2–4) and the
FamCare study (see Chapters 2 and 5) and consider their implications for clinical/organisational practice
and future applied research about the management of dementia and CB. The focus of this discussion is
on how the NHS in England might take a step forward to improve the delivery of interventions for the
management of CB in dementia care.
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Key findings
Key findings: the ResCare trial
The e-learning and decision support tool in its current form, without review of whether or not action plans
were being implemented or needed adjustment, was not more effective than in usual care, at reducing
CB. Neither did it demonstrate significant effects against usual care on secondary outcomes such as quality
of life in residents with dementia and CB, or staff coping and burden (see Chapter 3). This is despite huge
technological effort and resources, such as arranging broadband, and providing of computers, agreeing
costs of backfill for staff to attend training and access to an external dementia care facilitator to
support learning.
Individualised action plans using the decision support system of a resident’s profile, with recommendations
to request medical review of those in receipt of an antipsychotic or other psychotropic drugs, did not impact
on prescribing practices. This was despite the policy-driven environment to review use of antipsychotics112
and an observed weighting by practitioners in studies of interventions, such as ours, towards medical
aspects of biopsychosocial interventions.303
The care home industry in England does not at present appear ready to embrace, on its own, in-house
e-learning opportunities or technology-based innovation of this type (see Chapters 2–4). This observation
applies to care homes that were rated as ‘good and above’ by the CQC (see Chapter 3).
Staff gave positive feedback when we arranged off-worksite e-learning combined with facilitated group
discussion on the application of case-specific interventions for residents with dementia and CB (see Chapter 2).
They were particularly appreciative of the skills of the dementia care therapist who facilitated training
(see Chapters 2 and 4). They were also enthusiastic about the simulated real-life video material of resident
communications during episodes of CB in their settings (see Chapter 2). This has implications for augmenting
staff training interventions for the management of CB in dementia.
The embedded process evaluation (see Chapter 4) provided explanations for these findings in terms of
variation in care home managers’ trust of their staff; and variation in cultures of training and practices
within care homes. Smaller homes that were less hierarchically managed appeared to be more ready to
utilise innovation. Capable leadership and collective willingness were also important considerations in
understanding the readiness of a care home to invest time in innovation.
Using our analysis of the factors influencing implementation of the intervention in care homes, a toolkit for
future research and practice in the delivery of innovation, including digital technology in these settings has
been developed (see Chapter 4, Tables 36–38 and 40).
Key findings: the FamCare observational study
It was not possible to carry out the CRT of community mental health practitioners working with families to
deliver such interventions with people with dementia and clinically significant CB living in their own homes.
This low referral rate was hypothesised to be a new phenomenon, relating to the emergence of MASs; this
‘re-routing’ of the referral pathway in community settings is important in relation to the commissioning of
new services.
The cohort study noted that 63.1% of home-dwelling people with dementia and clinically significant CB,
referred to 28 specialist mental health services by their GP, were categorised as having mild dementia.
The observed low response by CMHTsOP to referrals of people with dementia (see Appendix 3, Tables 66
and 67) and lack of impact on BPSD over time (see Chapter 5) may have been in part attributable to the
perception that mild dementia reflects less complexity and associated low need in families. This striking
finding has implications for redesign of service pathways and the delivery of post-diagnostic interventions
for people with dementia and clinically significant CB living at home, when these are limited to those with
severe dementia or care home settings.
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This study and its stakeholder consultations noted an emerging care gap, across England, in the treatment
offered to families supporting a relative with dementia and clinically significant CB at home. This may be
attributable in part to the aforementioned potential for rerouting of services or a perception that mild
dementia reflects less complexity associated with BPSD. Other possible reasons are as follows:
l Evidence from this community study of people with dementia and clinically significant CB shows that
patient outcomes are variable; perhaps, as with those living in care homes, symptoms fluctuated312
even over the short period over which we observed these.
l The study showed that ‘usual’ treatment in family care settings did not have an overall positive effect
on CB. Indeed, over a 6-month period of input from specialist mental health services, averaging nine
contacts per family dyad, there was no change in the high levels of BPSD. This is not to say that
increased contact with mental health services was not at all helpful, as families may have reported
more of their concerns as they began to trust the practitioner and more contact with practitioners
appeared to have a positive impact on levels of guilt in family carers (see Chapter 5).
l Practitioners of all disciplines who attended stakeholder consultations were aware of the difficulties in
determining what constitutes ‘caseness’ or the threshold for offering a clinical intervention (see Chapter 5).
The majority of community mental health practitioners were positive about the bespoke version of
the e-tool and appreciated the workbook resources provided (see Chapter 2). This included a self-report
checklist of problem behaviours that are common concerns of family carers as a means of structuring
the initial assessment. Implications for practice using the manualised tools from this programme in the
screening for clinically significant CB in people with dementia living at home will be considered later in this
chapter (see Implications for service improvements and practice).
l Family carers supporting people with dementia and clinically significant CB contributed over 80% of
the total estimated cost of care, with an average of 112 hours a week at baseline, rising to 129 hours
a week at 6 months. The overall monthly health- and social-care costs were £2828 with an annual cost
average of £33,941 (see Table 65), where all informal care is costed at the minimum wage.
Key findings: prescribing practices, antipsychotics and costs across the Challenge
Demcare programme
Prescribing practices in care homes (see Chapter 3, Tables 20 and 24) indicated that these were contrary
to emerging clinical recommendations for antipsychotic use in dementia105,112,176,177 and clinical guidelines
advocating benzodiazepines prescription for no longer than 28 days.178
Changes in prescribed medication
There was very little change over time in prescribed medication for people living in care homes. However,
an interesting feature, as little is known about prescribing practice of the dementia drugs in care homes,
is that just under 15% living in care homes were prescribed a dementia drug (see Chapter 3, Table 20).
There appeared to be some review of these drugs for a small number of these residents (see Chapter 3,
Table 24). In contrast, there were large increases in use of the dementia drugs in the FamCare study
sample, and review of non-opioid pain relief treatment was also common (see Chapter 5, Table 63). Raised
expectations for early diagnosis to enhance treatment following launch of the National Dementia Strategy
in 2009250 may have contributed to these findings. Perhaps prescribing practices for some medications,
such as review of the non-opioids, was superior for participants living at home than for those in care
homes; and people on a dementia drug in care homes may have had a better opportunity to receive
medical attention than those residents not on a dementia drug, through organised review for this
particular type of medication. As we shall see next, review of the antipsychotics and other psychotropic
medication for BPSD was suboptimal in both the ResCare trial and FamCare study cohorts.
Antipsychotics
Overall, we found that 15.4% of participants in care homes and 9% of those living at home were
prescribed an antipsychotic. This is lower than the 25% estimates by Banerjee,112 and similar to the value
for care homes (but not the overall data which included family care settings), which was noted by Barnes
et al.269 However, disappointingly, in this subsample of participants in receipt of one or more antipsychotic,
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prescribing practice, which has been the focus of initiatives to improve quality of prescribing,112 did not
alter in either setting. We did not examine records for data on whether participant prescriptions were
reviewed by the GP or an old age psychiatrist during the 3-month period before baseline, or for the
6 months (this being the average duration for both groups) between baseline and final follow-up.
However, consistent with the findings of Ballard et al.,313 both the ResCare trial and FamCare study
participants remained on one or more antipsychotic (see Tables 24 and 63) for much longer than the
12 weeks recommended by good practice guidance.314 Suboptimal quality of prescribing practices was also
noted in the POMH-UK audit of quality improvement.269
Other psychotropic drugs
Prescribing practices for other psychotropic medication, particularly in the care home setting, were also
suboptimal (see Chapter 3). Disappointingly, for the FamCare study cohort, who received support from
multidisciplinary specialist old age psychiatry services, around 20% with dementia were prescribed at least
one antidepressant with a low likelihood of discontinuing in 3 months, despite knowledge of little clinical
benefit from some of these agents;270,271 and this pattern of suboptimal prescribing was also seen for the
hypnotics and anxiolytic (B/Z/A) drugs (see Chapter 5).
Pain relief
Prescriptions for pain relief were surprisingly low in people with dementia and CB living at home, when this may
be a legitimate pharmacological intervention for some of this group.35
Dementia drugs
The main medication intervention for our cohort with dementia and CB appeared to be driven by practitioner
understandings of mild dementia and prescription of the dementia drugs, such as the acetylcholinesterase
inhibitors and other cognitive enhancers. These findings need to be considered in the light of reports of the
practical, emotional and ethical problems that some family carers may be confronted with, in terms of all
medication interventions for people with dementia living at home.315
Quality of medical care
For both cohorts, the findings of suboptimal prescribing practice concur with those of a study in one
locality in the UK from over a decade ago, which noted inadequate medical care for older people,
particularly those in nursing homes.316 This is further supported by a more recent examination of the
quality of the annual dementia review in general practice in five primary care trusts in the north-west of
England.317 In a separate analysis of the ResCare trial baseline data, we found that prescribing of individual
psychotropic medications was not related to symptomology of BPSD (Hilton et al. unpublished); the data
were consistent with a study carried out in primary care in Germany, which found associations between
antipsychotic prescribing and non-psychotic domains of behavioural symptoms.318
Costs of medication
Over a 7-month period (3 months before baseline and the 4 months up to final follow-up), the total mean
medication cost per person was £598.98 in the ResCare trial and was £479.43 in the FamCare study.
In the 3 months before baseline, prescribing costs for the ResCare trial participants were higher than for
the FamCare study participants across antipsychotics, laxatives, hypnotics and anxiolytics, antidepressants,
anticonvulsants and pain relief. Only prescribing costs for acetylcholinesterase inhibitors were higher for
FamCare study participants in the 3 months before baseline, when for the FamCare study the average cost
was £67.15 (SD £115.67) and for the ResCare trial this was £29.01 (SD £86.02).
Summary of key findings
Owing to the low referral rate, the design of the programme was changed and the e-tool was tested only
empirically in the care home setting. The results showed that the computer-assisted intervention was
neither effective nor cost-effective, demonstrating that our comprehensive technology for CB was not
enough to change practice in care homes. This finding is in contrast with our now old pilot study of
functional analysis-based intervention for CB, which used face-to-face workshops for all care staff in three
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homes,63 and a recent systematic review of staff training interventions suggesting some evidence of their
impact on BPSD.60 A further, but related, finding was that the attempted use of e-learning in care homes
was highly problematic, with many of the care homes having neither the appropriate resources nor the
technology to engage in such an approach. The e-learning element and bespoke paper-and-pencil
workbook versions of the e-tool were tested separately by psychologists working alongside care staff and
by community mental health practitioners working with families. Both versions received positive feedback
from these practitioners. However, we were unable to test the e-tool in community settings. Take-up of
e-learning by staff in care homes and utilisation of the interventions (action plans) were poor. This was
disappointing, but is perhaps an indication that the intervention was never truly embedded within the
working practices.
An emerging care gap in the delivery of timely post-diagnostic interventions for home-dwelling people
with dementia and clinically significant CB, and their families is noted. The observational study of
community mental practitioners’ impact on CB presentations failed to demonstrate significant value for the
management of CB in dementia, with respect to their input. The inability to interpret the variable nature of
the clinicians’ input is in part attributable to the limitations of the methodology, resulting from the
difficulties recruiting to the original FamCare study design.
The quality of prescribing for the antipsychotics and some psychotropic medications was suboptimal,
in both care home and family care settings.
Limitations
Our intervention was conceived as an evidence-informed development to improve practice associated with
clinical guidelines. It additionally drew on studies from the Cochrane review on the management of CB.82
A recent literature review on the effectiveness of staff training for BPSD60 also indicated some promise
for the content of the training and intervention approach we adopted, as did a recent study of clinical
algorithm-based protocols for the management of CB in dementia.311 However, we additionally chose to
develop an online intervention, as we were keen to widen the scope of use in the real world of the full
range of ‘good-quality’ (as rated at the time by the CQC) care home settings. We anticipated that ready
access to knowledge and resources available for all staff and practitioners who delivered formal care
to people with dementia living at home and in care homes would be a way of sustaining ongoing
intervention for dementia with CB. Two key difficulties arose from our plan to widen the scope of delivery
of the intervention in care homes. First, the study was not designed to compare therapist-supported
functional analysis-based interventions with the present ‘ICT-plus-therapist’ intervention described in
Chapter 2. Second, in the event, only 92 staff champions attended training and became responsible for
co-ordinating delivery of the action plans, but data collection in intervention homes, including that of staff
experience, proceeded as we had planned and was not limited to those trained as staff champions.
Although we were keen to offer the intervention as widely as possible, in retrospect, the programme
may have benefited from prior scoping of the care homes’ ‘readiness’ to engage in an e-learning and
technology-assisted method of delivering the intervention. Earlier stakeholder involvement with respect to
this issue would have been beneficial and may have resulted in a non-technology-based intervention for
our CRT. Indeed, because of the difficulties concerning initial engagement, and ongoing training, the
content and timeliness of delivery of the intervention was in many ways undermined by the technological
difficulties.
Some of the difficulties with the study were attributable to the slow development of the e-tool and
associated implementation problems with the decision support software. Difficulties encountered by the
engineers to provide us with a stable e-tool delayed progress of the study. Thus, we were unable to fully
complete our developmental process evaluation and the e-tool was not fully tested and validated prior to
its inclusion in the CRT. Although an understandable consequence of such innovative programs, it is
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evident that the e-tool was not of the standard we had envisaged, and had intended to use. These
difficulties impacted on the training and learning experience of the trainees, as well as on the scope of the
specialist dementia therapist for monitoring and supporting staff in delivery of the intervention. Therefore,
our aspirations to widen the scope for the delivery of functional analysis-based interventions using ICT
may have undermined any potential robust conclusions about the use of this promising82,168 approach to
intervention in care homes.
The change of plan involving moving the training venues out of the care homes is worth highlighting.
First, staff inability to undertake training in the care home suggests a lack of prioritisation, difficulties in
ring-fencing training and commitment to the study, combined with general perceptions about the added
value of the ResCare programme. Second, staff who were selected as champions by their managers
were significantly younger than others in the home. This may have undermined diffusion and delivery of
the intervention, such as, the perceived need to use e-learning opportunities or co-operation with
‘younger’ staff to deliver action plans. Third, moving the training outside the homes, potentially provided
a notion of ‘separateness’ between academic training and the day-to-day support by clinicians that
underlies successful models of specialist ‘in-reach’ support services to care homes.190
As noted in Chapter 3, although clear care plans were developed, their appropriate and successful
implementation was not sufficiently monitored. In the Newcastle clinical protocol, which has grown out of
the FITS study,310 a trained therapist continues to monitor the delivery of care plans for a further 6 weeks
after initial implementation.97 Nor were actions plans adjusted when necessary, in line with the iterative
‘detective-like’ approach to problem-solving the external dementia care therapist to target the range of
multiple behaviours in this group of people with clinically significant CB, in which a resident could present
with several behaviours that challenged staff at different times. Thus, we highlight limitations in terms of
care planning, adherence and fidelity, issues that need to be addressed in future programmes.
Staff feedback about the e-learning course was positive, but it did not appear to strongly reflect the
aims and content of the course itself. For example, staff may not have understood that, additional to
person-centred dementia care, this was an evidence-informed course for the management of clinically
significant cases of dementia with CB (see Chapters 2 and 4). The assumption underlying the training was
that by encouraging by staff to ask ‘why’, to seek fuller understanding of individuals and their behaviour,
they would adopt a case-specific ‘detective-like’ enquiry about the potential multiple cause(s) of the
particular resident’s behaviour, during or shortly following an episode of CB, and thus take action, with
their colleagues, to address an unmet need. There were not enough qualitative data from our studies to
demonstrate that staff had fully understood the importance of this approach to management. The
methods of data collection that we used for feedback (see Chapter 2) and for our retrospective process
evaluation (see Chapter 4) are too limited in scope to draw conclusions about the effect of our interactive
training course on staff behaviour. Nor did we take outcome measures of staff knowledge, skills and
efficacy about the management of dementia with CB, when our mechanism for change was staff
behaviour. Perhaps more detailed secondary measurement of these aspects of staff behaviour would
have been beneficial.
The retrospective nature of the process evaluation (see Chapter 4) may have been compromised by the
accuracy of participant recall. Other difficulties with the process evaluation were our inability to access
and interview large numbers of staff who had not attended the training as champions. Thus, it was not
possible to explore, from differing perspectives, why the effects of training nominated staff champions did
not diffuse to non-exposed staff in the homes or how use of strategies documented in action plans might
be used in practice. For example, the third group of actions within the ResCare trial included strategies to
address system needs, such as assigning responsibility across shifts to encourage all staff to use strategies
within the action plan and adopt an ongoing consistent approach to management. However, we did not
examine in detail what might have helped staff champions to adhere to this group of actions.
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The absence of detailed interviews with staff who were not champions also weakens our conclusions
about the generalisability of the positive reports from staff about our e-learning course (see Chapter 2), as
staff champions who were selected by their managers had some significantly different characteristics when
compared with other staff in the homes: they were younger, had higher levels of educational attainment
and were more likely to have had dementia training. A wider range of views about e-learning and
technology-based support in care homes would need to be explored with staff of all ages, educational
status and motivations for dementia training.
Finally, our sample of the ‘ResCare’ trial stakeholders who were interviewed (see Chapter 2) may have
been tempted to overgeneralise, or to report their own opinions about training and care homes.
The alterations to the design of the FamCare trial mid-project meant that we were unable to control for
variables that we would have controlled for if the programme had been planned as an observational
longitudinal study at the outset. Hence, some of our explanations were limited to information taken from
interviews with practitioners and ongoing stakeholder consultations. Another important consequence of
the change in design was that we were no longer able to measure the impact of the training on the
community staff who had received the e-learning, thus preventing more detailed comparisons with the
ResCare trial participants. Furthermore, a serious, but unavoidable, limitation in the FamCare study was
that those families who chose not to participate in the study may have been the most distressed, and thus
the most likely to benefit from an intervention.
Community mental health practitioners who delivered care to people with dementia and CB were already
engaged in using online electronic systems for the assessment and clustering of ‘need’243 for every new
patient. This was in preparation for the PbR initiative.121 They were therefore co-operative in engaging with
our technology. However, due to the change in plan from a CRT to an observational study, we did not
address the perceived obstacle associated with security and use of the decision support tool for the purposes
of research within each NHS organisation. Practitioners were in receipt of our manual of resources, which
was used during training to augment decision-making about the three groups of interventions associated
with health, psychological and family carer need (see Chapter 2). However, as noted previously, our
observational cohort study did not allow us to examine their use of this compared with those practitioners
who did not have access to the manualised intervention.
Many of the studies included in our Cochrane review involved highly controlled research environments,
including close monitoring of the staff providing the intervention.82 In contrast, we planned to deliver the
intervention in wide-ranging ‘real-world’ settings where care is provided for people with dementia and CB.
We did not, for example, source research-rich environments, but adopted a broad approach to engagement
of care homes for the ResCare trial and NHS mental health teams across England for the FamCare study.
Although we cannot be sure that engaging research-rich facilities would have facilitated the progress
of our studies, the plan for wide engagement may have contributed to some of the difficulties we then
encountered with delivery of e-learning within care homes, and with recruiting people with dementia and
CB from community mental health services across England to a multicentre CRT.
A limitation to the generalisability of our findings for both the ResCare trial and FamCare observational
study is the lack of data on ethnicity and migration status from participants and the workforce. Future
study of dementia and CB in subgroups of the diverse population across England is warranted.
Implications for research methodology
The pragmatic RCT has become popular in comparative effectiveness research,188 as well as in social care
research.319 However, many challenges exist, including around delivery, which requires close ongoing
collaboration between researchers and the organisations for which the evidence is generated.188 The ResCare
study was a CRT entailing a much larger participant group than would have been required for a RCT; with
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much effort we recruited the necessary numbers for a CRT. However, although we overcame the obstacles
of resources, including providing financial contributions for staff backfill, it remained hard for some
managers to release staff for training and to attend case discussions with the dementia care therapist at the
care home. These ‘real-world’ delivery problems undermined our study – perhaps most significantly there
was a mismatch of follow-up time points, with shorter periods occurring for the control condition (see
Chapter 3). The FamCare study was also conceived as a CRT, but did not proceed because of changes in
NHS locations and audiences for which the evidence was being generated. Additionally, we noted that some
potential participants who would have been eligible for treatment excluded themselves from the research
(see Appendix 13), thus highlighting the difficulties in developing and testing new interventions for those
most in need, even in an applied research programme such as ours. More recently, there have been
recruitment initiatives such as the Enabling Research In Care Homes programme (URL: www.enrich.nihr.ac.uk/)
and JDR (Join Dementia Research, URL: www.joindementiaresearch.nihr.ac.uk/) initiative. However, use of
selected participants from research-rich registers such as these has its own methodological constraints.
For example, recruitment from registers alone may not capture the range of patient, carer or care home
motivations and needs for services, and thus undermine conclusions about generalisability of findings.
In an overview of large-scale RCTs of psychosocial interventions in dementia and their translation to other
settings, we concluded that effectiveness may be undermined because of the weak consideration of
implementation strategies at an early stage of the research process.189 Although we did not draw strongly
on implementation science in our programme, as we discovered gaps in our methodology (which was
informed by the MRC framework for complex interventions155), we embedded a mixed-methods process
enquiry within the ResCare trial.203 This provided new knowledge about how the intervention might be
implemented in routine practice (see Chapter 4). We also utilised high-level stakeholder consultations
within a participatory process design, to iteratively understand the progress and findings of the FamCare
study. Proactive study of the process of delivery of our intervention, may have addressed some of the
limitations to our studies outlined in this chapter and in previous chapters (see Chapters 2–5, Limitations).
We have therefore outlined new approaches to methodology,189 which refine the current MRC framework
for complex interventions155 that is commonly used in applied health-related research programmes. These
go some way to addressing the type III implementation error,320 which can threaten internal validity and
undermine the credibility of the findings of an intervention study. A subsequent NIHR applied programme
of dementia care in care homes has already benefited from this learning by early adoption of our
suggestions in this way.227
The range of approaches to widen methodological options within applied health programmes has been
outlined321 and a rationale, with guidance for a more detailed consideration of the complexities involved in
dementia care research, also exists.322 Although large-scale group designs that underpin RCTs remain the
gold standard, other designs may also be considered when difficulties arise in the progress of applied
research, as was the case in this programme of work. For example, Steingrimsdottir and Arntzen323 note that
researchers may be faced with a problem of too few participants available for randomisation, as was the
case in the FamCare study; or they may be limited to addressing the experimental question, thus hindering
the possibility of providing reliable information about which treatment can be used in the clinic setting,
as was the case in the ResCare trial, in which application of the technology hindered the enquiry of the
evidence-informed functional analysis-based interventions. Steingrimsdottir and Arntzen323 outline a range
of within-participant research designs which may provide valid information about whether the observed
changes are caused by manipulations of the independent variable or if they are attributable to other
variables.323 Although we used a within-participant design to model functional analysis-based interventions
in care homes,13,68,69 adopting this approach during the feasibility phase of the ResCare trial may have
assisted us in determining the effect of independent variables, such as technology versus face-to face
alternatives to staff support, on particular dependent variables, such as uptake of worksite opportunities.
Similarly, the effect of independent variables on the dependent variables, such as staff behaviour or levels of
external supervision required, of clinical protocols using technology versus a pencil-and-paper workbook
format could have been investigated at the feasibility stage of the ResCare trial. This may also have had
more meaning for the audiences in which research is delivered and allowed a more informed design for
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the large-scale enquiry. There is, we suggest, also scope for a wider range of designs, when implementation
and co-production components are embedded at an early stage of the research process. Thus, even at
the modelling phase, knowledge of practitioner qualities, training and skills, or varied organisational
contexts within which an intervention is delivered, can be studied using the wide range of implementation
strategies.324,325 Enquiry using implementation strategies can also be gained from feasibility, pilot or
exploratory controlled studies, which can then be embedded in a large-scale RCT.189
Another method to improve translation of research in practice is to conduct a realist evaluation alongside a
RCT.326 This may help the researcher to elucidate what might work for whom and in what clinical context.
Realist evaluation is an emerging area of enquiry that has strong potential for informing research questions
that take into account the different contexts of delivery on health-care innovation and interventions, and show
scope for refined approaches to process evaluation in applied health-care research327,328 and training.327,329,330
Challenging behaviour in dementia care home and family care settings:
a comparison of clinical presentations
At the time of our study development – and potentially to the present time as well – multidisciplinary
CMHTsOP across many NHS organisations were commissioned to deliver support to people with dementia
and CB who live at home or in care homes. Some services, such as those replicating the Newcastle model,
had also developed ‘in-reach’ care home services for dementia and CB, based on knowledge of the extra
support that is required to engage and maintain the system that provides care for the resident, in successful
implementation of care home interventions.
In bringing descriptive knowledge from this programme to the clinical setting of specialist mental health
support for people with dementia and CB in the NHS, we were interested in comparing CB presentations
between care home and home care settings. This could inform a better understanding of symptoms of
BPSD and the associated caregiving distress within these differing contextual environments. We therefore
used the NPI,135 which is identical to its care home counterpart, the Neuropsychiatric Inventory-Nursing
Home (NPI-NH) version,14 in measurement of symptoms and behaviours that constitute BPSD. The NPI135
‘carer distress’ domain is replaced by the interviewer with the term ‘occupational disruptiveness’ when
using the NPI-NH14 in a care home setting.
There were a number of differences between the ResCare and FamCare arms of the programme with
respect to the interventions or support that people with dementia and CB had received. For example, for
the ResCare CRT some participants had ‘action plans’, which were mostly for just one reported CB, as time
scales did not allow us to work on multiple behaviours, while others were in receipt of ‘usual care’, and all
FamCare study participants were in receipt of ‘usual care’ with an average of nine intervention contacts
from a mental health practitioner. However, participants in both arms of the programme had clinically
significant CB; the average duration of our observations, from baseline to final follow-up, was roughly
equivalent at 6.42 months for the ResCare trial and 6.55 months for the FamCare observational study;
and data collection occurred during the same time frame at a time when NHS policies were growing to
improve care for people with dementia. Therefore, some comparison about participants between the two
studies is perhaps justifiable, to inform services and practice improvements in the future. We did not
examine changes over time across the two studies, as the comparative time period was relatively short,
conclusions based on the findings from this comparison would be compromised by differing study designs
and fluctuations of individual symptoms are in any case known to occur in care home residents.312
In comparing the two cohorts, we first note that, unsurprisingly, participants recruited to the FamCare
study were, at baseline, less severely impaired, as measured by the CDR, than those from the ResCare trial
(see Appendix 20, Table 112). However, at baseline and follow-up, BPSD, as measured by NPI incidence,
frequency, severity and total scores (see Appendix 20, Table 113), were all higher in the FamCare study group.
OVERVIEW OF KEY FINDINGS FROM CHALLENGE DEMCARE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
172
Second, at baseline the types of BPSD differed in these two settings. NPI scores for apathy, depression,
anxiety and eating disorders were higher in family settings than for participants in care homes, whereas in
care homes agitation and aggression was more common (see Appendix 20, Figure 22). Despite lower
scores for levels of agitation and aggression in family settings, BPSD-related distress in families was higher
than among care staff (see Appendix 20, Table 113).
What is clear from these findings is that family carers, who made up 98% of the FamCare study group,
are, as we have suggested earlier, personally invested in their relative: they spend an average of 16 hours
per day (see Chapter 5, Table 61) with their relative, and are highly distressed (see Appendix 20, Table 113).
Their distress may be due to the perceived changes in their relative,86 including when the person appears
unable to initiate action and is therefore ‘doing nothing’ (‘apathy’) and/or appears depressed or anxious
or has changes in appetite (see Appendix 20, Figure 22).
Setting-specific differences in the presentation of CB need to be understood by practitioners who provide
care to people with dementia and CB in both care home and home care settings. Otherwise there is the
risk that some CB can go unrecognised or untreated with the best available evidence for its management,
particularly in family care settings, as demonstrated from our data and stakeholder consultations
(see Chapter 5).
Discussion: the management of challenging behaviour in dementia
This programme of work explored the same questions associated with the management of CB in dementia
in two different settings: the care home and the family home. These environmental settings and systems of
care are broadly different from each other: care home provision reflects systems of care that involve many
care providers, each with their own perspectives, experiences, skills and work responsibilities. In contrast,
home care systems have one or just a few ‘care providers,’ particularly at the start of developing dementia,
or perhaps when people with dementia are categorised as having ‘mild dementia’. These ‘informal care
providers’ are mostly family or friends, with personal relationship investment in their relative or friend who
has dementia. A single, perhaps co-resident, family member can, in this case, become key to the delivery
of interventions for dementia and CB at home, whereas within the care home numerous care staff are
necessarily involved in the delivery of these interventions. The initial concepts underlying this programme,
the high-level synthesis of the Cochrane review and the subsequent methodological improvements that we
have suggested for the design and delivery of a programme such as this, both highlight in several ways the
importance of understanding and attending in detail to the context within which a person lives and is
supported, when delivering interventions for the management of dementia and CB.
First, by studying dementia and CB in two different care contexts, that is, within care homes and family
homes during the same time period, we have compared cohorts from the ResCare trial and FamCare study
in terms of dementia severity; BPSD; aspects of the psychosocial system associated with BPSD, such as the
distress of staff or families; and aspects of management, such as prescribing practices. This will help to
inform future practice and service improvements and research on the management of CB in dementia
care, as summarised later in this chapter.
Second, our programme has highlighted how the same intervention, in this case functional analysis-based
interventions, can be tailored to the setting and system in which it is to be delivered; the care home and
family care settings had the same biopsychosocial functional analysis-based intervention, but we also
conceived a third group of setting-specific actions comprising differing strategies to address the system
supporting the person. Thus, one set of interventions was geared to the needs of the care home and its
staff, whereas the other was geared to the range of needs of the family carer (see Chapters 1 and 2). The
interventions conceived in the third component of action plans in the ResCare trial may not have been of
the strength necessary to impact on delivery of the other two sets of biopsychosocial action. However, this
paradigm of intervening in dementia care, when delivery involves incorporating the environment and needs
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of the caregiving system, remains important and has been reconceptualised from ‘non-pharmacological’
interventions to ‘ecopsychosocial’ interventions.331
The ResCare studies concluded that the care home industry in England was perhaps not yet ready to fully
embrace an infrastructure comprising computerised learning or an IMS for decision-making about the
management of CB in dementia (see Chapters 3 and 4). However, the potential for better uptake of
e-learning in smaller care homes with less hierarchical leadership and support from the equivalent of an
external supervisor, such as trained dementia therapist, may have potential (see Chapter 4). The toolkit for
the delivery of innovation, including digital technology in care homes, has implications for future service
improvements (see Chapter 4, Tables 36–38 and 40). In contrast, the FamCare study concluded that
specialist mental health practitioners working in NHS organisations across England are ready to engage
with e-learning and decision support tools to deliver interventions, if the obstacles associated with security
and shared patient information systems can be overcome (see Chapter 2).
Third, the findings from our wide-ranging stakeholder consultations, supported by the expert consensus
information,332 highlight the importance of other contextual considerations that underpin care for people
with dementia and CB in care homes. Relevant features include having better links with vocational
qualifications; training and commissioning practices (e.g. the NVQ, now the Quality and Credit Framework
initiative) to improve skills of the workforce; clarity about commissioning purpose, as, for example, in
determining training needs and relevant support associated with general person-centred dementia training
versus the more specialised higher order problem-solving333 approach required for interventions for
dementia with CB; and, finally, within models of specialist ‘in-reach’ support services,190 an appreciation
of the often locally produced shifting and delicate cultures, which often require careful consideration.334
Supportive cultures are important because even skilled managers need to employ a lot of effort to support
their staff to deal with the daily challenges in the care homes.334 The wider ‘context’ of specialist NHS
services to people with dementia was also important in the delivery of the FamCare study, where the
changing landscape of services across England undermined the CRT of an intervention that was planned
for delivery by mental health nurses working in their CMHTsOP (see Chapter 5 and Appendix 3). Of
concern were the findings from our review of every new case referred to CMHTsOP that a number of
patients referred by their GP to these specialist services were returned to the care of their GP or signposted
elsewhere without evaluation by the specialist mental health services (see Appendix 3, Table 67).
Thus, we note a significant emerging care gap within specialist NHS mental health organisations in the
delivery of timely support to families. The potential to miss families supporting a relative with dementia
and CB through rerouting of referrals to memory clinics, combined with the families’ own uncertainties in
knowing when to seek help for CB (see Chapter 5), highlight some of the potential hazards of early
recognition of dementia and the complex dilemmas associated with re-engineering dementia care services,
that were outlined over a decade ago.298
Fourth, our findings suggest that care homes need a much higher ‘dosage’ of external support from
specialist-trained practitioners than was provided in the present intervention. Aspects of adequate dosage
would include co-ordinated treatment support from a trained external dementia practitioner who has formal
access to experts, including medical and psychology professionals; attention to multiple behaviours in the
resident; and ongoing monitoring of potentially fluctuating CB over time in those residents with clinically
significant CB. Many of the UK’s specialist CB teams, which were conceived using the Newcastle clinical
protocols, now use a 12-week protocol when treating BPSD,97 with the final 6 weeks being a monitoring/
support phase for the implementation of the care plan. In the present study, process observations suggested
that some action plans, which can be seen as equivalent to care plans,335 may have been undermined by the
unwillingness of GPs to engage with care home staff to consider identified health needs or medication
review (see Chapter 2), although they may have engaged with external practitioners or medical colleagues
from the multidisciplinary team. Moreover, qualitative data from control group care staff suggested that
their positive appreciation of in-depth discussion with research staff external to their setting about residents
with CB (see Chapter 4) may have contributed to a Hawthorne effect for the control condition. The role of
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the specialist mental health support to further ensure the appropriate implementation of care plans must
not be underestimated, because poor adherence and lack of fidelity are common problems encountered in
formulation-led approaches.97
Staff training interventions for dementia with challenging behaviour in care homes
A key feature of the change mechanism in our intervention was staff behaviour, whereas care plans were
conceived as a tool to facilitate change. The process evaluation (see Chapter 4) suggested that the
intervention may have become embedded into ‘common sense ideas and practice’, in which staff champions
had not fully appreciated the importance of searching for the potential cause or causes of the person’s
varying communication of distress as a result of unmet need. This search for the potential causes of CB was
our planned mechanism for change in staff behaviour. Our training was designed to engender a more skilled
approach involving empathic curiosity,214,215 allowing a ‘detective-like’ approach to discovering unmet need
in the resident with dementia and CB. The training programme had indeed used simulated video material
to enhance observation skills of emotion and the meaning of non-verbal communication in residents with
dementia and CB, in a given situation (see Chapter 2), but others have noted that even staff who have
received training may not act on their observations to prevent escalation of CB.96 Therefore, it is unlikely that
all staff can, at any one point in time, understand enough of the perspective of the resident who has
dementia and CB, and respond to their need in an effective manner at all times. The data from the
stakeholder interviews confirmed the heterogeneity of care homes and that ‘one size’ training is not likely to
flourish, as ‘customers’ were changing, staff moved and could be replaced by staff with different experiences
or expectations, and the economy of care homes was changing, with investments often scrutinised for their
profits. Thus, we conclude that a staff training e-learning intervention is unlikely to hold traction for the
management of dementia with clinically significant CB. However, beneficial effects may be seen if training
interventions are combined with additional on-site visits, when care staff are given assistance to work with
individuals under supervision.60,170
In community mental health settings, the impact of staff training seen was not reflected in a CRT. Nor did
we replicate findings from an earlier exploratory RCT.65 This was because the FamCare study participants
constituted a ‘treatment as usual’ condition in which the revised design allowed us to observe usual practice
within specialist mental health services for home-dwelling people with dementia and CB. This cohort study
found that when experienced mental health practitioners provided care to participants with dementia and
clinically significant CB, with an average of nine contacts, there was no overall change in CB. This suggests
that they, and perhaps other specialist mental health nursing services,288 or indeed other professionals
commissioned to provide care for people with dementia and CB, would benefit from specialised training,
multidisciplinary support and supervision protocols for the effective delivery of interventions for CB in
dementia care. As with our observations for care home systems, the key change mechanism in the
application and delivery of case-specific interventions for people with dementia and CB living at home
is the trained dementia practitioner82 who works with the family carer. Empirically informed care plans are
a helpful tool in the co-ordination and iterative monitoring of an intervention and can improve the process
of delivery.336 Nevertheless, these do not in themselves affect outcomes for people with dementia and
families.336,337 Indeed, without support from a trained dementia practitioner, the care plans (no matter how
comprehensive) are frequently ineffective.338 Thus, one of the key roles of such a clinical practitioner –
whether they are CMHTsOP or Admiral nurses or dementia advisors, or any other type of practitioner with
knowledge about dementia – is to support implementation of the care plans, as poor adherence and lack of
fidelity are common problems encountered in formulation-led approaches.97
Implications for service improvements and practice
In Chapter 1 we outline a rationale for the elusiveness of the syndrome and the need to avoid limiting the
content of interventions to biomedical constructs,339 as this runs the risk of overlooking the complexity of
causation and maintenance of CBs in dementia care. Moreover, in the care home context, staff may not see
it as their role to manage BPSD,228 whereas in community settings, practitioners find it hard to make rational
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decisions about treatment options in dementia care than in other chronic conditions.290 Additionally,
although educational interventions can meet the needs of GPs and staff caring for people with dementia,
participation in these programmes can be low,340 as was the case in the ResCare trial (see Chapter 2). We
have argued that case-specific interventions to address the causes of CB are superior to other, simpler
solutions. Although interventions such as aromatherapy, activity programming, carer education or carer
counselling are worthy approaches, they can be effective only if they address the potential cause(s) of CB
and unmet need in a given situation at a given time. It is therefore not surprising that practitioners and
services that support people with dementia and CB, have difficulty in focusing their efforts on those with
significant CB. For this reason, algorithms for case-specific biopsychosocial interventions, conceived in the
current programme as functional analysis-based approaches (see Chapters 1 and 2), remain a promising
intervention for the management of CB in dementia.82 We will consider next what our programme adds to
delivery of NHS-led interventions for the management of CB in dementia care.
Five key aspects are discussed, including the notion of ‘caseness’, which affects our awareness and
responsiveness to treat in a timely manner. We also discuss the role of scaffolding185,186 via the use of
experienced therapists, and how this could better embed the approach and support the development
and delivery of functionally derived care plans. Next we highlight a clearer rationale for a setting-specific
content for future training innovation in the management of dementia with CB and then we consider the
notion of responsibility, helping to clarify roles and goals. Finally, we discuss the lack of internet facilities
in care homes within a modern economy in which greater efficiency increasingly depends on availability of
IT and use of the internet.
First, the possibility arises that the intervention may not in itself have been ineffective, but that there
were significant obstacles to its delivery in the real world of routine NHS practice. One obstacle that was
considered in Chapter 1 was the difficulty for practitioners and specialist services, of determining what
constitutes ‘caseness’, that is, the threshold for offering a clinical intervention. There are many measures
to ascertain levels of BPSD,341 and the NPI135 and NPI-NH14 are commonly used in research. However, the
NPI and NPI-NH are less easy to use in routine practice and do not describe the everyday concerns or
challenges experienced by staff and family carers. In the present programme we therefore used the CBS107
and the CMAI136 for care home settings and the RMBPC111 for family care settings, as these reflect the
language and the reported challenges of staff and family carers. Additionally, we incorporated the CBS
for care homes and its equivalent for family settings (see Chapter 2 and Appendix 1)65,109 within our
intervention approach. These offered practitioners the means of structured assessment that is needed
before treatment options are considered.
First, in both studies we used cut-off points to determine clinically significant CB in people with dementia.
A score of four and above on the 25-item CBS is a validated cut-off point for CB incidence, with a score of
> 10 reflecting severe CB in a resident.107 In the present study, in which residents were included if they had
dementia with a score of four and above, comparisons of average scores at baseline with the 12-item NPI
were as follows: control group: CBS incidence = 9.01 (SD 3.84) and NPI incidence = 4.80 (SD 2.34); and,
experimental group: CBS incidence = 8.94 (SD 3.85) and NPI incidence = 4.86 (SD 2.40) (see Table 18).
The 25-item CBS is now widely used by practitioners who provide in-reach services to care homes in the
UK (see Brechin et al.108) and clinicians using a cut-off point of four (or 10 for severe CB) can be more
confident of its value in detecting clinically significant BPSD against the NPI. This observation is relevant,
as stakeholder practitioners who were not medically trained reported some difficulties about using the NPI
as a measure to detect CB in people with dementia. The same observation applies to use of the 24-item
RMPBC in the FamCare study, in which comparisons of baseline average scores using a cut-off point
of five and above against the 12-item NPI were as follows: RMBPC incidence = 11.08 (SD 3.84); NPI
incidence = 5.35 (SD 2.65); NPI total = 25.75 (SD 19.17); and, NPI distress = 13.37 (SD 9.65) (see Table 48).
Thus, we suggest that these measures may be useful in service pathways where practitioners need to
assess behaviour and its management difficulty to detect CB in people with dementia in care homes and
family settings.
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Second, service-improvement models will also require the dedicated expertise of key professionals that we
have described as ‘scaffolding’,185,186 if practitioners are to maintain their effectiveness of delivery in each
setting. There are emerging multidisciplinary post-diagnostic dementia services for CB within which a
dementia practitioner has access to ‘diagnostics’, described as ‘formulations’, and where contextual factors
within the family or the care home setting can be systematically addressed, alongside unmet need in the
person with dementia.97,186,304 Newer practice models include professional pharmacy review,342 which
may go some way to address some of the suboptimal practices we found. This type of ‘scaffolding’185,187
includes the important role of a supervisor,223 which adds to the quality of intervention, as professional
dementia therapists are not commonly found across Europe.343 Indeed, trained dementia practitioners
who can provide therapeutic interventions have yet to be conceived as a workforce priority in England.
For care homes, where commissioning priorities are targeted towards dementia and significant CB, models
could incorporate links to NHS-led and co-ordinated centres of excellence described in the USA as
‘the teaching nursing home’.344 Here responsibilities for training, supervision and monitoring of care can
be operationalised within models of collaborative care. For family care settings models of intermediate
care that are currently in place345 could be improved in terms of clarity of purpose, to focus on people and
families with dementia and significant CB, with goals that address behavioural symptoms and associated
distress in families. This will require practitioner-led relationships with families and co-ordination with
ongoing support, as symptoms fluctuate or needs change within family systems.
Third, an important implication for practice for this subgroup of people with dementia who also have
clinically significant CB is that, once this has been detected, care staff and family carers should not be left
to make decisions and manage on their own, through the trajectory of the condition. Thus, we suggest
that there is an important role for co-ordinated care by a trained dementia practitioner,346 as there appears
to be a skill gap related to the management of dementia and CB in the current workforce. Given our
observations on the differing contextual resources required for delivery within care homes and family
care settings, a priority for service improvements for effective management of dementia and CB is the
development of separate service models for care home and family care settings within which specialist
dementia practitioners may be trained and resourced to have clarity of purpose in their goals for patient
care and related contextual outcomes. To determine the nature and content of the training required for
each group, a closer examination of the change mechanisms used by the carers in dealing with BPSD is
required. Our attempts to provide a third (additional) component to the biopsychosocial functional
analysis-based intervention using written action plans to attend to the caregiving system needs in the
ResCare trial was not strong enough to impact on CB. Thus, we need to consider improvements to our
intervention to overcome the weak adherence to actions for the caregiving system in care homes. One of
our research team has therefore developed a training course as an extension of Newcastle approach to CB
in care homes. The following principles have been used to determine the course content for this third
component of our intervention.
l Owing to the prevalence of CBs, the carers already must be dealing with problematic situations on a
daily basis. Therefore, carers have existing skills that may be used and developed further.
l The key mechanisms of change used by carers to deal with CBs are communication and interactive
skills. Some carers appear to be able to negotiate well and de-escalate situations that could have
become problematic.
l Carers are poor at articulating their CB skills. This is problematic, because they are then unable to
appreciate ‘what works and what doesn’t’. One of the goals of the training is to teach the carers
aspects of what they do already, but giving them a language (and rationale) to explain their actions.
l The vehicle through which the communication skills are delivered is a care plan. The care plan is
developed bespoke via a functional analytical approach.
Although the training requires adaptation to the different needs of care homes and families, the same
general principles apply. The initial manifestation of our communication training is CAIT (communication
and interaction training).338 As outlined above, this training acknowledges carers’ existing communication
and negotiating skills in dealing with CB, and supports the development of new approaches, both general
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and patient specific. CAIT is currently being used in the training of all 62 care homes over a 3-year period
in one local authority area in the north-east of England. CAIT teaches a functional analytical approach,
but supports the workshop training with 18 weeks of supervision delivered to two key individuals per
care home. The comprehensive supervision, a feature missing in the e-tool programme, is being used to
(1) embed the CAIT approach, and (2) support the implementation of care plans to ensure that they are
adhered to with fidelity.
Fourth, as we now have tools for screening of clinically significant CB in dementia, consideration must be
given to service responsibilities for the delivery of interventions. There is the potential for minimisation of
the level of need, and ‘everybody’s business’347 becoming ‘nobody’s business’. For example, professionals
appeared to expect other professionals to deliver interventions, even before they had evaluated the patient
need (see Appendix 3, Table 67), and families appeared unclear about whether they were worthy or
deserving of specialist support (see Chapter 5). Furthermore, many people with potential CB were simply
signposted onto memory clinics for which some organisations had waiting lists had emerged in some
organisations, while some teams had developed long and unwieldy procedures for diagnosis that had the
potential to exacerbate distress for some family carers. In care homes, suboptimal medical care and
prescribing was also noted. Furthermore, effective management of CB is considered difficult to deal with,
even in a NHS continuing care unit, as a result of a lack of treatment options348 when, as we have noted in
Chapter 1, usually there are avenues to explore even in the most difficult of cases.
Given the noted elusive nature of the syndrome and the complexity of the condition, particularly for those
with clinically significant CB, services and practitioners need to be cautious about adopting one solution as
an alternative to a case-specific approach to intervention. For example, even a recent well-designed family
caregiving intervention, which incorporated all of the elements of functional analysis-based interventions
and demonstrated impressive effectiveness on carer mood, did not have an impact on CB349 or on
caregiver abusive behaviour.350 Similarly, caution at this stage is needed regarding internet solutions for the
management of dementia with CB by family carers, in the absence of support by a trained practitioner.
Although this may be a seductive option to consider, this type of dosage might be helpful for some clinical
presentations, but would probably not be enough for sustained changes in behavioural symptoms, and
associated distress in those with clinically significant CB. For example, a recent internet-based dementia
support solution has been applied in family settings with good outcomes on some aspects of carer
well-being,351 but the authors do not report any impact on their measures of behavioural symptoms.
Finally, the lack of broadband internet availability in some care homes and the low use of electronic records
are of some concern for the future of care delivery in an environment where most of the economy is IT
based. Use of e-mails or electronic records in care homes has scope for better communication between care
home staff and external care providers, such as the GP, nurse practitioners or social workers. Furthermore,
internet access has the potential of allowing better communication between families and their relatives who
reside in care homes, for example through skype™ (Microsoft Corporation, Redmond, WA, USA) or use of
personal tablets and iPads (Apple Inc., Cupertino, CA, USA). This observation has implications for regulators
such as the CQC, as internet access at care homes could be a major focus for their inspections.
Recommendations for future research
Staff training and support for dementia with challenging behaviour
There have been at least two recent reviews of training programmes currently on offer. Spector et al.60
conducted a systematic review of staff training interventions for BPSD and found 13 RCTs and seven
non-randomised study designs. They note that effectiveness was enhanced in 10 studies in which individual
supervision sessions were offered to help staff incorporate strategies into everyday practice.60 In a second
study, Fossey et al.170 reviewed available dementia training materials and found that, of the 170 located,
only four had a robust evidence base. They too noted that, in addition to education, efficacious programmes
included a sustained period supervision with a trained mental health practitioner.170
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The present programme and an initial pilot study about the current day-to-day practices of carer approaches
to CB352 suggest that a next step in studying the impact of interventions for dementia with CB is to examine
the nature of the support required from external specialists in dementia care.
Future research on interventions for dementia with challenging behaviour
Future interventions based on the approaches we have developed may use conventional (face to face) or
other (e.g. online) innovative technology, or a combination of these, to enhance practice. However, the
design of studies requires systematic work programmes to examine in detail what might work for whom in
a given stakeholder context. A more collaborative approach than has been used to date, such as building
on existing skills of practitioners and paid staff carers, may, we suggest, facilitate an improved service for
the support of patients and carers. It is also important that potential improvements are measured in ways
that appear relevant to the range of stakeholders. Attention needs to be paid to current organisational
structures to determine whether or not we have the most appropriate service in terms of structures and
functions to effectively treat CB. This work is required because, as we have noted in the FamCare study,
the changing organisational structures, including those relating to the then changes associated with the
PbR initiative121 and those resulting from the implementation of the National Dementia Strategy,250 may
have proved to be a disservice to the timely and potentially effective management of home-dwelling
people with dementia and CB. A related issue concerns the treatment of people with dementia receiving
treatment in acute settings. Research is required to examine both the patients’ treatment and staff
training. The above ideas are discussed in more detail next.
First, we note that within our programme we perhaps paid inadequate attention to the care system,
where providing written strategies within action plans for staff champions to support others to deliver the
interventions was not enough to impact on CB. Development and evaluation of treatment programmes
built around existing carer skills seems sensible. An example of this, and an extension to Challenge
Demcare, has been the aforementioned CAIT programme.338 CAIT is a strength-based relationship
approach that involves developing good rapport with carers, and building on their current strengths and
knowledge about BPSD. Strength-based relationship principles are embedded in the style employed in
the teaching of CAIT, which works via the key concept that talking to people about using their strengths
(what the trainee brings to the training, including their hopes and expectations) accounts for the highest
level of success in teaching programmes.
Second, NHS-led service models for the formalised support of CB in dementia are important for the
co-ordination and delivery of interventions for dementia with CB. This will also require care homes that
are ready and perhaps commissioned, to support people with significant CB. Research can then be
designed to evaluate relevant outcomes for people with dementia and CB, and coping by care staff.
Third, the significant ‘care gap’ across England that appears to have emerged concerning the support of
home-dwelling people with dementia and CB and their families is highlighted. This may have resulted from,
for example, difficulties that practitioners may have in determining the threshold for what constitutes
clinically significant CB in dementia, from their misperceptions of the complexity of CB in people with mild
dementia or from the changing commissioning arrangements of health- and social-care services that has left
the variety of service providers, including care staff and practitioners, with uncertainties about their roles and
responsibilities. These factors may in turn undermine timely responses to prevent escalation of distress in
families. To address this gap, service improvements within a dementia care pathway could involve models in
which redesigned roles of the range of practitioners within the current landscape of provision of dementia
care may be supported by skills training to improve access to someone akin to a ‘dementia behavioural
therapist’. Health service research may then investigate what additional support is required to support
these practitioners by way of scaffolding185,187 from professionals with expertise in medical, psychological
and social care. Clarity of purpose would require local agreements between stakeholders, including
commissioners, GPs, specialist NHS organisations or providers of social care. Research can then be designed
to evaluate relevant outcomes for people with dementia and CB, and sustained coping by family carers.
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A gap in the care industry around the use of IT in the care of people with dementia living in care homes
may also exist. Future health service research on the availability of IT resources or motivations by care staff
to use this could also be undertaken, in readiness for future internet solutions to improving the efficiency
of care within care homes.
An analysis of the referral pathways for people with dementia and CB is important, and will have implications
for where commissioners choose to direct resources across the NHS and social care. For example, following
reorganisation of services in line with implementation of the National Dementia Strategy250 and a subsequent
growth of memory clinics, research suggests that cognitive stimulation therapy, already provided in many
memory clinics, may be an effective alternative to tranquillising medication.353 Such findings require replication
and reflect positive practice shifts in dementia care. However, what is important for the future management
of CBs in dementia is to avoid simplistic global practice interventions to reduce antipsychotics or other
tranquillising medications with ‘therapies’, such as cognitive stimulation therapy. There are, we suggest, few
alternatives to the case-specific formula-led types of interventions based on both biopsychosocial intervention
for unmet needs and attention to the caregiver needs in supporting such interventions, in the management of
clinically significant CB.
Involving stakeholders early in the research process in the development and delivery of complex interventions
for CB is an important strategy for the conduct of future research in dementia. It was particularly relevant for
our team to hear the views of frontline practitioners, care providers and family carers about the findings.
Furthermore, it is appropriate to examine the views of staff working in acute settings, who are frequently
dealing with CBs from their physically ill older patients. A recent paper on the use of communication issues
in a general hospital setting354 suggests that many staff feel untrained and unsupported. Also, it is evident
that the lower grades of staff (support workers) are left to respond to the problematic behaviours. In
contrast, the qualified staff (medical staff, nurses) do not necessarily see it as their responsibility to respond
to people who are disorientated or ‘time-shifted’.354
Conclusions
The NICE guidance, updated by our Cochrane review of functional analysis-based interventions for the
management of dementia with CB at home and in care homes, concludes that the approach shows
promise.82 An e-learning program to assist staff working in care homes to develop and deliver such
interventions gained little traction in care homes. Access to the internet was patchy in some care homes,
and worksite e-learning opportunities were not readily taken up by care home staff. Furthermore, training
with group discussion and decision support for individualised interventions did not change practice enough
to have an impact on CB in dementia. Smaller homes with a less hierarchical management appear more
ready than others to engage in innovation. Capable leadership and collective willingness are also important
considerations for the delivery of innovation in care homes.
People with dementia and CB were referred by their GP to specialist NHS services, but treatment over
6 months, averaging nine contacts per family, had no impact on high levels of CB. Over 60% of home-dwelling
people with clinically significant CB had mild dementia. Some mental health practitioners appear unaware of
thresholds for clinically significant CB in families. In this study, a cut-off point of five on the 24-item RMBPC111
was adequate for the detection of clinically significant CB when compared with NPI,135 which is a measure that
non-medical practitioners find difficult to use. Families bear the majority of the care costs of dementia with CB
and a care gap in the delivery of evidence-informed support to families and people with dementia with
clinically significant CB has emerged.
Higher levels of CB were recorded in family settings than in care homes; and prescribing practices were
suboptimal in both care home and family settings.
OVERVIEW OF KEY FINDINGS FROM CHALLENGE DEMCARE
NIHR Journals Library www.journalslibrary.nihr.ac.uk
180
The contexts of the care home and the family care setting are not equivalent, and delivery of interventions
for CB in dementia in these settings therefore requires similar approaches, but different resources and
service pathways. For example, care home support, staff training and ongoing resource provision will differ
from that of family carers and, when relevant, paid home care staff. Moreover, the differing skills and time
resource of trained dementia practitioners who co-ordinate and provide case-specific interventions for
CB will also need to be conceived as separate service-improvement developments for each of these two
settings. In both cases, these will additionally require clarity of purpose, as one size of service resource
will not fit both settings. This is particularly important when service pathways with care homes that are
commissioned specifically for people with dementia with CB are absent. Therefore, process and outcome
measures for each of the family care and care home settings will need to be set within formal agreements
between stakeholders, including commissioners and providers.
This programme has developed manualised instruments and decision support resources for the recognition
and targeting of interventions towards unmet need of the person with dementia and the care home or
family system that they live in. The resources have been met with enthusiasm by specialist mental health
practitioners. These manualised tools may be of value to practitioners within ‘in-reach’ models of specialist
mental health support to care homes. They have the potential to assist mental health practitioners in
recognition and provision of empirically informed interventions for CB in family settings. This may then
have the effect of reducing the impact of behavioural symptoms on the family carer. A toolkit for future
research and practice to facilitate the delivery digital technology and other innovative interventions within
care homes has also been developed.
No one size of intervention can address the complexity of CB in dementia. However, case specificity62 to
include examination of relevant biopsychosocial interventions for the person as well as good attention
to the needs of the caregiving system still appears to be the way forward for the management of CB in
dementia. A functional analysis approach to interventions for CB in dementia care provides a framework for
assessment and targeting of case-specific formulaic interventions. This programme has highlighted a gap in
attention to the needs of the caregiving system and has led to the development of the CAIT programme,338
by one of our research team. Application within ‘in-reach’ service models for the management of CB in
care homes is an area for future NHS applied research. As noted previously, functional analysis-based
intervention and its extension with CAIT338 is now being piloted in local authority care homes in the
north-east of England, thus bridging the gap between NHS and local authority care provision for people
with dementia. Given the changing landscape of the organisation of dementia care, there is scope for
research on the delivery of this specialist intervention across both NHS and social care provision in the
future. The intervention we have developed also has strong potential to fill the emerging care gap
associated with timely support for CB in family care settings. This is important as families can have deep
underlying beliefs that contribute to the variation in their responses to the relative’s unmet need and
associated behaviour that they find difficult to deal with.86 These need to be captured at an early stage,355
by trained dementia practitioners using a structured assessment to decide on appropriate treatment,294
with a focus on minimising the occurrence of CB and distress within families.
Approaches to the management of CB can be efficiently delivered only if there is a shift in current
emphases, from the early diagnosis of dementia to early recognition and interventions for CB, and a
sustainable pathway of dementia care within specialist mental health organisations in England. To deliver
case-specific interventions for CB, trained dementia practitioners (therapists), working within ‘in-reach’
services in care homes or in family settings, will need to work within commissioned systems, where they
have formalised access to professional experts who have responsibility for advising on the range of medical
and psychological interventions that underpin functional analysis approaches in care home and family care
systems. They may then be in a position to train and support care home and home care workers and allay
legitimate current concerns by the Alzheimer’s Society on the lack of this, particularly among the formal
home care workforce.356
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An independent assessment of improvements in dementia care since 2009 commissioned by the
Department of Health, outlines priorities for action in the final year of the ‘Prime Minister’s Challenge on
Dementia’, including the need for psychosocial and other alternatives to pharmacological management of
CB, to guide commissioners or providers (see Knapp et al. pp. 3, 62).302 Our programme of empirically
informed knowledge about practices and recommendations for post-diagnostic service improvements that
are urgently required for the management of CB in dementia care will go some way to address this
priority. To realise its full impact the next step is to disseminate the learning and resources from this
comprehensive programme of work. The mechanism for achieving this is planned within road shows and
workshops involving wide-ranging stakeholders, including commissioners and providers of care.
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Appendix 1 Description of the e-learning and
decision support tool
In preparing the content and focus of the modules, consultations were held in the first half of 2008 withinternational experts in the field (including Professor Linda Teri, Seattle, USA, and Dr Mike Bird, then in
Canberra, Australia), as well as with leading authorities on dementia care training in the UK (co-applicants
Professor Ian James, Professor Graham Stokes, Professor Bob Woods and Professor Esme Moniz-Cook).
The approach set out by Bird,13 encouraging careful holistic assessment and development of a highly
individualised action plan, was seen as a good basis from which to develop the modules. Co-applicant
Professor Ian James worked with Professors Esme Moniz-Cook and Bob Woods on the detailed
development of the modules, bringing many years of experience of work on functional analysis in the
context of working with people with intellectual disability.
Storyboards were prepared for the first three modules and an intensive period of filming the required clips
took place in September 2008. These modules formed an integrated e-learning course, suitable for staff
and care workers in care homes, but also with relevance for people with dementia living in the community.
Module 1: ‘it could happen to you’
The learner is invited to consider how they might themselves behave in difficult circumstances, and
through a series of video-clips reflect on the way in which actions that in dementia care are described as
CB may in certain situations appear an understandable human response. This module reinforces our shared
humanity with people with dementia, reducing the tendency to ‘them and us’ thinking, and situates CB in
the interaction with the environment and the perceived reactions and intentions of others.
Module 2: ‘developing observational skills’
This module introduces functional analysis and requires careful observation of video-clips showing CB in a
care home context. In each case the staff member is required to decide on the immediate function of the
behaviour, focusing on three primary functions: eliciting interaction with others, avoiding contact with
others and experiencing enjoyment or pleasure from sensation. Following several teaching examples,
where the learner is guided step by step through the process, there are a number of clips for the person to
work through. If a given criterion level is not reached, further guidance and additional training clips are
provided before the learner can move onto the next module.
Module 3: ‘developing skills in investigating and responding to
behaviour that challenges: the search for meaning’
This module takes the learner systematically through assessment and action-planning, with nine case
examples, increasing in levels of complexity, to work through. The cases cover a range of scenarios,
including people with dementia living in the community in their own homes, as well as in care homes.
A range of CB is depicted, from repeated questioning to shouting or aggression. Each is introduced with a
video-clip of the CB shown by the person with dementia. The learner answers a number of questions
regarding the clip, building on the skills developed in module 2. Interviews with relatives and care staff
offer supplementary information providing context and background. If an incorrect answer is given,
additional support and guidance are automatically provided to assist the learner in extracting the relevant
information. Following a detailed analysis of the specific CB, the assessment process moves on to consider
the physical health of the person with dementia, including medication, their biography, important
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relationships, preferences and disposition. The learner is encouraged to undertake ‘detective work’ to find
the information needed from a number of resources that are provided for each person; for example, life
story album, medical notes, care home notes and audio-recordings of family members or care staff. In
relation to medication and physical health problems, the learner can click on a particular item to obtain
more detailed information about the medication or health condition. Subject experts, a physician and
pharmacist who was also a trainer in prescribing (Professor Peter Campion and Dr Andrea Hilton),
contributed to and verified these sections. The learner’s responses then feed into an assessment summary,
detailing the CB, when and in what circumstances it occurs, who are the people affected by it, what its
function appears to be and what appears to influence its occurrence. This is placed in the context of the
health of the person with dementia, their biography and social environment. For each case example, this
then leads onto consideration of potential actions that could be taken to reduce the impact of the CB. In
each instance, actions can be selected in relation to three domains: actions to support physical health
needs, to alleviate, for example, pain or discomfort due to constipation, or review of drugs, such as
antipsychotics or sedatives that may not be helping, or to manage nutrition in those who declined food;
the care approach aimed at meeting psychological need in the person with dementia, for example aspects
of carer communication or interaction with the person with dementia that might be relevant; and actions
to support the caregiving environment. This last set of actions included the social as well as the physical
environment, to encompass needs such as distress experienced by relatives and/or care staff; actions by
other residents; and particular aspects of the context or system surrounding the person. In addition, this
last group of actions included actions to address the regime and needs of staff in a care home, or the
family carer’s personal needs, such as considering their physical health and medication issues as well as
their psychological needs. The actions selected in each domain were then collated to form an action plan
to address factors identified as potentially contributing to, or relevant to, the identified CB for the
particular case.
From November 2012 these three training modules have been made available as a self-contained,
online, interactive e-learning program on functional analysis-based interventions for CB in dementia:
www.livingwithdementia.tv.
The decision support tool
The e-tool was designed to follow the approach used in module 3, but allowed the learner to respond to
an actual person with dementia under their care. Two versions were designed, one for care home settings
and one for the community, starting with the care home version.
The initial section of the assessment, following completion of basic personal information, focused on
immediate risk, seeking to identify if the person had either an acute confusional state (using a standard
assessment for confusion), which would require immediate medical assessment, or had severe mental
health difficulties, posing an immediate risk to self and/or others, requiring assessment by a specialist
mental health service. If risks of these kinds were identified, the assessment process would not proceed
until the staff member could confirm that there was no longer an immediate risk.
The system was designed so that for each person with dementia, the staff member would choose one CB,
selected from a 25-item CBS,107 which covers the common CBs reported by care home staff. The system
allowed staff the option to indicate a behaviour if it was not included on the CBS. The staff member was
encouraged to consider the function(s) of the specific behaviour, using their skills developed in modules 2
and 3, from a generic list provided (Box 7). As with module 3, an assessment summary and an action plan
(which could be saved and printed out) were the outputs from the process, enabling a functional analysis-
based approach to be taken arising from detailed consideration of the specific CB. The assessment
summary covered a number of domains, including those shown in Box 8.
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Therefore, as far as possible, information entered by the staff member could be incorporated readily into
the ensuing algorithm-driven action-planning process, a wide range of applicable options for each
response were provided, with free text used exceptionally. For example, rather than the staff member
typing in a list of medication taken by the person with dementia, the e-tool included the great majority of
applicable medications, from which the staff member selected those being taken. This then enabled
the system to later suggest actions relevant to the specific class of medication (e.g. antipsychotics,
antidepressants, benzodiazepines, laxatives, analgesics) being taken.
The action-planning component decision support e-tool used a number of ‘if–then’ algorithms to suggest
potential actions based on the information provided during the assessment process and documented in the
assessment summary. For example, if the score on the pain scale included in the assessment was above a
certain threshold, actions relating to initiating further assessment of pain, or considering pain relief, would
be suggested; or if the person was in long-standing receipt of an antipsychotic or benzodiazepine then
approaching the GP to arrange review of this was suggested. Similarly, if the person had been reported to
be showing signs of curiosity, provision of activities, based on the person’s interests, would be among the
actions suggested. If the person had a raised score on the anxiety scale, potential actions relating to
relaxation and calming would be offered. The apparent function of the behaviour was targeted with a
suggested action wherever possible; for example, if the function was seen as experiencing failure, the
suggested action would be to seek to break the activity/task into manageable components. As with
module 3, actions were grouped in three domains: health, the care approach and the care environment.
Each plan would aim to include actions from each of these areas. Suggested actions were only included
in the final action plan if the staff member judged them to be relevant and feasible. This process was
BOX 7 Generic list of functions of CB used in the decision support tool
1. Frustration.
2. Being upset.
3. Behaving impulsively.
4. Enjoyment or pleasure.
5. Acting in self-defence.
6. Appearing to be trying to escape from the situation.
7. Showing signs of being alarmed.
8. Appearing to be trying to avoid something.
9. Misunderstanding the actions of others.
10. Actively seeking the attention of others.
11. Appearing to blame others.
12. Experiencing failure at something he/she is trying to do.
13. Appearing to be in pain.
14. Showing signs of fear.
15. Showing signs of curiosity.
16. Showing signs of embarrassment.
17. Showing signs of insecurity.
18. Trying to do something that is being prevented by others.
19. Trying to change something in the surroundings.
20. Showing signs of affection.
21. Trying to maintain privacy or personal space.
22. Seeking reassurance.
23. Seeking comfort.
24. Appearing to be helpful (e.g. cleaning or dusting, folding laundry, etc.).
25. Looking for someone.
26. Putting self in a dangerous situation.
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intended to be akin to the creative brainstorming that is associated with functional analysis-based
interventions (see chapter 8 in Stokes1), in which a wide range of suggestions are made, from which those
with the best fit could be selected.
A second version of the decision support e-tool was developed for use with people with dementia living in
the community. In this instance, the system was designed for a community mental health practitioner, such
as a CMHN, to input information gathered directly from the person with dementia and his/her family carer.
Again, a number of brief validated measures were used. For example, an adapted Problem Checklist,109
based on common concerns of family carers in the UK, replaced the CBS107 that was used in the care
home setting, as this has been used in a previous family care study.65,109 All measures were made available
BOX 8 Domains included in the decision support tool assessment summary
l Personal information (age, marital status, family).
l Personality and attachment style.
l The behaviour.
¢ Duration.
¢ Frequency.
¢ Location.
¢ Function.
¢ Impact on others.
l Health.
¢ Dementia diagnosis: type, duration, location.
¢ Physical abilities (activities of daily living).
¢ Health problems.
¢ Medication.
¢ Pain (assessed with a validated scale).
l Mood (assessed with validated scales).
¢ Depression.
¢ Anxiety.
l Relationships.
¢ Family.
¢ Friends.
¢ Visitors.
l Life story.
¢ Schooling.
¢ Occupation.
¢ Losses and difficult experiences.
¢ Hobbies and interests (current and past).
l Environmental preferences.
¢ Number of people.
¢ Quiet/busy.
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to the practitioner in an electronic form to either have them filled in directly by the carer or person with
dementia, or to be completed using the paper format in a face-to-face interview. In this version, there was
particular emphasis on the caregiving context to include assessments of the family carer’s mood, health,
personality and coping style, as well as assessments of the quality of interaction and relationship between
the carer and the person with dementia.
The sections of the assessment are shown in Box 9.
BOX 9 Assessment domains for community version of the decision support tool
1a. Core information regarding person with dementia and a specified carer (age, gender, diagnosis,
relationship of carer to person with dementia).
1b. Risk and delirium/confusion assessment: screen to ensure that there is not an immediate risk of harm, or of
health problem requiring urgent assessment.
2. Physical abilities, sight and hearing.
3. Problem Checklist (completed with carer).
4. Health conditions: (a) person with dementia; and (b) carer (only if spouse or sibling).
5. Medication (person with dementia).
6. Pain scale.
7. Mood scale for person with dementia (completed by carer).
8. Function of the behaviour of concern and attributions of carer regarding the behaviour.
9. Personality of person with dementia.
10. Roles and goals: what is important to the person?
11. RSS (completed by carer).
12. Quality of relationship scale (completed by carer).
13. Personality of carer (including attachment style, self-efficacy, neuroticism).
14. Mood of carer (PHQ-9 scale to be completed by carer).
15. Support available for carer: family, friends, services.
16. Demands on carer: other stressors, roles, etc.
17. Carer approach.
PHQ-9, Patient Health Questionnaire (nine questions).
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Appendix 2 The FamCare study: changes
to protocol
Challenge FamCare was conceived as a CRT of a computerised functional analysis-based intervention foruse by specialist CMHNs who support people with dementia living at home and their family carers.
We developed an online decision support system to improve adherence by practitioners to a selection of
case-specific interventions, as many may not have had regular access to supervision or support from
clinicians in psychiatry, geriatric medicine and clinical psychology. Additionally, in a previous exploratory
RCT, where access to clinical experts was available, this was not always taken up by CMHNs, and variation
in CMHN behaviour reported some ICCs as over 0.1.65
Following consultation with NHS organisations, the delivery of the intervention was widened to include
other specialist professional staff as well as CMHNs, which we described as specialist CMHTOP ‘practitioners’
who would act as therapists. This was necessary as roles and responsibilities for the delivery of specialist
support by CMHTsOP to people with dementia and CB at home were no longer limited to CMHNs. For the
development and field-testing of the intervention in all participating FamCare study NHS organisations see
Chapter 2.
Here we outline the progress of the CRT and reasons why it did not proceed.
Summary of design and methods
The pragmatic CRT had been designed to test the experimental intervention in a random sample of
CMHTsOP, stratified by specialist community mental health NHS organisation. Not all organisations were NHS
trusts (one was a social enterprise) and CMHTsOP were used for recruitment, as this was the commissioned
NHS service for support of people with dementia and CB living at home, and their family carers. Thus, all
practitioners in each participating team for older people (CMHTOP) would be randomised to either the
experimental or control group. Randomisation by CMHTOP accounted for the fact that practitioners work
together within teams (see Chapter 1). We anticipated conducting the trial in five NHS organisations (with
back-up of a further two, should some organisations have difficulty in assisting with delivery). These five
organisations reported a total of 30 CMHTsOP, with estimates of an average of 100 new dementia referrals
per CMHTOP per year. As noted previously, only one study65 took account of interpractitioner variation
and found a significant difference between them; no study has investigated the effect on outcomes for
participants because of differences in practices across CMHTsOP, either within or between organisations.
Therefore, our planned study design and proposed three-level analysis had anticipated lower ICCs and more
precise estimates. With an (intraCMHTOP) correlation of 0.03, the variance inflation factor was approximately
(1 + 20 × 0.03), that is, 1.6. Therefore, the likely usable sample of 600 participants from 30 CMHTsOP would
provide an effective sample size of about 360, with 80% power using a significance level of 5% to detect an
effect size of about 0.3 SDs. We judged this as a plausible, and clinically important, effect size.
Recruitment of participants was therefore planned to stop at a target of 600 and we had agreed with each
participating organisation that each CMHTOP would attempt to recruit every new eligible patient referred
to them over a 12-month period or until a total of 600 dyads of patients and carers were reached. Thus,
we anticipated an average of 20 dyads (up to a maximum of 40 dyads) per CMHTOP, or eight dyads per
practitioner, whichever was the larger in number.
Next, given the aforementioned variation we found in practitioner behaviour,65 we had included a pilot
phase of 3 months in all CMHTsOP, which directly preceded the introduction of the intervention to the
experimental CMHTsOP. This would allow us to monitor variation within practitioners and CMHTsOP for
both experimental and control groups. For this pilot phase, we had planned to recruit seven participant
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dyads per CMHTOP and 200 in total (i.e. up to 15 for each CMHTOP or three per practitioner), whichever
was the larger.
For the CRT, we estimated a likely loss to follow-up at 2 months of, on average, 16 of the 20 participant
dyads. This would have given a usable sample of 480 (80%) from the original 600 dyads. With an estimate
of 60% (120 dyads) of follow-up data from the pilot study added to the control arm of the CRT, a usable
sample of 600 (240 intervention and 360 control) participants at an average of 20 per CMHTOP would
reduce power by < 2%.
In conclusion, we had planned a pilot study and follow-up at 2 and 6 months to include 200 dyads from
30 CMHTsOP in five organisations; and a CRT of 600 dyads from these teams.
Progress
Following approvals from the REC (see Appendix 12) and consultation with NHS organisations, we
extended the study to seven NHS organisations involving 33 CMHTsOP, of which one organisation was a
social enterprise.
Recruitment across all seven organisations was slow from August 2010 to September 2011, requiring us to
request a number of amendments which were approved, including a change of design from a CRT to a
‘controlled feasibility trial of a functional analysis-based intervention for community mental health therapists
to support people living at home with dementia and CB; and their family carers’ (see Appendix 12).
However, the reasons for slow recruitment in the NHS organisations (see Chapter 5, Changes to protocol)
did not change and recruitment remained slow. We failed to recruit our planned pilot recruitment of 200
dyads across 33 CMHTsOP from seven NHS organisations and, therefore, did not complete our planned
controlled feasibility study of the intervention.
At the request of the NIHR funders, and in order to complete the programme within time scales, we
curtailed our plans to commence the intervention study and redesigned the FamCare trial to be an
observational cohort study, which was submitted to, and approved by, the REC (see Appendix 12).
Chapter 5 describes this cohort study, which used data from six NHS organisations and 28 CMHTsOP.
One NHS trust with five CMHTsOP withdrew from the study when, during the course of the study, its
services were recommissioned to another NHS organisation. During the process of an anticipated change
of contract, CMHTsOP at this organisation were unable to support recruitment and we therefore failed to
complete any baseline measures for dyads.
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Appendix 3 The FamCare study: summary of the
recruitment context
Background
Seven community mental health NHS organisations across England initially participated in the FamCare
study. They were in Greater Manchester West, Grimsby, Humber, North East London, Oxford and
Buckinghamshire, Sheffield and York. Nationally, CMHTsOP served older people with and without
dementia, but many organisations were redesigning the roles and responsibilities of teams at the time of
this study. Of the 33 CMHTsOP included in the audit of referrals, 14 had access to a discrete early MAS or
a memory clinic, whereas another 19 had their memory services subsumed within their CMHTOP. Six
CMHTsOP received referrals through a single point of access in their organisation, whereas 27 received
referrals into their team direct from the referrer. Twelve had access to an intensive home treatment or
crisis resolution team and 21 did not. In these seven NHS organisations, an audit of all new referrals to
33 participating CMHTsOP was conducted, from August 2010 to October 2011, in order to understand
what proportion of people with dementia living at home were served by CMHTsOP.
Procedure
The characteristics of every ‘new referral’, over an average of 30.97 weeks (SD 6.00 weeks; range
14–46 weeks), across 33 CMHTsOP were documented. These included people with a non-dementia
diagnosis (e.g. depression, psychosis, personality disorders, alcohol problems, delirium) and people with
dementia (including those residing in care homes and those living at home). Each CMHTOP recorded the
types of new referrals coming into their team each week, but no patient names or identification numbers
were entered. These data were taken from the information available to them from the initial referral record
that came into the team for each patient. The anonymised records were then collected on a weekly basis
and collated by research assistants at each site. Discharged patients, who had previously been on the
CMHTsOP case loads, but were referred back during this period, were classed as a new referral, as this
was seen as a new episode of care of potential eligibility for the planned FamCare intervention study.
Results
Table 66 shows the groupings of new referrals using the data collected by the 33 participating CMHTsOP.
The majority of new referrals to the CMHTsOP during this period were ineligible for the FamCare study as
they did not appear to have dementia, but were referred for other conditions; were primarily associated
with functional mental health problems (37.0%); they were not living in their own home and were in a
residential or nursing care home (22.0%); or they were accepted by the CMHTOP and referred straight
out to other services (25.8%). Of particular interest was the striking movement of patients referred to
CMHTsOP who were passed onto memory clinic waiting lists (852 cases) prior to evaluation, and the
smaller number of people (235 cases) who were returned to primary care without evaluation by the
specialist service that they were referred to (Table 67).
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People with dementia and challenging behaviour living at home and
their family carers: recruitment challenges
The FamCare study was conceived as an intervention trial for dementia and CB. It was to be delivered by
community mental health practitioners working in CMHTsOP, as this was where patients with dementia
and CB were usually referred for support. To be eligible for the study, the referral had to therefore be
accepted by the CMHTsOP and be placed on a practitioner’s case load.
Prior to data collection, practitioners and managers from CMHTsOP estimated significant numbers of
people referred to the CMHTsOP within the eligibility criteria, as it was thought that this constituted the
majority of their case work. However, this audit noted that the bulk of referrals to CMHTsOP appeared to
be focused on patients without potential dementia or those living in residential and nursing care homes
(see Table 66). Patients living at home with potential dementia were often redirected by CMHTsOP to
other services such as MAS (see Table 67).
TABLE 66 The FamCare study audit: new referrals to CMHTsOP
New referral categories Number of new referrals % of total number of referrals
Non-dementia diagnosisa 1985 37.0
Dementia: referred straight to other services
(see Table 67)
1385 25.8
Dementia: residential careb 1190 22.0
Dementia: at home with carerc 452 8.4
Dementia: no carer 307 5.7
Dementia: died or admitted to hospital before seen 41 0.8
Total 5360
a Includes functional illness (n= 1839), non-dementia neurological problems, delirium, physical health, alcohol-related,
learning disabilities and non-dementia disorders not specified.
b Also includes respite care (n= 34).
c Includes those referred to the study (n= 162), plus refused to be part of study (n= 238), palliative, non-English speaking,
communication problems and reasons not specified but known not to be any of the other categories in the table.
TABLE 67 The FamCare study audit: referred straight to other services
Type of service
Number of referrals made
straight to other services
% of total number of referrals
made straight to other services
Early MASs/clinicsa 852 61.5
GPs and other health professionalsb 235 17.0
Other mental health specific servicesc 138 9.96
Hospital services (acute or mental health) 53 3.83
Type of service not specified 107 7.73
Total 1385
a Includes discrete MASs and those provided within CMHTsOP.
b Includes referrals back to primary care/GPs and neurology.
c Includes adult services, other CMHTsOP, intensive treatment teams, psychiatry, psychology and the Alzheimer’s Society.
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Conclusion
Over a period of approximately 7 months of data collection, between August 2010 and October 2011, at
each of the seven NHS organisations, only 452 people with dementia living at home (around 8%), from a
total of 5360 new cases to CMHTsOP, were accepted for support by a practitioner in the team.
Chapter 5 describes a cohort study where we extended recruitment to MAS, to include the period of this
audit. Some participants (16.6%) in this cohort were located in newly emerging MASs or in memory
clinics. Follow-up data collection comprising data at 2 and 6 months continued until July 2012 (see
Chapter 5).
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Appendix 4 The ResCare trial: ethical permissions
Issues that were addressed prior to approval
The issues that the REC requested be addressed were as follows:
l time given between the provision of information and the taking of consent to be amended to 1 week
rather than 1 day
l alter the wording ‘medical team’ to ‘team of experts’ in the participant information sheet, as reference
to ‘medical team’ was felt to be confusing and could be misinterpreted
l amend the title of the ‘Relative/Friend Assent Form’ to read ‘Consultee Form – Record of Consultation’
instead.
Amendments
During the trial approval was sought and granted for a number of additional amendments as detailed below.
1. In June 2010, a request was made to the following:
l Change the 7 days required for residents to consent to the trial after receiving information about
the trial to ‘as long as they may wish to consent to consider taking part’; this provided the option of
consent being taken as soon as the information sheet and explanation of the study had been
provided, but would allow for longer periods too.
l Remove the Short Form questionnaire-12 items (SF-12) from the trial as it was no longer considered
necessary.
l Replace the GHQ-12 with the MBI Human Service Survey,137 which is more specific to care workers.
l Remove the Structured Medication Inventory from the care staff measures, as feedback from some
feasibility work indicated that this measure would make staff feel uncomfortable and suspicious
about providing information about personal medication use, and is not vital to the outcome of the
economic analyses.
l Include an abbreviated version of the CBS107 as an initial screen for all residents in the home prior to
taking consent from residents. Knowing the incidence of CB enabled the quick identification of
numbers of residents with CB in each home. As homes containing fewer than six residents with CB
were to be dropped from the trial, this enabled a quick evaluation of whether or not a home was
suitable to include without putting residents through the study process only to find the home had
insufficient numbers of residents with CB.
Each of these requests was granted in June 2010.
2. Later in June 2010 an additional request was submitted to extend the start date of the trial to
12 May 2011 because of the computerised intervention taking longer than anticipated to develop.
This extension to the start date was approved in July 2010.
In January 2011 a request was made for the following:
l Add the CMAI135 to the current measures based on the positive outcomes of the use of this
measure found in the Cochrane review.82
l That care homes should no longer be stratified by ‘type of home’ during randomisation, due to the
blurring in the distinction of types of homes away from distinct ‘nursing home’ and ‘residential
home’ to homes that essentially operate as both.
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
223
l Change the point at which homes were randomised. The original protocol had said we planned to
randomise homes as we went along. However, a larger than originally anticipated amount of
work was going to be required following consent for homes randomised to the intervention
(e.g. installing computers and broadband) and, therefore, it was decided that all homes would be
randomised in advance prior to baseline measures.
Approval was granted in January 2011 to all of these requested changes.
3. In August 2011 a final request was made to add the VAK Learning Styles Self-Assessment
Questionnaire117 for care home staff to complete.
This was granted in August 2011.
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Appendix 5 Management of the research
The research studies were managed as part of the overall NIHR Collaborative Research Programme,Challenge Demcare (Dementia Care for Behaviours that Challenge). Day-to-day operation of the
programme was managed by the research programme manager, Cathryn Hart, with overall responsibility
being that of the chief investigator, Professor Esme Moniz-Cook. In addition, the following management
structures were in place.
Programme Management Committee
The Programme Management Committee comprised a programme grant holder, the programme manager,
representatives from NWORTH Clinical Trials Unit, host organisation representatives from finance, business,
service operations and R&D, and the chief investigator (who was also the chairperson of the committee).
The purpose of the Programme Management Committee was to oversee the running of the programme
and ensure its smooth operation. It met on a regular basis, mostly every other month, and was split into
two parts: (1) core business relating specifically to the Humber NHS Foundation Trust, for example,
monitoring contracts and expenditure; and (2) other programme issues, for example, monitoring overall
timetables, study recruitment, promoting the programme and liaising with services.
Programme Steering Committee
The PSC comprised programme grant holders, other independent professionals, care providers, service
user representatives and programme staff, and had an independent chairperson, namely, David Jolley,
Professor of Old Age Psychiatry, University of Manchester. For the main part it met every 6 months,
with the frequency only reducing towards the end of the programme when the studies were closing.
The overall responsibility of the PSC was to ensure the scientific integrity and quality of the ResCare trial
and the FamCare study, with its specific aims being to (1) approve the study protocols; (2) monitor and
supervise the progress of the studies; (3) approve substantial amendments to the research; (4) consider the
recommendations of the DMEC; (5) review relevant information from other sources and recommend
appropriate action, if required; and (6) advise on dissemination and implementation.
Data Monitoring and Ethics Committee
The DMEC included independent clinical experts and was chaired by Martin Bland, Professor of Health
Statistics in the Department of Health Sciences, University of York. This committee was responsible for
looking at the data from an ethical standpoint, with the safety, rights and well-being of the trial
participants being paramount.
The DMEC usually conducted its business electronically (via telephone and e-mail) a few weeks prior to the
PSC and then submitted a report to the chairperson of the PSC. Its main functions were to (1) determine
if additional interim analyses of study data should be undertaken; (2) consider any safety issues for the
studies and relevant information from other sources; and (3) provide independent advice on analysis plans.
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Patient and public involvement
The PSC included a number of service user representatives, including a person with dementia and family
carers, some of whom also attended methodology meetings held during the course of the programme.
Once the studies were complete, three consultation events were held to discuss the emerging findings
from the studies and to explore implementation issues (see Chapters 4 and 5 for further details). Most, but
not all, stakeholders attending were volunteers, carers, representatives from charitable organisations, and
others who support those with dementia and their families.
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Appendix 6 Measures
The Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition
The DSM-IV130 criteria are used by a researcher to assess the likelihood that a person has dementia.
To meet the criteria for dementia the participant must have:
(1) A memory impairment.
AND
(2) One or more of the following: aphasia, apraxia, agnosia or disturbance in executive functioning.
AND
(3) The above must cause significant impairment in social or occupational functioning, represented by a
significant decline from previous level of functioning.
AND
(4) Cannot be better explained by delirium or other mental health problems (e.g. depression,
schizophrenia, etc.).
Challenging Behaviour Scale
The CBS107 is a 25-item interview whereby the researcher works down the list of 25 behaviours and for
each one asks the care staff member if they consider the resident to display that behaviour. For each that
is identified, the frequency of that behaviour is then selected from ‘occasionally’ (1) to ‘daily or more’
(4), and the difficulty for that care staff member is from ‘no problem’ (1) to ‘lots of problems’ (4). A
challenge score for each behaviour is obtained by multiplying the frequency score by the difficulty score.
Item challenge score = frequency × difficulty (score range 0–16).
Total incidence score = the total number of CBs (score range 0–25).
Total frequency score = sum of frequency scores (score range 0–100).
Total difficulty score = sum of difficulty scores (score range 0–100).
Total challenge score = sum of 25-item challenge scores (score range 0–400).
EuroQol-5 Dimensions
The EQ-5D138 is a two-part questionnaire that measures perceived levels of health.
The first part (index) consists of a five-item questionnaire based on a three-point Likert scale. Responders
are asked to rate on the following areas of health: mobility, self-care, usual activities, pain/discomfort and
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anxiety/depression. The rating scale goes from ‘no problems’ (1) to, depending on the question, ‘confined
to/unable to/ extreme’ (3).
EuroQol-5 Dimensions index (score range –0.59 to 1).
The second part consists of a thermometer-type VAS where people are asked to indicate current levels of
health from ‘worst imaginable health state’ (0) to ‘best imaginable health state’ (100).
EuroQol-5 Dimensions VAS (score range 0–100).
Quality of Life in Alzheimer’s Disease
The QoL-AD143 is a 13-item quality-of-life questionnaire based on a four-point Likert scale. It asks questions
on areas such as physical health, energy levels and mood, and responders answer from a range of options
between ‘poor’ (1) and ‘excellent’ (4).
Total score = sum of all the items (score range 13–52).
Neuropsychiatric Inventory
The NPI135 is an informant interview and is designed to rate ‘frequency’ and ‘severity’, and the version used for
this study also included ratings for ‘caregiver distress’. The NPI has 12 CB categories: delusions, hallucinations,
agitation/aggression, depression/dysphoria, anxiety, elation/euphoria, apathy/indifference, disinhibition,
irritability/lability, aberrant motor behaviour, sleep, appetite/eating disorders (plus subquestions for each
where more specific areas of disorder can be recorded). Each of the 12 categories has three Likert scales for
frequency, severity and caregiver distress. Frequency is rated from ‘occasionally’ (1) to ‘very frequently’ (4).
Severity is rated from ‘mild’ (1) to ‘marked’ (3). Distress is rated from ‘not at all’ (0) to ‘extremely’ (5).
Total CB category score = frequency × severity (score range 0–4).
Incidence score = the total number of CBs (score range 0–12).
Frequency score = the total frequency of the 12 behaviours (score range 0–48).
Severity score = sum of severity scores of the 12 behaviours (score range 0–36).
Total score (frequency × severity) = sum of total category scores of the 12 behaviours (score range 0–144).
Distress score = sum of distress scores of the 12 behaviours (score range 0–60).
Cohen–Mansfield Agitation Inventory
The CMAI136 is a 29-item questionnaire based on a seven-point Likert scale. Care staff are asked to rate
how often a number of agitated behaviours occur. Answers range from ‘never’ (1) to ‘a few times an
hour’ (7).
The measure has four subscales:
1. physical (aggressive) = sum of question 1 to question 11 (score range 11–77)
2. physical (non-aggressive) = sum of question 12 to question 21 (score range 10–70)
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3. verbal (aggressive) = sum of question 22 to question 24 (score range 3–21)
4. verbal (non-aggressive) = sum of question 25 to question 29 (score range 5–35).
Total score = sum of all items (score range 29–203).
Clinical Dementia Rating
The CDR144 is a rating scale to be completed by the researcher and is based on how they rate the person
with dementia’s performance during an interview (which should last around 1 hour). The researcher rates
on six domains: memory, orientation, judgement and problem-solving, community affairs, home and
hobbies, and personal care.
The CDR scores are healthy = 0; questionable dementia = 0.5; mild dementia = 1; moderate dementia = 2;
severe dementia = 3.
Sum of boxes score (CDR-SB) = sum of domain scores (score range 0–18).
Maslach Burnout Inventory
The MBI137 is a 22-item questionnaire and uses a seven-point Likert scale. Staff report on their levels of
burnout working with residents with CB. The measure consists of questions such as ‘I feel emotionally
drained from my work’ and staff can answer from a range of options from ‘never’ to ‘everyday’.
The following questions require reverse scoring: questions 4, 7, 9, 12, 17–19 and 21.
There are three subscales:
1. emotional exhaustion: questions 1–3, 6, 8, 13, 14, 16 and 20 (score range 0–54)
2. personal accomplishment: questions 4, 7, 9, 12, 17–19 and 21 (score range 0–48)
3. depersonalisation: questions 5, 10, 11, 15 and 22 (score range 0–30).
Self-Efficacy Scale
The SES140 is a nine-item questionnaire that uses a seven-point Likert scale and asks care staff how
effective they believe they are in their role as a care worker. The measure consists of challenging scenarios
in care homes and the person has to rate how confident they feel in dealing with that scenario: ‘not at all
confident’ (1) to ‘very confident’ (7).
Total score = sum of all the items.
Approaches to Dementia Questionnaire
The ADQ139 is a 19-item questionnaire that uses a five-point Likert scale and asks care staff to indicate their
attitudes towards people with dementia. The measures consist of questions such as ‘there is no hope for
people with dementia’ and staff can answer a range of options from ‘strongly agree’ to ‘strongly disagree’.
Questions 1–4, 6, 8, 10, 13 and 14 are scored with ‘strongly disagree’ as (5).
Questions 5, 7, 9, 11, 12 and 15–19 are scored with ‘strongly agree’ as (5).
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This measure has two subscales:
1. hope = sum of questions 1–4, 6, 8, 10 and 13 (score range 8–40)
2. person-centred = sum of questions 5, 7, 9, 11, 12 and 14–19 (score range 11–55).
Total score = sum of all items (score range 19–95).
Visual–auditory–kinaesthetic
The VAK117 is a 30-item self-completion learning styles questionnaire. For each question people have to
indicate if they would choose option (a), (b) or (c).
Mostly (a) = visual learning style.
Mostly (b) = auditory learning style.
Mostly (a) = kinaesthetic learning style.
Some people have a blend of two or three different styles.
Revised Memory and Behaviour Problems Checklist
The RMBPC111 is a 24-item questionnaire on behavioural problems in the person with dementia. It records
incidence, and frequency, of the behaviour and the caregiver’s reaction to the behaviour. The higher the
score on this scale, the greater the level of problems.
The incidence is scored as ‘yes’ (1) or ‘no’ (0). Frequency ranges from ‘never’ (0) to ‘daily or more often’
(4) and ‘don’t know/not applicable’ (9). The caregiver’s reaction to the reported problem (how much the
behaviour bothers them) is rated from ‘not at all’ (0) to ‘extremely’ (4) and ‘don’t know/not applicable’ (9).
The measure has three subscales:
1. memory-related = sum of questions 1–7 (score range 0–7)
2. depression = sum of questions 12, 14, 17–22 and 23 (score range 0–9)
3. disruptive behaviours = sum of questions 8–11, 13, 15, 16 and 24 (score range 0–8).
Quality of the Caregiver/Patient Relationship
The QCPR258 is a 14-item questionnaire that measures the quality of the relationship between the person
with dementia and the caregiver via 14 five-point Likert items. A higher score overall on this scale indicates
a higher quality of relationship.
The measure consists of statements such as ‘my carer/relative and I often spend time together in an
enjoyable way’. The responder can answer from ‘totally disagree’ to ‘totally agree’ with the statement and
the answers are scored from 1 to 5, with five being the most positive response to each statement.
The measure has two subscales:
1. warmth = sum of questions 1, 4–7, 9, 12 and 14; scored with ‘totally disagree’ as (1) (score range 8–40)
2. criticism = sum of questions 2, 3, 8, 10, 11 and 13; scored with totally disagree as (5) (score range 6–30).
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Total score = sum of two subscales (score range 14–70).
ICEpop CAPability measure for older people
The ICECAP-O257 is a five-item questionnaire which measures the quality of life of the responder via five
four-point Likert items. A higher score overall on this scale indicates a higher quality of life.
The measures cover the categories of (1) love and friendship; (2) thinking about the future; (3) doing
things that make you feel valued; (4) enjoyment and pleasure; and (5) independence.
The responder can answer from a range of options, which vary from category to category. For the love and
friendship category the responder can answer from ‘I can have all of the love and friendship that I want’
(4) to ‘I cannot have any of the love and friendship that I want’ (1). The answers are scored from 1 to 4,
with 4 being the most positive response in each category.
ICECAP-O index (score range 0–1).
Short Sense of Competence Questionnaire
The SSCQ255 is a seven-item questionnaire that measures the quality of the relationship between the carer
and the person with dementia via seven five-point Likert items. A higher score overall on this scale
indicates a higher quality of relationship.
The measures consist of statements such as ‘I feel that my relative behaves the way he/she does to have
his/her own way’ and the carer can answer from ‘agree very strongly’ (1) to ‘strongly disagree’ (5). The
answers are scored from 1 to 5, with 5 being the most positive response to each of the statements.
Total score = sum of the items (score range 7–35).
General Health Questionnaire
The GHQ-12254 is a 12-item questionnaire that measures the condition of the responder’s recent and
present mental health via 12 four-point Likert items. A higher score overall on this scale indicates a lower
mental health condition.
The measure consists of questions (Qs) such as ‘Have you recently been able to concentrate on what you
are doing?’ The responder can answer from a range of options, which vary from question to question. For
the question above about ability to concentrate, the responder can answer from ‘Better than usual’ (0) to
‘Much less than usual’ (3). The answers are scored from 0 to 3, with 0 being the most positive response to
each question.
The measure has two subscales:
1. positive = sum of questions 1, 3, 4, 7, 8 and 12 (score range 0–18)
2. negative = sum of questions 2, 5, 6 and 9–11 (score range 0–18).
Total score = sum of the positive and negative subscales (score range 0–36).
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Hospital Anxiety and Depression Scale
The HADS253 is a 14-item questionnaire that measures the responder’s anxiety and depression state via
14 four-point Likert items. A higher score overall on this scale indicates a higher level of anxiety and
depression.
The measure consists of statements such as ‘I feel tense or ‘wound up’. The responder can answer from a
range of options, which vary from statement to statement. For the statement above about feeling tense, the
responder can answer from ‘Most of the time’ (3) to ‘Not at all’ (0). The answers are scored from 0 to 3,
with 0 being the most positive response to each statement.
The measure has two subscales:
1. anxiety = sum of questions 1, 3, 5, 7, 9, 11 and 13 (score range 0–21)
2. depression = sum of questions 2, 4, 6, 8, 10, 12 and 14 (score range 0–21).
Total score = sum of anxiety and depression subscales (score range 0–42).
Guilt Scale
The GS252 is a 10-item questionnaire that measures the carer’s feelings of guilt via 10 five-point Likert
items. A higher score overall on this scale indicates more feelings of guilt.
The measures consist of statements such as ‘Do you worry that you might unintentionally hurt your relative’s
feelings?’ The carer can answer from ‘always’ (4) to ‘never’ (0). The answers are scored from 0 to 4, with 0
being the most positive response to each question.
Total score = sum of the items (score range 0–40).
Relative Stress Scale
The RSS256 is a 15-item questionnaire that measures stress specific to caregiving via 15 five-point Likert
items. A higher score overall on this scale indicates more stress.
The measures consist of questions such as ‘Do you ever feel that you can no longer cope with the
situation?’ The carer can answer from ‘never’ (0) to ‘always/considerably’ (4). The answers are scored from
0 to 4, with 0 being the most positive response to each question.
The measure has three subscales:
1. emotional distress = sum of questions 1–6 (score range 0–24)
2. social distress = sum of questions 7–11 (score range 0–20)
3. negative feelings = sum of questions 12–15 (score range 0–16).
Total score = sum of three subscales (score range 0–60).
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Appendix 7 Unit costs and sources
F igures have been taken from Curtis,153 the NHS’s England Statement of Dental Remuneration –Amendment 93357 and the Department of Health’s General Ophthalmic Services Letter.358
TABLE 68 Health- and social-care unit costs
Item Unit Cost (£) Source/notes
NHS district nurse,
home visit
Per hour 70 District nurse home visit, including qualification and travel costs (PSSRU 2012,
p. 175)
NHS district nurse,
clinic visit
Per hour 58 District nurse per hour of patient-related work, including qualification
costs (PSSRU 2012, p. 175)
GP surgery visit Per minute 4 GP per surgery/clinic minute including qualification costs and direct care
staff costs (PSSRU 2012, p. 183)
GP home visit Per minute 5 Per minute of home visit, including travel time, qualification costs and
direct care staff costs (PSSRU 2012, p. 183). Assuming out-of-hours costs
are same as for home visit
Community
specialist doctor
Per minute 4 Assumed same as GP per surgery/clinic visit. This category includes
audiologists, dermatologists, ophthalmologists, oncologists, gynaecologists
and general medics
Practice nurse Per hour 53 Assumed home visit is the same as clinic visit. Per hour of face-to-face
contact, including qualification costs (PSSRU 2012, p. 180)
NHS health visitor,
home visit
Per hour 71 Health visitor home visit, including qualification costs (PSSRU 2012, p. 177)
NHS health visitor,
clinic visit
Per hour 59 Health visitor per hour of clinic contact, including qualification costs
(PSSRU 2012, p. 177)
NHS psychiatrist Per hour 289 Assumed home visit is the same as clinic visit. Consultant: psychiatric cost
per hour of patient contact, including qualification costs (PSSRU 2012,
p. 237)
NHS psychologist Per hour 136 Assumed home visit is the same as clinic visit. Per hour of client contact,
clinical psychologist. £1.50 per visit for travel (PSSRU 2012, p. 171)
NHS counsellor Per hour 65 Assumed to be the same as clinic visit. Per hour of client contact for
counselling service in primary care (PSSRU 2012, p. 53)
NHS CMHN Per hour 53 Assumed home visit is the same as clinic visit. Per hour of face-to-face
contact, including qualification costs. £1.50 per visit for travel (PSSRU
2012, p. 176)
Rapid response
team
Per hour 37 Per delivered hour (excludes cost for enhanced payments, cost of
assessments, discharge and travel costs) (PSSRU 2012, p. 113)
NHS
physiotherapist
Per hour 33 Assuming home visit is the same as clinic visit. Per physiotherapist hour,
including qualification costs (PSSRU 2013, p. 167)
NHS occupational
therapist
Per hour 33 Assumed home visit is the same as clinic visit. NHS community
occupational therapist, including qualification costs (PSSRU 2012, p. 168)
Home care worker Per hour 23 Per hour of weekday face-to-face contact, Based on the price multipliers for
the independent sector provided for social services (PSSRU 2012, p. 193)
Care attendant Per hour 23 Assumed same as home care worker
Sitting service Per session 14.50 Based on five agencies in Torbay 2005 (Charlesworth et al. 2008, p. 52359);
adjusted to 2012 prices
continued
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TABLE 68 Health- and social-care unit costs (continued )
Item Unit Cost (£) Source/notes
Carer’s support
worker
Per hour 49 Assumed same as clinic visit, per hour of client-related work for family
support worker, including training costs (PSSRU 2012, p. 196)
NHS chiropodist/
podiatrist
Per hour 30 Assumed home visit and clinic visit the same. Per hour, community
chiropodist (PSSRU 2012, p. 170)
NHS dietitian Per hour 34 Per hour, hospital-based dietitian including qualification costs (PSSRU 2012,
p. 216)
Alternative
therapist
Per hour 17 Taken as mid-point of NHS pay band 5 including national insurance and
pension
Meals on Wheels Per visit 6 Cost per meal (PSSRU 2012, p. 125)
NHS optician Per visit 21 NHS sight test fee for optometrists and ophthalmic medical practitioners:
£20.70 (Department of Health, General Ophthalmic Services letter 2010;
URL: http://webarchive.nationalarchives.gov.uk/20130107105354/
http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/documents/
digitalasset/dh_114691.pdf)
NHS dentist Per visit 25 Fee code 0121 provision of care and treatment for a patient (NHS
Statement of Dental Remuneration 2012, p. 6)
Social worker/care
co-ordinator
Per hour 74 Per hour of client-related work (adult services), including qualification costs
(PSSRU 2012, p. 190)
Speech and
language therapist
Per hour 33 Per hour, including qualification costs (PSSRU 2012, p. 169)
Specialist nurse Per hour 70 Assumed same as district nurse home visit, including qualification and
travel costs (PSSRU 2012, p. 175). Includes asthma nurses, stroke nurses,
Parkinson’s nurses, diabetes nurses, ‘stop smoking’ nurses
Falls team Per hour 42 Falls teams consist of occupational therapists, physiotherapists, specialist
nurses and chiropodists. The unit cost has been assumed as the mean
hourly rate of the above
Emergency care
practitioner
Per hour 70 Assumed same as district nurse home visit, including qualification costs
(PSSRU 2012, p. 175)
Crisis team Per hour 38 Per hour, per team member (PSSRU 2012, p. 201)
Paramedic Per visit 230 Per visit (PSSRU 2012, p. 109)
Independent
mental capacity
advocate
Per visit 110 Per visit (PSSRU 2012, p. 56)
Home care
manager
Per hour 57 Per hour of client-related work (PSSRU 2012, p. 195)
Safeguarding
practitioner
Per visit 358 Per assessment by mental health assessor, including travel costs (PSSRU 2012,
p. 56)
Adult family
placement/shared
lives arrangement
Per hour 9.05 Per hour of day time support, including on costs. Taken from appendix 10a
of Blackpool Council’s Shared Lives scheme360
Chiropractor Per visit 32 Cost for chiropractic adjustment, taken from www.the-chiropractors.co.uk/
our-fees/
PSSRU, Personal Social Services Research Unit.
Note
The above costs have been used for all categories, regardless of provider agency. The only categories with private
organisation providers were chiropodists (n= 158), opticians (n= 17) and specialist nurses (n= 1). Intensive home treatment
team and admiral nurses have been costed as a CMHN.
APPENDIX 7
NIHR Journals Library www.journalslibrary.nihr.ac.uk
234
TABLE 69 Hospital unit costs
Item Unit Cost (£) Source/notes
Inpatient ward Per night 919 PA32B, elective inpatient: minor Injury without intracranial injury without CC
Assessment/
rehabilitation
inpatient
Per night 308 VC28Z, ’non-specialist’ rehabilitation services (NSRS) – bed-days: admitted
patient care
Respite inpatient Per night 327 MHIPE1, mental health inpatients, elderly
Outpatient services Per visit 30 WA20Y, outpatient procedures: examination, follow-up, special screening,
without CC
Day surgery Per visit 138 WA21Y, outpatient procedures: other procedures or health-care problems,
without CC
A&E Per visit 91 VB09Z, A&E services: not leading to admitted; emergency medicine,
category 1 investigation with category 1–2 treatment
Ambulance Per transfer 263 Paramedic services, emergency transfer (PSSRU 2012, p. 109)
CC, complications and comorbidities; PSSRU, Personal Social Services Research Unit.
Notes
Taken from the Department of Health’s National Schedule of Unit Costs 2011–12.361
Reasons for using hospital were not given, so an average cost was used.
TABLE 70 Day care unit costs
Item Unit Cost (£) Source/notes
Day care: local
authority social
services
Per session 40 Local authority day care for older people (PSSRU 2012, p. 40)
Day care: voluntary
organisation
Per session 18 Taken from a Sheffield charitable day care centre (URL: www.sheffield
helpyourself.org.uk/keyword_search.asp)
Day care: NHS Per session 40 Assumed same as local authority day care
Lunch club Per meal 3.17 Taken from an average of 57 lunch clubs in Sheffield (URL: www.shef
fieldhelpyourself.org.uk/keyword_search.asp)
Social club Per session 3.17 Assumed same as lunch club
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Appendix 8 ResCare: factors affecting resident
and staff dropout
TABLE 71 The ResCare trial: logistic regression results of resident dropouts by the forward (Wald) selection method
using data after 25% missing rule
Variable Dropouts (n= 174), odds ratio (95% CI)
Treatment group 1.69 (1.06 2.70)
Number of beds
40–49 2.10 (1.37 3.20)
≥ 50 3.07 (1.96 4.83)
Gender 0.57 (0.38 0.86)
Age 1.04 (1.02 1.07)
Length between baseline and follow-up at home level 1.01 (1.00 1.01)
Number of cases in selection = 826.
TABLE 72 The ResCare trial: chi-squared/Fisher’s results of demographic factors on the staff dropouts
Demographic factor
Staff
Stayed (n= 413) Dropouts at follow-up (n= 174)
Age group (years)
< 25 87 48
25–49 227 93
≥ 50 98 33
Missing data 1
Sig. 0.169
Gender
Male 45 15
Female 368 159
Sig. 0.495
Another paid employment
Yes 18 12
No 395 162
Sig. 0.285
Smoking
Yes 177 85
No 236 89
Sig. 0.214
continued
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TABLE 72 The ResCare trial: chi-squared/Fisher’s results of demographic factors on the staff dropouts (continued )
Demographic factor
Staff
Stayed (n= 413) Dropouts at follow-up (n= 174)
Number of beds
25–39 223 85
40–49 136 45
≥ 50 54 44
Sig. 0.001
Proportion of residents with a CBS incidence score of > 10
< 0.4 342 153
≥ 0.4 71 21
Sig. 0.151
Organisation change
Yes 262 93
No 151 81
Sig. 0.030
Home type
Local 69 17
Private 180 93
Private nursing 57 19
Voluntary/charity 107 45
Sig. 0.061
Accommodation
Missing data 6 2
Owned 239 91
Rented 116 57
Housing Association 52 24
Sig. 0.424
Treatment groups
Control 233 61
Intervention 180 113
Sig. < 0.001
Sig., significance level.
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Appendix 9 The ResCare trial: tables relating to
the analysis of the dose effect of the intervention
TABLE 73 The ResCare trial: NPI frequency model 1 results
Descriptive
Results
Before imputation Pooled
β SE t (p-value) β SE t (p-value)
Number of champions 0.67 0.62 1.08 (0.284) 0.72 0.55 1.30 (0.194)
Proportion of action plans/CB residents 2.62 2.33 1.12 (0.266) 2.89 2.05 1.41 (0.161)
Baseline frequency 0.36 0.04 8.69 (< 0.001) 0.32 0.04 7.38 (< 0.001)
TABLE 74 The ResCare trial: NPI frequency model 2 results
Descriptive
Results
Before imputation Pooled
β SE t (p-value) β SE t (p-value)
Number of champions 1.31 0.64 2.04 (0.042) 1.13 0.58 1.97 (0.050)
Proportion of action plans/CB residents 3.09 2.31 1.34 (0.181) 2.90 2.06 1.40 (0.161)
Baseline frequency 0.36 0.04 8.55 (< 0.001) 0.32 0.04 7.38 (< 0.001)
Organisational change 1.22 0.79 1.55 (0.122) 1.17 0.80 1.46 (0.146)
Gender 0.36 0.76 0.48 (0.634) 0.30 0.81 0.37 (0.715)
Number of beds
40–49 0.74 0.70 1.05 (0.296) 0.82 0.72 1.14 (0.253)
≥ 50 1.83 0.96 1.91 (0.057) 1.55 1.07 1.44 (0.155)
Home type
Private 2.35 1.19 1.97 (0.049) 2.00 1.19 1.67 (0.094)
Private (with nursing) 1.04 1.48 0.70 (0.485) 0.92 1.51 0.61 (0.542)
Voluntary/charity 1.29 1.22 1.05 (0.293) 0.83 1.24 0.67 (0.542)
Proportion of residents with a CBS incidence score of > 10
≥ 0.4 0.94 0.91 1.04 (0.299) 0.82 0.97 0.85 (0.398)
Age –0.02 0.04 –0.44 (0.660) –0.01 0.04 –0.33 (0.743)
Length between baseline and follow-up (days) 0.01 0.01 1.51 (0.133) 0.01 0.01 1.06 (0.290)
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TABLE 75 The ResCare trial: NPI severity model 1 results
Descriptive
Results
Before imputation Pooled
β SE t (p-value) β SE t (p-value)
Number of champions 1.03 0.43 2.40 (0.020) 0.50 0.52 0.95 (0.351)
Proportion of action plans/CB residents 4.07 1.60 2.54 (0.014) 2.14 1.94 1.10 (0.285)
Baseline severity 0.37 0.04 9.13 (< 0.001) 0.33 0.04 7.78 (< 0.001)
TABLE 76 The ResCare trial: NPI severity model 2 results
Descriptive
Results
Before imputation Pooled
β SE t (p-value) β SE t (p-value)
Number of champions 1.24 0.48 2.62 (0.013) 0.63 0.53 1.19 (0.243)
Proportion of action plans/CB residents 4.75 1.71 2.78 (0.008) 2.62 2.03 1.29 (0.209)
Baseline severity 0.38 0.04 9.01 (< 0.001) 0.33 0.04 7.63 (< 0.001)
Organisational change 0.70 0.58 –1.20 (0.240) 0.56 0.64 –0.87 (0.385)
Gender –0.15 0.50 –0.31 (0.759) –0.01 0.52 –0.02 (0.982)
Number of beds
40–49 1.02 0.53 1.94 (0.060) 0.94 0.60 1.57 (0.117)
≥ 50 1.09 0.73 1.50 (0.144) 0.39 0.77 0.51 (0.612)
Home type
Private 0.54 0.90 0.60 (0.553) 0.83 0.96 0.87 (0.386)
Private (with nursing) 0.64 1.12 0.57 (0.572) 1.17 1.22 0.96 (0.337)
Voluntary/charity 0.34 0.91 0.37 (0.712) 0.45 0.98 0.46 (0.645)
Proportion of residents with a CBS incidence score of > 10
≥ 0.4 0.01 0.69 0.01 (0.992) 0.16 0.77 0.20 (0.839)
Age –0.01 0.03 –0.54 (0.591) –0.02 0.03 –0.60 (0.547)
Length between baseline and follow-up (days) 0.001 0.006 0.17 (0.863) –0.001 0.006 –0.23 (0.821)
TABLE 77 The ResCare trial: hospital inpatient days model 1 results
Descriptive
Results
β SE t (p-value)
Number of champions –0.13 0.38 –0.34 (0.736)
Proportion of action plans/CB residents –0.84 1.43 –0.59 (0.564)
Baseline inpatient days 0.03 0.06 0.42 (0.678)
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TABLE 78 The ResCare trial: hospital inpatient days model 2 results
Descriptive
Results
β SE t (p-value)
Champions –0.25 0.48 –0.53 (0.601)
Proportion of action plans/CB residents –1.29 1.71 –0.76 (0.460)
Baseline inpatient days 0.03 0.06 0.42 (0.677)
Organisational change 0.28 0.59 0.47 (0.644)
Gender –0.17 0.37 –0.46 (0.648)
Number of beds
Medium (40–49) –0.64 0.53 –1.21 (0.240)
Large (≥ 50) –0.56 0.74 –0.76 (0.457)
Home type
Private –1.25 0.89 –1.41 (0.176)
Private (with nursing) –1.59 1.12 –1.41 (0.174)
Voluntary/charity –1.41 0.91 –1.54 (0.140)
Proportion of residents with a CBS incidence score of > 10
≥ 0.4 –0.88 0.69 –1.27 (0.223)
Age 0.02 0.02 0.80 (0.427)
Length between baseline and follow-up (days) –0.002 0.006 –0.32 (0.754)
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Appendix 10 The ResCare trial: analysis of
residents with inpatient stays
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FIGURE 17 The ResCare trial: box dot plot of NPI frequency by categories of inpatient stays.
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FIGURE 18 The ResCare trial: box dot plot of NPI severity by categories of inpatient stays.
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FIGURE 19 The ResCare trial: box dot plot of CBS frequency × difficulty by categories of inpatient stays.
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FIGURE 20 The ResCare trial: box dot plot of total inpatient cost by categories of inpatient stays. Note that
1028005 is the ID of an outlier.
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FIGURE 21 The ResCare trial: box dot plot of follow-up medication cost by categories of inpatient stays.
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Appendix 11 The ResCare trial: breakdown of
resource use and costs in the 4 months up to
follow-up
TABLE 79 The ResCare trial: resource use and costs in the 4 months up to follow-up
Service
Group, mean (SD)
Mean difference (£)
(intervention – control)
(95% CI bootstrapped)
Control (n= 226) Intervention (n= 202)
Frequencya Cost (£) Frequencya Cost (£)
District nurse 32.64 (68.35) 38.06 (79.74) 41.44 (105.47) 48.34 (123.05) 10.28
GP 39.80 (57.38) 186.47 (269.40) 37.97 (46.50) 177.79 (218.36) –8.68
Practice nurse 1.86 (10.29) 1.64 (9.09) 1.83 (12.33) 1.62 (10.89) –0.02
Community
psychiatrist
0.46 (6.07) 2.24 (29.21) 0.15 (2.11) 0.72 (10.17) –1.52
Psychologist 0.93 (12.13) 2.11 (27.49) 0.47 (5.72) 1.07 (12.97) –1.04
CMHN/CMHT 4.87 (18.94) 4.30 (16.73) 1.56 (7.05) 1.38 (6.22) –2.92
Physiotherapist 1.37 (8.62) 0.75 (4.74) 6.61 (33.84) 3.64 (18.61) 2.89
Occupational
health therapist
0.62 (4.77) 0.34 (2.62) 1.19 (8.56) 0.65 (4.71) 0.31
Chiropodist 17.94 (22.53) 8.97 (11.27) 25.23 (28.96) 12.61 (14.48) 3.64
Dietitian 4.69 (14.03) 2.66 (7.95) 6.13 (17.44) 3.47 (9.88) 0.81
Optician 3.69 (10.02) 3.11 (7.91) 3.66 (10.37) 3.17 (8.54) 0.06
Dentist 1.06 (10.56) 0.67 (5.80) 2.28 (13.67) 2.00 (11.94) 1.33
Social worker 1.70 (8.67) 2.10 (10.69) 1.81 (9.53) 2.24 (11.76) 0.14
Speech and
language
therapist
0.62 (4.28) 0.34 (2.35) 0.99 (6.77) 0.55 (3.72) 0.21
Specialist nurse 0.27 (2.82) 0.31 (3.29) 0.45 (3.00) 0.52 (3.50) 0.21
Falls team 0.22 (2.39) 0.15 (1.66) 0.50 (2.91) 0.34 (2.01) 0.19
Emergency care
practitioner
2.65 (13.03) 3.10 (15.20) 3.00 (13.57) 3.49 (15.83) 0.39
Otherb 0.66 (5.96) 0.60 (5.52) 2.60 (12.54) 14.11 (63.10) 13.51
Primary care
total
116.06 (119.12) 257.92 (310.16) 137.84 (151.21) 277.89 (302.22) 19.97 (–39.22 to 81.38)
Surgical
inpatient
0 0 0.02 (0.35) 22.75 (323.30) 22.75
Medical
inpatient
0.55 (3.74) 508.30 (3436.32) 0.25 (1.33) 227.48 (1218.96) –280.82
Other inpatient 0.15 (0.92) 138.26 (846.47) 0.10 (0.80) 95.54 (735.71) –42.72
Outpatient 0.10 (0.33) 2.92 (9.77) 0.09 (0.37) 2.82 (11.04) –0.10
continued
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TABLE 79 The ResCare trial: resource use and costs in the 4 months up to follow-up (continued )
Service
Group, mean (SD)
Mean difference (£)
(intervention – control)
(95% CI bootstrapped)
Control (n= 226) Intervention (n= 202)
Frequencya Cost (£) Frequencya Cost (£)
Day case 0.00 (0.07) 0.61 (9.18) 0.02 (0.14) 2.73 (19.27) 2.12
A&E 0.15 (0.49) 13.29 (44.66) 0.10 (0.34) 10.76 (41.64) –2.53
Secondary care
total
0.95 (4.05) 663.37 (3634.81) 0.59 (1.81) 362.08 (1544.66) –301.29 (–924.05 to 160.61)
Medication
total
7.47 (3.84) 384.21 (655.88) 7.87 (4.06) 334.88 (386.97) –49.33 (–153.39 to 51.60)
Total service use 1305.51 (3752.74) 974.85 (1601.40) –330.66 (–926.87 to 272.10)
a Frequency denotes minutes for primary care services, number of prescriptions for medication, number of days for
inpatient services, and number of visits for outpatient services and A&E.
b Other consists of care managers, paramedics and safeguarding.
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Appendix 12 The FamCare study: ethical
permissions
Prior to approval (April 2009)
The REC requested that we address the following:
l a change in the title of the consultee form
l the addition of a separate information leaflet and consent form for carers as participants, rather than it
being combined with the consultee information
l a change to some of the language in the information leaflets to be more neutral
l an extension of the time period given between the provision of information and the taking of consent
to 1 week rather than 1 day (this was returned to the original 24 hours, following application – and
approval – in a subsequent amendment).
Final approval (May 2009)
l This was following alterations to the protocol as requested above by the REC.
Amendments (February 2010–October 2011)
During the study, approval was sought and gained for a number of additional amendments as
listed below.
l In February 2010, a request was made and approved to return to the original proposal of participants
having 24 hours to consider taking part.
l In June 2010, a request was made to:
¢ obtain the consent of cluster gatekeepers (CMHTOP manager) rather than individual CMHTOP
staff, with the consent of people with dementia and their carers remaining the same; this was
because the pragmatic CRT was designed to test the experimental intervention in a random sample
of CMHTsOP stratified by NHS organisation, thus this was an improved process reflecting the
CMHTOP rather than individual practitioners, and also facilitated engagement with governance
requirements of some participating NHS organisations
¢ add the ICECAP-O Index of Capability;257 the purpose of the ICECAP-O questionnaire was to test
alternative hypotheses concerning the quality of life of both people with dementia and their carers
¢ to remove the SF-12, as the EQ-5D was already included in the study and so the SF-12 was no
longer felt to be necessary.
These requests were approved in July 2010.
l In March 2011, a request was made and approved to change the named principal investigator at
one site.
l In October 2011, as a result of slow recruitment between August 2010 and September 2011, and our
consequent inability to conduct the planned pilot study, a request was made and approved (protocol
version 7.0) to change a large number of aspects of the study.
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l In July 2012, because of ongoing delays to recruitment and the view that completion was unlikely
within our time scale, a site visit by the funders recommended that we discontinued the FamCare study
as an intervention trial and altered the design to that of an observational cohort study. To achieve this,
we designed a cohort study and submitted this with an analysis plan to the NIHR funders. We used
some, but not all, changes that had been approved in October 2011 (protocol version 7.0).
These were:
¢ alteration of the study design so it was no longer a pragmatic cluster RCT
¢ collection of data retrospectively from NHS organisation patient administration systems about the
number of contacts with mental health professionals over the 6-month period in which participants
were in the study
¢ revision of the data analysis to take account of the change in study design; for example, multilevel
modelling was no longer appropriate
¢ use of the term ‘therapist’ in study documentation as a result of the move in some organisations
towards generic mental health therapists or practitioners rather than staff specifically known by
their professional registration
¢ withdrawal of one NHS trust, to now include six NHS organisations and 28 CMHTsOP.
Final amendment: following National Institute for Health Research
funder review of this study (October 2013)
The REC approved this final change to the protocol. It was now described as a naturalistic cohort study
entitled ‘Challenge FamCare: a study of people with dementia and CBs living at home; and their carers’.
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Appendix 13 The FamCare study: reasons for
declining participation
The researchers recorded reasons for why 83 of the 99 (83.8%) potential participants declined (Box 10):32% stated ‘not enough time to participate/too busy’, 19% stated ‘just don’t want to take part’ and
11% stated ‘too stressed/anxious’.
Additional researcher notes were recorded for 56 potential participants who declined, which allowed an
in-depth qualitative perusal of why some people felt unable to participate in the study. Anonymised
examples from the notes taken for this group are noted below. These are people who would have
potentially been eligible for the CRT of the intervention for CB (see Appendix 2), had they not declined to
participate. Not all 56 responses documented by researchers are included below, as some addressed similar
issues and others did not provide enough detail to be described. Two types of circumstances appeared to
affect carer engagement in this research study which was designed to help them manage distress and CB
in dementia: first, their own psychological state, including their distress anxiety and perceived burden; and,
second, the complexities of their understandings and current circumstances. These are outlined next.
Distress, anxiety and perceived time burden: examples from
researcher notes
Patient diagnosed with vascular dementia by neurologist, currently experiencing an episode of high
anxiety and depression, gets anxious about her forgetting – carer called CMHN to say they just don’t
want anything else at the moment.
BOX 10 Reasons declined to take part in the FamCare study (n= 99)
Not enough time to participate/too busy, n = 32.
Just do not want to take part, n = 19.
Too stressed/anxious, n = 11.
Do not like research, n = 5.
Unable to contact, n = 5.
Do not like answering questions, n = 4.
Family querying diagnosis, n = 4.
Illness, n = 3.
Declined, reason not specified, n = 16.
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Very challenging – been very verbally and physically aggressive towards wife, has not been aggressive
to nurses, presentation fluctuates, major hallucinations, dizziness, query mixed dementia/Lewy, wife
very down – carer felt that they had too much going on at the moment s/he did not feel s/he wanted
to take part. (Researcher suggested that s/he calls the CMHN for help after this phone call.)
Couple have had a lot of medical matters to sort recently (physiotherapy, hospital visits etc.) and feel
they would not have time to participate.
CMHN offered social services; not wanting social services; carer feels that s/he has enough going on at
the minute and therefore does not have the time to take part.
Daughter is too stressed due to mother’s cognitive impairment and father going through chemotherapy
for cancer.
Person with dementia worried s/he will be taken into a home – refused to let us visit. Daughter very
restricted on time.
Wife quite stressed, Vascular Dementia – diagnosed 3 years ago. Appeared stressed due to current
family circumstances; including own illness, husband’s memory problems and her brother’s deteriorating
physical health. Wife stated that she ‘wished she didn’t have to do it [the research]’ due to current
stresses within the family. Researcher reassured carer that she did not have to take part.
Carer felt it was too much as she is unwell too.
Carer said she did not want to talk about her feelings she wanted ‘some action’.
Complexities of understandings and circumstances: examples
from researcher notes
Carer thinks no diagnosis as yet but wanting a diagnosis and medication. Patient has expressive and
receptive dysphasia and dyspraxia; gets very frustrated. CMHN says diagnosis has been given and
CMHN due next visit in 3 weeks. Carer reports too busy with family matters so feels they don’t have
the time to participate.
Carer tells me that problems relate to alcohol and not dementia.
Person does not believe he has dementia. Carer does not want to take part in research as may upset them.
Carer felt that she was struggling coming to terms with diagnosis, too many people wanting to visit at
current time.
Living with daughter at the moment – person not accepted memory problems – do not mention
dementia. Carer has a lot going on at the moment.
Carer requested contact be made through daughter to arrange interview. Spoke to her and
appointments with CMHTOP cancelled, as patient has been put on meds for heart and is now 90%
improved, so psychiatry not considered necessary.
Carer phoned researcher to cancel appointment – said waiting to see psychologist first and agreed to
discuss again in a month; CMHN said that after they have seen psychiatrist s/he would call and let us
know if they want to take part in research. Status update after 1 month: currently they have a lot
going on, son is unwell with heart condition, and still not seen the psychiatrist.
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Psychiatrist exploring medication options with patient and carer; CMHN due to go back in a month’s
time. Patient is currently trying new medication and things up in the air at the moment.
Telephone call from carer – person with dementia to go into a care home when s/he leaves hospital.
One daughter has no transport. Other daughter away; awaiting contact from her sister on arrival back
from holiday. They called – a message was left informing us that they did not wish to take part.
Carer works full time and has various other commitments and would not have the time to commit to
the study.
Wife very distressed, may appear quite forgetful herself. Participant has very poor literacy skills. This
case will be discussed in multi-disciplinary team meeting in 2 weeks. Called to see if interested in
taking part – carer reported that she was still not sure and wouldn’t like to say no or yes. Carer very
unwell – chronic obstructive pulmonary disease.
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
253

Appendix 14 The FamCare study: results of the
backward regression analysis (using the data set after
the 25% missing rule for predictors of change)
TABLE 80 The FamCare study: selected model using general linear regression with backward regression analysis on
RMBPC frequency
Descriptive
After 25% missing rule
Regression coefficient SE 95% CI
Carer’s gender –3.59 1.96 –7.43 to 0.25
RMBPC reaction 0.28 0.11 0.06 to 0.50
NPI total –0.21 0.08 –0.37 to –0.05
EQ-5D VAS (participant) –0.10 0.06 –0.22 to 0.02
Notes
The carer’s gender was selected in four of the five imputed data sets.
No common model could be selected for all five imputed data sets.
TABLE 81 The FamCare study: selected model using general linear regression with backward regression analysis on
RMBPC reaction
Descriptive
After 25% missing rule
Regression coefficient SE 95% CI
Carer’s gender –4.67 2.26 –9.10 to –0.24
Living together –5.79 2.53 –10.75 to –0.83
RMBPC frequency 0.46 0.14 0.19 to 0.73
NPI total –0.21 0.09 –0.39 to –0.03
Note
No common model could be selected for all five imputed data sets.
TABLE 82 The FamCare study: selected model using general linear regression with backward regression analysis on
NPI total score (frequency × severity)
Descriptive
After 25% missing rule
Regression coefficient SE 95% CI
Carer’s gender –9.73 3.59 –16.77 to –2.69
RMBPC incidence 2.17 1.07 0.07 to 4.27
RMBPC frequency –0.86 0.33 –1.51 to –0.21
GS 1.22 0.42 0.40 to 2.04
Notes
The carer’s gender was selected in all five imputed data sets.
No other variables were consistently selected across the five imputed data sets.
DOI: 10.3310/pgfar05150 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 15
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Moniz-Cook et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
255
TABLE 83 The FamCare study: selected model using general linear regression with backward regression analysis on
NPI distress
Descriptive
After 25% missing rule
Regression coefficient SE 95% CI
Carer’s gender –5.30 1.81 –8.85 to –1.75
NPI incidence 0.68 0.34 0.01 to 1.35
NPID distress –0.33 0.14 –0.60 to –0.06
GS 0.60 0.21 0.19 to 1.01
Notes
The carer’s gender was selected in all five imputed data sets.
No other variables were consistently selected across the five imputed data sets.
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Appendix 15 The FamCare study service use
frequencies and costs for participants with data
recorded at all time points
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TABLE 90 The FamCare study: day care use for the 3 months before baseline – person with dementia only (n= 114)
Service n (%)
Day care use
Frequency Cost (£)
Total (minimum–
maximum) Mean (SD)
Total (minimum–
maximum) Mean (SD)
Day care: local authority 13 (11.4) 196 (0–40) 1.72 (6.38) 7840 (0–1600) 68.77 (225.35)
Day care: voluntary 5 (4.4) 70 (0–32) 0.61 (3.81) 1260 (0–576) 11.05 (68.59)
Day care: NHS (not hospital) 5 (4.4) 56 (0–24) 0.49 (2.78) 2240 (0–960) 19.65 (111.02)
Lunch club 5 (4.4) 39 (0–20) 0.34 (2.20) 124 (0–63) 1.08 (6.98)
Social club 10 (8.8) 77 (0–12) 0.68 (2.61) 244 (0–38) 2.14 (8.27)
Total 34 (29.8) 438 (0–40) 3.84 (8.4) 11,708 (0–1600) 102.70 (278.20)
TABLE 91 The FamCare study: day care use for the 2 months between baseline and first follow-up – person with
dementia only (n= 114)
Service n (%)
Day care use
Frequency Cost (£)
Total (minimum–
maximum) Mean (SD)
Total (minimum–
maximum) Mean (SD)
Day care: local authority 13 (11.4) 204 (0–24) 1.79 (5.58) 8160 (0–960) 71.58 (223.34)
Day care: voluntary 8 (7.0) 59 (0–16) 0.52 (2.42) 1062 (0–288) 9.32 (43.52)
Day care: NHS (not hospital) 2 (1.8) 22 (0–16) 0.19 (1.60) 880 (0–640) 7.72 (63.83)
Lunch club 4 (3.5) 18 (0–12) 0.16 (1.16) 57 (0–38) 0.50 (3.69)
Social club 7 (6.1) 74 (0–24) 0.65 (3.04) 235 (0–76) 2.06 (9.63)
Total 33 (28.9) 377 (0–36) 3.31 (6.94) 10,394 (0–960) 91.17 (230.09)
TABLE 92 The FamCare study: day care use for the 4 months between first and second follow-up – person with
dementia only (n= 114)
Service n (%)
Day care use
Frequency Cost (£)
Total (minimum–
maximum) Mean (SD)
Total (minimum–
maximum) Mean (SD)
Day care: local authority 19 (16.7) 428 (0–64) 3.79 (11.78) 17,680 (0–2560) 155.09 (470.68)
Day care: voluntary 3 (2.6) 58 (0–32) 0.51 (3.73) 1044 (0–576) 9.16 (67.19)
Day care: NHS (not hospital) 3 (2.6) 12 (0–6) 0.10 (0.70) 480 (0–240) 4.21 (27.84)
Lunch club 5 (4.4) 24 (0–8) 0.21 (1.14) 76 (0–25) 0.67 (3.61)
Social club 6 (5.3) 126 (0–36) 1.11 (5.46) 399 (0–114) 3.50 (17.31)
Total 35 (30.7) 662 (0–64) 5.81 (13.01) 19,680 (0–2560) 172.63 (470.96)
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TABLE 102 The FamCare study: day care use for the 3 months before baseline – person with dementia
only (n= 157)
Service n (%)
Day care use
Frequency Cost (£)
Total (minimum–
maximum) Mean (SD)
Total (minimum–
maximum) Mean (SD)
Day care: local authority 19 (12.1) 235 (0–40) 1.50 (5.63) 9400 (0–1600) 59.87 (225.17)
Day care: voluntary 7 (4.5) 100 (0–32) 0.64 (3.66) 1800 (0–576) 11.46 (65.86)
Day care: NHS (not hospital) 5 (3.2) 56 (0–24) 0.36 (2.37) 2240 (0–960) 14.27 (94.90)
Lunch club 7 (4.5) 69 (0–20) 0.44 (2.53) 219 (0–63) 1.39 (8.02)
Social club 12 (7.6) 104 (0–26) 0.66 (3.03) 330 (0–82) 2.10 (9.59)
Total 44 (28.0) 564 (0–44) 3.59 (8.36) 13,988 (0–1600) 89.10 (246.20)
TABLE 103 The FamCare study: day care use for the 2 months between baseline and first follow-up – person with
dementia only (n= 126)
Service n (%)
Day care use
Frequency Cost (£)
Total (minimum–
maximum) Mean (SD)
Total (minimum–
maximum) Mean (SD)
Day care: local authority 15 (11.9) 212 (0–24) 1.68 (5.35) 8480 (0–960) 67.30 (213.81)
Day care: voluntary 9 (7.1) 67 (0–16) 0.53 (2.40) 1206 (0–288) 9.57 (43.18)
Day care: NHS (not hospital) 2 (1.6) 22 (0–16) 0.17 (1.52) 880 (0–640) 6.98 (60.73)
Lunch club 5 (4.0) 34 (0–16) 0.27 (1.80) 108 (0–51) 0.86 (5.69)
Social club 8 (6.3) 75 (0–24) 0.60 (2.90) 295 (0–76) 2.34 (10.40)
Total 39 (31.0) 428 (0–36) 3.40 (6.88) 10,969 (0–960) 87.05 (220.29)
TABLE 104 The FamCare study: day care use for the 4 months between first and second follow-up – person with
dementia only (n= 117)
Service n (%)
Day care use
Frequency Cost (£)
Total (minimum–
maximum) Mean (SD)
Total (minimum–
maximum) Mean (SD)
Day care: local authority 20 (17.1) 460 (0–64) 3.97 (11.93) 18,960 (0–2560) 162.05 (476.53)
Day care: voluntary 3 (2.6) 58 (0–32) 0.50 (3.69) 1044 (0–576) 8.92 (66.33)
Day care: NHS (not hospital) 3 (2.6) 12 (0–6) 0.10 (0.69) 480 (0–240) 4.10 (27.49)
Lunch club 5 (4.3) 24 (0–8) 0.21 (1.13) 76 (0–25) 0.65 (3.57)
Social club 6 (5.1) 126 (0–36) 1.08 (5.39) 399 (0–114) 3.41 (17.09)
Total 36 (30.8) 694 (0–64) 5.93 (13.09) 20,960 (0–2560) 179.14 (476.56)
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Appendix 17 The FamCare study: mean monthly
frequencies of health- and social-care contacts for
participants with data recorded at all time points
TABLE 108 The FamCare study: health- and social-care contacts – person with dementia (n= 114)
Service
Time point, mean frequencya (SD)
Baseline First follow-up Second follow-up
District nurse 0.20 (0.82) 0.25 (0.78) 0.47 (3.05)
GP 0.67 (0.76) 0.40 (0.78) 0.44 (0.68)
Practice nurse 0.27 (0.50) 0.22 (0.41) 0.15 (0.27)
Health visitor 0.02 (0.11) 0 0.06 (0.13)
Chiropodist 0.12 (0.22) 0.12 (0.25) 0.12 (0.23)
Dietitian 0.01 (0.04) 0.02 (0.08) 0.01 (0.04)
Physiotherapist 0.06 (0.48) 0.10 (0.54) 0.31 (2.82)
OT 0.07 (0.21) 0.05 (0.17) 0.04 (0.17)
Community care excluding mental health 1.40 (1.62) 1.14 (1.45) 1.58 (4.27)
Community psychiatrist 0.11 (0.40) 0.11 (0.25) 0.01 (0.04)
Psychologist 0.02 (0.09) 0.05 (0.21) 0.01 (0.09)
Counsellor 0 0 0
CMHT/rapid response/admiral nursing 0.45 (0.62) 0.43 (0.70) 0.35 (0.98)
Community mental health services 0.57 (0.73) 0.58 (0.75) 0.37 (0.98)
Care manager 0.01 (0.10) 0.04 (0.29) 0.01 (0.09)
Social worker 0.09 (0.21) 0.13 (0.36) 0.07 (0.25)
Home care worker 2.72 (12.69) 2.65 (10.50) 5.52 (17.80)
Care attendant 0.75 (4.20) 0.80 (3.87) 0.99 (5.22)
Sitting service 0.12 (0.83) 0.28 (1.57) 0.10 (0.79)
Carer support worker 0.01 (0.07) 0.78 (7.87) 0.06 (0.56)
Day care: local authority 0.57 (2.13) 0.90 (2.79) 0.95 (2.95)
Day care: voluntary 0.20 (1.27) 0.26 (1.21) 0.13 (0.93)
Day care: NHS (not hospital) 0.16 (0.93) 0.10 (0.80) 0.03 (0.18)
Lunch club 0.11 (0.73) 0.08 (0.58) 0.05 (0.29)
Social club 0.23 (0.87) 0.33 (1.52) 0.28 (1.37)
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TABLE 108 The FamCare study: health- and social-care contacts – person with dementia (n= 114) (continued )
Service
Time point, mean frequencya (SD)
Baseline First follow-up Second follow-up
Social services, including day care 4.99 (13.59) 6.30 (14.83) 8.19 (18.83)
Dentist 0.09 (0.27) 0.08 (0.19) 0.07 (0.15)
Optician 0.07 (0.17) 0.05 (0.15) 0.05 (0.13)
Other 0.11 (0.56) 0.03 (0.13) 0
Meals on Wheels 0.36 (2.87) 0.25 (2.62) 0.20 (1.98)
Other 0.63 (2.95) 0.39 (2.62) 0.32 (1.97)
Assessment/rehabilitation inpatient 0.09 (0.68) 0.04 (0.15) 0.02 (0.10)
Continuing care/respite inpatient 0.00 (0.03) 0.32 (2.72) 0.02 (0.17)
Medical inpatient 0.12 (0.63) 0.08 (0.75) 0.07 (0.52)
Other inpatient 0.06 (0.49) 0 0.07 (0.44)
Outpatient 0.21 (0.72) 0.14 (0.33) 0.17 (0.67)
Day case 0.06 (0.48) 0.09 (0.44) 0.04 (0.33)
A&E 0.05 (0.48) 0.02 (0.12) 0.04 (0.12)
Hospital services 0.59 (1.39) 0.70 (2.87) 0.83 (2.19)
Mean monthly service use 8.19 (15.69) 9.13 (15.20) 10.87 (19.65)
OT, occupational therapist.
a Frequency denotes visits, apart from inpatient services where it is the number of days.
TABLE 109 The FamCare study: health- and social-care contacts – carer (n= 114)
Service
Time point, mean frequencya (SD)
Baseline First follow-up Second follow-up
District nurse 0.02 (0.16) 0.05 (0.20) 0.03 (0.15)
GP 0.34 (0.44) 0.29 (0.43) 0.30 (0.54)
Practice nurse 0.11 (0.22) 0.12 (0.26) 0.11 (0.22)
Health visitor 0 0 0
Chiropodist 0.04 (0.19) 0.06 (0.18) 0.04 (0.15)
Dietitian 0.02 (0.19) 0 0.01 (0.03)
Physiotherapist 0.01 (0.08) 0.04 (0.16) 0.06 (0.39)
OT 0.01 (0.10) 0 0.01 (0.05)
Community care excluding mental health 0.55 (0.64) 0.54 (0.70) 0.53 (0.87)
Community psychiatrist 0 0 0
Psychologist 0.03 (0.21) 0.01 (0.05) 0.00 (0.02)
Counsellor 0 0 0.03 (0.33)
CMHT/rapid response/admiral nursing 0.02 (0.13) 0.02 (0.16) 0.04 (0.22)
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TABLE 109 The FamCare study: health- and social-care contacts – carer (n= 114) (continued )
Service
Time point, mean frequencya (SD)
Baseline First follow-up Second follow-up
Community mental health services 0.04 (0.24) 0.03 (0.16) 0.07 (0.39)
Care manager 0 0.02 (0.12) 0
Social worker 0.02 (0.14) 0.03 (0.21) 0.01 (0.05)
Home care worker 0.07 (0.75) 0 0.03 (0.33)
Care attendant 0 0 0
Sitting service 0 0 0
Carer support worker 0.01 (0.04) 0.04 (0.38) 0
Day care: local authority – – –
Day care: voluntary – – –
Day care: NHS (not hospital) – – –
Lunch club – – –
Social club – – –
Social services, including day care 0.10 (0.79) 0.09 (0.55) 0.04 (0.33)
Dentist 0.10 (0.22) 0.36 (0.31) 0.08 (0.16)
Optician 0.04 (0.11) 0.07 (0.26) 0.03 (0.09)
Other 0.01 (0.09) 0.05 (0.23) 0.01 (0.08)
Meals on Wheels 0 0 0
Other 0.14 (0.26) 0.22 (0.44) 0.11 (0.21)
Assessment/rehabilitation inpatient 0.00 (0.03) 0.02 (0.12) 0.02 (0.07)
Continuing care/respite inpatient 0 0.01 (0.05) 0
Medical inpatient 0.04 (0.24) 0.02 (0.19) 0.08 (0.48)
Other inpatient 0.01 (0.09) 0 0.02 (0.17)
Outpatient 0.10 (0.26) 0.13 (0.73) 0.15 (0.72)
Day case 0.02 (0.09) 0.01 (0.05) 0.01 (0.03)
A&E 0.02 (0.10) 0.05 (0.47) 0.01 (0.05)
Hospital services 0.18 (0.38) 0.23 (0.89) 0.28 (0.91)
Mean monthly service use 1.03 (1.32) 1.10 (1.69) 1.04 (1.52)
OT, occupational therapist.
a Frequency denotes visits, apart from inpatient services where it is the number of days.
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Appendix 18 The FamCare study: alternative
accommodation
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Appendix 19 The FamCare study: medication
prescribing for people with dementia in the 3 months
before baseline (whole sample)
TABLE 111 The FamCare study: medication prescribing in the 3 months before baseline – person with
dementia (n= 157)
Category
Number of
Mean (SD) number
of prescriptions
per participant
Cost (£)
Prescriptions Participants (%) Total
Mean (SD) per
participant
Antipsychotics
Atypical antipsychotic 13 12 (7.6) 0.08 (0.30) 544.30 3.47 (17.32)
Typical antipsychotic 2 2 (1.3) 0.01 (0.11) 51.11 0.33 (2.91)
Hypnotics and anxiolytics
B/Z/A drug 10 9 (5.7) 0.06 (0.27) 89.75 0.57 (2.70)
Non-B/Z/A drug 1 1 (0.6) 0.01 (0.08) 57.86 0.37 (4.62)
Antidepressants
SSRI 18 18 (11.5) 0.11 (0.32) 300.19 1.91 (6.69)
Tricyclic 10 10 (6.4) 0.06 (0.24) 211.84 1.35 (12.12)
Other 9 8 (5.1) 0.06 (0.26) 65.66 0.42 (1.88)
Anticonvulsants 3 3 (1.9) 0.02 (0.14) 46.76 0.30 (2.27)
Dementia drugs
Acetylcholinesterase
inhibitors
45 44 (28) 0.29 (0.47) 10,542.48 67.15 (115.67)
Cognitive enhancers 4 4 (2.5) 0.03 (0.16) 847.82 5.40 (41.31)
Pain relief
Opioida 20 16 (10.2) 0.13 (0.42) 1782 11.35 (81.50)
Non-opioid 23 23 (14.6) 0.15 (0.35) 192.54 1.23 (3.76)
Laxatives 15 12 (7.6) 0.10 (0.35) 172.02 1.10 (4.99)
Otherb 647 142 (90.5) 4.12 (3.02) 14,344.45 91.37 (145.99)
No medication 7 (4.5)
Total 820 – 5.22 (3.30) 29,248.77 186.30 (196.05)
a Co-codamol is listed under opioid.
b All other medication categories are not of specific interest.
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Appendix 20 Comparisons of the ResCare trial
and the FamCare study
TABLE 112 The ResCare trial and FamCare study: dementia rating (CDR score)
CDR score
Time point, %
Baseline Follow-up
ResCare CB group
(n= 555) FamCare (n= 157)
ResCare CB group
(n= 428) FamCare (n= 109)a
0: no cognitive impairment 0.7 3.2 0.2 5.5
0.5: very mild dementia 3.3 22.3 4.48 16.5
1: mild 15.9 37.6 14.9 35.8
2: moderate 30.6 28.0 23.8 25.7
3: severe 49.5 8.9 56.6 16.5
a CDR data for eight people in FamCare at follow-up were excluded because of a suspected interviewer error.
TABLE 113 The ResCare trial and FamCare study: NPI scores
NPI
Time point, mean score (SD; range)
Baseline Follow-up
ResCare CB group
(n= 555) FamCare (n= 157)
ResCare CB group
(n= 428) FamCare (n= 117)
Incidence 4.83 (2.37; 0–12) 5.35 (2.65; 0–11) 4.64 (2.3; 0–12) 5.30 (2.85; 0–11)
Frequency 12.38 (7.3; 0–36) 14.05 (8.32; 0–34) 11.6 (6.69; 0–32) 13.11 (8.41; 0–38)
Severity 7.76 (4.83; 0–23) 9.12 (5.73; 0–27) 7.19 (4.48; 0–26) 8.96 (6.04; 0–26)
Total (frequency × severity) 21.14 (15.96; 0–84) 25.75 (19.17; 0–94) 19.08 (14; 0–87) 24.21 (19.42; 0–89)
Distress 4.80 (6.56; 0–38) 13.37 (9.65; 0–48) 3.34 (5.23; 0–36) 12.37(9.31; 0–39)
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FIGURE 22 The ResCare trial and FamCare study: incidence of NPI behaviours at baseline.
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